Eomesodermin    O
/    O
Tbr2    O
is    O
highly    O
expressed    O
in    O
CD8+    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
but    O
not    O
CD4+    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
.    O

SCID    O
involves    O
defective    O
antibody    O
response    O
due    O
to    O
either    O
direct    O
involvement    O
with    O
B    B-Cell102991711
lymphocytes    I-Cell102991711
or    O
through    O
improper    O
B    O
lymphocyte    O
activation    O
due    O
to    O
non    O
-    O
functional    O
T-helper    B-Cell102991711
cell    I-Cell102991711
.    O

This    O
relatively    O
newly    O
described    O
group    O
of    O
cells    O
has    O
varying    O
physiological    O
functions    O
;    O
some    O
functions    O
are    O
analogous    O
to    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
while    O
the    O
group    O
also    O
includes    O
cytotoxic    O
NK    B-Cell102991711
cells    I-Cell102991711
.    O

Through    O
several    O
studies    O
,    O
the    O
Th1    B-Cell102991711
and    O
Th2    B-Cell102991711
cytokines    O
and    O
cytokine    O
mRNA    O
are    O
both    O
detectable    O
in    O
tonsillar    O
hypertrophy    O
(    O
or    O
obstructive    O
sleep    O
apnea    O
,    O
OSA    O
)    O
and    O
recurrent    O
tonsillitis    O
groups    O
.    O

There    O
are    O
two    O
major    O
subtypes    O
of    O
T    O
cells    O
:    O
the    O
killer    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
and    O
the    O
helper    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
.    O

Helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
regulate    O
both    O
the    O
innate    O
and    O
adaptive    O
immune    O
responses    O
and    O
help    O
determine    O
which    O
immune    O
responses    O
the    O
body    O
makes    O
to    O
a    O
particular    O
pathogen    O
.    O

In    O
addition    O
to    O
these    O
effects    O
,    O
the    O
milieu    O
of    O
hormones    O
produced    O
at    O
this    O
time    O
(    O
leptin    O
,    O
pituitary    O
growth    O
hormone    O
,    O
and    O
prolactin    O
)    O
support    O
the    O
interactions    O
between    O
APCs    O
and    O
T    O
-    O
cells    O
,    O
a    O
shift    O
of    O
the    O
Th1/Th2    B-Cell102991711
cytokine    O
balance    O
towards    O
one    O
that    O
supports    O
Th1    O
,    O
an    O
increase    O
in    O
overall    O
Th    O
cell    O
proliferation    O
,    O
and    O
naïve    O
T    O
cell    O
migration    O
to    O
lymph    O
nodes    O
.    O

Furthermore    O
,    O
type    O
II    O
interferons    O
are    O
released    O
by    O
T    B-Cell102991711
helper    I-Cell102991711
cell    I-Cell102991711
,    O
type    O
1    O
specifically    O
.    O

However    O
,    O
they    O
block    O
the    O
proliferation    O
of    O
T    B-Cell102991711
helper    I-Cell102991711
cell    I-Cell102991711
type    O
two    O
.    O

The    O
previous    O
results    O
in    O
an    O
inhibition    O
of    O
Th2    B-Cell102991711
immune    O
response    O
and    O
a    O
further    O
induction    O
of    O
Th1    B-Cell102991711
immune    O
response    O
,    O
which    O
leads    O
to    O
the    O
development    O
of    O
debilitating    O
diseases    O
such    O
as    O
multiple    O
sclerosis    O
.    O

Higher    O
MHC    O
II    O
expression    O
increases    O
presentation    O
of    O
viral    O
peptides    O
to    O
helper    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
;    O
these    O
cells    O
release    O
cytokines    O
(    O
such    O
as    O
more    O
interferons    O
and    O
interleukins    O
,    O
among    O
others    O
)    O
that    O
signal    O
to    O
and    O
co    O
-    O
ordinate    O
the    O
activity    O
of    O
other    O
immune    O
cells    O
.    O

Triggering    O
monocytes    O
-    O
expressed    O
PD-1    O
by    O
its    O
ligand    O
PD    O
-    O
L1    O
induces    O
IL-10    O
production    O
which    O
activates    O
CD4    O
Th2    B-Cell102991711
cells    I-Cell102991711
and    O
inhibits    O
CD4    O
Th1    B-Cell102991711
cell    I-Cell102991711
function    O
.    O

Common    O
human    O
diseases    O
such    O
as    O
allergy    O
,    O
autoimmunity    O
,    O
chronic    O
infections    O
and    O
sepsis    O
are    O
characterized    O
by    O
a    O
dysregulation    O
of    O
the    O
pro    O
-    O
inflammatory    O
versus    O
anti    O
-    O
inflammatory    O
and    O
T    B-Cell102991711
helper    I-Cell102991711
(    O
Th1    O
)    O
versus    O
(    O
Th2    O
)    O
cytokine    O
balance    O
.    O

They    O
found    O
consistent    O
stress    O
-    O
related    O
increases    O
in    O
numbers    O
of    O
total    O
white    O
blood    O
cells    O
,    O
as    O
well    O
as    O
decreases    O
in    O
the    O
numbers    O
of    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
suppressor    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
Natural    B-Cell102991711
killer    I-Cell102991711
cells    O
(    O
NK    O
)    O
.    O

Naturalistic    O
stressors    O
were    O
associated    O
with    O
increases    O
in    O
number    O
of    O
circulating    O
neutrophils    O
,    O
decreases    O
in    O
number    O
and    O
percentages    O
of    O
total    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
and    O
decreases    O
in    O
percentages    O
of    O
Natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
(    O
NK    O
)    O
cells    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
lymphocytes    O
.    O

recruits    O
Th2    B-Cell102991711
cells    I-Cell102991711
,    O
eosinophils    O
,    O
and    O
basophils    O
.    O

The    O
immune    O
response    O
in    O
those    O
infected    O
with    O
HIV    O
is    O
typically    O
characterized    O
by    O
cellular    O
signals    O
from    O
Th2    B-Cell102991711
subset    I-Cell102991711
of    I-Cell102991711
CD4+    I-Cell102991711
helper    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
whereas    O
the    O
immune    O
response    O
in    O
psoriasis    O
vulgaris    O
is    O
characterized    O
by    O
a    O
pattern    O
of    O
cellular    O
signals    O
typical    O
of    O
Th1    B-Cell102991711
subset    I-Cell102991711
of    I-Cell102991711
CD4+    I-Cell102991711
helper    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
and    O
Th17    B-Cell102991711
helper    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
.    O

Targeted    O
immunotherapy    O
as    O
well    O
as    O
psoralen    O
and    O
ultraviolet    O
A    O
(    O
PUVA    O
)    O
therapy    O
can    O
reduce    O
the    O
number    O
of    O
dendritic    O
cells    O
and    O
favors    O
a    O
Th2    B-Cell102991711
cell    I-Cell102991711
cytokine    O
secretion    O
pattern    O
over    O
a    O
Th1/Th17    O
cell    O
cytokine    O
profile    O
.    O

When    O
the    O
function    O
of    O
ROS    O
are    O
impaired    O
,    O
there    O
becomes    O
a    O
higher    O
susceptibility    O
to    O
atopic    O
disorders    O
or    O
diseases    O
due    O
to    O
an    O
obstruction    O
of    O
an    O
attack    O
-    O
kill    O
-    O
present    O
-    O
respond    O
methodology    O
utilized    O
by    O
the    O
Th-1    B-Cell102991711
immune    I-Cell102991711
response    I-Cell102991711
chain    I-Cell102991711
.    O

In    O
addition    O
,    O
IL-21    O
expression    O
is    O
up    O
-    O
regulated    O
in    O
Th2    O
and    O
Th17    B-Cell102991711
subsets    O
of    O
T    B-Cell102991711
helper    I-Cell102991711
cell    I-Cell102991711
,    O
as    O
well    O
as    O
T    B-Cell102991711
follicular    I-Cell102991711
cell    I-Cell102991711
.    O

Besides    O
,    O
these    O
mice    O
with    O
impaired    O
IL-21    O
signaling    O
had    O
more    O
dramatic    O
exhaustion    O
of    O
LCMV    O
-    O
specific    O
CD8+    B-Cell102991711
T    B-Cell102991711
cell    I-Cell102991711
,    O
suggesting    O
that    O
IL-21    O
produced    O
by    O
CD4+    B-Cell102991711
T    O
cells    O
is    O
required    O
for    O
sustained    O
CD8    O
+    O
T    O
cell    O
effector    O
activity    O
and    O
then    O
,    O
for    O
maintaining    O
immunity    O
to    O
resolve    O
persistent    O
viral    O
infection    O
.    O

IL33    O
is    O
a    O
ligand    O
for    O
ST2    O
(    O
IL1RL1    O
)    O
,    O
an    O
IL-1    O
family    O
receptor    O
that    O
is    O
highly    O
expressed    O
on    O
Th2    B-Cell102991711
cell    I-Cell102991711
,    O
mast    O
cells    O
and    O
group    O
2    O
innate    O
lymphocytes    O
.    O

IL-33    O
induces    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
mast    O
cells    O
,    O
eosinophils    O
and    O
basophils    O
to    O
produce    O
type    O
2    O
cytokines    O
.    O

As    O
a    O
cytokine    O
,    O
IL-33    O
interacts    O
with    O
the    O
receptors    O
ST2    O
(    O
also    O
known    O
as    O
IL1RL1    O
)    O
and    O
IL-1    O
Receptor    O
Accessory    O
Protein    O
(    O
IL1RAP    O
)    O
,    O
activating    O
intracellular    O
molecules    O
in    O
the    O
NF-κB    O
and    O
MAP    O
kinase    O
signaling    O
pathways    O
that    O
drive    O
production    O
of    O
type    O
2    O
cytokines    O
(    O
e.g.    O
IL-5    O
and    O
IL-13    O
)    O
from    O
polarized    O
Th2    B-Cell102991711
cells    O
.    O

5    O
)    O
It    O
enhances    O
the    O
differentiation    O
of    O
uncommitted    O
T    B-Cell102991711
cell    I-Cell102991711
lymphocytes    O
to    O
the    O
Th1    B-Cell102991711
cell    I-Cell102991711
phenotype    O
and    O
may    O
thereby    O
favor    O
the    O
development    O
of    O
inflammatory    O
rather    O
than    O
allergic    O
responses    O
to    O
immune    O
stimulation    O
in    O
rodents    O
.    O

showed    O
a    O
greatly    O
reduced    O
ability    O
to    O
stimulate    O
the    O
proliferation    O
of    O
T    B-Cell102991711
helper    I-Cell102991711
cell    I-Cell102991711
as    O
well    O
as    O
the    O
ability    O
of    O
these    O
cells    O
to    O
produce    O
pro    O
-    O
allergic    O
cytokines    O
(    O
i.e.    O
IL-5    O
and    O
IL-13)s    O
.    O

Arsenic    O
exposure    O
in    O
small    O
children    O
distorts    O
the    O
ratio    O
of    O
T    B-Cell102991711
helper    I-Cell102991711
cell    I-Cell102991711
(    O
CD4    O
)    O
to    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
(    O
CD8    O
)    O
,    O
which    O
are    O
responsible    O
for    O
immunodepression    O
.    O

Th1    B-Cell102991711
cell    I-Cell102991711
,    O
a    O
type    O
of    O
T    O
helper    O
cells    O

CD4    O
+    O
Th    B-Cell102991711
(T    I-Cell102991711
helper)    I-Cell102991711
cells    I-Cell102991711
:    O
activate    O
and    O
regulate    O
T    O
and    O
B    O
cells    O

CD4    O
+    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
:    O
T    O
cells    O
displaying    O
co    O
-    O
receptor    O
CD4    O
are    O
known    O
as    O
CD4    O
+    O
T    O
cells    O
.    O

MHC    O
class    O
I    O
are    O
found    O
on    O
all    O
cells    O
and    O
stimulate    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
(    O
CD8    O
cells    O
)    O
,    O
and    O
MHC    O
class    O
II    O
are    O
found    O
on    O
APCs    O
and    O
stimulate    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
(    O
CD4    O
cells    O
)    O
.    O

Antidepressants    O
have    O
also    O
been    O
shown    O
to    O
suppress    O
TH1    B-Cell102991711
upregulation    O
.    O

Lymphocytes    O
of    O
specific    O
immunity    O
T    B-Cell102991711
cell    I-Cell102991711
—    O
including    O
the    O
subclasses    O
helper    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
and    O
killer    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
—    O
and    O
B    B-Cell102991711
cell    I-Cell102991711
.    O

The    O
differentiation    O
,    O
induced    O
by    O
γδ    O
T    O
-    O
APC    O
,    O
most    O
often    O
led    O
to    O
T    B-Cell102991711
helper    I-Cell102991711
cell    I-Cell102991711
response    O
,    O
in    O
the    O
most    O
of    O
cases    O
to    O
pro    O
-    O
inflammatory    O
Th1    O
response    O
with    O
subsequent    O
production    O
of    O
IFN-γ    O
and    O
TNF-α.    O

Helper    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711

These    O
cells    O
produce    O
large    O
amounts    O
of    O
TGF    O
beta    O
and    O
other    O
suppressive    O
cytokines    O
,    O
including    O
IL-10    O
,    O
to    O
prevent    O
damage    O
to    O
the    O
eye    O
by    O
reducing    O
inflammation    O
and    O
causing    O
T    O
cells    O
to    O
differentiate    O
to    O
inducible    O
T    O
reg    O
cells    O
.    O
Innate    O
immune    O
stimulation    O
by    O
bacteria    O
and    O
cellular    O
stress    O
is    O
normally    O
suppressed    O
by    O
myeloid    O
suppression    O
while    O
inducible    O
Treg    B-Cell102991711
cells    O
prevent    O
activation    O
and    O
clonal    O
expansion    O
of    O
the    O
autoreactive    O
Th1    B-Cell102991711
and    O
Th17    B-Cell102991711
cells    O
that    O
possess    O
potential    O
to    O
cause    O
damage    O
to    O
the    O
eye    O
.    O

The    O
increased    O
VISTA    O
levels    O
correlated    O
with    O
an    O
increase    O
in    O
immune    O
activation    O
and    O
a    O
decrease    O
in    O
CD4-positive    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
.    O

APCs    O
then    O
present    O
the    O
fragments    O
to    O
T    B-Cell102991711
helper    I-Cell102991711
cells    I-Cell102991711
(    O
CD4    O
+    O
)    O
by    O
the    O
use    O
of    O
class    O
II    O
histocompatibility    O
molecules    O
on    O
their    O
surface    O
.    O

Affinity    O
maturation    O
occurs    O
in    O
mature    O
B    O
cells    O
after    O
V(D)J    O
recombination    O
,    O
and    O
is    O
dependent    O
on    O
help    O
from    O
helper    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
.    O

Antigens    O
from    O
the    O
extracellular    O
space    O
and    O
sometimes    O
also    O
endogenous    O
ones    O
,    O
are    O
enclosed    O
into    O
endocytic    O
vesicles    O
and    O
presented    O
on    O
the    O
cell    O
surface    O
by    O
MHC    O
-    O
II    O
molecules    O
to    O
the    O
helper    O
T    B-Cell102991711
cells    I-Cell102991711
expressing    O
CD4    O
molecule    O
.    O

They    O
discovered    O
that    O
the    O
"    O
smooth    O
"    O
type    O
of    O
"    O
Mycobacterium    O
vaccae    O
"    O
has    O
a    O
substance    O
on    O
the    O
outside    O
of    O
its    O
cell    O
wall    O
which    O
interferes    O
with    O
the    O
production    O
of    O
Th-1    O
cytokines    O
,    O
responsible    O
for    O
some    O
kinds    O
of    O
T-helper    B-Cell102991711
cell    I-Cell102991711
immune    O
response    O
.    O

CXCR3    O
and    O
CCR5    O
are    O
preferentially    O
expressed    O
on    O
Th1    B-Cell102991711
cell    I-Cell102991711
,    O
whereas    O
Th2    O
cells    O
favor    O
the    O
expression    O
of    O
CCR3    O
and    O
CCR4    O
.    O

It    O
significantly    O
reduces    O
replication    O
of    O
HIV-1    O
in    O
cocultures    O
of    O
human    O
dendritic    B-Cell102991711
cell    I-Cell102991711
(    O
DCs    O
)    O
and    O
CD4+    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
,    O
which    O
is    O
due    O
to    O
a    O
rapid    O
secretion    O
of    O
soluble    O
factors    O
and    O
is    O
associated    O
with    O
induction    O
of    O
type    O
-    O
I    O
interferon    O
(    O
IFN    O
)    O
in    O
the    O
human    O
cells    O
.    O

Powrie    O
worked    O
with    O
Don    O
Mason    O
at    O
the    O
Sir    O
William    O
Dunn    O
School    O
of    O
Pathology    O
studying    O
the    O
interactions    O
of    O
different    O
subsets    O
of    O
CD4+    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
in    O
rats    O
.    O

Low    O
natural    O
killer    O
syndrome    O
,    O
a    O
term    O
,    O
used    O
mainly    O
in    O
Japan    O
,    O
reflecting    O
research    O
showing    O
diminished    O
in    O
-    O
vitro    O
activity    O
of    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
(    O
NKs    O
)    O
isolated    O
from    O
patients    O
.    O

The    O
innate    O
leukocytes    O
include    O
the    O
phagocytes    O
(    O
macrophages    O
,    O
neutrophils    O
,    O
and    O
dendritic    B-Cell102991711
cell    I-Cell102991711
)    O
,    O
innate    O
lymphoid    O
cells    O
,    O
mast    O
cells    O
,    O
eosinophils    O
,    O
basophils    O
,    O
and    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
.    O

Natural    O
killer    O
(    O
NK    B-Cell102991711
cells    I-Cell102991711
)    O
cells    O
are    O
leukocytes    O
that    O
attack    O
and    O
destroy    O
tumor    O
cells    O
,    O
or    O
cells    O
that    O
have    O
been    O
infected    O
by    O
viruses    O
.    O

Natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
,    O
or    O
NK    O
cells    O
,    O
are    O
lymphocytes    O
and    O
a    O
component    O
of    O
the    O
innate    O
immune    O
system    O
which    O
does    O
not    O
directly    O
attack    O
invading    O
microbes    O
.    O

IFNs    O
also    O
have    O
various    O
other    O
functions    O
:    O
they    O
activate    O
immune    O
cells    O
,    O
such    O
as    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
and    O
macrophages    O
;    O
they    O
increase    O
host    O
defenses    O
by    O
up    O
-    O
regulating    O
antigen    O
presentation    O
by    O
virtue    O
of    O
increasing    O
the    O
expression    O
of    O
major    O
histocompatibility    O
complex    O
(    O
MHC    O
)    O
antigens    O
.    O

Interferons    O
,    O
such    O
as    O
interferon    O
gamma    O
,    O
directly    O
activate    O
other    O
immune    O
cells    O
,    O
such    O
as    O
macrophages    O
and    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
.    O

They    O
found    O
consistent    O
stress    O
-    O
related    O
increases    O
in    O
numbers    O
of    O
total    O
white    O
blood    O
cells    O
,    O
as    O
well    O
as    O
decreases    O
in    O
the    O
numbers    O
of    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
suppressor    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
Natural    B-Cell102991711
killer    I-Cell102991711
cells    O
(    O
NK    O
)    O
.    O

Naturalistic    O
stressors    O
were    O
associated    O
with    O
increases    O
in    O
number    O
of    O
circulating    O
neutrophils    O
,    O
decreases    O
in    O
number    O
and    O
percentages    O
of    O
total    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
and    O
decreases    O
in    O
percentages    O
of    O
Natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
(    O
NK    O
)    O
cells    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
lymphocytes    O
.    O

Alefacept    O
also    O
blocks    O
the    O
molecules    O
that    O
dendritic    O
cells    O
use    O
to    O
communicate    O
with    O
T    O
cells    O
and    O
even    O
causes    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
to    O
kill    O
T    O
cells    O
as    O
a    O
way    O
of    O
controlling    O
inflammation    O
.    O

CCDC109B    O
is    O
expressed    O
in    O
B-cells    B-Cell102991711
,    O
Dendritic    O
Cells    O
,    O
T-Cells    B-Cell102991711
,    O
and    O
Natural    B-Cell102991711
Killer    I-Cell102991711
Cells    I-Cell102991711
.    O

ZAP-70    O
(    O
Zeta    O
-    O
chain    O
-    O
associated    O
protein    O
kinase    O
70    O
)    O
is    O
a    O
protein    O
normally    O
expressed    O
near    O
the    O
surface    O
membrane    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
.    O

This    O
cytokine    O
induces    O
cell    B-Cell102991711
proliferation    I-Cell102991711
of    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
;    O
cells    O
of    O
the    O
innate    O
immune    O
system    O
whose    O
principal    O
role    O
is    O
to    O
kill    O
virally    O
infected    O
cells    O
.    O

IL-15    O
regulates    O
the    O
activation    O
and    O
proliferation    O
of    O
T    B-Cell102991711
and    O
natural    B-Cell102991711
killer    I-Cell102991711
(    O
NK    O
)    O
cells    O
.    O

After    O
stimulation    O
with    O
IL-18    O
,    O
natural    B-Cell102991711
killer    I-Cell102991711
(    O
NK    O
)    O
cells    O
and    O
certain    O
T    B-Cell102991711
cells    I-Cell102991711
release    O
another    O
important    O
cytokine    O
called    O
interferon-γ    O
(    O
IFN-γ    O
)    O
or    O
type    O
II    O
interferon    O
that    O
plays    O
an    O
important    O
role    O
in    O
activating    O
the    O
macrophages    O
or    O
other    O
cells    O
.    O

Interleukin-21    O
is    O
a    O
cytokine    O
that    O
has    O
potent    O
regulatory    O
effects    O
on    O
cells    O
of    O
the    O
immune    O
system    O
,    O
including    O
natural    B-Cell102991711
killer    I-Cell102991711
(    O
NK    O
)    O
cells    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
that    O
can    O
destroy    O
virally    O
infected    O
or    O
cancerous    O
cells    O
.    O

In    O
addition    O
,    O
there    O
was    O
an    O
increase    O
of    O
perforin    O
,    O
granzyme    O
B    O
,    O
IFN-γ    O
,    O
and    O
CXCR3    O
mRNA    O
in    O
peripheral    O
NK    B-Cell102991711
cell    I-Cell102991711
and    O
CD8    O
+    O
T    B-Cell102991711
cell    I-Cell102991711
.    O

In    O
HIV    O
infected    O
subjects    O
,    O
IL-21    O
has    O
been    O
reported    O
to    O
critically    O
improve    O
the    O
HIV    O
-    O
specific    O
cytotoxic    O
T    O
cell    O
responses    O
and    O
NK    B-Cell102991711
cell    O
functions    O
.    O

Expression    O
of    O
this    O
protein    O
is    O
increased    O
after    O
the    O
activation    O
of    O
T-cell    B-Cell102991711
by    O
mitogens    O
or    O
the    O
activation    O
of    O
NK    B-Cell102991711
cell    I-Cell102991711
by    O
IL-2    O
.    O

More    O
recently    O
it    O
has    O
been    O
shown    O
to    O
be    O
a    O
marker    O
for    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
and    O
a    O
subgroup    O
of    O
Natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
.    O

However    O
,    O
EP2    O
activation    O
also    O
has    O
anti    O
-    O
inflammatory    O
actions    O
on    O
pro    O
-    O
inflammatory    O
cells    O
(    O
e.g.    O
neutrophils    O
,    O
monocytes    O
,    O
macrophages    O
,    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
NK    B-Cell102991711
cell    I-Cell102991711
,    O
TH1    O
cells    O
,    O
TH2    O
cells    O
,    O
and    O
fibroblasts    O
in    O
various    O
tissues    O
and    O
on    O
microglia    O
cells    O
in    O
the    O
central    O
nervous    O
system    O
,    O
.    O

In    O
particular    O
,    O
sheep    O
uterine    O
serpin    O
can    O
inhibit    O
lymphocyte    O
and    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
function    O
in    O
vitro    O
and    O
reduce    O
natural    O
-    O
killer    O
cell    O
mediated    O
abortion    O
in    O
a    O
mouse    O
model    O
.    O

LRC    O
:    O
The    O
Leukocyte    O
Receptor    O
Complex    O
is    O
a    O
family    O
of    O
immunoreceptors    O
expressed    O
predominantly    O
on    O
monocytes    O
and    O
B    O
cells    O
and    O
at    O
lower    O
levels    O
on    O
dendritic    O
cells    O
and    O
natural    O
killer    O
(    O
NK    B-Cell102991711
)    O
cells    O
.    O

Further    O
subtypes    O
can    O
be    O
classified    O
;    O
for    O
example    O
,    O
among    O
lymphocytes    O
,    O
there    O
are    O
B    B-Cell102991711
cell    I-Cell102991711
,    O
T    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
NK    B-Cell102991711
cells    I-Cell102991711
.    O

Natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
:    O
virus    O
-    O
infected    O
and    O
tumor    O
cells    O
.    O

Natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
are    O
able    O
to    O
kill    O
cells    O
of    O
the    O
body    O
that    O
do    O
not    O
display    O
MHC    O
class    O
I    O
molecules    O
,    O
or    O
display    O
stress    O
markers    O
such    O
as    O
MHC    O
class    O
I    O
polypeptide    O
-    O
related    O
sequence    O
A    O
(    O
MIC    O
-    O
A    O
)    O
.    O

The    O
cytotoxicity    O
of    O
Natural    B-Cell102991711
Killer    I-Cell102991711
(    O
NK    O
)    O
cells    O
and    O
the    O
antigen    O
-    O
presenting    O
function    O
of    O
dendritic    O
cells    O
is    O
known    O
to    O
diminish    O
with    O
old    O
age    O
.    O

Senescent    O
hepatic    O
stellate    O
cells    O
have    O
been    O
demonstrated    O
to    O
limit    O
liver    O
fibrosis    O
by    O
activating    O
interactions    O
with    O
NK    B-Cell102991711
cells    I-Cell102991711
.    O

While    O
the    O
exact    O
mechanism    O
is    O
unknown    O
,    O
the    O
net    O
effect    O
is    O
a    O
reduction    O
of    O
T    O
-    O
cell    O
responses    O
and    O
expansion    O
of    O
CD56bright    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
.    O

However    O
,    O
a    O
report    O
of    O
an    O
infection    O
of    O
the    O
erythrocytes    O
in    O
a    O
Chinese    O
woman    O
with    O
a    O
deficiency    O
of    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
has    O
been    O
reported    O
.    O

Peripheral    O
T    O
-    O
cell    O
lymphoma    O
(    O
PTCL    O
)    O
is    O
defined    O
as    O
a    O
diverse    O
group    O
of    O
aggressive    O
lymphomas    O
that    O
develop    O
from    O
mature    O
-    O
stage    O
white    O
blood    O
cells    O
called    O
T-cells    B-Cell102991711
and    O
natural    O
killer    O
cells    O
(    O
NK    B-Cell102991711
cells    I-Cell102991711
)    O
(    O
see    O
figure    O
for    O
an    O
overview    O
of    O
PTCL    O
subtypes    O
)    O
.    O

IL-12    O
is    O
also    O
produced    O
during    O
"    O
T.    O
gondii    O
"    O
infection    O
to    O
activate    O
natural    B-Cell102991711
killer    I-Cell102991711
(NK)    I-Cell102991711
cells    I-Cell102991711
.    O

The    O
protein    O
belongs    O
to    O
a    O
family    O
of    O
isozymes    O
,    O
including    O
cyclophilins    O
B    O
and    O
C    O
,    O
and    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
cyclophilin    O
-    O
related    O
protein    O
.    O

CD94/NKG2    O
is    O
a    O
family    O
of    O
C    O
-    O
type    O
lectin    O
receptors    O
which    O
are    O
expressed    O
predominantly    O
on    O
the    O
surface    O
of    O
NK    B-Cell102991711
cells    I-Cell102991711
and    O
a    O
subset    O
of    O
CD8+    B-Cell102991711
T-lymphocyte    I-Cell102991711
.    O

Natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711

Eva    O
Klein    O
(    O
born    O
Eva    O
Fischer    O
;    O
January    O
22    O
,    O
1925    O
)    O
is    O
a    O
Hungarian    O
-    O
Swedish    O
scientist    O
best    O
known    O
for    O
leading    O
the    O
discovery    O
of    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
and    O
developing    O
Burkitt    O
Lymphoma    O
cell    O
lines    O
in    O
the    O
1960s    O
.    O

Klein    O
named    O
them    O
"    O
natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
"    O
.    O

The    O
engagement    O
of    O
a    O
particular    O
antibody    O
with    O
the    O
Fc    O
receptor    O
on    O
a    O
particular    O
cell    O
triggers    O
an    O
effector    O
function    O
of    O
that    O
cell    O
;    O
phagocytes    O
will    O
phagocytose    O
,    O
mast    O
cells    O
and    O
neutrophils    O
will    O
degranulate    O
,    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
will    O
release    O
cytokines    O
and    O
cytotoxic    O
molecules    O
;    O
that    O
will    O
ultimately    O
result    O
in    O
destruction    O
of    O
the    O
invading    O
microbe    O
.    O

Signalling    O
from    O
these    O
receptors    O
normally    O
promotes    O
growth    O
and    O
differentiation    O
of    O
T-cells    B-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
,    O
glial    O
cells    O
,    O
and    O
cells    O
of    O
the    O
monocyte    O
lineage    O
,    O
depending    O
on    O
the    O
cell    O
type    O
and    O
receptor    O
activated    O
.    O

A    O
healthy    O
immune    O
system    O
should    O
contain    O
large    O
amounts    O
of    O
lymphocytes    O
,    O
but    O
individuals    O
with    O
X    O
-    O
SCID    O
will    O
contain    O
unusually    O
small    O
amounts    O
of    O
T    O
-    O
cells    O
,    O
non    O
-    O
functional    O
B-cells    B-Cell102991711
,    O
and    O
some    O
natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
.    O

CXCR3    O
is    O
expressed    O
primarily    O
on    O
activated    O
T    B-Cell102991711
lymphocytes    I-Cell102991711
and    O
NK    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
some    O
epithelial    O
cells    O
.    O

However    O
most    O
species    O
have    O
the    O
ability    O
to    O
perform    O
movements    O
that    O
are    O
coordinated    O
all    O
over    O
their    O
bodies    O
,    O
mainly    O
contractions    O
of    O
the    O
pinacocyte    B-Cell102991711
,    O
squeezing    O
the    O
water    O
channels    O
and    O
thus    O
expelling    O
excess    O
sediment    O
and    O
other    O
substances    O
that    O
may    O
cause    O
blockages    O
.    O

These    O
fossils    O
,    O
which    O
include    O
spicules    O
,    O
pinacocyte    B-Cell102991711
,    O
porocyte    B-Cell102991711
,    O
archeocyte    B-Cell102991711
,    O
sclerocyte    B-Cell102991711
and    O
the    O
internal    O
cavity    O
,    O
have    O
been    O
classified    O
as    O
demosponges    O
.    O

These    O
retinal    O
ganglion    O
cells    O
were    O
found    O
to    O
be    O
innately    O
photosensitive    O
,    O
since    O
they    O
responded    O
to    O
light    O
even    O
while    O
isolated    O
,    O
and    O
were    O
thus    O
named    O
intrinsically    B-Cell102991711
photosensitive    I-Cell102991711
Retinal    I-Cell102991711
Ganglion    I-Cell102991711
Cells    I-Cell102991711
(ipRGCs)    I-Cell102991711
.    O

The    O
human    O
melanopsin    O
gene    O
,    O
"    O
opn4    O
"    O
,    O
is    O
expressed    O
in    O
ipRGCs    B-Cell102991711
,    O
which    O
comprises    O
only    O
1    O
-    O
2%    O
of    O
RGCs    O
in    O
the    O
inner    O
mammalian    O
retina    O
,    O
as    O
studied    O
by    O
Samer    O
Hattar    O
and    O
colleagues    O
.    O

However    O
,    O
while    O
rods    O
and    O
cones    O
are    O
responsible    O
for    O
the    O
analysis    O
of    O
images    O
,    O
patterns    O
,    O
motion    O
,    O
and    O
color    O
,    O
melanopsin    O
-    O
containing    O
ipRGCs    B-Cell102991711
contribute    O
to    O
various    O
reflexive    O
responses    O
of    O
the    O
brain    O
and    O
body    O
to    O
the    O
presence    O
of    O
light    O
.    O

Intrinsically    B-Cell102991711
Photosensitive    I-Cell102991711
Retinal    I-Cell102991711
Ganglion    I-Cell102991711
Cells    I-Cell102991711
(ipRGCs)    I-Cell102991711

The    O
origin    O
of    O
the    O
retinohypothalamic    O
tract    O
is    O
the    O
intrinsically    B-Cell102991711
photosensitive    I-Cell102991711
retinal    I-Cell102991711
ganglion    I-Cell102991711
cells    I-Cell102991711
(    O
ipRGC    O
)    O
,    O
which    O
contain    O
the    O
photopigment    O
melanopsin    O
.    O

A    O
distinct    O
population    O
of    O
ganglion    O
cells    O
,    O
known    O
as    O
intrinsically    B-Cell102991711
photosensitive    I-Cell102991711
retinal    I-Cell102991711
ganglion    I-Cell102991711
cells    I-Cell102991711
(    O
ipRGCs    O
)    O
,    O
is    O
critically    O
responsible    O
for    O
providing    O
non    O
-    O
image    O
-    O
forming    O
visual    O
signals    O
to    O
the    O
brain    O
.    O

There    O
are    O
five    O
known    O
types    O
of    O
intrinsically    B-Cell102991711
photosensitive    I-Cell102991711
retinal    I-Cell102991711
ganglion    I-Cell102991711
cells    I-Cell102991711
(ipRGCs)    I-Cell102991711
:    O
M1    O
,    O
M2    O
,    O
M3    O
,    O
M4    O
,    O
and    O
M5    O
.    O

Lpp    O
,    O
along    O
with    O
another    O
lipoprotein    O
called    O
Pal    O
,    O
maintains    O
the    O
stability    O
of    O
the    O
cell    B-Cell102991711
envelope    I-Cell102991711
by    O
attaching    O
the    O
outer    O
membrane    O
to    O
the    O
cell    O
wall    O
.    O

Its    O
cell    B-Cell102991711
envelope    I-Cell102991711
contains    O
an    O
S    O
-    O
layer    O
,    O
Isopranyl    O
ether    O
lipids    O
and    O
caldariellaquinone    O
.    O

The    O
difference    O
in    O
the    O
genomes    O
of    O
these    O
strains    O
lies    O
in    O
variant    O
cell    B-Cell102991711
envelope    I-Cell102991711
,    O
secretory    O
proteins    O
,    O
and    O
polysaccharides    O
.    O

The    O
interterritorial    O
space    O
between    O
the    O
isogenous    B-Cell102991711
cell    I-Cell102991711
groups    I-Cell102991711
contains    O
relatively    O
more    O
collagen    O
fibers    O
,    O
causing    O
it    O
to    O
maintain    O
its    O
shape    O
while    O
the    O
actual    O
cells    O
shrink    O
,    O
creating    O
the    O
lacunae    O
.    O

Carbon    B-Cell102991711
nanotubes    I-Cell102991711
in    I-Cell102991711
photovoltaics    I-Cell102991711

Porocytes    B-Cell102991711
are    O
tubular    O
cells    O
which    O
make    O
up    O
the    O
pores    O
of    O
a    O
sponge    O
known    O
as    O
ostia    O
.    O

A    O
fat    B-Cell102991711
pad    I-Cell102991711
(    O
aka    O
haversian    B-Cell102991711
gland    I-Cell102991711
)    O
is    O
a    O
mass    O
of    O
closely    O
packed    O
fat    B-Cell102991711
cell    I-Cell102991711
surrounded    O
by    O
fibrous    O
tissue    O
septa    O
.    O

Another    O
difference    O
from    O
Dolly    O
the    O
Sheep    O
was    O
the    O
source    O
cell    B-Cell102991711
type    I-Cell102991711
of    O
the    O
nucleus    O
that    O
was    O
transferred    O
.    O

There    O
is    O
typically    O
considerable    O
desmoplasia    O
or    O
formation    O
of    O
a    O
dense    O
fibrous    O
stroma    O
or    O
structural    O
tissue    O
consisting    O
of    O
a    O
range    O
of    O
cell    B-Cell102991711
type    I-Cell102991711
(    O
including    O
myofibroblast    B-Cell102991711
,    O
macrophages    O
,    O
lymphocytes    O
and    O
mast    O
cells    O
)    O
and    O
deposited    O
material    O
(    O
such    O
as    O
type    O
I    O
collagen    O
and    O
hyaluronic    O
acid    O
)    O
.    O

Numerous    O
cell    O
lines    O
are    O
well    O
established    O
as    O
representative    O
of    O
particular    O
cell    B-Cell102991711
type    I-Cell102991711
.    O

In    O
immunology    O
,    O
activation    O
is    O
the    O
transition    O
of    O
leucocytes    O
and    O
other    O
cell    B-Cell102991711
types    I-Cell102991711
involved    O
in    O
the    O
immune    O
system    O
.    O

IL-15    O
is    O
constitutively    O
expressed    O
by    O
a    O
large    O
number    O
of    O
cell    B-Cell102991711
types    I-Cell102991711
and    O
tissues    O
,    O
including    O
monocytes    O
,    O
macrophages    O
,    O
dendritic    B-Cell102991711
cells    I-Cell102991711
(    O
DC    B-Cell102991711
)    O
,    O
keratinocytes    B-Cell102991711
,    O
fibroblasts    O
and    O
nerve    O
cells    O
.    O

It    O
is    O
essentially    O
harnessing    O
the    O
potential    O
of    O
stem    O
cells    O
by    O
constraining    O
their    O
differentiation    O
in    O
vitro    O
toward    O
a    O
specific    O
cell    B-Cell102991711
type    I-Cell102991711
or    O
tissue    O
of    O
interest    O
.    O

Cell    B-Cell102991711
type    I-Cell102991711
–    O
Distinct    O
morphological    O
or    O
functional    O
form    O
of    O
cell    O
.    O

:*    O
B-1    B-Cell102991711
cell    I-Cell102991711

Antibodies    O
against    O
phosphorylcholine    O
are    O
naturally    O
occurring    O
autoantibodies    O
that    O
are    O
created    O
by    O
B-1    B-Cell102991711
B    I-Cell102991711
cell    I-Cell102991711
and    O
are    O
referred    O
to    O
as    O
non    O
-    O
pathogenic    O
autoantibodies    O
.    O

Electropolishing    O
is    O
accomplished    O
by    O
creating    O
electrochemical    B-Cell102991711
cell    I-Cell102991711
where    O
the    O
material    O
of    O
interest    O
is    O
used    O
as    O
the    O
anode    O
.    O

The    O
long    O
-    O
term    O
goals    O
of    O
the    O
lab    O
include    O
innovation    O
in    O
clean    O
combustion    O
for    O
propulsion    O
and    O
power    O
,    O
gasification    O
for    O
power    O
and    O
biofuel    O
production    O
,    O
and    O
oxy    O
-    O
combustion    O
and    O
electrochemical    B-Cell102991711
/    O
thermochemical    O
conversion    O
in    O
ion    O
transport    O
membrane    O
reactors    O
and    O
high    O
-    O
temperature    O
fuel    O
cells    O
.    O

It    O
is    O
advantageous    O
in    O
that    O
it    O
performs    O
well    O
with    O
minimal    O
discrete    O
components    O
,    O
and    O
can    O
run    O
from    O
a    O
single    O
1.5-volt    O
cell    B-Cell102991711
.    O

The    O
Daniell    O
cell    O
is    O
a    O
type    O
of    O
electrochemical    B-Cell102991711
cell    I-Cell102991711
invented    O
in    O
1836    O
by    O
John    O
Frederic    O
Daniell    O
,    O
a    O
British    O
chemist    O
and    O
meteorologist    O
,    O
and    O
consisted    O
of    O
a    O
copper    O
pot    O
filled    O
with    O
a    O
copper    O
(    O
II    O
)    O
sulfate    O
solution    O
,    O
in    O
which    O
was    O
immersed    O
an    O
unglazed    O
earthenware    O
container    O
filled    O
with    O
sulfuric    O
acid    O
and    O
a    O
zinc    O
electrode    O
.    O

Sometimes    O
called    O
the    O
crowfoot    O
cell    O
due    O
to    O
the    O
distinctive    O
shape    O
of    O
the    O
electrodes    O
,    O
this    O
arrangement    O
was    O
less    O
costly    O
for    O
large    O
multicell    B-Cell102991711
batteries    I-Cell102991711
and    O
it    O
quickly    O
became    O
the    O
battery    O
of    O
choice    O
for    O
the    O
American    O
and    O
British    O
telegraph    O
networks    O
.    O

Electrosynthesis    O
in    O
chemistry    O
is    O
the    O
synthesis    O
of    O
chemical    O
compounds    O
in    O
an    O
electrochemical    B-Cell102991711
cell    I-Cell102991711
.    O

An    O
electrolytic    O
cell    O
is    O
an    O
electrochemical    B-Cell102991711
cell    I-Cell102991711
that    O
drives    O
a    O
non    O
-    O
spontaneous    O
redox    O
reaction    O
through    O
the    O
application    O
of    O
electrical    O
energy    O
.    O

Electrochemical    B-Cell102991711
cell    I-Cell102991711

Electrochemical    B-Cell102991711
cell    I-Cell102991711

It    O
differs    O
from    O
a    O
nickel    O
–    O
metal    O
hydride    O
(    O
NIMH    O
)    O
battery    O
by    O
the    O
use    O
of    O
hydrogen    O
in    O
gaseous    O
form    O
,    O
stored    O
in    O
a    O
pressurized    O
cell    B-Cell102991711
at    O
up    O
to    O
1200    O
psi    O
(    O
82.7    O
bar    O
)    O
pressure    O
.    O

Johann    O
Wilhelm    O
Ritter    O
builds    O
the    O
first    O
electrochemical    B-Cell102991711
cell    I-Cell102991711
.    O

To    O
construct    O
this    O
battery    O
,    O
he    O
joined    O
together    O
577    O
individual    O
batteries    O
(    O
"cells"    B-Cell102991711
)    O
,    O
which    O
used    O
over    O
30    O
gallons    O
of    O
acid    O
.    O

The    O
first    O
tests    O
of    O
electric    O
traction    O
on    O
Berlin    O
's    O
standard    O
gauge    O
began    O
on    O
1    O
May    O
1882    O
,    O
with    O
overhead    O
supply    O
and    O
in    O
1886    O
with    O
chemical    B-Cell102991711
accumulators    I-Cell102991711
,    O
were    O
not    O
very    O
successful    O
.    O

Water    O
and    O
the    O
two    O
metals    O
form    O
an    O
electrochemical    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
if    O
the    O
coating    O
is    O
less    O
reactive    O
than    O
the    O
coatee    O
,    O
the    O
coating    O
actually    O
"    O
promotes    O
"    O
corrosion    O
.    O

A    O
lemon    O
battery    O
is    O
a    O
simple    O
battery    B-Cell102991711
often    O
made    O
for    O
the    O
purpose    O
of    O
education    O
.    O

The    O
electrical    O
side    O
of    O
the    O
business    O
was    O
involved    O
in    O
the    O
production    O
of    O
field    O
telephone    O
sets    O
,    O
and    O
accumulators    O
(    O
electrochemical    B-Cell102991711
cell    I-Cell102991711
batteries    O
)    O
for    O
war    O
purposes    O
.    O

Unlike    O
other    O
automakers    O
,    O
Tesla    O
does    O
not    O
use    O
individual    O
large    O
battery    B-Cell102991711
cell    I-Cell102991711
,    O
but    O
thousands    O
of    O
small    O
,    O
cylindrical    O
,    O
lithium    O
-    O
ion    O
commodity    O
cells    O
like    O
those    O
used    O
in    O
consumer    O
electronics    O
.    O

Panasonic    O
is    O
the    O
sole    O
supplier    O
of    O
the    O
cells    O
and    O
cooperates    O
with    O
Tesla    O
in    O
the    O
Gigafactory    O
1    O
's    O
'    O
21    O
-    O
70    O
'    O
cells    B-Cell102991711
.    O

Statocyte    B-Cell102991711
,    O
a    O
similar    O
structure    O
in    O
plants    O

This    O
seems    O
to    O
be    O
a    O
mutualistic    O
arrangement    O
in    O
which    O
the    O
crab    O
benefits    O
from    O
the    O
fact    O
that    O
potential    O
predators    O
are    O
deterred    O
by    O
the    O
anemone    O
's    O
stinging    B-Cell102991711
cells    I-Cell102991711
while    O
the    O
anemone    O
gains    O
a    O
greater    O
access    O
to    O
food    O
as    O
the    O
crab    O
moves    O
around    O
.    O

There    O
are    O
no    O
acontia    O
with    O
stinging    O
nematocyst    B-Cell102991711
protruding    O
through    O
the    O
body    O
wall    O
.    O

The    O
research    O
indicated    O
that    O
the    O
fish    O
seemed    O
to    O
be    O
unharmed    O
by    O
the    O
anemone    O
's    O
nematocyst    B-Cell102991711
.    O

The    O
pseudotentacles    O
are    O
armed    O
with    O
small    O
vesicles    O
containing    O
nematocyst    B-Cell102991711
and    O
these    O
are    O
mostly    O
concentrated    O
near    O
the    O
tips    O
.    O

Like    O
other    O
members    O
of    O
the    O
Phylum    O
Cnidaria    O
,    O
"    O
Hydra    O
"    O
possesses    O
specialized    O
defensive    O
epithelial    O
cells    O
called    O
cnidocyte    B-Cell102991711
that    O
shoot    O
toxic    O
barbs    O
into    O
organisms    O
they    O
come    O
in    O
physical    O
contact    O
with    O
.    O

Since    O
the    O
time    O
of    O
their    O
description    O
,    O
nematosomes    O
have    O
been    O
known    O
to    O
be    O
populated    O
by    O
abundant    O
cnidocyte    B-Cell102991711
(    O
also    O
known    O
as    O
nematocytes    O
)    O
and    O
"    O
flagellated    O
cells    O
"    O
.    O

The    O
stingers    O
(    O
nematocyst    B-Cell102991711
)    O
are    O
in    O
clumps    O
,    O
appearing    O
as    O
rings    O
of    O
small    O
red    O
dots    O
around    O
the    O
bell    O
and    O
along    O
the    O
tentacles    O
.    O

When    O
fully    O
formed    O
cnidae    O
are    O
called    O
cnidocytes    B-Cell102991711
.    O

Each    O
strand    O
has    O
numerous    O
branchlets    O
,    O
each    O
of    O
which    O
ends    O
in    O
knobs    O
of    O
stinging    O
cells    O
called    O
nematocysts    B-Cell102991711
.    O

This    O
is    O
because    O
they    O
contain    O
in    O
their    O
tissues    O
many    O
examples    O
of    O
an    O
organ    O
called    O
the    O
cnidosac    O
which    O
contains    O
undischarged    O
cnidocytes    B-Cell102991711
(    O
also    O
known    O
as    O
nematocyst    B-Cell102991711
)    O
.    O

In    O
addition    O
to    O
colloblasts    O
,    O
members    O
of    O
the    O
genus    O
"    O
Haeckelia    O
"    O
,    O
which    O
feed    O
mainly    O
on    O
jellyfish    O
,    O
incorporate    O
their    O
victims    O
'    O
stinging    O
cnidocyte    B-Cell102991711
into    O
their    O
own    O
tentacles    O
—    O
some    O
cnidaria    O
-    O
eating    O
nudibranchs    O
similarly    O
incorporate    O
cnidocytes    O
into    O
their    O
bodies    O
for    O
defense    O
.    O

Like    O
other    O
sea    O
anemones    O
,    O
this    O
species    O
catches    O
prey    O
with    O
its    O
tentacles    O
which    O
are    O
armed    O
with    O
many    O
cnidocyte    B-Cell102991711
,    O
stinging    O
cells    O
which    O
kill    O
the    O
prey    O
.    O

These    O
contain    O
nematocyst    B-Cell102991711
that    O
are    O
very    O
large    O
.    O

The    O
cnidom    O
(    O
the    O
types    O
of    O
cnidocyte    B-Cell102991711
present    O
)    O
consists    O
of    O
spirocysts    O
,    O
basitrichs    O
and    O
microbasic    O
p    O
-    O
mastigophors    O
.    O

Actually    O
hydrozoans    O
rather    O
than    O
true    O
corals    O
,    O
fire    O
corals    O
possess    O
stinging    O
cells    O
(    O
nematocyst    B-Cell102991711
)    O
,    O
which    O
would    O
normally    O
prevent    O
close    O
contact    O
.    O

The    O
purple    O
lady    O
eats    O
the    O
hydroid    O
and    O
passes    O
its    O
nematocyst    B-Cell102991711
unharmed    O
through    O
its    O
digestive    O
system    O
to    O
the    O
tips    O
of    O
its    O
cerata    O
.    O

The    O
white    O
-    O
edged    O
nudibranch    O
eats    O
the    O
hydroid    O
and    O
passes    O
its    O
nematocyst    B-Cell102991711
unharmed    O
through    O
its    O
digestive    O
system    O
to    O
the    O
tips    O
of    O
its    O
cerata    O
.    O

The    O
candy    O
nudibranch    O
eats    O
the    O
hydroid    O
and    O
passes    O
its    O
nematocyst    B-Cell102991711
unharmed    O
through    O
its    O
digestive    O
system    O
to    O
the    O
tips    O
of    O
its    O
cerata    O
.    O

Their    O
diet    O
comprises    O
small    O
fish    O
and    O
crustaceans    O
,    O
which    O
they    O
immobilize    O
by    O
firing    O
groups    O
of    O
stinging    O
cells    O
(    O
cnidae    B-Cell102991711
)    O
into    O
them    O
.    O

The    O
tentacles    O
also    O
have    O
stinging    B-Cell102991711
cell    I-Cell102991711
that    O
can    O
capture    O
tiny    O
crustaceans    O
and    O
other    O
plankton    O
.    O

One    O
study    O
carried    O
out    O
at    O
Marineland    O
of    O
the    O
Pacific    O
by    O
Dr.    O
Demorest    O
Davenport    O
and    O
Dr.    O
Kenneth    O
Noris    O
in    O
1958    O
revealed    O
that    O
the    O
mucus    O
secreted    O
by    O
the    O
anemone    O
fish    O
prevented    O
the    O
anemone    O
from    O
discharging    O
its    O
lethal    O
stinging    O
nematocyst    B-Cell102991711
.    O

A.    O
percula    O
"    O
belongs    O
to    O
a    O
group    O
of    O
fishes    O
that    O
are    O
not    O
stung    O
by    O
the    O
nematocyst    B-Cell102991711
of    O
the    O
anemone    O
.    O

JPG|Fire    O
coral    O
,    O
"    O
millepora    O
"    O
spp    O
is    O
a    O
hydrozoan    O
which    O
has    O
stinging    O
nematocyst    B-Cell102991711
on    O
its    O
surface    O
.    O

Below    O
these    O
,    O
on    O
the    O
side    O
of    O
the    O
frond    O
are    O
small    O
,    O
whitish    O
spherical    O
vesicles    O
containing    O
nematocyst    B-Cell102991711
that    O
are    O
powerful    O
enough    O
to    O
sting    O
a    O
human    O
.    O

It    O
seldom    O
moves    O
away    O
from    O
the    O
anemone    O
and    O
seems    O
to    O
be    O
immune    O
to    O
the    O
stings    O
produced    O
by    O
its    O
host    O
's    O
nematocyst    B-Cell102991711
.    O

Its    O
cnidocyte    B-Cell102991711
are    O
so    O
powerful    O
that    O
no    O
other    O
Caribbean    O
corals    O
can    O
successfully    O
attack    O
it    O
.    O

Usually    O
,    O
Treg    B-Cell102991711
cells    I-Cell102991711
,    O
TR1    O
,    O
and    O
Th3    B-Cell102991711
cells    I-Cell102991711
at    O
mucosal    O
surfaces    O
suppress    O
type    O
2    O
CD4    O
helper    O
cells    O
,    O
mast    O
cells    O
,    O
and    O
eosinophils    O
,    O
which    O
mediate    O
allergic    O
response    O
.    O

parvicellular    B-Cell102991711
neurosecretory    I-Cell102991711
nuclei    I-Cell102991711

In    O
addition    O
Cervarix    O
induced    O
twice    O
as    O
many    O
memory    B-Cell102991711
B    I-Cell102991711
cells    I-Cell102991711
as    O
Gardasil    O
for    O
both    O
these    O
HPV    O
strains    O
.    O

impaired    O
development    O
of    O
CD4    O
+    O
T    B-Cell102991711
follicular    I-Cell102991711
helper    I-Cell102991711
cells    I-Cell102991711
,    O
which    O
are    O
specialized    O
in    O
facilitating    O
peripheral    O
B    B-Cell102991711
cell    I-Cell102991711
maturation    O
,    O
and    O
the    O
generation    O
of    O
antibody    O
-    O
producing    O
plasma    O
cells    O
and    O
memory    B-Cell102991711
B    I-Cell102991711
cell    I-Cell102991711

The    O
more    O
limited    O
set    O
of    O
proteins    O
and    O
RNAs    O
produced    O
in    O
Latency    O
II    O
induces    O
the    O
B    O
cell    O
to    O
differentiate    O
into    O
a    O
memory    B-Cell102991711
B    I-Cell102991711
cell    I-Cell102991711
.    O

Atacicept    O
is    O
thought    O
to    O
selectively    O
impair    O
mature    O
B    O
cells    O
and    O
plasma    O
cells    O
with    O
less    O
impact    O
on    O
progenitor    B-Cell102991711
cell    I-Cell102991711
and    O
memory    B-Cell102991711
B    I-Cell102991711
cell    I-Cell102991711
.    O

The    O
BCR    O
is    O
found    O
only    O
on    O
the    O
surface    O
of    O
B    O
cells    O
and    O
facilitates    O
the    O
activation    O
of    O
these    O
cells    O
and    O
their    O
subsequent    O
differentiation    O
into    O
either    O
antibody    O
factories    O
called    O
plasma    O
cells    O
or    O
memory    B-Cell102991711
B    I-Cell102991711
cell    I-Cell102991711
that    O
will    O
survive    O
in    O
the    O
body    O
and    O
remember    O
that    O
same    O
antigen    O
so    O
the    O
B    O
cells    O
can    O
respond    O
faster    O
upon    O
future    O
exposure    O
.    O

Activated    O
B    O
cells    O
differentiate    O
into    O
either    O
antibody    O
-    O
producing    O
cells    O
called    O
plasma    O
cells    O
that    O
secrete    O
soluble    O
antibody    O
or    O
memory    B-Cell102991711
cells    I-Cell102991711
that    O
survive    O
in    O
the    O
body    O
for    O
years    O
afterward    O
in    O
order    O
to    O
allow    O
the    O
immune    O
system    O
to    O
remember    O
an    O
antigen    O
and    O
respond    O
faster    O
upon    O
future    O
exposures    O
.    O

It    O
contains    O
three    O
components    O
:    O
the    O
macula    B-Cell102991711
densa    I-Cell102991711
,    O
juxtaglomerular    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
extraglomerular    B-Cell102991711
mesangial    I-Cell102991711
cell    I-Cell102991711
.    O

Instead    O
of    O
forming    O
collagen    O
molecules    O
,    O
the    O
abnormal    O
protein    O
builds    O
up    O
in    O
cartilage    O
cells    O
(    O
chondrocytes    B-Cell102991711
)    O
.    O

Chondrocyte    B-Cell102991711
are    O
the    O
only    O
cell    O
type    O
in    O
cartilage    O
,    O
in    O
which    O
they    O
are    O
surrounded    O
by    O
the    O
extracellular    O
matrix    O
that    O
they    O
secrete    O
and    O
assemble    O
.    O

In    O
cartilage    O
,    O
the    O
lacunae    O
and    O
hence    O
,    O
the    O
chondrocytes    B-Cell102991711
,    O
are    O
isolated    O
from    O
each    O
other    O
.    O

Notch1    O
is    O
expressed    O
in    O
the    O
mesenchymal    O
condensation    O
area    O
and    O
subsequently    O
in    O
the    O
hypertrophic    O
chondrocytes    B-Cell102991711
during    O
chondrogenesis    O
.    O

Phase    O
-    O
contrast    O
light    O
micrograph    O
of    O
hyaline    O
cartilage    O
showing    O
chondrocyte    B-Cell102991711
and    O
organelles    O
,    O
lacunae    O
and    O
extracellular    O
matrix    O
.    O

Transmission    O
electron    O
micrograph    O
of    O
a    O
chondrocyte    B-Cell102991711
,    O
stained    O
for    O
calcium    O
,    O
showing    O
its    O
nucleus    O
(    O
N    O
)    O
and    O
mitochondria    O
(    O
M    O
)    O
.    O

Mesenchymal    O
stem    O
cells    O
are    O
found    O
in    O
umbilical    O
cord    O
blood    O
,    O
amniotic    O
fluid    O
,    O
and    O
adipose    O
tissue    O
and    O
can    O
generate    O
a    O
number    O
of    O
cell    O
types    O
,    O
including    O
osteoblasts    O
,    O
chondrocyte    B-Cell102991711
,    O
and    O
adipocyte    B-Cell102991711
.    O

In    O
the    O
process    O
of    O
chondrogenesis    O
,    O
chondrocyte    B-Cell102991711
differentiate    O
from    O
the    O
condensations    O
to    O
form    O
cartilage    O
,    O
giving    O
rise    O
to    O
the    O
skeletal    O
primordia    O
.    O

During    O
the    O
implantation    O
,    O
chondrocyte    B-Cell102991711
are    O
applied    O
on    O
the    O
damaged    O
area    O
in    O
combination    O
with    O
a    O
membrane    O
(    O
tibial    O
periosteum    O
or    O
biomembrane    O
)    O
or    O
pre    O
-    O
seeded    O
in    O
a    O
scaffold    O
matrix    O
.    O

Examples    O
include    O
using    O
living    O
fibroblasts    O
in    O
skin    O
replacement    O
or    O
repair    O
,    O
cartilage    O
repaired    O
with    O
living    O
chondrocyte    B-Cell102991711
,    O
or    O
other    O
types    O
of    O
cells    O
used    O
in    O
other    O
ways    O
.    O

For    O
example    O
,    O
certain    O
cells    O
respond    O
to    O
changes    O
in    O
oxygen    O
tension    O
as    O
part    O
of    O
their    O
normal    O
development    O
,    O
such    O
as    O
chondrocyte    B-Cell102991711
,    O
which    O
must    O
adapt    O
to    O
low    O
oxygen    O
conditions    O
or    O
hypoxia    O
during    O
skeletal    O
development    O
.    O

Amyloid    O
deposited    O
in    O
the    O
knee    O
following    O
surgery    O
consists    O
largely    O
of    O
apo    O
A1    O
secreted    O
from    O
chondrocytes    B-Cell102991711
(    O
cartilage    O
cells    O
)    O
.    O

#    O
Fibrocartilaginous    O
region    O
of    O
variable    O
thickness    O
where    O
the    O
structure    O
of    O
the    O
cells    O
changes    O
to    O
chondrocyte    B-Cell102991711

MSCs    O
have    O
been    O
shown    O
to    O
differentiate    O
,    O
in    O
vitro    O
or    O
in    O
vivo    O
,    O
into    O
osteoblasts    O
,    O
chondrocyte    B-Cell102991711
,    O
myocyte    B-Cell102991711
,    O
marrow    O
adipocytes    O
and    O
beta    O
-    O
pancreatic    O
islets    O
cells    O
.    O

Osteopontin    O
is    O
biosynthesized    O
by    O
a    O
variety    O
of    O
tissue    O
types    O
including    O
cardiac    O
fibroblasts    O
,    O
preosteoblasts    O
,    O
osteoblasts    O
,    O
osteocytes    O
,    O
odontoblasts    O
,    O
some    O
bone    O
marrow    O
cells    O
,    O
hypertrophic    O
chondrocytes    B-Cell102991711
,    O
dendritic    B-Cell102991711
cells    I-Cell102991711
,    O
macrophages    O
,    O
smooth    O
muscle    O
,    O
skeletal    O
muscle    O
myoblasts    B-Cell102991711
,    O
endothelial    O
cells    O
,    O
and    O
extraosseous    O
(    O
non    O
-    O
bone    O
)    O
cells    O
in    O
the    O
inner    O
ear    O
,    O
brain    O
,    O
kidney    O
,    O
deciduum    O
,    O
and    O
placenta    O
.    O

In    O
hemoperfusion    O
,    O
the    O
blood    O
perfuses    O
a    O
filter    O
composed    O
of    O
artificial    B-Cell102991711
cell    I-Cell102991711
filled    O
with    O
activated    O
carbon    O
or    O
another    O
microporous    O
material    O
.    O

Polymersomes    O
can    O
be    O
used    O
to    O
make    O
an    O
artificial    B-Cell102991711
cell    I-Cell102991711
if    O
hemoglobin    O
and    O
other    O
components    O
are    O
added    O
.    O

Artificial    B-Cell102991711
cell    I-Cell102991711

Flammeovirga    O
is    O
a    O
Gram    O
-    O
negative    O
,    O
aerobic    O
,    O
non    O
-    O
spore    O
-    O
forming    O
and    O
chemoorganotrophic    B-Cell102991711
genus    O
from    O
the    O
family    O
of    O
Flammeovirgaceae    O
which    O
occur    O
in    O
marine    O
environments    O
.    O

Primary    B-Cell102991711
nutritional    I-Cell102991711
groups    I-Cell102991711

Chemoorganotroph    B-Cell102991711

It    O
is    O
facultatively    O
anaerobic    O
and    O
chemo-organotrophic    B-Cell102991711
,    O
and    O
produces    O
acid    O
when    O
carbohydrates    O
are    O
catabolized    O
.    O

Desulfobulbus    O
propionicus    O
is    O
a    O
Gram    O
-    O
negative    O
,    O
anaerobic    O
chemoorganotroph    B-Cell102991711
.    O

D.    O
propionicus    O
"    O
functions    O
as    O
an    O
anaerobic    O
chemoorganotroph    B-Cell102991711
.    O

"    O
Desulfobulbus    O
propionicus    O
"    O
is    O
an    O
anaerobic    O
chemoorganotroph    B-Cell102991711
.    O
"    O

Like    O
all    O
"    O
Bordetella    O
"    O
species    O
,    O
"    O
B.    O
trematum    O
"    O
is    O
a    O
chemoorganotroph    B-Cell102991711
and    O
requires    O
nicotinamide    O
,    O
organic    O
sulfur    O
such    O
as    O
cysteine    O
,    O
and    O
organic    O
nitrogen    O
such    O
as    O
amino    O
acids    O
for    O
growth    O
by    O
respiratory    O
metabolism    O
.    O

"    O
Thiothrix    O
"    O
species    O
can    O
be    O
facultative    O
autotrophs    O
,    O
chemoorganotroph    B-Cell102991711
and    O
mixotrophs    O
.    O

M    O
cells    O
in    O
the    O
LGN    O
receive    O
input    O
from    O
parasol    B-Cell102991711
ganglion    I-Cell102991711
cells    I-Cell102991711
(    O
which    O
some    O
neuroscientists    O
call    O
M    O
cells    O
)    O
,    O
and    O
P    O
cells    O
receive    O
input    O
from    O
midget    B-Cell102991711
retinal    I-Cell102991711
ganglion    I-Cell102991711
cells    I-Cell102991711
(    O
which    O
some    O
neuroscientists    O
call    O
P    O
cells    O
)    O
.    O

Myrosinase    O
is    O
stored    O
largely    O
as    O
myrosin    O
grains    O
in    O
the    O
vacuoles    O
of    O
particular    O
idioblasts    B-Cell102991711
called    O
myrosin    O
cells    O
,    O
but    O
have    O
also    O
been    O
reported    O
in    O
protein    O
bodies    O
or    O
vacuoles    O
,    O
and    O
as    O
cytosolic    O
enzymes    O
that    O
tend    O
to    O
bind    O
to    O
membranes    O
.    O

Raphides    O
are    O
found    O
in    O
specialized    O
plant    O
cells    O
or    O
crystal    O
chambers    O
called    O
idioblast    B-Cell102991711
.    O

Targets    O
of    O
this    O
cytokine    O
are    O
mostly    O
non    O
-    O
hematopoietic    O
cells    O
such    O
as    O
hepatocytes    B-Cell102991711
,    O
keratinocytes    B-Cell102991711
,    O
and    O
lung    O
and    O
intestinal    O
epithelial    O
cells    O
.    O
Pancreatic    O
islets    O
also    O
express    O
high    O
levels    O
of    O
IL-22    O
receptor    O
.    O

This    O
cytokine    O
has    O
been    O
shown    O
to    O
transduce    O
its    O
signal    O
through    O
signal    O
transducer    O
and    O
activator    O
of    O
transcription    O
3    O
(    O
STAT3    O
)    O
in    O
keratinocyte    B-Cell102991711
.    O

IL-20    O
is    O
produced    O
by    O
activated    O
keratinocyte    B-Cell102991711
and    O
monocytes    O
and    O
transmits    O
an    O
intracellular    O
signal    O
through    O
two    O
distinct    O
cell    O
-    O
surface    O
receptor    O
complexes    O
on    O
keratinocytes    O
and    O
other    O
epithelial    O
cells    O
.    O

IL-17    O
induces    O
the    O
production    O
of    O
many    O
other    O
cytokines    O
(    O
such    O
as    O
IL-6    O
,    O
G    O
-    O
CSF    O
,    O
GM    O
-    O
CSF    O
,    O
IL-1β    O
,    O
TGF-β    O
,    O
TNF-α    O
)    O
,    O
chemokines    O
(    O
including    O
IL-8    O
,    O
GRO-α    O
,    O
and    O
MCP-1    O
)    O
,    O
and    O
prostaglandins    O
(    O
e.g.    O
,    O
PGE2    O
)    O
from    O
many    O
cell    O
types    O
(    O
fibroblasts    O
,    O
endothelial    O
cells    O
,    O
epithelial    O
cells    O
,    O
keratinocytes    B-Cell102991711
,    O
and    O
macrophages    O
)    O
.    O

IL-17    O
acts    O
with    O
IL-22    O
(    O
produced    O
by    O
T    B-Cell102991711
helper    I-Cell102991711
17    I-Cell102991711
cells    O
)    O
to    O
induce    O
expression    O
of    O
antimicrobial    O
peptide    O
by    O
keratinocytes    B-Cell102991711
.    O

IL-17    O
promotes    O
psoriasis    O
by    O
contributing    O
to    O
the    O
inflammatory    O
response    O
that    O
damages    O
and    O
overturns    O
the    O
keratinocyte    B-Cell102991711
cells    O
of    O
the    O
epidermal    O
layer    O
.    O

Freckles    O
do    O
not    O
have    O
an    O
increased    O
number    O
of    O
the    O
melanin    O
-    O
producing    O
cells    O
,    O
or    O
melanocytes    O
,    O
but    O
instead    O
have    O
melanocytes    O
that    O
overproduce    O
melanin    O
granules    O
(    O
melanosomes    O
)    O
changing    O
the    O
coloration    O
of    O
the    O
outer    O
skin    O
cells    O
(    O
keratinocyte    B-Cell102991711
)    O
.    O

The    O
epidermal    O
differentiation    O
complex    O
(    O
EDC    O
)    O
is    O
a    O
gene    O
complex    O
comprising    O
over    O
fifty    O
genes    O
encoding    O
proteins    O
involved    O
in    O
the    O
terminal    O
differentiation    O
and    O
cornification    O
of    O
keratinocytes    B-Cell102991711
,    O
the    O
primary    O
cell    O
type    O
of    O
the    O
epidermis    O
.    O

MiR-203    O
is    O
a    O
microRNA    O
that    O
is    O
specifically    O
expressed    O
in    O
keratinocyte    B-Cell102991711
(    O
the    O
most    O
abundant    O
cell    O
type    O
in    O
the    O
epidermis    O
)    O
and    O
in    O
normal    O
conditions    O
promotes    O
epidermal    O
differentiation    O
by    O
restricting    O
proliferative    O
potential    O
and    O
inducing    O
cell    O
-    O
cycle    O
exit    O
.    O

The    O
epidermis    O
contains    O
four    O
cell    O
types    O
:    O
keratinocyte    B-Cell102991711
,    O
melanocytes    O
,    O
Langerhans    O
cells    O
,    O
and    O
Merkel    B-Cell102991711
cell    I-Cell102991711
.    O

Suberoylanilide    O
hydroxamic    O
acid    O
(    O
SAHA    O
)    O
(    O
a    O
HDAC    O
inhibitor    O
)    O
increases    O
expression    O
of    O
aquaporin-3    O
in    O
normal    O
skin    O
cells    O
(    O
keratinocyte    B-Cell102991711
)    O
.    O

A    O
keratinocyte    B-Cell102991711
is    O
the    O
predominant    O
cell    O
type    O
in    O
the    O
epidermis    O
,    O
the    O
outermost    O
layer    O
of    O
the    O
skin    O
,    O
constituting    O
90%    O
of    O
the    O
cells    O
found    O
there    O
.    O

It    O
is    O
95%    O
keratinocytes    B-Cell102991711
(    O
proliferating    B-Cell102991711
basal    O
and    O
differentiated    O
suprabasal    O
)    O
but    O
also    O
contains    O
melanocytes    O
,    O
Langerhans    O
cells    O
,    O
Merkel    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
inflammatory    O
cells    O
.    O

To    O
date    O
,    O
elastase    O
1    O
expression    O
has    O
only    O
been    O
detected    O
in    O
skin    O
keratinocyte    B-Cell102991711
.    O

Both    O
proteins    O
co    O
-    O
localize    O
on    O
basal    O
keratinocytes    B-Cell102991711
surface    O
.    O

Other    O
immune    O
system    O
cells    O
that    O
are    O
known    O
to    O
express    O
CYP27B1    O
and    O
thus    O
activate    O
vitamin    O
D    O
calcidiol    O
,    O
are    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
keratinocyte    B-Cell102991711
and    O
macrophages    O
.    O

In    O
this    O
phase    O
,    O
keratinocytes    B-Cell102991711
are    O
covering    O
the    O
wound    O
,    O
forming    O
the    O
epithelium    O
.    O

The    O
underlying    O
mechanism    O
involves    O
the    O
immune    O
system    O
reacting    O
to    O
skin    B-Cell102991711
cell    I-Cell102991711
.    O

These    O
changes    O
are    O
believed    O
to    O
stem    O
from    O
the    O
premature    O
maturation    O
of    O
keratinocytes    B-Cell102991711
induced    O
by    O
an    O
inflammatory    O
cascade    O
in    O
the    O
dermis    O
involving    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
macrophages    O
,    O
and    O
T    B-Cell102991711
cell    I-Cell102991711
(    O
three    O
subtypes    O
of    O
white    O
blood    O
cells    O
)    O
.    O

IL-15    O
is    O
constitutively    O
expressed    O
by    O
a    O
large    O
number    O
of    O
cell    B-Cell102991711
types    I-Cell102991711
and    O
tissues    O
,    O
including    O
monocytes    O
,    O
macrophages    O
,    O
dendritic    B-Cell102991711
cells    I-Cell102991711
(    O
DC    B-Cell102991711
)    O
,    O
keratinocytes    B-Cell102991711
,    O
fibroblasts    O
and    O
nerve    O
cells    O
.    O

However    O
,    O
the    O
expression    O
of    O
EP1    O
In    O
humans    O
,    O
its    O
expression    O
appears    O
to    O
be    O
more    O
limited    O
:    O
EP1    O
receptors    O
have    O
been    O
detected    O
in    O
human    O
mast    O
cells    O
,    O
pulmonary    O
veins    O
,    O
keratinocyte    B-Cell102991711
,    O
myometrium    O
,    O
and    O
colon    O
smooth    O
muscle    O
.    O

Since    O
skin    O
melanocytes    O
use    O
their    O
dendrites    O
to    O
transfer    O
the    O
skin    O
pigment    O
melanin    O
to    O
skin    O
keratinocytes    B-Cell102991711
thereby    O
darkening    O
skin    O
and    O
since    O
tyrosinase    O
is    O
the    O
rate    O
-    O
limiting    O
enzyme    O
in    O
the    O
synthesis    O
of    O
melanin    O
,    O
these    O
studies    O
suggest    O
that    O
FP    O
receptor    O
activation    O
may    O
be    O
a    O
useful    O
means    O
to    O
increase    O
skin    O
pigmentation    O
.    O

Keratin    O
5    O
(    O
and    O
K14    O
)    O
are    O
expressed    O
primarily    O
in    O
basal    O
keratinocyte    B-Cell102991711
in    O
the    O
epidermis    O
,    O
specifically    O
in    O
the    O
stratified    O
epithelium    O
lining    O
the    O
skin    O
and    O
digestive    O
tract    O
.    O

Careful    O
and    O
detailed    O
documentation    O
concerning    O
the    O
characteristics    O
of    O
the    O
starting    O
materials    O
(    O
e.g.    O
history    O
of    O
the    O
cell    O
line    O
derivation    O
and    O
cell    B-Cell102991711
bank    I-Cell102991711
)    O
and    O
manufacturing    O
process    O
steps    O
(    O
e.g.    O
procurement    O
of    O
tissue    O
or    O
cells    O
and    O
manipulation    O
)    O
must    O
be    O
maintained    O
.    O

Upon    O
infecting    O
a    O
resting    O
naive    B-Cell102991711
B    I-Cell102991711
cell    I-Cell102991711
,    O
EBV    O
enters    O
Latency    O
III    O
.    O

Magnocellular    B-Cell102991711
neurons    I-Cell102991711
:    O

In    O
mammals    O
,    O
magnocellular    B-Cell102991711
neurosecretory    I-Cell102991711
cell    I-Cell102991711
in    O
the    O
paraventricular    O
nucleus    O
and    O
the    O
supraoptic    O
nucleus    O
of    O
the    O
hypothalamus    O
produce    O
neurohypophysial    O
hormones    O
,    O
oxytocin    O
and    O
vasopressin    O
.    O

The    O
activation    O
of    O
a    O
resting    O
helper    O
T    O
cell    O
causes    O
it    O
to    O
release    O
cytokines    O
and    O
other    O
stimulatory    O
signals    O
(    O
green    O
arrows    O
)    O
that    O
stimulate    O
the    O
activity    O
of    O
macrophages    O
,    O
killer    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
and    O
B    B-Cell102991711
cell    I-Cell102991711
,    O
the    O
latter    O
producing    O
antibodies    O
.    O

Higher    O
MHC    O
I    O
expression    O
increases    O
presentation    O
of    O
viral    O
peptides    O
to    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
,    O
while    O
the    O
immunoproteasome    O
processes    O
viral    O
peptides    O
for    O
loading    O
onto    O
the    O
MHC    O
I    O
molecule    O
,    O
thereby    O
increasing    O
the    O
recognition    O
and    O
killing    O
of    O
infected    O
cells    O
.    O

They    O
found    O
consistent    O
stress    O
-    O
related    O
increases    O
in    O
numbers    O
of    O
total    O
white    O
blood    O
cells    O
,    O
as    O
well    O
as    O
decreases    O
in    O
the    O
numbers    O
of    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
suppressor    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
Natural    B-Cell102991711
killer    I-Cell102991711
cells    O
(    O
NK    O
)    O
.    O

Naturalistic    O
stressors    O
were    O
associated    O
with    O
increases    O
in    O
number    O
of    O
circulating    O
neutrophils    O
,    O
decreases    O
in    O
number    O
and    O
percentages    O
of    O
total    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
and    O
decreases    O
in    O
percentages    O
of    O
Natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
(    O
NK    O
)    O
cells    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
lymphocytes    O
.    O

Interleukin-21    O
is    O
a    O
cytokine    O
that    O
has    O
potent    O
regulatory    O
effects    O
on    O
cells    O
of    O
the    O
immune    O
system    O
,    O
including    O
natural    B-Cell102991711
killer    I-Cell102991711
(    O
NK    O
)    O
cells    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
that    O
can    O
destroy    O
virally    O
infected    O
or    O
cancerous    O
cells    O
.    O

Besides    O
,    O
these    O
mice    O
with    O
impaired    O
IL-21    O
signaling    O
had    O
more    O
dramatic    O
exhaustion    O
of    O
LCMV    O
-    O
specific    O
CD8+    B-Cell102991711
T    B-Cell102991711
cell    I-Cell102991711
,    O
suggesting    O
that    O
IL-21    O
produced    O
by    O
CD4+    B-Cell102991711
T    O
cells    O
is    O
required    O
for    O
sustained    O
CD8    O
+    O
T    O
cell    O
effector    O
activity    O
and    O
then    O
,    O
for    O
maintaining    O
immunity    O
to    O
resolve    O
persistent    O
viral    O
infection    O
.    O

More    O
recently    O
it    O
has    O
been    O
shown    O
to    O
be    O
a    O
marker    O
for    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
and    O
a    O
subgroup    O
of    O
Natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
.    O

Arsenic    O
exposure    O
in    O
small    O
children    O
distorts    O
the    O
ratio    O
of    O
T    B-Cell102991711
helper    I-Cell102991711
cell    I-Cell102991711
(    O
CD4    O
)    O
to    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
(    O
CD8    O
)    O
,    O
which    O
are    O
responsible    O
for    O
immunodepression    O
.    O

CD8    O
+    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
:    O
virus    O
-    O
infected    O
and    O
tumor    O
cells    O
.    O

CD8    O
+    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
:    O
T    O
cells    O
displaying    O
co    O
-    O
receptor    O
CD8    O
are    O
known    O
as    O
CD8    O
+    O
T    O
cells    O
.    O

hampered    O
immune    O
defences    O
against    O
viral    O
pathogens    O
,    O
especially    O
by    O
cytotoxic    B-Cell102991711
CD8+    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711

MHC    O
class    O
I    O
are    O
found    O
on    O
all    O
cells    O
and    O
stimulate    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
(    O
CD8    O
cells    O
)    O
,    O
and    O
MHC    O
class    O
II    O
are    O
found    O
on    O
APCs    O
and    O
stimulate    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
(    O
CD4    O
cells    O
)    O
.    O

Lymphocytes    O
of    O
specific    O
immunity    O
T    B-Cell102991711
cell    I-Cell102991711
—    O
including    O
the    O
subclasses    O
helper    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
and    O
killer    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
—    O
and    O
B    B-Cell102991711
cell    I-Cell102991711
.    O

Alloreactive    O
killer    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
also    O
called    O
cytotoxic    O
T    O
lymphocytes    O
(    O
CTLs    O
)    O
,    O
have    O
CD8    O
receptors    O
that    O
dock    O
to    O
the    O
transplanted    O
tissue    O
's    O
MHC    O
class    O
I    O
molecules    O
,    O
which    O
display    O
the    O
donor    O
's    O
self    O
peptides    O
.    O

CD8    O
+    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
.    O

Cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711

CD94/NKG2    O
is    O
a    O
family    O
of    O
C    O
-    O
type    O
lectin    O
receptors    O
which    O
are    O
expressed    O
predominantly    O
on    O
the    O
surface    O
of    O
NK    B-Cell102991711
cells    I-Cell102991711
and    O
a    O
subset    O
of    O
CD8+    B-Cell102991711
T-lymphocyte    I-Cell102991711
.    O

Usually    O
the    O
terms    O
CD8    O
+    O
,    O
CD8    O
+    O
cell    O
,    O
CD8    O
T    O
cell    O
,    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
are    O
interchangeable    O
.    O

They    O
become    O
activated    O
and    O
start    O
to    O
secrete    O
cytokines    O
,    O
substances    O
that    O
activate    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
lymphocytes    I-Cell102991711
(    O
CTL    O
)    O
,    O
antibody    O
-    O
secreting    O
B    B-Cell102991711
cell    I-Cell102991711
,    O
macrophages    O
and    O
other    O
particles    O
.    O

If    O
activated    O
cytotoxic    B-Cell102991711
CD8+    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
recognize    O
them    O
,    O
the    O
T    O
cells    O
secrete    O
various    O
toxins    O
that    O
cause    O
the    O
lysis    O
or    O
apoptosis    O
of    O
the    O
infected    O
cell    O
.    O

Cytotoxic    B-Cell102991711
T    I-Cell102991711
lymphocytes    I-Cell102991711
that    O
recognize    O
these    O
antigens    O
may    O
be    O
able    O
to    O
destroy    O
tumor    O
cells    O
.    O

Cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
(    O
also    O
known    O
as    O
Tc    O
,    O
killer    O
T    O
cell    O
,    O
or    O
cytotoxic    O
T    O
-    O
lymphocyte    O
(    O
CTL    O
)    O
)    O
express    O
CD8    O
coreceptor    O
are    O
a    O
population    O
of    O
T    O
cells    O
that    O
are    O
specialised    O
for    O
inducing    O
programmed    O
cell    O
death    O
of    O
other    O
cells    O
.    O

Cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
regularly    O
patrol    O
all    O
body    O
cells    O
to    O
maintain    O
the    O
organismal    O
homeostasis    O
.    O

Naïve    O
anti    O
-    O
viral    O
T    B-Cell102991711
cells    I-Cell102991711
(    O
CD8+    B-Cell102991711
)    O
can    O
not    O
directly    O
eliminate    O
transformed    O
or    O
infected    O
cells    O
.    O

Elevated    O
expression    O
levels    O
of    O
CCL2/MCP-1    O
,    O
CCL5/RANTES    O
and    O
CCL17/TARC    O
which    O
result    O
in    O
chemoattracted    O
CD4    O
+    O
and    O
CD8+    B-Cell102991711
T    O
cell    O
populations    O
to    O
the    O
surrounding    O
area    O
may    O
be    O
responsible    O
for    O
exerting    O
a    O
downmodulatory    O
effect    O
on    O
the    O
AchE    O
and    O
CHRM3    O
expressions    O
.    O

CD8+    B-Cell102991711
T    O
-    O
lymphocyte    O
count    O

They    O
are    O
thought    O
to    O
assume    O
a    O
more    O
"    O
quiescent    B-Cell102991711
"    O
phenotype    O
.    O

This    O
blocks    O
the    O
progression    O
of    O
mitosis    O
due    O
to    O
a    O
prolonged    O
activation    O
of    O
the    O
microtubule    O
in    O
the    O
mitotic    O
checkpoint    O
,    O
resulting    O
in    O
cell    O
apoptosis    O
or    O
reversion    O
to    O
the    O
G0    B-Cell102991711
phase    I-Cell102991711
.    O

Other    O
experiments    O
demonstrated    O
that    O
quiescent    B-Cell102991711
rat    O
thyroid    O
cells    O
entering    O
S    O
phase    O
as    O
a    O
result    O
of    O
thyroid    O
-    O
stimulating    O
hormone    O
treatment    O
was    O
matched    O
with    O
a    O
concurrent    O
increase    O
in    O
asparagine    O
synthetase    O
mRNA    O
content    O
.    O

IRS-1    O
inhibiting    O
the    O
cell    O
cycle    O
from    O
progressing    O
from    O
G0    B-Cell102991711
S    O
phase    O
.    O

The    O
biological    O
process    O
in    O
which    O
a    O
cell    O
ceases    O
to    O
continue    O
growing    O
and    O
dividing    O
is    O
called    O
quiescence    B-Cell102991711
(    O
the    O
opposite    O
of    O
cancer    O
)    O
.    O

The    O
binding    O
of    O
Hsp70    O
to    O
BAG-1    O
diminishes    O
Raf-1    O
signalling    O
and    O
inhibits    O
subsequent    O
events    O
,    O
such    O
as    O
DNA    O
synthesis    O
,    O
as    O
well    O
as    O
arrests    O
the    O
cell    O
cycle    O
.    O
BAG-1    O
has    O
been    O
suggested    O
to    O
function    O
as    O
a    O
molecular    O
switch    O
that    O
encourages    O
cells    O
to    O
proliferate    O
in    O
normal    O
conditions    O
but    O
become    O
quiescent    B-Cell102991711
under    O
a    O
stressful    O
environment    O
.    O

In    O
molecular    O
biology    O
,    O
extracellular    O
signal    O
–    O
regulated    O
kinases    O
(    O
ERKs    O
)    O
or    O
classical    O
MAP    O
kinases    O
are    O
widely    O
expressed    O
protein    O
kinase    O
intracellular    O
signalling    O
molecules    O
that    O
are    O
involved    O
in    O
functions    O
including    O
the    O
regulation    O
of    O
meiosis    O
,    O
mitosis    O
,    O
and    O
postmitotic    B-Cell102991711
functions    O
in    O
differentiated    O
cells    O
.    O

Basophil    B-Cell102991711
activation    I-Cell102991711

Distinctive    O
features    O
(    O
Brodmann-1905    O
)    O
:    O
a    O
wide    O
,    O
dense    O
internal    O
granular    B-Cell102991711
cell    I-Cell102991711
layer    O
(    O
IV    O
)    O
;    O
a    O
distinct    O
sublayer    O
3b    O
of    O
closely    O
packed    O
large    O
pyramidal    O
cells    O
positioned    O
in    O
the    O
external    O
pyramidal    O
layer    O
(    O
III    O
)    O
directly    O
above    O
layer    O
IV    O
;    O
an    O
almost    O
cell    O
-    O
free    O
,    O
narrow    O
internal    O
pyramidal    O
layer    O
(    O
V    O
)    O
with    O
no    O
larger    O
ganglion    O
cells    O
;    O
a    O
very    O
narrow    O
,    O
dense    O
multiform    O
layer    O
(    O
VI    O
)    O
composed    O
of    O
small    O
polymorphic    O
cells    O
that    O
form    O
a    O
distinct    O
boundary    O
with    O
the    O
underlying    O
subcortical    O
white    O
matter    O
.    O

Extraglomerular    O
mesangial    O
cells    O
are    O
part    O
of    O
the    O
juxtaglomerular    O
apparatus    O
,    O
along    O
with    O
the    O
macula    B-Cell102991711
densa    I-Cell102991711
cells    O
of    O
the    O
distal    O
convoluted    O
tubule    O
and    O
the    O
juxtaglomerular    B-Cell102991711
cells    I-Cell102991711
of    O
the    O
afferent    O
arteriole    O
.    O

It    O
contains    O
three    O
components    O
:    O
the    O
macula    B-Cell102991711
densa    I-Cell102991711
,    O
juxtaglomerular    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
extraglomerular    B-Cell102991711
mesangial    I-Cell102991711
cell    I-Cell102991711
.    O

The    O
juxtaglomerular    B-Cell102991711
cells    I-Cell102991711
(    O
JG    B-Cell102991711
cells    I-Cell102991711
,    O
or    O
granular    B-Cell102991711
cells    I-Cell102991711
)    O
are    O
cells    O
in    O
the    O
kidney    O
that    O
synthesize    O
,    O
store    O
,    O
and    O
secrete    O
the    O
enzyme    O
renin    O
.    O

It    O
also    O
is    O
produced    O
by    O
brown    O
adipose    O
tissue    O
,    O
placenta    O
(    O
syncytiotrophoblasts    O
)    O
,    O
ovaries    O
,    O
skeletal    O
muscle    O
,    O
stomach    O
(    O
the    O
lower    O
part    O
of    O
the    O
fundic    O
glands    O
)    O
,    O
mammary    O
epithelial    O
cells    O
,    O
bone    O
marrow    O
,    O
gastric    O
chief    O
cells    O
and    O
P/D1    B-Cell102991711
cell    I-Cell102991711
.    O

Chromaffin    B-Cell102991711
cell    I-Cell102991711
contained    O
in    O
the    O
adrenal    O
medulla    O
act    O
as    O
postganglionic    O
nerve    O
fibers    O
that    O
release    O
this    O
chemical    O
response    O
into    O
the    O
blood    O
as    O
circulating    O
messenger    O
.    O

It    O
was    O
developed    O
in    O
parallel    O
to    O
the    O
adrenal    O
chromaffin    B-Cell102991711
cell    I-Cell102991711
model    O
because    O
of    O
its    O
extreme    O
versatility    O
for    O
pharmacological    O
manipulation    O
,    O
ease    O
of    O
culture    O
,    O
and    O
the    O
large    O
amount    O
of    O
information    O
on    O
their    O
proliferation    O
and    O
differentiation    O
.    O

Enterochromaffin    B-Cell102991711
cell    I-Cell102991711
are    O
enteroendocrine    O
and    O
neuroendocrine    B-Cell102991711
cell    I-Cell102991711
with    O
a    O
close    O
similarity    O
to    O
adrenomedullary    O
chromaffin    B-Cell102991711
cell    I-Cell102991711
secreting    O
serotonin    O
and    O
histamine    O
.    O

The    O
chromaffin    B-Cell102991711
cell    I-Cell102991711
of    O
the    O
medulla    O
are    O
the    O
body    O
's    O
main    O
source    O
of    O
the    O
catecholamines    O
adrenaline    O
and    O
noradrenaline    O
,    O
released    O
by    O
the    O
medulla    O
.    O

Cells    O
of    O
the    O
adrenal    O
medulla    O
are    O
called    O
chromaffin    B-Cell102991711
cells    I-Cell102991711
because    O
they    O
contain    O
granules    O
that    O
stain    O
with    O
chromium    O
salts    O
,    O
a    O
characteristic    O
not    O
present    O
in    O
all    O
sympathetic    O
organs    O
.    O

Pheochromocytomas    O
are    O
tumors    O
of    O
the    O
adrenal    O
medulla    O
that    O
arise    O
from    O
chromaffin    B-Cell102991711
cell    I-Cell102991711
.    O

Carboxypeptidase    O
E    O
is    O
found    O
in    O
brain    O
and    O
throughout    O
the    O
neuroendocrine    O
system    O
,    O
including    O
the    O
endocrine    O
pancreas    O
,    O
pituitary    O
,    O
and    O
adrenal    O
gland    O
chromaffin    B-Cell102991711
cell    I-Cell102991711
.    O

For    O
example    O
,    O
a    O
lower    O
plating    O
density    O
makes    O
granulosa    B-Cell102991711
cell    I-Cell102991711
exhibit    O
estrogen    O
production    O
,    O
while    O
a    O
higher    O
plating    O
density    O
makes    O
them    O
appear    O
as    O
progesterone    O
-    O
producing    O
theca    O
lutein    O
cells    O
.    O

However    O
,    O
there    O
is    O
partial    O
anovulation    O
and    O
subfertility    O
,    O
which    O
is    O
due    O
to    O
ovarian    O
defects    O
,    O
namely    O
compromised    O
follicular    O
maturation    O
via    O
loss    O
of    O
estradiol    O
signaling    O
in    O
ovarian    O
granulosa    B-Cell102991711
cell    I-Cell102991711
.    O

Expression    O
of    O
CYP17A1    O
has    O
been    O
found    O
in    O
all    O
of    O
the    O
traditional    O
steroidogenic    O
tissues    O
except    O
the    O
placenta    O
,    O
including    O
the    O
zona    O
reticularis    O
and    O
zona    O
fasciculata    O
of    O
the    O
adrenal    O
cortex    O
,    O
the    O
Leydig    B-Cell102991711
cell    I-Cell102991711
of    O
the    O
testes    O
,    O
the    O
thecal    O
cells    O
of    O
the    O
ovaries    O
,    O
and    O
,    O
more    O
recently    O
,    O
in    O
luteinized    O
granulosa    B-Cell102991711
cell    I-Cell102991711
in    O
ovarian    O
follicles    O
.    O

For    O
ovulation    O
to    O
be    O
successful    O
,    O
the    O
ovum    O
must    O
be    O
supported    O
by    O
the    O
corona    O
radiata    O
and    O
cumulus    O
oophorous    O
granulosa    B-Cell102991711
cell    I-Cell102991711
.    O

Although    O
the    O
oocytes    O
are    O
surrounded    O
by    O
a    O
layer    O
of    O
granulosa    B-Cell102991711
cells    O
harbouring    O
high    O
levels    O
of    O
active    O
lipoprotein    O
lipase    O
,    O
non    O
-    O
lipolysed    O
VLDL    O
is    O
transported    O
into    O
the    O
yolk    O
.    O

The    O
follicular    O
theca    O
cells    O
luteinize    O
into    O
small    O
luteal    O
cells    O
(    O
thecal    O
-    O
lutein    O
cells    O
)    O
and    O
follicular    O
granulosa    B-Cell102991711
cell    I-Cell102991711
luteinize    O
into    O
large    O
luteal    O
cells    O
(    O
granulosal    O
-    O
lutein    O
cells    O
)    O
forming    O
the    O
corpus    O
luteum    O
.    O

|    O
Granulosa    B-Cell102991711
cell    I-Cell102991711

It    O
is    O
thin    O
-    O
walled    O
,    O
lined    O
by    O
one    O
or    O
more    O
layers    O
of    O
granulosa    B-Cell102991711
cell    O
,    O
and    O
filled    O
with    O
clear    O
fluid    O
.    O

CYSLTR1    O
mRNA    O
is    O
expressed    O
in    O
lung    O
smooth    O
muscle    O
,    O
lung    O
macrophages    O
,    O
monocytes    O
,    O
eosinophils    O
,    O
basophils    O
,    O
neutrophils    O
,    O
platelets    O
,    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
B    B-Cell102991711
lymphocytes    I-Cell102991711
,    O
pluripotent    O
hematopoietic    O
stem    O
cells    O
(    O
CD34    O
+    O
)    O
,    O
mast    O
cells    O
,    O
pancreas    O
,    O
small    O
intestine    O
,    O
prostate    O
,    O
interstitial    B-Cell102991711
cell    I-Cell102991711
of    O
the    O
nasal    O
mucosa    O
,    O
airway    O
smooth    O
muscle    O
cells    O
,    O
bronchial    O
fibroblasts    O
and    O
vascular    O
endothelial    O
cells    O
.    O

A    O
contusion    O
,    O
commonly    O
known    O
as    O
a    O
bruise    O
,    O
is    O
a    O
type    O
of    O
hematoma    O
of    O
tissue    O
in    O
which    O
capillaries    O
and    O
sometimes    O
venules    O
are    O
damaged    O
by    O
trauma    O
,    O
allowing    O
blood    O
to    O
seep    O
,    O
hemorrhage    O
,    O
or    O
extravasate    O
into    O
the    O
surrounding    O
interstitial    B-Cell102991711
tissues    O
.    O

Among    O
other    O
things    O
,    O
this    O
technique    O
is    O
used    O
to    O
isolate    O
specific    O
cell    O
types    O
(    O
e.g.    O
,    O
guard    B-Cell102991711
cells    I-Cell102991711
from    O
leaves    O
,    O
pericycle    O
cells    O
from    O
roots    O
)    O
for    O
further    O
investigations    O
,    O
such    O
as    O
transcriptomics    O
.    O

Whereas    O
most    O
land    O
plants    O
'    O
stomata    O
have    O
guard    B-Cell102991711
cells    I-Cell102991711
with    O
chloroplasts    O
in    O
their    O
cytoplasm    O
(    O
including    O
those    O
of    O
closely    O
related    O
"    O
Phragmipedium    O
"    O
slipper    O
orchids    O
)    O
,    O
"    O
Paphiopedilum    O
"    O
stomata    O
do    O
not    O
.    O

These    O
cells    O
,    O
along    O
with    O
the    O
epidermal    O
guard    B-Cell102991711
cell    I-Cell102991711
of    O
the    O
stoma    O
,    O
form    O
a    O
system    O
of    O
air    O
spaces    O
and    O
chambers    O
that    O
regulate    O
the    O
exchange    O
of    O
gases    O
.    O

Carcinoma    O
associated    O
fibroblasts    O
(    O
CAFs    O
)    O
are    O
a    O
heterogenous    O
group    O
of    O
fibroblasts    O
whose    O
function    O
is    O
pirated    O
by    O
cancer    O
cells    O
and    O
redirected    O
toward    O
carcinogenesis    O
These    O
cells    O
are    O
usually    O
derived    O
from    O
the    O
normal    O
fibroblasts    O
in    O
the    O
surrounding    O
stroma    O
but    O
can    O
also    O
come    O
from    O
pericyte    B-Cell102991711
,    O
smooth    O
muscle    O
cells    O
,    O
fibrocyte    B-Cell102991711
,    O
mesenchymal    O
stem    O
cells    O
(    O
MSCs    O
,    O
often    O
derived    O
from    O
bone    O
marrow    O
)    O
,    O
or    O
via    O
epithelial-mesenchymal    B-Cell102991711
transition    I-Cell102991711
(    O
EMT    O
)    O
or    O
endothelial    O
-    O
mesenchymal    O
transition    O
(    O
EndMT    O
)    O
.    O

The    O
usage    O
of    O
the    O
term    O
is    O
most    O
vocally    O
supported    O
by    O
Lynn    O
Margulis    O
,    O
especially    O
in    O
support    O
of    O
her    O
endosymbiotic    B-Cell102991711
theory    I-Cell102991711
.    O

According    O
to    O
endosymbiotic    B-Cell102991711
theory    I-Cell102991711
,    O
extreme    O
cases    O
of    O
primary    O
endosymbionts    O
include    O
mitochondria    O
,    O
plastids    O
(    O
including    O
chloroplasts    O
)    O
,    O
and    O
possibly    O
other    O
organelles    O
of    O
eukaryotic    O
cells    O
.    O

The    O
existence    O
of    O
these    O
cytoplasmic    O
genomes    O
is    O
consistent    O
with    O
,    O
and    O
counts    O
as    O
evidence    O
for    O
,    O
the    O
endosymbiont    B-Cell102991711
hypothesis    I-Cell102991711
.    O

Viral    O
eukaryogenesis    O
is    O
the    O
hypothesis    O
that    O
the    O
cell    O
nucleus    O
of    O
eukaryotic    O
life    O
forms    O
evolved    O
from    O
a    O
large    O
DNA    O
virus    O
in    O
a    O
form    O
of    O
endosymbiosis    B-Cell102991711
within    O
a    O
methanogenic    O
archaeon    O
.    O

Lake    O
's    O
research    O
focuses    O
in    O
four    O
areas    O
:    O
prokaryotic    O
ancestors    O
of    O
eukaryotes    O
,    O
evidence    O
for    O
early    O
prokaryotic    O
endosymbioses    B-Cell102991711
,    O
genomic    O
analyses    O
,    O
and    O
rooting    O
of    O
the    O
biological    O
tree    O
of    O
life    O
.    O

Diagram    O
according    O
to    O
symbiogenetic    B-Cell102991711
origin    O
of    O
plant    O
cells    O
,    O
and    O
phylogeny    O
of    O
algae    O
,    O
bryophytes    O
,    O
vascular    O
plants    O
,    O
and    O
flowering    O
plants    O
..    O

A    B-Cell102991711
generally    I-Cell102991711
accepted    I-Cell102991711
hypothesis    I-Cell102991711
is    O
that    O
mitochondria    O
originated    O
as    O
an    O
aerobic    O
prokaryote    O
in    O
a    O
symbiotic    O
relationship    O
within    O
an    O
anaerobic    O
eukaryote    O
.    O

There    O
are    O
two    O
hypotheses    O
about    O
the    O
origin    O
of    O
mitochondria    O
:    O
endosymbiotic    B-Cell102991711
and    O
autogenous    O
.    O

The    O
endosymbiotic    B-Cell102991711
hypothesis    I-Cell102991711
suggests    O
that    O
mitochondria    O
descended    O
from    O
bacteria    O
that    O
somehow    O
survived    O
endocytosis    O
by    O
another    O
cell    O
,    O
and    O
became    O
incorporated    O
into    O
the    O
cytoplasm    O
.    O

Within    O
the    O
hologenome    O
theory    O
,    O
the    O
holobiont    O
has    O
not    O
only    O
become    O
the    O
principal    O
unit    O
of    O
natural    O
selection    O
but    O
also    O
the    O
result    O
of    O
other    O
step    O
of    O
integration    O
that    O
it    O
is    O
also    O
observed    O
at    O
the    O
cell    O
(    O
symbiogenesis    B-Cell102991711
,    O
endosymbiosis    O
)    O
and    O
genomic    O
levels    O
.    O

Andrey    O
Famintsyn    O
,    O
plant    O
physiologist    O
,    O
inventor    O
of    O
grow    O
lamp    O
,    O
developer    O
of    O
symbiogenesis    B-Cell102991711
theory    O

Konstantin    O
Merezhkovsky    O
,    O
major    O
lichenologist    O
,    O
developer    O
of    O
symbiogenesis    B-Cell102991711
theory    O
,    O
a    O
founder    O
of    O
endosymbiosis    O
theory    O

It    O
originated    O
from    O
an    O
alga    O
(    O
there    O
is    O
debate    O
as    O
to    O
whether    O
this    O
was    O
a    O
green    O
or    O
red    O
alga    O
)    O
through    O
secondary    B-Cell102991711
endosymbiosis    I-Cell102991711
.    O

This    O
earliest    O
plant    O
molecular    O
biology    O
phase    O
of    O
Mucke    O
's    O
work    O
concerned    O
the    O
characterization    O
and    O
partial    O
sequencing    O
of    O
the    O
"    O
Cyanophora    O
"    O
cyanelle    O
genome    O
,    O
believed    O
to    O
resemble    O
early    O
stages    O
of    O
chloroplast    O
evolution    O
according    O
to    O
the    O
endosymbiotic    B-Cell102991711
theory    I-Cell102991711
.    O

As    O
such    O
,    O
the    O
organism    O
was    O
potentially    O
a    O
modern    O
analogue    O
of    O
the    O
ancestral    O
eukaryote    O
that    O
,    O
according    O
to    O
the    O
theory    B-Cell102991711
of    I-Cell102991711
serial    I-Cell102991711
endosymbiosis    I-Cell102991711
,    O
internalized    O
the    O
bacterial    O
symbiont    O
that    O
later    O
evolved    O
into    O
the    O
mitochondria    O
of    O
the    O
modern    O
cell    O
.    O

Endosymbiotic    B-Cell102991711
theory    I-Cell102991711
–    O

Konstantin    O
Mereschkowski    O
–    O
Russian    O
botanist    O
who    O
in    O
1905    O
described    O
the    O
Theory    B-Cell102991711
of    I-Cell102991711
Endosymbiosis    I-Cell102991711
.    O

This    O
concept    O
is    O
often    O
termed    O
the    O
endosymbiotic    B-Cell102991711
theory    I-Cell102991711
.    O

Mucosal    B-Cell102991711
associated    I-Cell102991711
invariant    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
a    O
hitherto    O
little    O
-    O
known    O
T    B-Cell102991711
cell    I-Cell102991711
type    O
.    O

Hyperactivated    O
Notch    O
causes    O
a    O
reduction    O
in    O
the    O
number    O
of    O
secretory    O
cell    O
types    O
(    O
i.e.    O
goblet    O
cells    O
,    O
enteroendocrine    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
Paneth    B-Cell102991711
cells    I-Cell102991711
)    O
.    O

In    O
an    O
accompanying    O
editorial    O
,    O
Pasquale    O
Accardo    O
and    O
Howard    O
Bostwick    O
of    O
New    O
York    O
Medical    O
College    O
wrote    O
that    O
Horvath    O
's    O
study    O
"    O
demonstrates    O
consistent    O
physiologic    O
abnormalities    O
(    O
increased    O
density    O
of    O
Paneth’s    B-Cell102991711
cell    I-Cell102991711
along    O
with    O
diminished    O
pancreatic    O
secretin    O
secretion    O
)    O
in    O
autism    O
that    O
are    O
not    O
known    O
to    O
occur    O
in    O
any    O
other    O
specific    O
gastrointestinal    O
disorder    O
.    O
"    O

The    O
goblet    O
cell    O
carcinoid    O
,    O
abbreviated    O
GCC    O
and    O
also    O
known    O
as    O
crypt    O
cell    O
carcinoma    O
and    O
neuroendocrine    O
tumour    O
with    O
goblet    O
cell    O
differentiation    O
,    O
is    O
a    O
rare    O
biphasic    O
gastrointestinal    O
tract    O
tumour    O
that    O
consists    O
of    O
a    O
neuroendocrine    O
component    O
and    O
a    O
conventional    O
carcinoma    O
,    O
histologically    O
arising    O
from    O
Paneth    B-Cell102991711
cell    I-Cell102991711
.    O

They    O
have    O
double    O
-    O
layered    O
cell    O
walls    O
and    O
mesosome    B-Cell102991711
.    O

A    O
prominent    O
example    O
is    O
the    O
bacterial    O
"    O
mesosome    B-Cell102991711
"    O
,    O
which    O
was    O
thought    O
to    O
be    O
an    O
organelle    O
in    O
gram    O
-    O
positive    O
bacteria    O
in    O
the    O
1970s    O
,    O
but    O
was    O
later    O
shown    O
by    O
new    O
techniques    O
developed    O
for    O
electron    O
microscopy    O
to    O
be    O
simply    O
an    O
artifact    O
of    O
chemical    O
fixation    O
.    O

The    O
gaps    O
between    O
endothelial    O
cells    O
(    O
cell    B-Cell102991711
junction    I-Cell102991711
)    O
are    O
strictly    O
regulated    O
depending    O
on    O
the    O
type    O
and    O
physiological    O
state    O
of    O
the    O
tissue    O
.    O

Cell    B-Cell102991711
junctions    I-Cell102991711
allow    O
cells    O
to    O
adhere    O
to    O
one    O
another    O
in    O
multicellular    O
organisms    O
.    O

EBs    O
are    O
formed    O
by    O
the    O
homophilic    B-Cell102991711
binding    I-Cell102991711
of    O
the    O
Ca2    O
+    O
dependent    O
adhesion    O
molecule    O
E    O
-    O
cadherin    O
,    O
which    O
is    O
highly    O
expressed    O
on    O
undifferentiated    O
ESCs    O
.    O

Three    O
types    O
of    O
cell    B-Cell102991711
junction    I-Cell102991711
make    O
up    O
an    O
intercalated    O
disc    O
—    O
fascia    O
adherens    O
,    O
desmosomes    O
and    O
gap    O
junctions    O
.    O

In    O
the    O
epithelium    O
the    O
cells    O
'    O
reads    O
'    O
its    O
shape    O
through    O
the    O
specific    O
cell    B-Cell102991711
junction    I-Cell102991711
called    O
tricellular    O
junctions    O
(    O
TCJ    O
)    O
.    O

When    O
the    O
cells    O
number    O
around    O
sixteen    O
the    O
solid    O
sphere    O
of    O
cells    O
within    O
the    O
zona    O
pellucida    O
is    O
referred    O
to    O
as    O
a    O
morula    O
At    O
this    O
stage    O
the    O
cells    O
start    O
to    O
bind    B-Cell102991711
firmly    O
together    O
in    O
a    O
process    O
called    O
compaction    O
,    O
and    O
cleavage    O
continues    O
as    O
cellular    O
differentiation    O
.    O

The    O
inner    O
limiting    O
membrane    O
is    O
the    O
boundary    O
between    O
the    O
retina    O
and    O
the    O
vitreous    O
body    O
,    O
formed    O
by    O
astrocytes    O
and    O
the    O
end    O
feet    O
of    O
Müller    B-Cell102991711
cells    I-Cell102991711
.    O

For    O
example    O
,    O
activation    O
of    O
Notch    O
signaling    O
in    O
the    O
retina    O
favors    O
the    O
generation    O
of    O
Muller    B-Cell102991711
glia    I-Cell102991711
cells    O
at    O
the    O
expense    O
of    O
neurons    O
,    O
whereas    O
reduced    O
Notch    O
signaling    O
induces    O
production    O
of    O
ganglion    O
cells    O
,    O
causing    O
a    O
reduction    O
in    O
the    O
number    O
of    O
Muller    O
glia    O
.    O

In    O
the    O
retina    O
,    O
GLAST    O
is    O
expressed    O
in    O
Muller    B-Cell102991711
cell    I-Cell102991711
.    O

DNIC    O
refers    O
to    O
the    O
mechanism    O
by    O
which    O
dorsal    O
horn    O
wide    B-Cell102991711
dynamic    I-Cell102991711
range    I-Cell102991711
neuron    I-Cell102991711
responsive    O
to    O
stimulation    O
from    O
one    O
location    O
of    O
the    O
body    O
may    O
be    O
inhibited    O
by    O
noxious    O
stimuli    O
(    O
such    O
as    O
heat    O
,    O
high    O
pressure    O
or    O
electric    O
stimulation    O
)    O
applied    O
to    O
another    O
,    O
remote    O
location    O
in    O
the    O
body    O
.    O

Limb    O
formation    O
results    O
from    O
series    O
of    O
epithelial-mesenchymal    B-Cell102991711
inductions    O
between    O
the    O
mesenchymal    O
cells    O
of    O
the    O
lateral    O
plate    O
mesoderm    O
and    O
the    O
overlying    O
ectodermal    O
cells    O
.    O

DNA    O
methylation    O
of    O
the    O
mir-200c    O
/    O
mir-141    O
promoter    O
occurs    O
aberrantly    O
in    O
certain    O
aggressive    O
carcinoma    O
cells    O
that    O
are    O
of    O
epithelial    O
origin    O
,    O
but    O
have    O
undergone    O
epithelial    B-Cell102991711
to    I-Cell102991711
mesenchymal    I-Cell102991711
transition    I-Cell102991711
and    O
have    O
the    O
mir-200    O
family    O
silenced    O
.    O

The    O
miR-200    O
family    O
is    O
believed    O
to    O
play    O
an    O
essential    O
role    O
in    O
tumor    O
suppression    O
by    O
inhibiting    O
epithelial-mesenchymal    B-Cell102991711
transition    I-Cell102991711
(    O
EMT    O
)    O
,    O
the    O
initiating    O
step    O
of    O
metastasis    O
(    O
Korpal    O
)    O
.    O

Colorectal    O
cancer    O
:    O
MiR-200a    O
regulates    O
epithelial    B-Cell102991711
to    I-Cell102991711
mesenchymal    I-Cell102991711
transition    I-Cell102991711
-    O
related    O
gene    O
expression    O
and    O
determines    O
prognosis    O
in    O
colorectal    O
cancer    O
patients    O
.    O

Studies    O
has    O
shown    O
that    O
—    O
by    O
targeting    O
the    O
transcriptional    O
repressors    O
of    O
E    O
-    O
cadherin    O
,    O
ZEB1    O
and    O
ZEB2    O
miR-205    O
is    O
involved    O
in    O
epithelial    B-Cell102991711
to    I-Cell102991711
mesenchymal    I-Cell102991711
transition    I-Cell102991711
(EMT)    I-Cell102991711
and    O
tumor    O
invasion    O
.    O

More    O
recent    O
transcriptional    O
analysis    O
suggests    O
that    O
chronically    O
impeded    O
extracellular    O
matrix    O
turnover    O
and    O
epithelium-to-mesenchyme    B-Cell102991711
transitions    I-Cell102991711
in    O
neglected    O
scar    O
tissue    O
might    O
give    O
rise    O
to    O
this    O
malignancy    O
.    O

As    O
a    O
result    O
of    O
the    O
three    O
-    O
dimensional    O
EB    O
structure    O
,    O
complex    O
morphogenesis    O
occurs    O
during    O
EB    O
differentiation    O
,    O
including    O
the    O
appearance    O
of    O
both    O
epithelial-    O
and    O
mesenchymal    O
-    O
like    O
cell    O
populations    O
,    O
as    O
well    O
as    O
the    O
appearance    O
of    O
markers    O
associated    O
with    O
the    O
epithelial-mesenchymal    B-Cell102991711
transition    I-Cell102991711
(    O
EMT    O
)    O
.    O

Cadherins    O
play    O
a    O
vital    O
role    O
in    O
the    O
migration    O
of    O
cells    O
through    O
the    O
the    O
epithelial-mesenchymal    B-Cell102991711
transition    I-Cell102991711
(EMT)    I-Cell102991711
,    O
which    O
requires    O
cadherins    O
to    O
forms    O
adherents    O
junctions    O
with    O
neighboring    O
cells    O
.    O

The    O
expression    O
of    O
K5    O
is    O
linked    O
to    O
the    O
intermediate    O
phenotype    O
of    O
cells    O
undergoing    O
the    O
epithelial-mesenchymal    B-Cell102991711
transition    I-Cell102991711
(    O
EMT    O
)    O
.    O

In    O
vertebrates    O
,    O
functional    O
differentiation    O
continues    O
even    O
after    O
birth    O
,    O
with    O
the    O
transformation    O
into    O
the    O
adult    O
phenotype    O
occurring    O
through    O
epithelial-mesenchymal    B-Cell102991711
transition    I-Cell102991711
.    O

In    O
addition    O
,    O
JDP2    O
overexpression    O
reverses    O
the    O
epithelial-to-mesenchymal    B-Cell102991711
transition    I-Cell102991711
(    O
EMT    O
)    O
induced    O
by    O
co    O
-    O
treatment    O
with    O
TGF-β1    O
and    O
EGF    O
in    O
human    O
pancreatic    O
BxPC3    O
cells    O
,    O
suggesting    O
that    O
JDP2    O
may    O
be    O
a    O
molecular    O
target    O
for    O
pancreatic    O
carcinoma    O
intervention    O
.    O

This    O
ingression    O
sees    O
the    O
cells    O
from    O
the    O
epiblast    O
move    O
into    O
the    O
primitive    O
streak    O
in    O
an    O
epithelial-mesenchymal    B-Cell102991711
transition    I-Cell102991711
;    O
epithelial    O
cells    O
become    O
mesenchymal    O
stem    O
cells    O
,    O
multipotent    O
stromal    B-Cell102991711
cells    O
that    O
can    O
differentiate    O
into    O
various    O
cell    O
types    O
.    O

Protocrystalline    B-Cell102991711

The    O
use    O
of    O
protocrystalline    B-Cell102991711
Si    O
:    O
H    O
has    O
been    O
shown    O
to    O
improve    O
stability    O
but    O
not    O
eliminate    O
it    O
.    O

intraglomerular    B-Cell102991711
mesangial    I-Cell102991711
cells    I-Cell102991711

In    O
pathology    O
,    O
cerebriform    B-Cell102991711
nuclei    I-Cell102991711
refers    O
to    O
convoluted    O
(    O
"    O
brain    O
-    O
like    O
"    O
)    O
cell    O
nuclei    O
,    O
such    O
as    O
the    O
nuclei    O
seen    O
in    O
T-cells    B-Cell102991711
in    O
T    O
-    O
cell    O
prolymphocytic    O
leukemia    O
or    O
Sézary    O
's    O
disease    O
.    O

hair    O
cell    O
-    O
half    O
-    O
life    O
-    O
halobacteria    O
-    O
Halotolerance    O
-    O
haploid    O
-    O
Heat    O
of    O
fusion    O
-    O
Heat    O
of    O
vaporization    O
-    O
heat    O
shock    O
protein    O
-    O
Hsp70    O
(    O
70    O
kDa    O
heat    O
shock    O
proteins    O
)    O
-    O
Hsp90    O
(    O
90    O
kDa    O
heat    O
shock    O
proteins    O
)    O
-    O
heavy    O
-    O
chain    O
immunoglobulin    O
-    O
Hela    O
cell    O
-    O
helminth    O
protein    O
-    O
helper    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
-    O
hemopexin    O
-    O
hemoglobin    O
-    O
herpes    O
simplex    O
virus    O
protein    O
vmw65    O
-    O
heterocyclic    O
compound    O
-    O
heterotroph    O
-    O
heterozygote    O
-    O
Hfr    B-Cell102991711
cell    I-Cell102991711
-    O
Hill    O
reaction    O
-    O
His    O
tag    O
-    O
histamine    O
H1    O
receptor    O
-    O
histamine    O
H2    O
receptor    O
-    O
histamine    O
receptor    O
-    O
Histidine    O
-    O
histone    O
-    O
History    O
of    O
science    O
and    O
technology    O
-    O
HIV    O
receptor    O
-    O
holoenzyme    O
-    O
homeobox    O
-    O
homeodomain    O
protein    O
-    O
homology    O
-    O
homoserine    O
-    O
homozygote    O
-    O
homunculus    O
-    O
Hormone    O
-    O
housekeeping    O
gene    O
-    O
Human    O
Genome    O
Project    O
-    O
hybridization    O
-    O
hydrocarbon    O
-    O
Hydrogen    O
-    O
Hydrogen    O
bond    O
-    O
hydrogenation    O
-    O
hydrogen    O
-    O
deuterium    O
exchange    O
-    O
hydrolysis    O
-    O
hydrolytic    O
enzyme    O
-    O
hydrophilic    O
-    O
Hydrophobe    O
-    O
hydrophobic    O
-    O
hydrophobicity    O
analysis    O
-    O
hydroxyl    O
-    O

OX40    B-Cell102991711
.    O

A    O
few    O
days    O
after    O
T    O
cells    O
are    O
activated    O
,    O
they    O
produce    O
a    O
molecule    O
called    O
OX40    B-Cell102991711
(    O
also    O
known    O
as    O
CD134    B-Cell102991711
)    O
,    O
a    O
"    O
survival    O
signal    O
"    O
that    O
keeps    O
activated    O
T    O
cells    O
working    O
at    O
the    O
site    O
of    O
inflammation    O
during    O
infection    O
with    O
influenza    O
or    O
other    O
pathogens    O
.    O

This    O
stratum    O
also    O
contains    O
the    O
cell    O
bodies    O
of    O
many    O
interneurons    O
,    O
including    O
axo    O
-    O
axonic    O
cells    O
,    O
bistratified    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
radial    O
trilaminar    O
cells    O
.    O

Their    O
vegetative    O
cells    O
are    O
coenocytic    B-Cell102991711
;    O
sporulation    O
occurs    O
by    O
production    O
of    O
forcibly    O
discharged    O
dispersive    O
or    O
infective    O
conidia    O
;    O
and    O
their    O
zygospores    O
(    O
which    O
also    O
function    O
as    O
resting    O
spores    O
)    O
are    O
homothallic    O
.    O

Non    O
-    O
articulated    O
laticifers    O
,    O
consisting    O
of    O
one    O
long    O
coenocytic    B-Cell102991711
cell    O
.    O

;    O
Hyphae    O
:    O
"    O
Pythium    O
"    O
species    O
,    O
like    O
others    O
in    O
the    O
family    O
Pythiaceae    O
,    O
are    O
usually    O
characterized    O
by    O
their    O
production    O
of    O
coenocytic    B-Cell102991711
hyphae    O
without    O
septations    O
.    O

A    O
coenocyte    B-Cell102991711
(    O
from    O
Greek    O
:    O
κοινός    O
(    O
"    O
koinós    O
"    O
)    O
=    O
"    O
common    O
"    O
+    O
κύτος    O
(    O
"    O
kýtos    O
"    O
)    O
=    O
"    O
box    O
,    O
i.e.    O
cell    O
"    O
)    O
is    O
a    O
multinucleate    O
cell    O
which    O
can    O
result    O
from    O
multiple    O
nuclear    O
divisions    O
without    O
their    O
accompanying    O
cytokinesis    O
,    O
in    O
contrast    O
to    O
a    O
syncytium    O
,    O
which    O
results    O
from    O
cellular    O
aggregation    O
followed    O
by    O
dissolution    O
of    O
the    O
cell    O
membranes    O
inside    O
the    O
mass    O
.    O

Inflammation    O
begins    O
with    O
keratinocyte    O
cells    O
entering    O
the    O
final    O
stages    O
of    O
their    O
cell    O
cycle    O
,    O
which    O
activates    O
immature    O
dendritic    B-Cell102991711
cell    I-Cell102991711
(    O
DC    O
)    O
.    O

This    O
is    O
followed    O
by    O
the    O
induction    O
of    O
inflammatory    O
signals    O
which    O
is    O
essential    O
for    O
recruiting    O
cells    O
of    O
the    O
innate    O
immune    O
system    O
(    O
e.g.    O
natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
,    O
natural    O
killer    O
T    O
cells    O
,    O
macrophages    O
and    O
dendritic    B-Cell102991711
cells    I-Cell102991711
)    O
to    O
the    O
tumor    O
site    O
.    O

They    O
are    O
populated    O
largely    O
by    O
T    B-Cell102991711
cell    I-Cell102991711
and    O
surround    O
central    O
arteries    O
within    O
the    O
spleen    O
;    O
the    O
PALS    O
T    O
-    O
cells    O
are    O
presented    O
with    O
blood    O
borne    O
antigens    O
via    O
myeloid    B-Cell102991711
dendritic    I-Cell102991711
cells    I-Cell102991711
.    O

FLT3L    O
is    O
crucial    O
for    O
steady    O
-    O
state    O
plasmacytoid    O
dendritic    O
cell    O
(    O
pDC    O
)    O
and    O
classical    B-Cell102991711
dendritic    I-Cell102991711
cell    I-Cell102991711
(cDC)    I-Cell102991711
development    O
.    O

A    O
lack    O
of    O
FLT3L    O
results    O
in    O
low    O
levels    O
of    O
dendritic    B-Cell102991711
cell    I-Cell102991711
.    O

The    O
patient    O
's    O
white    O
blood    O
cells    O
,    O
primarily    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
a    O
type    O
of    O
antigen-presenting    B-Cell102991711
cells    I-Cell102991711
(    O
APCs    O
)    O
,    O
are    O
extracted    O
in    O
a    O
leukapheresis    O
procedure    O
.    O

These    O
antigens    O
can    O
be    O
recognized    O
and    O
processed    O
by    O
antigen-presenting    B-Cell102991711
cells    I-Cell102991711
within    O
the    O
tumor    O
(    O
dendritic    B-Cell102991711
cells    I-Cell102991711
and    O
macrophages    O
)    O
.    O

Its    O
cellular    O
component    O
involves    O
primarily    O
monocyte    O
/    O
macrophages    O
,    O
granulocytes    O
,    O
and    O
dendritic    B-Cell102991711
cells    I-Cell102991711
(    O
DCs    O
)    O
,    O
which    O
are    O
activated    O
upon    O
sensing    O
of    O
conserved    O
pathogen    O
structures    O
(    O
PAMPs    O
)    O
by    O
pattern    O
recognition    O
receptors    O
such    O
as    O
Toll    O
-    O
like    O
receptors    O
(    O
(    O
TLRs    O
)    O
)    O

Activated    O
B    O
and    O
T    O
cells    O
show    O
increased    O
miR-155    O
expression    O
,    O
the    O
same    O
goes    O
for    O
macrophages    O
and    O
dendritic    B-Cell102991711
cell    I-Cell102991711
of    O
the    O
immune    O
system    O
.    O

Immature    O
dendritic    O
cells    O
,    O
a    O
type    O
of    O
dendritic    B-Cell102991711
cell    I-Cell102991711

FcαRI    O
is    O
found    O
on    O
the    O
surface    O
of    O
neutrophils    O
,    O
eosinophils    O
,    O
monocytes    O
,    O
some    O
macrophages    O
(    O
including    O
Kupffer    O
cells    O
)    O
,    O
and    O
some    O
dendritic    B-Cell102991711
cell    I-Cell102991711
.    O

ILC1    O
also    O
recruit    O
DC    B-Cell102991711
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
.    O

Similar    O
to    O
other    O
filoviruses    O
,    O
EBOV    O
replicates    O
very    O
efficiently    O
in    O
many    O
cells    O
,    O
producing    O
large    O
amounts    O
of    O
virus    O
in    O
monocytes    O
,    O
macrophages    O
,    O
dendritic    B-Cell102991711
cell    I-Cell102991711
and    O
other    O
cells    O
including    O
liver    B-Cell102991711
cells    I-Cell102991711
,    O
fibroblasts    O
,    O
and    O
adrenal    O
gland    O
cells    O
.    O

The    O
innate    O
leukocytes    O
include    O
the    O
phagocytes    O
(    O
macrophages    O
,    O
neutrophils    O
,    O
and    O
dendritic    B-Cell102991711
cell    I-Cell102991711
)    O
,    O
innate    O
lymphoid    O
cells    O
,    O
mast    O
cells    O
,    O
eosinophils    O
,    O
basophils    O
,    O
and    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
.    O

Other    O
immune    O
system    O
cells    O
that    O
are    O
known    O
to    O
express    O
CYP27B1    O
and    O
thus    O
activate    O
vitamin    O
D    O
calcidiol    O
,    O
are    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
keratinocyte    B-Cell102991711
and    O
macrophages    O
.    O

The    O
most    O
well    O
-    O
known    O
disease    O
that    O
affects    O
the    O
immune    O
system    O
itself    O
is    O
AIDS    O
,    O
an    O
immunodeficiency    O
characterized    O
by    O
the    O
suppression    O
of    O
CD4    O
+    O
(    O
"    O
helper    O
"    O
)    O
T    B-Cell102991711
cell    I-Cell102991711
,    O
dendritic    B-Cell102991711
cells    I-Cell102991711
and    O
macrophages    O
by    O
the    O
Human    O
Immunodeficiency    O
Virus    O
(    O
HIV    O
)    O
.    O

In    O
vitro    O
"    O
,    O
TSLP    O
directs    O
the    O
maturation    O
of    O
dendritic    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
increases    O
the    O
ability    O
of    O
dendritic    O
cells    O
to    O
convert    O
naive    O
thymocytes    O
to    O
a    O
Foxp3    O
+    O
regulatory    O
T    O
cell    O
lineage    O
.    O

They    O
are    O
the    O
largest    O
type    O
of    O
leukocyte    O
and    O
can    O
differentiate    O
into    O
macrophages    O
and    O
myeloid    O
lineage    O
dendritic    B-Cell102991711
cell    I-Cell102991711
.    O

Such    O
roles    O
include    O
:    O
replenishing    O
resident    O
macrophages    O
under    O
normal    O
conditions    O
;    O
migration    O
within    O
approximately    O
8–12    O
hours    O
in    O
response    O
to    O
inflammation    O
signals    O
from    O
sites    O
of    O
infection    O
in    O
the    O
tissues    O
;    O
and    O
differentiation    O
into    O
macrophages    O
or    O
dendritic    B-Cell102991711
cell    I-Cell102991711
to    O
effect    O
an    O
immune    O
response    O
.    O

Monocytes    O
circulate    O
in    O
the    O
bloodstream    O
for    O
about    O
one    O
to    O
three    O
days    O
and    O
then    O
typically    O
move    O
into    O
tissues    O
throughout    O
the    O
body    O
where    O
they    O
differentiate    O
into    O
macrophages    O
and    O
dendritic    B-Cell102991711
cell    I-Cell102991711
.    O

Monocytes    O
which    O
migrate    O
from    O
the    O
bloodstream    O
to    O
other    O
tissues    O
will    O
then    O
differentiate    O
into    O
tissue    O
resident    O
macrophages    O
or    O
dendritic    B-Cell102991711
cell    I-Cell102991711
.    O

"    O
In    O
vitro    O
"    O
,    O
monocytes    O
can    O
differentiate    O
into    O
dendritic    B-Cell102991711
cells    I-Cell102991711
by    O
adding    O
the    O
cytokines    O
granulocyte    O
macrophage    O
colony    O
-    O
stimulating    O
factor    O
(    O
GM    O
-    O
CSF    O
)    O
and    O
interleukin    O
4    O
.    O

CXCL16    O
is    O
produced    O
by    O
dendritic    B-Cell102991711
cell    I-Cell102991711
found    O
in    O
the    O
T    B-Cell102991711
cell    I-Cell102991711
zones    O
of    O
lymphoid    O
organs    O
,    O
and    O
by    O
cells    O
found    O
in    O
the    O
red    O
pulp    O
of    O
the    O
spleen    O
.    O

These    O
changes    O
are    O
believed    O
to    O
stem    O
from    O
the    O
premature    O
maturation    O
of    O
keratinocytes    B-Cell102991711
induced    O
by    O
an    O
inflammatory    O
cascade    O
in    O
the    O
dermis    O
involving    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
macrophages    O
,    O
and    O
T    B-Cell102991711
cell    I-Cell102991711
(    O
three    O
subtypes    O
of    O
white    O
blood    O
cells    O
)    O
.    O

Dendritic    B-Cell102991711
cell    I-Cell102991711
bridge    O
the    O
innate    O
immune    O
system    O
and    O
adaptive    O
immune    O
system    O
.    O

However    O
,    O
slightly    O
elevated    O
levels    O
of    O
"    O
CCDC94    O
"    O
are    O
expressed    O
in    O
the    O
thyroid    O
,    O
lung    O
,    O
dendritic    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
lymphoblasts    O
.    O

IL-15    O
is    O
constitutively    O
expressed    O
by    O
a    O
large    O
number    O
of    O
cell    B-Cell102991711
types    I-Cell102991711
and    O
tissues    O
,    O
including    O
monocytes    O
,    O
macrophages    O
,    O
dendritic    B-Cell102991711
cells    I-Cell102991711
(    O
DC    B-Cell102991711
)    O
,    O
keratinocytes    B-Cell102991711
,    O
fibroblasts    O
and    O
nerve    O
cells    O
.    O

It    O
exists    O
in    O
two    O
forms    O
,    O
secreted    O
and    O
membrane    O
-    O
bound    O
particularly    O
on    O
dendritic    B-Cell102991711
cells    I-Cell102991711
.    O

Although    O
IL-15    O
mRNA    O
can    O
be    O
found    O
in    O
many    O
cells    O
and    O
tissues    O
including    O
mast    O
cells    O
,    O
cancer    O
cells    O
or    O
fibroblasts    O
,    O
this    O
cytokine    O
is    O
produced    O
as    O
a    O
mature    O
protein    O
mainly    O
by    O
dendritic    B-Cell102991711
cells    I-Cell102991711
,    O
monocytes    O
and    O
macrophages    O
.    O

Since    O
then    O
,    O
this    O
interleukin    O
has    O
been    O
shown    O
to    O
recruit    O
and    O
activate    O
many    O
other    O
cells    O
expressing    O
the    O
CD4    O
molecule    O
,    O
including    O
monocytes    O
,    O
eosinophils    O
,    O
and    O
dendritic    B-Cell102991711
cells    I-Cell102991711
.    O

Its    O
protein    O
is    O
expressed    O
in    O
human    O
small    O
intestine    O
,    O
lung    O
,    O
media    O
of    O
arteries    O
and    O
arterioles    O
of    O
the    O
kidney    O
,    O
thymus    O
,    O
uterus    O
,    O
brain    O
cerebral    O
cortex    O
,    O
brain    O
striatum    O
,    O
brain    O
hippocampus    O
,    O
corneal    O
epithelium    O
,    O
corneal    O
choriocapillaries    O
,    O
Myometriuml    O
cells    O
,    O
eosinophiles    O
,    O
sclera    O
of    O
the    O
eye    O
,    O
articular    O
cartilage    O
,    O
the    O
corpus    O
cavernosum    O
of    O
the    O
penis    O
,    O
and    O
airway    O
smooth    O
muscle    O
cells    O
;    O
its    O
mRNA    O
is    O
expressed    O
in    O
gingival    O
fibroblasts    O
,    O
monocyte    O
-    O
derived    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
aorta    O
,    O
corpus    O
cavernosum    O
of    O
the    O
penis    O
,    O
articular    O
cartilage    O
,    O
airway    O
smooth    O
muscle    O
,    O
and    O
airway    O
epithelial    O
cells    O
.    O

Activation    O
of    O
EP2    O
contributes    O
to    O
regulating    O
B    B-Cell102991711
cell    I-Cell102991711
immunoglobulin    O
class    O
switching    O
,    O
maturation    O
of    O
T    O
lymphocyte    O
CD4−CD8−    O
cells    O
to    O
CD4+CD8    O
+    O
cells    O
,    O
and    O
the    O
function    O
of    O
Antigen-presenting    B-Cell102991711
cell    I-Cell102991711
,    O
particularly    O
Dendritic    B-Cell102991711
cells    I-Cell102991711
.    O

However    O
,    O
EP2    O
activation    O
also    O
has    O
anti    O
-    O
inflammatory    O
actions    O
on    O
pro    O
-    O
inflammatory    O
cells    O
(    O
e.g.    O
neutrophils    O
,    O
monocytes    O
,    O
macrophages    O
,    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
NK    B-Cell102991711
cell    I-Cell102991711
,    O
TH1    O
cells    O
,    O
TH2    O
cells    O
,    O
and    O
fibroblasts    O
in    O
various    O
tissues    O
and    O
on    O
microglia    O
cells    O
in    O
the    O
central    O
nervous    O
system    O
,    O
.    O

The    O
axis    O
inhibits    O
bone    O
marrow    O
-    O
derived    O
dendritic    B-Cell102991711
cell    I-Cell102991711
(    O
i.e.    O
antigen-presenting    B-Cell102991711
cells    I-Cell102991711
that    O
process    O
antigen    O
material    O
,    O
present    O
it    O
on    O
their    O
surfaces    O
for    O
delivery    O
to    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
otherwise    O
regulate    O
innate    O
and    O
adaptive    O
immune    O
system    O
responses    O
)    O
from    O
producing    O
pro    O
-    O
inflammatory    O
cytokines    O
(    O
e.g.    O
IL-12    O
,    O
TNF    O
-    O
alpha    O
,    O
IL-1-alpha    O
,    O
and    O
IL-6    O
)    O
while    O
stimulating    O
them    O
to    O
increase    O
production    O
of    O
the    O
anti    O
-    O
inflammatory    O
cytokine    O
,    O
IL-10    O
.    O

In    O
addition    O
,    O
IL-3    O
stimulates    O
proliferation    O
of    O
all    O
cells    O
in    O
the    O
myeloid    O
lineage    O
(    O
granulocytes    O
,    O
monocytes    O
,    O
and    O
dendritic    B-Cell102991711
cell    I-Cell102991711
)    O
,    O
in    O
conjunction    O
with    O
other    O
cytokines    O
,    O
e.g.    O
,    O
Erythropoietin    O
(    O
EPO    O
)    O
,    O
Granulocyte    O
macrophage    O
colony    O
-    O
stimulating    O
factor    O
(    O
GM    O
-    O
CSF    O
)    O
,    O
and    O
IL-6    O
.    O

Dendritic    B-Cell102991711
cell    I-Cell102991711
(    O
Although    O
these    O
will    O
often    O
migrate    O
to    O
local    O
lymph    O
nodes    O
upon    O
ingesting    O
antigens    O
)    O

Hematopoietic    O
stem    O
cells    O
(    O
HSC    O
)    O
,    O
which    O
provide    O
the    O
regulated    O
lifelong    O
supply    O
of    O
leukocyte    O
progenitors    O
that    O
are    O
in    O
turn    O
able    O
to    O
differentiate    O
into    O
a    O
diversity    O
of    O
specialised    O
immune    O
cells    O
(    O
including    O
lymphocytes    O
,    O
antigen-presenting    B-Cell102991711
dendritic    B-Cell102991711
cells    I-Cell102991711
and    O
phagocytes    O
)    O
diminish    O
in    O
their    O
self    O
-    O
renewal    O
capacity    O
.    O

It    O
has    O
a    O
molecular    O
weight    O
of    O
64.9    O
KDa    O
that    O
activated    O
dendritic    B-Cell102991711
cells    I-Cell102991711
of    O
the    O
human    O
immune    O
system    O
.    O

aAPCs    O
remove    O
the    O
need    O
to    O
harvest    O
patient    O
specific    O
APCs    O
such    O
as    O
dendritic    B-Cell102991711
cells    I-Cell102991711
(    O
DCs    O
)    O
and    O
the    O
process    O
of    O
activating    O
the    O
DCs    O
in    O
the    O
stimulation    O
of    O
antigen    O
-    O
specific    O
T    O
cells    O
.    O

Dendritic    B-Cell102991711
cells    I-Cell102991711
(    O
DCs    O
)    O
,    O
which    O
are    O
the    O
primary    O
antigen-presenting    B-Cell102991711
cells    I-Cell102991711
(    O
APCs    O
)    O
,    O
of    O
the    O
donor    O
tissue    O
migrate    O
to    O
the    O
recipient    O
's    O
peripheral    O
lymphoid    O
tissue    O
(    O
lymphoid    O
follicles    O
and    O
lymph    O
nodes    O
)    O
,    O
and    O
present    O
the    O
donor    O
's    O
"    O
self    O
"    O
peptides    O
to    O
the    O
recipient    O
's    O
lymphocytes    O
(    O
immune    O
cells    O
residing    O
in    O
lymphoid    O
tissues    O
)    O
.    O

Osteopontin    O
is    O
biosynthesized    O
by    O
a    O
variety    O
of    O
tissue    O
types    O
including    O
cardiac    O
fibroblasts    O
,    O
preosteoblasts    O
,    O
osteoblasts    O
,    O
osteocytes    O
,    O
odontoblasts    O
,    O
some    O
bone    O
marrow    O
cells    O
,    O
hypertrophic    O
chondrocytes    B-Cell102991711
,    O
dendritic    B-Cell102991711
cells    I-Cell102991711
,    O
macrophages    O
,    O
smooth    O
muscle    O
,    O
skeletal    O
muscle    O
myoblasts    B-Cell102991711
,    O
endothelial    O
cells    O
,    O
and    O
extraosseous    O
(    O
non    O
-    O
bone    O
)    O
cells    O
in    O
the    O
inner    O
ear    O
,    O
brain    O
,    O
kidney    O
,    O
deciduum    O
,    O
and    O
placenta    O
.    O

She    O
pushed    O
forward    O
the    O
study    O
of    O
dendritic    B-Cell102991711
cells    I-Cell102991711
,    O
realising    O
that    O
they    O
were    O
derived    O
from    O
Langerhans    O
cells    O
and    O
played    O
an    O
important    O
role    O
in    O
initiating    O
and    O
promoting    O
immune    O
reactions    O
.    O

Autoreactive    O
T    O
cells    O
must    O
normally    O
be    O
held    O
in    O
check    O
by    O
the    O
suppressive    O
environment    O
produced    O
by    O
microglia    O
and    O
dendritic    B-Cell102991711
cells    I-Cell102991711
in    O
the    O
eye    O
.    O

Only    O
APCs    O
do    O
express    O
the    O
class    O
II    O
of    O
MHC    O
molecules    O
on    O
the    O
surface    O
in    O
large    O
quantity    O
,    O
such    O
as    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
B    B-Cell102991711
cell    I-Cell102991711
or    O
macrophages    O
,    O
so    O
expression    O
of    O
MHC    O
-    O
II    O
molecules    O
is    O
more    O
cell    O
-    O
specific    O
than    O
MHC    O
-    O
I.    O

Dendritic    B-Cell102991711
cells    I-Cell102991711

It    O
significantly    O
reduces    O
replication    O
of    O
HIV-1    O
in    O
cocultures    O
of    O
human    O
dendritic    B-Cell102991711
cell    I-Cell102991711
(    O
DCs    O
)    O
and    O
CD4+    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
,    O
which    O
is    O
due    O
to    O
a    O
rapid    O
secretion    O
of    O
soluble    O
factors    O
and    O
is    O
associated    O
with    O
induction    O
of    O
type    O
-    O
I    O
interferon    O
(    O
IFN    O
)    O
in    O
the    O
human    O
cells    O
.    O

In    O
addition    O
,    O
CD137    O
expression    O
is    O
found    O
on    O
dendritic    B-Cell102991711
cells    I-Cell102991711
,    O
B    O
cells    O
,    O
follicular    O
dendritic    O
cells    O
,    O
natural    O
killer    O
cells    O
,    O
granulocytes    O
and    O
cells    O
of    O
blood    O
vessel    O
walls    O
at    O
sites    O
of    O
inflammation    O
.    O

Calcitonin    O
-    O
producing    O
parafollicular    B-Cell102991711
cell    I-Cell102991711
(    O
C    O
cells    O
)    O
can    O
be    O
found    O
scattered    O
along    O
the    O
basement    O
membrane    O
of    O
the    O
thyroid    O
epithelium    O
.    O

Parafollicular    B-Cell102991711
cells    I-Cell102991711
(    O
also    O
called    O
C    B-Cell102991711
cells    I-Cell102991711
)    O
are    O
neuroendocrine    B-Cell102991711
cell    I-Cell102991711
in    O
the    O
thyroid    O
which    O
primary    O
function    O
is    O
to    O
secrete    O
calcitonin    O
.    O

superior    O
parathyroid    O
glands    O
and    O
ultimobranchial    O
body    O
which    O
forms    O
the    O
parafollicular    B-Cell102991711
C    O
-    O
Cells    O
of    O
the    O
thyroid    O
gland    O
.    O

The    O
protein    O
deficiency    O
appeared    O
to    O
reduce    O
sertoli    B-Cell102991711
cell    I-Cell102991711
number    O
,    O
sperm    O
motility    O
,    O
and    O
sperm    O
count    O
.    O

In    O
men    O
the    O
FSH    O
acts    O
on    O
the    O
sperm    O
producing    O
Sertoli    B-Cell102991711
cells    O
in    O
the    O
testes    O
.    O

This    O
was    O
later    O
determined    O
to    O
be    O
paramesonephric    O
inhibiting    O
substance    O
(    O
MIS    O
)    O
,    O
a    O
140    O
kD    O
dimeric    O
glycoprotein    O
that    O
is    O
produced    O
by    O
sertoli    B-Cell102991711
cells    I-Cell102991711
.    O

It    O
weakens    O
the    O
adhesion    O
between    O
the    O
Sertoli    B-Cell102991711
cell    I-Cell102991711
and    O
maturing    O
sperm    O
leading    O
to    O
a    O
sloughing    O
and    O
loss    O
of    O
the    O
latter    O
.    O

The    O
mutant    O
FSH    O
is    O
modified    O
such    O
that    O
it    O
no    O
longer    O
induces    O
Inhibin    O
B    O
production    O
,    O
but    O
the    O
membrane    O
-    O
bound    O
FSH    O
receptors    O
on    O
Sertoli    B-Cell102991711
cells    I-Cell102991711
still    O
bind    O
to    O
it    O
,    O
delivering    O
the    O
Adjudin    O
directly    O
to    O
the    O
target    O
cells    O
.    O

ACVR2B    O
was    O
found    O
to    O
be    O
localized    O
primarily    O
in    O
the    O
gonocytes    O
as    O
well    O
as    O
in    O
sertoli    B-Cell102991711
cells    I-Cell102991711
.    O

Expression    O
of    O
this    O
protein    O
has    O
been    O
found    O
in    O
peritubular    O
myoid    O
cells    O
,    O
gonocytes    O
,    O
pachytene    O
spermatocytes    O
,    O
spermatogonia    O
,    O
myoid    O
cells    O
,    O
and    O
Sertoli    B-Cell102991711
cell    I-Cell102991711
.    O

The    O
frequency    O
of    O
mutations    O
in    O
mouse    O
somatic    O
tissue    O
(    O
brain    O
,    O
liver    O
,    O
Sertoli    B-Cell102991711
cell    I-Cell102991711
)    O
was    O
compared    O
to    O
the    O
mutation    O
frequency    O
in    O
male    O
germline    B-Cell102991711
cells    O
at    O
sequential    O
stages    O
of    O
spermatogenesis    O
.    O

If    O
a    O
substance    O
affects    O
Sertoli    B-Cell102991711
and    O
Leydig    B-Cell102991711
cell    I-Cell102991711
differentiation    O
(    O
a    O
common    O
feature    O
of    O
TDS    O
disorders    O
)    O
at    O
an    O
early    O
developmental    O
stage    O
,    O
germ    O
cell    O
growth    O
and    O
testosterone    O
production    O
will    O
be    O
impaired    O
.    O

Spermatogonia    O
stem    O
cells    O
in    O
mammals    O
are    O
found    O
between    O
the    O
basal    O
membrane    O
of    O
the    O
seminiferous    O
tubules    O
and    O
the    O
Sertoli    B-Cell102991711
cell    I-Cell102991711
.    O

The    O
SSC    O
niche    O
is    O
found    O
in    O
the    O
seminiferous    O
epithelium    O
of    O
mammalian    O
testis    O
,    O
and    O
is    O
primarily    O
constituted    O
of    O
Sertoli    B-Cell102991711
and    O
peritubular    O
myoid    O
cells    O
.    O

There    O
are    O
theories    O
supporting    O
the    O
hypotheses    O
of    O
both    O
an    O
indirect    O
(    O
via    O
Sertoli    B-Cell102991711
cell    I-Cell102991711
)    O
or    O
a    O
direct    O
pathway    O
.    O

Stereocilia    B-Cell102991711
dynamics    O
.    O

It    O
seems    O
that    O
they    O
affect    O
the    O
stereocilia    B-Cell102991711
of    O
the    O
ciliated    O
cells    O
present    O
in    O
the    O
inner    O
ear    O
’s    O
Organ    O
of    O
Corti    O
.    O

Each    O
of    O
these    O
bundles    O
are    O
approximately    O
4    O
-    O
10    O
μm    O
high    O
and    O
have    O
30    O
-    O
300    O
stereocilia    B-Cell102991711
and    O
one    O
kinocilium    O
,    O
which    O
has    O
motile    O
characteristics    O
.    O

Stereocilia    B-Cell102991711

stereocilia    B-Cell102991711

BMPs    O
are    O
involved    O
in    O
a    O
host    O
of    O
cellular    O
functions    O
including    O
osteogenesis    O
,    O
cell    B-Cell102991711
growth    I-Cell102991711
and    O
cell    O
differentiation    O
.    O

The    O
researchers    O
found    O
that    O
if    O
NF-κB    O
activity    O
was    O
blocked    O
in    O
elderly    O
mice    O
by    O
bathing    O
them    O
in    O
bleach    O
solution    O
,    O
the    O
animals    O
'    O
skin    O
began    O
to    O
look    O
younger    O
,    O
going    O
from    O
old    O
and    O
fragile    O
to    O
thicker    O
,    O
with    O
increased    O
cell    B-Cell102991711
proliferation    I-Cell102991711
.    O

Javier    O
Orozco    O
proposed    O
using    O
these    O
techniques    O
leading    O
to    O
cell    B-Cell102991711
growth    I-Cell102991711
in    O
textile    O
matrices    O
which    O
will    O
provide    O
the    O
necessary    O
mechanical    O
strength    O
.    O

The    O
CodY    O
protein    O
also    O
has    O
a    O
repressor    O
effect    O
on    O
many    O
genes    O
in    O
"    O
Lactococcus    O
lactis    O
"    O
during    O
growth    B-Cell102991711
in    O
milk    O
.    O

Fibrosarcoma    O
(    O
fibroblastic    O
sarcoma    O
)    O
is    O
a    O
malignant    O
mesenchymal    O
tumour    O
derived    O
from    O
fibrous    O
connective    O
tissue    O
and    O
characterized    O
by    O
the    O
presence    O
of    O
immature    O
proliferating    B-Cell102991711
fibroblasts    O
or    O
undifferentiated    O
anaplastic    O
spindle    O
cells    O
in    O
a    O
storiform    O
pattern    O
.    O

tissue    B-Cell102991711
growth    I-Cell102991711

The    O
role    O
of    O
versican    O
in    O
cell    O
adhesion    O
,    O
migration    O
,    O
and    O
proliferation    B-Cell102991711
has    O
been    O
extensively    O
studied    O
.    O

Cellular    O
processes    O
(    O
cell    B-Cell102991711
growth    I-Cell102991711
,    O
cell    O
death    O
,    O
cell    O
membrane    O
functions    O
,    O
etc    O
.    O
)    O

The    O
disease    O
phenotype    O
probably    O
originates    O
from    O
reduced    O
ability    O
of    O
cells    O
to    O
proliferate    B-Cell102991711
,    O
reduced    O
cell    O
number    O
,    O
and    O
general    O
growth    O
failure    O
.    O

If    O
the    O
toxin    O
is    O
then    O
added    O
to    O
the    O
cell    O
culture    O
,    O
only    O
those    O
few    O
cells    O
with    O
the    O
marker    O
gene    O
integrated    O
into    O
their    O
genomes    O
will    O
be    O
able    O
to    O
proliferate    B-Cell102991711
,    O
while    O
other    O
cells    O
will    O
die    O
.    O

Growth    O
hormone    O
,    O
also    O
called    O
somatotropin    O
,    O
is    O
a    O
polypeptide    O
hormone    O
which    O
stimulates    O
growth    O
and    O
cell    B-Cell102991711
reproduction    I-Cell102991711
.    O

Growth    O
hormone    O
is    O
a    O
peptide    O
hormone    O
secreted    O
by    O
the    O
pituitary    O
gland    O
that    O
stimulates    O
growth    B-Cell102991711
and    O
cell    O
reproduction    O
.    O

One    O
of    O
the    O
main    O
actions    O
of    O
MyoD    O
is    O
to    O
remove    O
cells    O
from    O
the    O
cell    O
cycle    O
(    O
halt    O
proliferation    B-Cell102991711
for    O
terminal    O
cell    O
cycle    O
arrest    O
in    O
differentiated    O
myocytes    O
)    O
by    O
enhancing    O
the    O
transcription    O
of    O
p21    O
and    O
myogenin    O
.    O

In    O
"    O
Saccharomyces    O
cerevisiae    O
"    O
(    O
Baker    O
's    O
yeast    O
)    O
,    O
the    O
transcriptional    O
regulation    O
of    O
the    O
INO1    O
gene    O
encoding    O
inositol-3-phosphate    O
synthase    O
has    O
been    O
studied    O
in    O
detail    O
and    O
its    O
expression    O
is    O
sensitive    O
to    O
the    O
availability    O
of    O
phospholipid    O
precursors    O
as    O
well    O
as    O
growth    B-Cell102991711
phase    O
.    O

In    O
addition    O
to    O
supplying    O
cellular    O
energy    O
,    O
mitochondria    O
are    O
involved    O
in    O
other    O
tasks    O
,    O
such    O
as    O
signaling    O
,    O
cellular    O
differentiation    O
,    O
and    O
cell    O
death    O
,    O
as    O
well    O
as    O
maintaining    O
control    O
of    O
the    O
cell    O
cycle    O
and    O
cell    B-Cell102991711
growth    I-Cell102991711
.    O

IL-24    O
appears    O
to    O
control    O
in    O
cell    O
survival    O
and    O
proliferation    B-Cell102991711
by    O
inducing    O
rapid    O
activation    O
of    O
particular    O
transcription    O
factors    O
called    O
STAT1    O
and    O
STAT3    O
.    O

IL-20    O
regulates    O
proliferation    B-Cell102991711
and    O
differentiation    O
of    O
keratinocytes    O
during    O
inflammation    O
,    O
particularly    O
inflammation    O
associated    O
with    O
the    O
skin    O
.    O

Its    O
functions    O
contribute    O
to    O
biological    O
processes    O
including    O
signal    O
transduction    O
,    O
apoptosis    O
,    O
protein    O
homeostasis    O
,    O
and    O
cell    B-Cell102991711
growth    I-Cell102991711
and    O
differentiation    O
.    O

As    O
an    O
essential    O
component    O
of    O
the    O
MAP    O
kinase    O
signal    O
transduction    O
pathway    O
,    O
this    O
kinase    O
is    O
involved    O
in    O
many    O
cellular    O
processes    O
such    O
as    O
proliferation    B-Cell102991711
,    O
differentiation    O
,    O
transcription    O
regulation    O
and    O
development    O
.    O

For    O
one    O
,    O
14    O
-    O
3    O
-    O
3ζ    O
plays    O
a    O
central    O
role    O
in    O
cell    B-Cell102991711
proliferation    I-Cell102991711
and    O
,    O
by    O
extension    O
,    O
tumor    O
progression    O
.    O

The    O
events    O
within    O
the    O
cell    O
that    O
cause    O
disordered    O
pituitary    O
cell    B-Cell102991711
growth    I-Cell102991711
and    O
GH    O
oversecretion    O
currently    O
are    O
the    O
subject    O
of    O
intensive    O
research    O
.    O

CK2    O
is    O
a    O
constitutively    O
and    O
widely    O
expressed    O
serine    O
/    O
threonine    O
kinase    O
that    O
has    O
many    O
substrates    O
related    O
to    O
signal    O
transduction    O
and    O
cell    B-Cell102991711
growth    I-Cell102991711
regulation    O
.    O

These    O
conditions    O
will    O
then    O
result    O
in    O
a    O
selective    O
pressure    O
towards    O
cancer    O
cell    O
proliferation    B-Cell102991711
.    O

Kudzu    O
also    O
has    O
low    O
forage    O
yields    O
despite    O
its    O
rate    O
of    O
growth    B-Cell102991711
,    O
yielding    O
around    O
two    O
to    O
four    O
tons    O
of    O
dry    O
matter    O
per    O
acre    O
annually    O
.    O

They    O
exhibit    O
slow    O
growth    B-Cell102991711
and    O
their    O
main    O
role    O
is    O
to    O
replace    O
cells    O
lost    O
by    O
normal    O
attrition    O
.    O

Periostin    O
in    O
turn    O
seems    O
to    O
partake    O
in    O
a    O
number    O
of    O
asthma    O
related    O
problems    O
,    O
such    O
as    O
bronchial    O
hyperresponsiveness    O
,    O
inflammation    O
,    O
and    O
activation    O
and    O
proliferation    B-Cell102991711
of    O
airway    O
fibroblasts    O
,    O
which    O
are    O
involved    O
in    O
airway    O
remodelling    O
.    O

Cramer    O
's    O
specialty    O
dealt    O
with    O
the    O
physiology    O
,    O
genealogy    O
and    O
growth    B-Cell102991711
of    O
plant    O
cells    O
.    O

This    O
knowledge    O
would    O
ultimately    O
help    O
in    O
the    O
understanding    O
of    O
the    O
machinery    O
behind    O
gene    O
regulation    O
,    O
cell    B-Cell102991711
proliferation    I-Cell102991711
,    O
and    O
disease    O
progression    O
.    O

Hall    O
is    O
a    O
pioneer    O
in    O
the    O
fields    O
of    O
TOR    O
signaling    O
and    O
cell    B-Cell102991711
growth    I-Cell102991711
control    O
.    O

MicroRNAs    O
are    O
likely    O
to    O
play    O
roles    O
in    O
most    O
cellular    O
processes    O
,    O
including    O
proliferation,    B-Cell102991711
development    I-Cell102991711
,    O
differentiation    O
and    O
apoptosis    O
.    O

It    O
targets    O
CD117    O
,    O
which    O
then    O
prevents    O
cell    O
migration    O
and    O
proliferation    B-Cell102991711
in    O
endothelial    O
cells    O
.    O

It    O
has    O
been    O
found    O
experimentally    O
through    O
knock    O
out    O
studies    O
,    O
that    O
mice    O
lacking    O
Eomesodermin    O
/    O
Tbr2    O
during    O
early    O
development    O
have    O
a    O
reduced    O
number    O
of    O
actively    O
dividing    O
cells    O
,    O
called    O
proliferating    B-Cell102991711
cells    I-Cell102991711
,    O
in    O
the    O
subventricular    O
zone    O
,    O
a    O
key    O
area    O
of    O
neurogenesis    O
in    O
the    O
brain    O
.    O

Regucalcin    O
can    O
control    O
enhancement    O
of    O
cell    B-Cell102991711
proliferation    I-Cell102991711
due    O
to    O
hormonal    O
stimulation    O
.    O

Therefore    O
,    O
the    O
regulation    O
of    O
Pol    O
III    O
transcription    O
is    O
primarily    O
tied    O
to    O
the    O
regulation    O
of    O
cell    B-Cell102991711
growth    I-Cell102991711
and    O
the    O
cell    O
cycle    O
,    O
thus    O
requiring    O
fewer    O
regulatory    O
proteins    O
than    O
RNA    O
polymerase    O
II    O
.    O

They    O
are    O
involved    O
in    O
a    O
host    O
of    O
physiological    O
processes    O
including    O
,    O
growth    B-Cell102991711
,    O
cell    O
differentiation    O
,    O
homeostasis    O
,    O
osteogenesis    O
,    O
apoptosis    O
and    O
many    O
other    O
functions    O
.    O

Tetraspanins    O
display    O
numerous    O
properties    O
that    O
indicate    O
their    O
physiological    O
importance    O
in    O
cell    O
adhesion    O
,    O
motility    O
,    O
activation    O
,    O
and    O
proliferation    B-Cell102991711
,    O
as    O
well    O
as    O
their    O
contribution    O
to    O
pathological    O
conditions    O
such    O
as    O
metastasis    O
or    O
viral    O
infection    O
.    O

Lacritin    O
also    O
promotes    O
tear    O
secretion    O
,    O
the    O
proliferation    B-Cell102991711
and    O
survival    O
of    O
epithelial    O
cells    O
,    O
and    O
corneal    O
wound    O
healing    O
Lacritin    O
is    O
thus    O
a    O
multifunctional    O
prosecretory    O
mitogen    O
with    O
cell    O
survival    O
activity    O
.    O

"    O
BDNF    O
"    O
has    O
been    O
implicated    O
as    O
a    O
critical    O
regulator    O
in    O
drug    O
dependency    O
,    O
and    O
Cdk5    O
is    O
implicated    O
in    O
the    O
regulation    O
of    O
cell    B-Cell102991711
proliferation    I-Cell102991711
genes    O
.    O

Vitamin    O
D3    O
(    O
cholecalciferol    O
)    O
regulates    O
keratinocyte    O
proliferation    B-Cell102991711
and    O
differentiation    O
mostly    O
by    O
modulating    O
calcium    O
concentrations    O
and    O
regulating    O
the    O
expression    O
of    O
genes    O
involved    O
in    O
keratinocyte    O
differentiation    O
.    O

It    O
is    O
95%    O
keratinocytes    B-Cell102991711
(    O
proliferating    B-Cell102991711
basal    O
and    O
differentiated    O
suprabasal    O
)    O
but    O
also    O
contains    O
melanocytes    O
,    O
Langerhans    O
cells    O
,    O
Merkel    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
inflammatory    O
cells    O
.    O

Keratinocyte    O
growth    O
factor    O
(    O
KGF    O
or    O
FGF7    O
)    O
is    O
a    O
paracrine    B-Cell102991711
growth    O
factor    O
produced    O
by    O
the    O
underlying    O
dermal    O
fibroblasts    O
in    O
which    O
the    O
proliferation    B-Cell102991711
of    O
basal    O
cells    O
is    O
regulated    O
.    O

Ergtoxin    O
may    O
potentially    O
have    O
a    O
role    O
in    O
treatment    O
of    O
patients    O
with    O
ovarian    O
cancer    O
by    O
inhibiting    O
the    O
proliferation    B-Cell102991711
of    O
cells    O
and    O
thus    O
the    O
progression    O
of    O
cancer    O
.    O

A    O
third    O
possible    O
source    O
of    O
tumor    O
antigens    O
are    O
proteins    O
normally    O
important    O
for    O
regulating    O
cell    B-Cell102991711
growth    I-Cell102991711
and    O
survival    O
,    O
that    O
commonly    O
mutate    O
into    O
cancer    O
inducing    O
molecules    O
called    O
oncogenes    O
.    O

The    O
IGF    O
axis    O
has    O
been    O
shown    O
to    O
play    O
roles    O
in    O
the    O
promotion    O
of    O
cell    B-Cell102991711
proliferation    I-Cell102991711
and    O
the    O
inhibition    O
of    O
cell    O
death    O
(    O
apoptosis    O
)    O
.    O

cell    B-Cell102991711
growth    I-Cell102991711
,    O

However    O
,    O
additional    O
experiments    O
have    O
merely    O
stated    O
that    O
levels    O
of    O
TS    O
may    O
be    O
associated    O
with    O
stage    O
of    O
disease    O
,    O
cell    B-Cell102991711
proliferation    I-Cell102991711
and    O
tumor    O
differentiation    O
for    O
those    O
with    O
lung    O
adenocarcinoma    O
but    O
low    O
levels    O
are    O
not    O
necessarily    O
indicators    O
of    O
high    O
success    O
.    O

However    O
,    O
their    O
involvement    O
in    O
immunomodulation    O
,    O
cell    B-Cell102991711
proliferation    I-Cell102991711
,    O
inflammation    O
and    O
other    O
homeostatic    O
processes    O
has    O
been    O
since    O
identified    O
.    O

This    O
cytokine    O
induces    O
cell    B-Cell102991711
proliferation    I-Cell102991711
of    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
;    O
cells    O
of    O
the    O
innate    O
immune    O
system    O
whose    O
principal    O
role    O
is    O
to    O
kill    O
virally    O
infected    O
cells    O
.    O

This    O
cytokine    O
induces    O
cell    O
division    O
/    O
proliferation    B-Cell102991711
in    O
its    O
target    O
cells    O
.    O

Ftr    O
from    O
the    O
thermophilic    O
methanogen    O
"    O
Methanopyrus    O
kandleri    O
"    O
(    O
which    O
has    O
an    O
optimum    O
growth    B-Cell102991711
temperature    O
98    O
degrees    O
C    O
)    O
is    O
a    O
hyperthermophilic    O
enzyme    O
that    O
is    O
absolutely    O
dependent    O
on    O
the    O
presence    O
of    O
lyotropic    O
salts    O
for    O
activity    O
and    O
thermostability    O
.    O

Abnormal    O
cannabidiol    O
(    O
Abn    O
-    O
CBD    O
)    O
is    O
a    O
synthetic    O
regioisomer    O
of    O
cannabidiol    O
,    O
which    O
unlike    O
most    O
other    O
cannabinoids    O
produces    O
vasodilator    O
effects    O
,    O
lowers    O
blood    O
pressure    O
,    O
and    O
induces    O
cell    O
migration    O
,    O
cell    B-Cell102991711
proliferation    I-Cell102991711
and    O
mitogen    O
-    O
activated    O
protein    O
kinase    O
activation    O
in    O
microglia    O
,    O
but    O
without    O
producing    O
any    O
psychoactive    O
effects    O
.    O

The    O
two    O
commonly    O
used    O
categories    O
of    O
white    O
blood    O
cell    O
disorders    O
divide    O
them    O
quantitatively    O
into    O
those    O
causing    O
excessive    O
numbers    O
(    O
proliferative    B-Cell102991711
disorders    O
)    O
and    O
those    O
causing    O
insufficient    O
numbers    O
(    O
leukopenias    O
)    O
.    O

However    O
,    O
studies    O
of    O
supplementation    O
with    O
large    O
doses    O
of    O
β-carotene    O
in    O
smokers    O
have    O
shown    O
an    O
increase    O
in    O
cancer    O
risk    O
,    O
possibly    O
because    O
excessive    O
β-carotene    O
results    O
in    O
breakdown    O
products    O
that    O
reduce    O
plasma    O
vitamin    O
A    O
and    O
worsen    O
the    O
lung    O
cell    B-Cell102991711
proliferation    I-Cell102991711
induced    O
by    O
smoke    O
.    O

In    O
this    O
example    O
(    O
Figure    O
1    O
,    O
see    O
Lac    O
operon    O
for    O
details    O
)    O
the    O
number    O
of    O
bacteria    O
present    O
in    O
a    O
nutrient    O
-    O
containing    O
broth    O
was    O
measured    O
during    O
the    O
course    O
of    O
an    O
8-hour    O
cell    B-Cell102991711
growth    I-Cell102991711
experiment    O
.    O
The    O
observed    O
pattern    O
of    O
bacterial    O
growth    O
is    O
bi    O
-    O
phasic    O
because    O
two    O
different    O
sugars    O
were    O
present    O
,    O
glucose    O
and    O
lactose    O
.    O

Their    O
functions    O
include    O
activation    O
of    O
growth    B-Cell102991711
factors    O
,    O
degradation    O
of    O
polypeptides    O
,    O
and    O
processing    O
of    O
extracellular    O
proteins    O
.    O

BAG-1    O
promotes    O
cell    B-Cell102991711
growth    I-Cell102991711
by    O
binding    O
to    O
and    O
stimulating    O
Raf-1    O
activity    O
.    O

The    O
dynamic    O
mechanical    O
behavior    O
of    O
cell    O
-    O
ECM    O
and    O
cell    O
-    O
cell    O
interactions    O
is    O
known    O
to    O
influence    O
a    O
vast    O
range    O
of    O
cellular    O
functions    O
,    O
including    O
necrosis    O
,    O
differentiation    O
,    O
adhesion    B-Cell102991711
,    O
migration    O
,    O
locomotion    O
,    O
and    O
growth    B-Cell102991711
.    O

The    O
galectin-3    O
inhibitor    O
,    O
TD139    O
,    O
has    O
the    O
potential    O
to    O
treat    O
many    O
diseases    O
due    O
to    O
its    O
involvement    O
in    O
many    O
key    O
biological    O
pathways    O
such    O
as    O
cell    O
differentiation    O
,    O
cell    B-Cell102991711
growth    I-Cell102991711
,    O
and    O
apoptosis    O
.    O
Galecto    O
Biotech    O
is    O
using    O
this    O
inhibitor    O
to    O
treat    O
idiopathic    O
pulmonary    O
fibrosis    O
(    O
IPF    O
)    O
,    O
which    O
is    O
a    O
progressive    O
,    O
irreversible    O
and    O
ultimately    O
fatal    O
lung    O
disease    O
that    O
has    O
poor    O
prognosis    O
and    O
no    O
effective    O
therapies    O
.    O

Phosphatase    O
enzymes    O
are    O
essential    O
to    O
many    O
biological    O
functions    O
,    O
because    O
phosphorylation    O
(    O
e.g.    O
by    O
protein    O
kinases    O
)    O
and    O
dephosphorylation    O
(    O
by    O
phosphatases    O
)    O
serve    O
diverse    O
roles    O
in    O
cellular    B-Cell102991711
regulation    I-Cell102991711
and    O
signaling    O
.    O

Nilotinib    O
is    O
10    O
-    O
30    O
fold    O
more    O
potent    O
than    O
imatinib    O
in    O
inhibiting    O
activity    O
of    O
the    O
Bcr    O
-    O
Abl    O
tyrosine    O
kinase    O
and    O
proliferation    B-Cell102991711
of    O
Bcr    O
-    O
Abl    O
expressing    O
cells    O
.    O

These    O
are    O
joined    O
by    O
fibrous    O
sutures    O
,    O
which    O
allow    O
movement    O
that    O
facilitates    O
childbirth    O
and    O
brain    O
growth    B-Cell102991711
.    O

A    O
study    O
was    O
performed    O
to    O
determine    O
the    O
effect    O
of    O
netrin-1    O
on    O
schwann    O
cell    O
proliferation    B-Cell102991711
.    O

It    O
was    O
also    O
found    O
that    O
the    O
netrin-1-induced    O
Schwann    O
cell    O
proliferation    B-Cell102991711
was    O
blocked    O
by    O
the    O
specific    O
inhibition    O
of    O
Unc5b    O
expression    O
with    O
RNAi    O
.    O

Knowing    O
that    O
caspase    O
is    O
involved    O
in    O
apoptosis    O
,    O
this    O
information    O
leads    O
us    O
to    O
believe    O
that    O
NOXP20    O
could    O
have    O
a    O
role    O
in    O
apoptosis    O
and    O
regulation    O
of    O
cell    B-Cell102991711
proliferation    I-Cell102991711
.    O

These    O
include    O
muscle    O
contraction    O
,    O
neuronal    O
transmission    O
as    O
in    O
an    O
excitatory    O
synapse    O
,    O
cellular    O
motility    O
(    O
including    O
the    O
movement    O
of    O
flagella    O
and    O
cilia    B-Cell102991711
)    O
,    O
fertilisation    O
,    O
cell    B-Cell102991711
growth    I-Cell102991711
or    O
proliferation    O
,    O
neurogenesis    O
,    O
learning    O
and    O
memory    O
as    O
with    O
synaptic    O
plasticity    O
,    O
and    O
secretion    O
of    O
saliva    O
.    O

The    O
encoded    O
protein    O
contains    O
a    O
RING    O
-    O
finger    O
domain    O
and    O
is    O
also    O
thought    O
to    O
have    O
a    O
role    O
in    O
control    O
of    O
cell    B-Cell102991711
proliferation    I-Cell102991711
.    O

The    O
design    O
of    O
the    O
structure    O
was    O
inspired    O
from    O
cellular    O
structure    O
and    O
growth    B-Cell102991711
and    O
had    O
a    O
solar    O
reflective    O
exterior    O
,    O
natural    O
wind    O
ventilation    O
and    O
rainwater    O
flow    O
drainage    O
.    O

More    O
precisely    O
,    O
they    O
have    O
critical    O
roles    O
in    O
the    O
control    O
of    O
cellular    O
differentiation    O
,    O
proliferation    B-Cell102991711
and    O
regulation    O
of    O
oncogenesis    O
.    O

Tooth    O
development    O
is    O
the    O
complex    O
process    O
by    O
which    O
teeth    O
form    O
from    O
embryonic    O
cells    O
,    O
grow    B-Cell102991711
,    O
and    O
erupt    O
into    O
the    O
mouth    O
.    O

It    O
is    O
strictly    O
associated    O
with    O
cell    B-Cell102991711
proliferation    I-Cell102991711
.    O

However    O
,    O
they    O
may    O
stimulate    O
breast    O
tumor    O
growth    B-Cell102991711
due    O
to    O
their    O
inherent    O
estrogenic    O
activity    O
and    O
are    O
said    O
to    O
be    O
devoid    O
of    O
major    O
therapeutic    O
efficacy    O
in    O
breast    O
cancer    O
,    O
although    O
estramustine    O
phosphate    O
has    O
been    O
approved    O
for    O
and    O
is    O
used    O
(    O
almost    O
exclusively    O
)    O
in    O
the    O
treatment    O
of    O
prostate    O
cancer    O
.    O

The    O
fetal    O
adrenal    O
cortex    O
is    O
different    O
from    O
its    O
adult    O
counterpart    O
,    O
as    O
it    O
is    O
composed    O
of    O
two    O
distinct    O
zones    O
:    O
the    O
inner    O
"    O
fetal    O
"    O
zone    O
,    O
which    O
carries    O
most    O
of    O
the    O
hormone    O
-    O
producing    O
activity    O
,    O
and    O
the    O
outer    O
"    O
definitive    O
"    O
zone    O
,    O
which    O
is    O
in    O
a    O
proliferative    B-Cell102991711
phase    O
.    O

Developmental    O
biology    O
–    O
the    O
study    O
of    O
the    O
process    O
by    O
which    O
organisms    O
grow    O
and    O
develop    O
,    O
including    O
the    O
genetic    O
control    O
of    O
cell    B-Cell102991711
growth    I-Cell102991711
,    O
differentiation    O
and    O
"    O
morphogenesis    O
"    O
,    O
which    O
is    O
the    O
process    O
that    O
gives    O
rise    O
to    O
tissues    O
,    O
organs    O
and    O
anatomy    O
.    O

When    O
DCC    O
is    O
present    O
on    O
the    O
membrane    O
and    O
bound    O
to    O
netrin-1    O
,    O
signals    O
are    O
conveyed    O
that    O
can    O
lead    O
to    O
proliferation    B-Cell102991711
and    O
cell    O
migration    O
.    O

Cysmethynil    O
is    O
a    O
compound    O
that    O
was    O
reported    O
to    O
be    O
responsible    O
for    O
the    O
uninhibited    O
cell    B-Cell102991711
growth    I-Cell102991711
,    O
one    O
of    O
the    O
main    O
characteristics    O
of    O
cancer    O
.    O

The    O
entire    O
process    O
of    O
embryogenesis    O
involves    O
coordinated    O
spatial    O
and    O
temporal    O
changes    O
in    O
gene    O
expression    O
,    O
cell    B-Cell102991711
growth    I-Cell102991711
and    O
cellular    O
differentiation    O
.    O

Functional    O
roles    O
of    O
lipids    O
are    O
in    O
fact    O
many    O
:    O
They    O
serve    O
as    O
regulatory    O
agents    O
in    O
cell    B-Cell102991711
growth    I-Cell102991711
and    O
adhesion    B-Cell102991711
.    O

Nonmucinous    O
BAC    O
is    O
thought    O
to    O
derive    O
from    O
a    O
transformed    O
cell    O
in    O
the    O
distal    O
airways    O
and    O
terminal    O
respiratory    O
units    O
,    O
and    O
often    O
shows    O
features    O
of    O
club    B-Cell102991711
cell    I-Cell102991711
or    O
Type    B-Cell102991711
II    I-Cell102991711
pneumocyte    I-Cell102991711
differentiation    O
.    O

The    O
toxic    O
metabolite    O
,    O
an    O
enedial    O
,    O
is    O
mostly    O
formed    O
in    O
the    O
bronchiolar    O
exocrine    O
cells    O
(    O
club    B-Cell102991711
cells    I-Cell102991711
)    O
in    O
the    O
lungs    O
of    O
rodents    O
.    O

In    O
1937    O
,    O
he    O
discovered    O
previously    O
unknown    O
cells    O
found    O
in    O
human    O
lungs    O
,    O
which    O
were    O
later    O
eponymously    O
named    O
Clara    B-Cell102991711
cell    I-Cell102991711
;    O
in    O
2015    O
,    O
they    O
were    O
renamed    O
"    O
club    O
cells    O
"    O
.    O

Another    O
way    O
enzyme    O
malfunctions    O
can    O
cause    O
disease    O
comes    O
from    O
germline    B-Cell102991711
mutation    I-Cell102991711
in    O
genes    O
coding    O
for    O
DNA    O
repair    O
enzymes    O
.    O

In    O
multicellular    O
organisms    O
with    O
dedicated    O
reproductive    O
cells    O
,    O
mutations    O
can    O
be    O
subdivided    O
into    O
germline    B-Cell102991711
mutation    I-Cell102991711
,    O
which    O
can    O
be    O
passed    O
on    O
to    O
descendants    O
through    O
their    O
reproductive    O
cells    O
,    O
and    O
somatic    O
mutations    O
(    O
also    O
called    O
acquired    O
mutations    O
)    O
,    O
which    O
involve    O
cells    O
outside    O
the    O
dedicated    O
reproductive    O
group    O
and    O
which    O
are    O
not    O
usually    O
transmitted    O
to    O
descendants    O
.    O

The    O
von    O
Hippel    O
-    O
Lindau    O
tumor    O
suppressor    O
gene    O
generally    O
has    O
a    O
germline    B-Cell102991711
mutation    I-Cell102991711
.    O

Because    O
they    O
are    O
inherited    O
from    O
the    O
parents    O
,    O
they    O
are    O
classified    O
as    O
"    O
hereditary    O
"    O
or    O
"    O
germline    B-Cell102991711
mutation    I-Cell102991711
"    O
rather    O
than    O
"    O
acquired    O
"    O
or    O
"    O
somatic    O
mutations    O
"    O
.    O

Most    O
germline    B-Cell102991711
or    O
somatic    O
mutations    O
in    O
the    O
MEN1    O
gene    O
predict    O
truncation    O
or    O
absence    O
of    O
encoded    O
menin    O
resulting    O
in    O
the    O
inability    O
of    O
MEN1    O
to    O
act    O
as    O
a    O
tumor    O
suppressor    O
gene    O
.    O

The    O
myosin-1a    O
protein    O
is    O
expressed    O
by    O
enterocytes    B-Cell102991711
,    O
the    O
epithelial    O
cells    O
that    O
line    O
the    O
luminal    O
surface    O
of    O
the    O
small    O
intestine    O
.    O

A    O
120-kDa    O
protease    O
secreted    O
by    O
"    O
S.    O
boulardii    O
"    O
has    O
been    O
observed    O
to    O
have    O
an    O
effect    O
on    O
enterocytes    B-Cell102991711
lining    O
the    O
large    O
and    O
small    O
intestinal    O
tract    O
–    O
inhibiting    O
the    O
stimulation    O
of    O
adenylate    O
cyclase    O
,    O
which    O
led    O
to    O
the    O
reduction    O
in    O
enterocytic    O
cyclic    O
adenosine    O
monophosphate    O
(    O
cAMP    O
)    O
production    O
and    O
chloride    O
secretion    O
.    O

During    O
an    O
"    O
E.    O
coli    O
"    O
infection    O
,    O
myosin    O
light    O
chain    O
is    O
phosphorylated    O
leading    O
to    O
the    O
degradation    O
of    O
the    O
tight    O
junctions    O
between    O
intestinal    O
mucosa    O
enterocyte    B-Cell102991711
.    O
"    O

A    O
transporter    O
protein    O
on    O
the    O
cells    B-Cell102991711
of    I-Cell102991711
the    I-Cell102991711
small    I-Cell102991711
bowel    I-Cell102991711
,    O
copper    O
membrane    O
transporter    O
1    O
(    O
Ctr1    O
;    O
SLC31A1    O
)    O
,    O
carries    O
copper    O
inside    O
the    O
cells    O
,    O
where    O
some    O
is    O
bound    O
to    O
metallothionein    O
and    O
part    O
is    O
carried    O
by    O
ATOX1    O
to    O
an    O
organelle    O
known    O
as    O
the    O
trans    O
-    O
Golgi    O
network    O
.    O

Fructose    O
malabsorption    O
,    O
formerly    O
named    O
"    O
dietary    O
fructose    O
intolerance    O
"    O
(    O
DFI    O
)    O
,    O
is    O
a    O
digestive    O
disorder    O
in    O
which    O
absorption    O
of    O
fructose    O
is    O
impaired    O
by    O
deficient    O
fructose    O
carriers    O
in    O
the    O
small    O
intestine    O
's    O
enterocyte    B-Cell102991711
.    O

DGAT1    O
is    O
mainly    O
located    O
in    O
absorptive    O
enterocyte    B-Cell102991711
cells    O
that    O
line    O
the    O
intestine    O
and    O
duodenum    O
where    O
it    O
reassembles    O
triglycerides    O
that    O
were    O
decomposed    O
through    O
lipolysis    O
in    O
the    O
process    O
of    O
intestinal    O
absorption    O
.    O

The    O
mutation    O
is    O
in    O
downregulated    O
-    O
in    O
-    O
adenoma    O
(    O
DRA    O
)    O
,    O
a    O
gene    O
that    O
encodes    O
a    O
membrane    O
protein    O
of    O
intestinal    B-Cell102991711
cells    I-Cell102991711
.    O

It    O
infects    O
and    O
damages    O
the    O
cells    B-Cell102991711
that    O
line    O
the    O
small    O
intestine    O
and    O
causes    O
gastroenteritis    O
(    O
which    O
is    O
often    O
called    O
"    O
stomach    O
flu    O
"    O
despite    O
having    O
no    O
relation    O
to    O
influenza    O
)    O
.    O

Malabsorption    O
occurs    O
because    O
of    O
the    O
destruction    O
of    O
gut    O
cells    O
called    O
enterocyte    B-Cell102991711
.    O

Severe    O
zinc    O
deficiency    O
is    O
rare    O
,    O
and    O
is    O
mainly    O
seen    O
in    O
persons    O
with    O
acrodermatitis    O
enteropathica    O
,    O
a    O
severe    O
defect    O
in    O
zinc    O
absorption    O
due    O
to    O
a    O
congenital    O
deficiency    O
in    O
the    O
zinc    O
carrier    O
protein    O
ZIP4    O
in    O
the    O
enterocyte    B-Cell102991711
.    O

Aldolase    O
A    O
is    O
preferentially    O
expressed    O
in    O
muscle    O
and    O
brain    O
;    O
aldolase    O
B    O
in    O
liver    O
,    O
kidney    O
,    O
and    O
in    O
enterocyte    B-Cell102991711
;    O
and    O
aldolase    O
C    O
in    O
brain    O
.    O

This    O
,    O
in    O
turn    O
,    O
means    O
that    O
eukaryotic    O
organisms    O
express    O
different    O
genes    O
that    O
give    O
rise    O
to    O
:    O
α-actin    O
,    O
which    O
is    O
found    O
in    O
contractile    O
structures    O
;    O
β-actin    O
,    O
found    O
at    O
the    O
expanding    O
edge    O
of    O
cells    O
that    O
use    O
the    O
projection    O
of    O
their    O
cellular    O
structures    O
as    O
their    O
means    O
of    O
mobility    O
;    O
and    O
γ-actin    O
,    O
which    O
is    O
found    O
in    O
the    O
filaments    O
of    O
stress    B-Cell102991711
fibre    I-Cell102991711
.    O

On    O
the    O
other    O
hand    O
,    O
the    O
stress    O
-    O
induced    O
triggering    O
of    O
apoptosis    O
causes    O
the    O
reorganization    O
of    O
the    O
actin    O
cytoskeleton    O
(    O
which    O
also    O
involves    O
its    O
polymerization    O
)    O
,    O
giving    O
rise    O
to    O
structures    O
called    O
stress    B-Cell102991711
fiber    I-Cell102991711
;    O
this    O
is    O
activated    O
by    O
the    O
MAP    O
kinase    O
pathway    O
.    O

.    O
does    O
not    O
seem    O
to    O
be    O
involved    O
in    O
spermatogenesis    O
outside    O
of    O
its    O
role    O
in    O
inducing    O
production    O
of    O
testosterone    O
by    O
the    O
Leydig    B-Cell102991711
cell    I-Cell102991711
in    O
the    O
seminiferous    O
tubules    O
(    O
which    O
make    O
up    O
approximately    O
80%    O
of    O
the    O
bulk    O
of    O
the    O
testes    O
)    O
,    O
whereas    O
this    O
is    O
not    O
the    O
case    O
for    O
,    O
which    O
is    O
importantly    O
involved    O
.    O

Male    O
to    O
female    O
sex    O
reversal    O
,    O
however    O
,    O
does    O
not    O
occur    O
because    O
Leydig    B-Cell102991711
cell    I-Cell102991711
remain    O
normal    O
.    O

Deletion    O
of    O
TSPO    O
in    O
steroidogenic    O
Leydig    B-Cell102991711
cells    I-Cell102991711
did    O
not    O
impair    O
synthesis    O
of    O
the    O
steroid    O
testosterone    O
.    O

For    O
men    O
it    O
acts    O
in    O
the    O
same    O
way    O
as    O
LH    O
;    O
stimulating    O
the    O
Leydig    B-Cell102991711
cells    I-Cell102991711
in    O
the    O
testes    O
to    O
produce    O
testosterone    O
.    O

Also    O
,    O
the    O
testes    O
show    O
Leydig    B-Cell102991711
cell    I-Cell102991711
hyperplasia    I-Cell102991711
,    O
which    O
is    O
due    O
to    O
the    O
increased    O
levels    O
of    O
LH    O
and    O
intratesticular    O
testosterone    O
.    O

Expression    O
of    O
CYP17A1    O
has    O
been    O
found    O
in    O
all    O
of    O
the    O
traditional    O
steroidogenic    O
tissues    O
except    O
the    O
placenta    O
,    O
including    O
the    O
zona    O
reticularis    O
and    O
zona    O
fasciculata    O
of    O
the    O
adrenal    O
cortex    O
,    O
the    O
Leydig    B-Cell102991711
cell    I-Cell102991711
of    O
the    O
testes    O
,    O
the    O
thecal    O
cells    O
of    O
the    O
ovaries    O
,    O
and    O
,    O
more    O
recently    O
,    O
in    O
luteinized    O
granulosa    B-Cell102991711
cell    I-Cell102991711
in    O
ovarian    O
follicles    O
.    O

In    O
addition    O
to    O
receptor    O
binding    O
,    O
the    O
compound    O
has    O
been    O
found    O
to    O
affect    O
Leydig    B-Cell102991711
cell    I-Cell102991711
steroidogenesis    O
,    O
including    O
affecting    O
17α-hydroxylase/17,20    O
lyase    O
and    O
aromatase    O
expression    O
and    O
interfering    O
with    O
LH    O
receptor    O
-    O
ligand    O
binding    O
.    O

Physiologic    O
levels    O
of    O
prolactin    O
in    O
males    O
enhance    O
luteinizing    O
hormone    O
-    O
receptors    O
in    O
Leydig    B-Cell102991711
cells    I-Cell102991711
,    O
resulting    O
in    O
testosterone    O
secretion    O
,    O
which    O
leads    O
to    O
spermatogenesis    O
.    O

If    O
a    O
substance    O
affects    O
Sertoli    B-Cell102991711
and    O
Leydig    B-Cell102991711
cell    I-Cell102991711
differentiation    O
(    O
a    O
common    O
feature    O
of    O
TDS    O
disorders    O
)    O
at    O
an    O
early    O
developmental    O
stage    O
,    O
germ    O
cell    O
growth    O
and    O
testosterone    O
production    O
will    O
be    O
impaired    O
.    O

The    O
most    O
important    O
somatic    O
cells    O
that    O
support    O
regulation    O
of    O
SSCs    O
are    O
Sertoli    O
cells    O
Various    O
other    O
somatic    O
cells    O
in    O
the    O
interstitial    O
tissue    O
support    O
Sertoli    O
cells    O
such    O
as    O
Leydig    B-Cell102991711
cell    I-Cell102991711
and    O
peritubular    O
myoid    O
cells    O
therefore    O
indirectly    O
influencing    O
SSCs    O
and    O
the    O
location    O
of    O
their    O
niche    O
.    O

Mural    B-Cell102991711
cell    I-Cell102991711
,    O
a    O
type    O
of    O
vascular    O
cell    O

It    O
should    O
not    O
be    O
confused    O
with    O
the    O
term    O
"    O
Downey    B-Cell102991711
bodies    I-Cell102991711
"    O
,    O
which    O
refers    O
to    O
a    O
type    O
of    O
T    B-Cell102991711
cell    I-Cell102991711
observed    O
in    O
infectious    O
mononucleosis    O
.    O

#    O
Clonal    O
selection    O
:    O
B    O
cells    O
that    O
have    O
undergone    O
SHM    O
must    O
compete    O
for    O
limiting    O
growth    O
resources    O
,    O
including    O
the    O
availability    O
of    O
antigen    O
and    O
paracrine    O
signals    O
from    O
Tfh    B-Cell102991711
cells    I-Cell102991711
.    O

In    O
addition    O
,    O
IL-21    O
expression    O
is    O
up    O
-    O
regulated    O
in    O
Th2    O
and    O
Th17    B-Cell102991711
subsets    O
of    O
T    B-Cell102991711
helper    I-Cell102991711
cell    I-Cell102991711
,    O
as    O
well    O
as    O
T    B-Cell102991711
follicular    I-Cell102991711
cell    I-Cell102991711
.    O

impaired    O
development    O
of    O
CD4    O
+    O
T    B-Cell102991711
follicular    I-Cell102991711
helper    I-Cell102991711
cells    I-Cell102991711
,    O
which    O
are    O
specialized    O
in    O
facilitating    O
peripheral    O
B    B-Cell102991711
cell    I-Cell102991711
maturation    O
,    O
and    O
the    O
generation    O
of    O
antibody    O
-    O
producing    O
plasma    O
cells    O
and    O
memory    B-Cell102991711
B    I-Cell102991711
cell    I-Cell102991711

"    O
Lamella    O
"    O
,    O
in    O
cell    O
biology    O
,    O
is    O
also    O
used    O
to    O
describe    O
the    O
leading    O
edge    O
of    O
a    O
motile    O
cell    O
,    O
of    O
which    O
the    O
lamellipodia    B-Cell102991711
is    O
the    O
most    O
forward    O
portion    O
.    O

At    O
the    O
front    O
of    O
the    O
cell    O
is    O
the    O
leading    O
edge    O
,    O
which    O
is    O
often    O
defined    O
by    O
a    O
flat    O
ruffling    O
of    O
the    O
cell    O
membrane    O
called    O
the    O
lamellipodium    B-Cell102991711
or    O
thin    O
protrusions    O
called    O
filopodia    O
.    O

PHACTR1    O
can    O
be    O
induced    O
by    O
NRP    O
and    O
VEGF    O
through    O
NRP-1    O
and    O
VEGF    O
-    O
R1    O
receptors    O
to    O
control    O
tubulogenesis    O
,    O
actin    O
polymerization    O
,    O
and    O
lamellipodial    B-Cell102991711
dynamics    O
.    O

To    O
try    O
to    O
get    O
single    O
developing    O
nerve    O
cells    O
with    O
long    O
processes    B-Cell102991711
visible    O
in    O
one    O
plane    O
of    O
focus    O
under    O
the    O
microscope    O
,    O
Dr.    O
Reddick    O
used    O
a    O
“    O

Lamellipodium    B-Cell102991711

"    O
Gardnerella    O
"    O
reveals    O
a    O
classic    O
"    O
clue    B-Cell102991711
cell    I-Cell102991711
"    O
under    O
the    O
microscope    O
,    O
showing    O
bacteria    O
adhering    O
to    O
the    O
surface    O
of    O
squamous    O
epithelial    O
cells    O
.    O

It    O
develops    O
genome    O
-    O
edited    O
chimeric    B-Cell102991711
antigen    I-Cell102991711
receptor    I-Cell102991711
T-cell    B-Cell102991711
technologies    O
for    O
cancer    O
immunotherapy    O
.    O

It    O
restructured    O
,    O
closed    O
laboratories    O
and    O
reduced    O
staff    O
,    O
and    O
shifted    O
research    O
emphasis    O
toward    O
CAR-T    B-Cell102991711
technologies    O
for    O
cancer    O
immunotherapy    O
.    O

Chimeric    B-Cell102991711
antigen    I-Cell102991711
receptors    I-Cell102991711
(    O
CARs    B-Cell102991711
,    O
also    O
known    O
as    O
chimeric    B-Cell102991711
immunoreceptors    I-Cell102991711
,    O
chimeric    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
receptors    I-Cell102991711
,    O
artificial    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
receptors    I-Cell102991711
or    O
CAR-T    B-Cell102991711
)    O
are    O
engineered    O
receptors    O
which    O
graft    O
an    O
arbitrary    O
specificity    O
onto    O
an    O
immune    B-Cell102991711
effector    I-Cell102991711
cell    I-Cell102991711
(    O
T    O
cell    O
)    O
.    O

ScFvs    O
have    O
many    O
uses    O
,    O
e.g.    O
,    O
flow    O
cytometry    O
,    O
immunohistochemistry    O
,    O
and    O
as    O
antigen    O
-    O
binding    O
domains    O
of    O
artificial    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
receptors    I-Cell102991711
.    O

The    O
deal    O
will    O
add    O
the    O
promising    O
CAR-T    B-Cell102991711
candidate    O
to    O
the    O
companys    O
existing    O
portfolio    O
.    O

The    O
microbe    O
then    O
induces    O
T    O
-    O
helper    O
lymphocytes    O
,    O
epitheloid    O
cells    O
,    O
and    O
giant    B-Cell102991711
cell    I-Cell102991711
infiltration    O
of    O
the    O
skin    O
,    O
causing    O
infected    O
individuals    O
to    O
exhibit    O
large    O
flattened    O
patches    O
with    O
raised    O
and    O
elevated    O
red    O
edges    O
on    O
their    O
skin    O
.    O

Endogenous    O
:    O
from    O
the    O
body    O
itself    O
,    O
for    O
example    O
,    O
when    O
an    O
airway    O
is    O
obstructed    O
,    O
it    O
is    O
often    O
the    O
case    O
that    O
distal    O
to    O
the    O
obstruction    O
,    O
lipid    O
-    O
laden    O
macrophages    O
(    O
foamy    O
macrophages    O
)    O
and    O
giant    B-Cell102991711
cell    I-Cell102991711
fill    O
the    O
lumen    O
of    O
the    O
disconnected    O
airspace    O
.    O

This    O
nucleus    O
tapers    O
into    O
the    O
lower    O
mesencephalic    O
reticular    O
formation    O
and    O
contains    O
sporadic    O
giant    B-Cell102991711
cells    I-Cell102991711
.    O

The    O
nodules    O
are    O
composed    O
of    O
epithelioid    B-Cell102991711
cell    I-Cell102991711
and    O
giant    B-Cell102991711
cell    I-Cell102991711
surrounded    O
by    O
lymphocytes    O
.    O

Biopsy    O
shows    O
multinucleated    B-Cell102991711
giant    I-Cell102991711
cells    I-Cell102991711
and    O
thus    O
the    O
name    O
.    O

Giant    B-Cell102991711
cell    I-Cell102991711

Micrograph    O
of    O
Alzheimer    B-Cell102991711
type    I-Cell102991711
II    I-Cell102991711
astrocyte    I-Cell102991711
,    O
as    O
may    O
be    O
seen    O
in    O
hepatic    O
encephalopathy    O
.    O

The    O
body    O
has    O
a    O
single    O
opening    O
,    O
the    O
hypostome    O
,    O
surrounded    O
by    O
sensory    O
tentacles    O
equipped    O
with    O
either    O
nematocysts    B-Cell102991711
or    O
colloblast    B-Cell102991711
to    O
capture    O
mostly    O
planktonic    O
prey    O
.    O

The    O
tentacles    O
and    O
tentilla    O
are    O
densely    O
covered    O
with    O
microscopic    O
colloblast    B-Cell102991711
that    O
capture    O
prey    O
by    O
sticking    O
to    O
it    O
.    O

A    O
gene    O
expressed    O
by    O
cells    O
in    O
the    O
primitive    O
streak    O
during    O
germ    B-Cell102991711
line    I-Cell102991711
development    I-Cell102991711
.    O

Excessive    O
matrix    O
metalloproteinase    O
and    O
myofibroblast    B-Cell102991711
accumulation    O
in    O
the    O
wound    O
margins    O
can    O
result    O
in    O
contracture    O
.    O

A    O
variety    O
of    O
insults    O
that    O
cause    O
inflammation    O
can    O
result    O
in    O
the    O
cells    O
transforming    O
into    O
myofibroblast    B-Cell102991711
,    O
resulting    O
in    O
collagen    O
production    O
,    O
fibrosis    O
,    O
and    O
cirrhosis    O
.    O

In    O
murine    O
liver    O
,    O
Reelin    O
expressed    O
by    O
Ito    O
cells    O
has    O
been    O
shown    O
to    O
be    O
a    O
reliable    O
marker    O
in    O
discerning    O
them    O
from    O
other    O
myofibroblast    B-Cell102991711
.    O

First    O
noted    O
is    O
infiltration    O
by    O
lymphocytes    O
,    O
followed    O
by    O
epithelial    O
cell    O
injury    O
,    O
then    O
inflammatory    O
lesions    O
and    O
recruitment    O
of    O
fibroblasts    O
and    O
myofibroblasts    B-Cell102991711
,    O
which    O
proliferate    O
and    O
secrete    O
proteins    O
forming    O
scar    O
tissue    O
.    O

After    O
heavier    O
injuries    O
or    O
at    O
the    O
advanced    O
stages    O
of    O
healing    O
process    O
a    O
number    O
of    O
keratocytes    O
transforms    O
into    O
myofibroblast    B-Cell102991711
actively    O
secreting    O
ECM    O
components    O
;    O
this    O
transformation    O
is    O
thought    O
to    O
be    O
caused    O
by    O
TGF    O
-    O
beta    O
.    O

Microrafts    B-Cell102991711
,    O
or    O
IsoRafts    O
,    O
are    O
arrays    O
of    O
microwells    O
which    O
provide    O
a    O
method    O
for    O
sorting    B-Cell102991711
cells    I-Cell102991711
,    O
isolating    O
cells    O
,    O
analyzing    O
cells    O
over    O
time    O
,    O
and    O
generating    O
clonal    O
populations    O
.    O

Thus    O
,    O
the    O
presence    O
of    O
a    O
functional    O
Vγ9/Vδ2    O
TCR    O
appears    O
mandatory    O
for    O
a    O
response    O
to    O
non-peptidic    B-Cell102991711
antigen    I-Cell102991711
although    O
the    O
basis    O
for    O
the    O
huge    O
differences    O
in    O
bioactivity    O
between    O
closely    O
related    O
molecules    O
like    O
HMB    O
-    O
PP    O
and    O
IPP    O
can    O
not    O
be    O
explained    O
by    O
conventional    O
epitope    O
presentation    O
/    O
recognition    O
models    O
.    O

FcεRI    O
is    O
also    O
expressed    O
on    O
antigen-presenting    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
controls    O
the    O
production    O
of    O
important    O
immune    O
mediators    O
called    O
cytokines    O
that    O
promote    O
inflammation    O
.    O

This    O
molecule    O
,    O
found    O
on    O
a    O
variety    O
of    O
immune    O
system    O
cells    O
including    O
antigen    B-Cell102991711
presenting    I-Cell102991711
cells    I-Cell102991711
has    O
CD40L    O
,    O
otherwise    O
known    O
as    O
CD154    O
and    O
transiently    O
expressed    O
on    O
the    O
surface    O
of    O
activated    O
CD4    O
+    O
T    O
cells    O
,    O
as    O
its    O
ligand    O
.    O

The    O
ligand    O
for    O
GITR    O
is    O
mainly    O
expressed    O
on    O
antigen    B-Cell102991711
presenting    I-Cell102991711
cells    I-Cell102991711
.    O

Macrophages    O
are    O
versatile    O
cells    O
that    O
reside    O
within    O
tissues    O
and    O
:    O
(    O
i    O
)    O
produce    O
a    O
wide    O
array    O
of    O
chemicals    O
including    O
enzymes    O
,    O
complement    O
proteins    O
,    O
and    O
cytokines    O
,    O
while    O
they    O
can    O
also    O
(    O
ii    O
)    O
act    O
as    O
scavengers    O
that    O
rid    O
the    O
body    O
of    O
worn    O
-    O
out    O
cells    O
and    O
other    O
debris    O
,    O
and    O
as    O
antigen-presenting    B-Cell102991711
cell    I-Cell102991711
that    O
activate    O
the    O
adaptive    O
immune    O
system    O
.    O

Since    O
many    O
antigens    O
derived    O
from    O
acellular    O
vaccines    O
do    O
not    O
strongly    O
induce    O
the    O
adaptive    O
response    O
,    O
most    O
bacterial    O
vaccines    O
are    O
provided    O
with    O
additional    O
adjuvants    O
that    O
activate    O
the    O
antigen-presenting    B-Cell102991711
cell    I-Cell102991711
of    O
the    O
innate    O
immune    O
system    O
and    O
maximize    O
immunogenicity    O
.    O

Function    O
of    O
T    O
helper    O
cells    O
:    O
Antigen    O
-    O
presenting    O
cells    O
(    O
APCs    B-Cell102991711
)    O
present    O
antigen    O
on    O
their    O
Class    O
II    O
MHC    O
molecules    O
(    O
MHC2    O
)    O
.    O

Antigen-presenting    B-Cell102991711
cell    I-Cell102991711
in    O
newborns    O
have    O
a    O
reduced    O
capability    O
to    O
activate    O
T    O
cells    O
.    O

The    O
ligand    O
of    O
OX40    O
,    O
called    O
OX40    O
ligand    O
(    O
OX40L    O
,    O
TNFSF4    O
,    O
gp34    O
)    O
,    O
which    O
is    O
expressed    O
by    O
antigen    B-Cell102991711
presenting    I-Cell102991711
cells    I-Cell102991711
,    O
binds    O
to    O
OX40    O
on    O
T    O
cells    O
,    O
preventing    O
them    O
from    O
dying    O
and    O
subsequently    O
increasing    O
cytokine    O
production    O
.    O

Activation    O
of    O
EP2    O
contributes    O
to    O
regulating    O
B    B-Cell102991711
cell    I-Cell102991711
immunoglobulin    O
class    O
switching    O
,    O
maturation    O
of    O
T    O
lymphocyte    O
CD4−CD8−    O
cells    O
to    O
CD4+CD8    O
+    O
cells    O
,    O
and    O
the    O
function    O
of    O
Antigen-presenting    B-Cell102991711
cell    I-Cell102991711
,    O
particularly    O
Dendritic    B-Cell102991711
cells    I-Cell102991711
.    O

The    O
axis    O
inhibits    O
bone    O
marrow    O
-    O
derived    O
dendritic    B-Cell102991711
cell    I-Cell102991711
(    O
i.e.    O
antigen-presenting    B-Cell102991711
cells    I-Cell102991711
that    O
process    O
antigen    O
material    O
,    O
present    O
it    O
on    O
their    O
surfaces    O
for    O
delivery    O
to    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
otherwise    O
regulate    O
innate    O
and    O
adaptive    O
immune    O
system    O
responses    O
)    O
from    O
producing    O
pro    O
-    O
inflammatory    O
cytokines    O
(    O
e.g.    O
IL-12    O
,    O
TNF    O
-    O
alpha    O
,    O
IL-1-alpha    O
,    O
and    O
IL-6    O
)    O
while    O
stimulating    O
them    O
to    O
increase    O
production    O
of    O
the    O
anti    O
-    O
inflammatory    O
cytokine    O
,    O
IL-10    O
.    O

These    O
cells    O
have    O
T    O
-    O
cell    O
receptors    O
and    O
CD4    O
molecules    O
that    O
,    O
in    O
combination    O
,    O
bind    O
antigenic    O
peptides    O
presented    O
on    O
major    O
histocompatibility    O
complex    O
(    O
MHC    O
)    O
class    O
II    O
molecules    O
on    O
antigen-presenting    B-Cell102991711
cells    I-Cell102991711
.    O

Hematopoietic    O
stem    O
cells    O
(    O
HSC    O
)    O
,    O
which    O
provide    O
the    O
regulated    O
lifelong    O
supply    O
of    O
leukocyte    O
progenitors    O
that    O
are    O
in    O
turn    O
able    O
to    O
differentiate    O
into    O
a    O
diversity    O
of    O
specialised    O
immune    O
cells    O
(    O
including    O
lymphocytes    O
,    O
antigen-presenting    B-Cell102991711
dendritic    B-Cell102991711
cells    I-Cell102991711
and    O
phagocytes    O
)    O
diminish    O
in    O
their    O
self    O
-    O
renewal    O
capacity    O
.    O

The    O
age    O
-    O
associated    O
impairment    O
of    O
dendritic    O
Antigen    B-Cell102991711
Presenting    I-Cell102991711
Cells    I-Cell102991711
(    O
APCs    O
)    O
has    O
profound    O
implications    O
as    O
this    O
translates    O
into    O
a    O
deficiency    O
in    O
cell    O
-    O
mediated    O
immunity    O
and    O
thus    O
,    O
the    O
inability    O
for    O
effector    O
T-lymphocytes    B-Cell102991711
to    O
modulate    O
an    O
adaptive    O
immune    O
response    O
(    O
see    O
below    O
)    O
.    O

Recent    O
evidence    O
suggests    O
a    O
role    O
as    O
a    O
liver    O
-    O
resident    O
antigen-presenting    B-Cell102991711
cell    I-Cell102991711
,    O
presenting    O
lipid    O
antigens    O
to    O
and    O
stimulating    O
proliferation    O
of    O
NKT    B-Cell102991711
cells    I-Cell102991711
.    O

Antigen    B-Cell102991711
presenting    I-Cell102991711
cells    I-Cell102991711
are    O
the    O
sentinels    O
of    O
the    O
immune    O
system    O
and    O
patrol    O
the    O
body    O
for    O
pathogens    O
.    O

Dendritic    B-Cell102991711
cells    I-Cell102991711
(    O
DCs    O
)    O
,    O
which    O
are    O
the    O
primary    O
antigen-presenting    B-Cell102991711
cells    I-Cell102991711
(    O
APCs    O
)    O
,    O
of    O
the    O
donor    O
tissue    O
migrate    O
to    O
the    O
recipient    O
's    O
peripheral    O
lymphoid    O
tissue    O
(    O
lymphoid    O
follicles    O
and    O
lymph    O
nodes    O
)    O
,    O
and    O
present    O
the    O
donor    O
's    O
"    O
self    O
"    O
peptides    O
to    O
the    O
recipient    O
's    O
lymphocytes    O
(    O
immune    O
cells    O
residing    O
in    O
lymphoid    O
tissues    O
)    O
.    O

These    O
Vγ9Vδ2    O
T    O
cells    O
can    O
also    O
behave    O
like    O
professional    O
antigen    O
-    O
presenting    O
cells    O
(    O
APC    B-Cell102991711
)    O
.    O

CD1    O
(    O
cluster    O
of    O
differentiation    O
1    O
)    O
is    O
a    O
family    O
of    O
glycoproteins    O
expressed    O
on    O
the    O
surface    O
of    O
various    O
human    O
antigen-presenting    B-Cell102991711
cells    I-Cell102991711
.    O
They    O
are    O
related    O
to    O
the    O
class    O
I    O
MHC    O
molecules    O
,    O
and    O
are    O
involved    O
in    O
the    O
presentation    O
of    O
lipid    O
antigens    O
to    O
T    B-Cell102991711
cells    I-Cell102991711
.    O

Each    O
antibody    O
(    O
immune    O
response    O
)    O
is    O
specifically    O
produced    O
by    O
the    O
immune    O
system    O
to    O
match    O
an    O
antigen    O
after    O
cells    B-Cell102991711
in    O
the    O
immune    O
system    O
come    O
into    O
contact    O
with    O
it    O
;    O
this    O
allows    O
a    O
precise    O
identification    O
/    O
matching    O
of    O
the    O
antigen    O
and    O
the    O
initiation    O
of    O
a    O
tailored    O
response    O
.    O

Furthermore    O
,    O
for    O
a    O
peptide    O
to    O
induce    O
an    O
immune    O
response    O
(    O
activation    O
of    O
T    O
-    O
cells    O
by    O
antigen-presenting    B-Cell102991711
cell    I-Cell102991711
)    O
it    O
must    O
be    O
a    O
large    O
enough    O
size    O
,    O
since    O
peptides    O
too    O
small    O
will    O
also    O
not    O
elicit    O
an    O
immune    O
response    O
.    O

Antigen    B-Cell102991711
presenting    I-Cell102991711
cell    I-Cell102991711
present    O
antigens    O
in    O
the    O
form    O
of    O
peptides    O
on    O
histocompatibility    O
molecules    O
.    O

By    O
endocytosis    O
or    O
phagocytosis    O
,    O
exogenous    O
antigens    O
are    O
taken    O
into    O
the    O
antigen-presenting    B-Cell102991711
cell    I-Cell102991711
(    O
APCs    O
)    O
and    O
processed    O
into    O
fragments    O
.    O

They    O
have    O
to    O
be    O
activated    O
by    O
the    O
pMHC    O
-    O
I    O
complexes    O
of    O
antigen-presenting    B-Cell102991711
cell    I-Cell102991711
(    O
APCs    O
)    O
.    O

Cementoblast    B-Cell102991711

Additionally    O
,    O
the    O
junction    O
between    O
the    O
dental    O
papilla    O
and    O
inner    O
enamel    O
epithelium    O
determines    O
the    O
crown    O
shape    O
of    O
a    O
tooth    O
.    O
The    O
"    O
dental    O
follicle    O
"    O
gives    O
rise    O
to    O
three    O
important    O
entities    O
:    O
cementoblast    B-Cell102991711
,    O
osteoblasts    O
,    O
and    O
fibroblasts    O
.    O

Other    O
anatomical    O
structures    O
bearing    O
his    O
name    O
are    O
the    O
Merkel-Ranvier    B-Cell102991711
cell    I-Cell102991711
,    O
melanocyte    O
-    O
like    O
cells    O
in    O
the    O
basal    O
layer    O
of    O
the    O
epidermis    O
that    O
contain    O
catecholamine    O
granules    O
;    O
and    O
Ranvier    O
's    O
tactile    O
disks    O
,    O
a    O
special    O
type    O
of    O
sensory    O
nerve    O
ending    O
.    O

In    O
structure    O
,    O
it    O
consists    O
of    O
a    O
keratinized    O
stratified    O
squamous    O
epithelium    O
comprising    O
four    O
types    O
of    O
cells    O
:    O
keratinocytes    B-Cell102991711
,    O
melanocytes    O
,    O
Merkel    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
Langerhans    O
'    O
cells    O
.    O

The    O
epidermis    O
contains    O
four    O
cell    O
types    O
:    O
keratinocyte    B-Cell102991711
,    O
melanocytes    O
,    O
Langerhans    O
cells    O
,    O
and    O
Merkel    B-Cell102991711
cell    I-Cell102991711
.    O

It    O
is    O
95%    O
keratinocytes    B-Cell102991711
(    O
proliferating    B-Cell102991711
basal    O
and    O
differentiated    O
suprabasal    O
)    O
but    O
also    O
contains    O
melanocytes    O
,    O
Langerhans    O
cells    O
,    O
Merkel    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
inflammatory    O
cells    O
.    O

The    O
roots    O
of    O
"    O
Marsilea    O
"    O
and    O
"    O
Regnellidium    O
"    O
are    O
noteworthy    O
for    O
containing    O
vessel    B-Cell102991711
element    I-Cell102991711
.    O

It    O
has    O
partially    O
developed    O
vessels    B-Cell102991711
as    O
found    O
in    O
the    O
angiosperms    O
,    O
and    O
the    O
megasporangium    O
is    O
covered    O
by    O
three    O
envelopes    O
,    O
like    O
the    O
ovary    O
structure    O
of    O
angiosperm    O
flowers    O
.    O

Older    O
morphological    O
studies    O
believed    O
in    O
a    O
close    O
relationship    O
between    O
the    O
gnetophytes    O
and    O
the    O
angiosperms    O
,    O
in    O
particular    O
based    O
on    O
vessel    B-Cell102991711
elements    I-Cell102991711
.    O

A    O
vessel    B-Cell102991711
element    I-Cell102991711
or    O
vessel    B-Cell102991711
member    I-Cell102991711
(    O
trachea    O
)    O
is    O
one    O
of    O
the    O
cell    O
types    O
found    O
in    O
xylem    O
,    O
the    O
water    O
conducting    O
tissue    O
of    O
plants    O
.    O

Antibodies    O
,    O
the    O
main    O
effectors    O
of    O
a    O
humoral    O
response    O
,    O
are    O
ineffective    O
against    O
"    O
M.    O
leprae    O
"    O
because    O
of    O
the    O
unusually    O
dense    O
and    O
waxy    O
nature    O
of    O
the    O
mycolic    O
acid    O
containing    O
bacterial    B-Cell102991711
cell    I-Cell102991711
wall    I-Cell102991711
,    O
and    O
so    O
the    O
bacterium    O
proliferates    O
,    O
causing    O
the    O
cutaneous    O
disfigurements    O
and    O
peripheral    O
neuropathologies    O
characteristic    O
of    O
the    O
disease    O
.    O

Bacterial    B-Cell102991711
cells    I-Cell102991711
–    O
A    O
prokaryotic    O
cell    O
belonging    O
to    O
the    O
mostly    O
unicellular    O
Domain    O
Bacteria    O
.    O

They    O
constitute    O
an    O
enteric    B-Cell102991711
endocrine    I-Cell102991711
system    I-Cell102991711
as    O
a    O
subset    O
of    O
the    O
endocrine    O
system    O
just    O
as    O
the    O
enteric    O
nervous    O
system    O
is    O
a    O
subset    O
of    O
the    O
nervous    O
system    O
.    O

Enteroendocrine    B-Cell102991711
cells    I-Cell102991711
are    O
sometimes    O
also    O
called    O
"    O
argentaffins    O
"    O
,    O
because    O
they    O
take    O
up    O
this    O
stain    O
.    O

Enteroendocrine    B-Cell102991711
cell    I-Cell102991711

In    O
these    O
cases    O
,    O
a    O
booster    O
dose    O
is    O
required    O
to    O
"    O
boost    O
"    O
the    O
memory    B-Cell102991711
B    I-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
count    O
back    O
up    O
again    O
.    O

In    O
the    O
case    O
of    O
the    O
polio    O
vaccine    O
,    O
the    O
memory    B-Cell102991711
B    I-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
produced    O
in    O
response    O
to    O
the    O
vaccine    O
persist    O
only    O
six    O
months    O
after    O
consumption    O
of    O
the    O
oral    O
polio    O
vaccine    O
(    O
OPV    O
)    O
.    O

:*    O
Memory    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711

If    O
a    O
cell    O
is    O
stimulated    O
,    O
it    O
will    O
go    O
on    O
to    O
produce    O
more    O
antibodies    O
(    O
a    O
plasma    O
cell    O
)    O
or    O
act    O
as    O
a    O
memory    B-Cell102991711
cell    I-Cell102991711
to    O
help    O
the    O
body    O
fight    O
future    O
infection    O
.    O

E    O
-    O
selectin    O
mediates    O
the    O
adhesion    O
of    O
tumor    O
cells    O
to    O
endothelial    O
cells    O
,    O
by    O
binding    O
to    O
E    O
-    O
selectin    O
ligands    O
expressed    O
by    O
neutrophils    O
,    O
monocytes    O
,    O
eosinophils    O
,    O
memory-effector    B-Cell102991711
T-like    I-Cell102991711
lymphocyte    I-Cell102991711
,    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
or    O
cancer    O
cells    O
.    O

Memory    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711

A    O
hallmark    O
of    O
CXCR3    O
is    O
its    O
prominent    O
expression    O
in    O
"    O
in    O
vitro    O
"    O
cultured    O
effector/memory    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
and    O
in    O
T    O
cells    O
present    O
in    O
many    O
types    O
of    O
inflamed    O
tissues    O
.    O

CD8+    B-Cell102991711
(    O
CD8    O
positive    O
)    O
cell    O
commonly    O
refers    O
to    O
a    O
T    O
cell    O
that    O
expresses    O
CD8    O
on    O
its    O
cells    O
surface    O
.    O

Enterochromaffin    O
-    O
like    O
cells    O
or    O
ECL    O
cells    O
are    O
a    O
type    O
of    O
neuroendocrine    B-Cell102991711
cell    I-Cell102991711
found    O
in    O
the    O
gastric    O
glands    O
of    O
the    O
gastric    O
mucosa    O
beneath    O
the    O
epithelium    O
,    O
in    O
particular    O
in    O
the    O
vicinity    O
of    O
parietal    B-Cell102991711
cell    I-Cell102991711
,    O
that    O
aid    O
in    O
the    O
production    O
of    O
gastric    O
acid    O
via    O
the    O
release    O
of    O
histamine    O
.    O

He    O
began    O
his    O
research    O
career    O
with    O
the    O
National    O
Institute    O
of    O
Mental    O
Health    O
Intramural    O
Program    O
in    O
1966    O
,    O
using    O
neuroendocrine    B-Cell102991711
strategies    O
to    O
study    O
the    O
psychobiology    O
of    O
affective    O
disorders    O
.    O

A    O
neurohormone    O
is    O
any    O
hormone    O
produced    O
and    O
released    O
by    O
neuroendocrine    B-Cell102991711
cell    I-Cell102991711
(    O
also    O
called    O
neurosecretory    O
cells    O
)    O
into    O
the    O
blood    O
.    O

neuroendocrine    B-Cell102991711
control    O

The    O
hypothalamus    O
has    O
a    O
central    O
neuroendocrine    B-Cell102991711
function    O
,    O
most    O
notably    O
by    O
its    O
control    O
of    O
the    O
anterior    O
pituitary    O
,    O
which    O
in    O
turn    O
regulates    O
various    O
endocrine    O
glands    O
and    O
organs    O
.    O

The    O
hypothalamus    O
coordinates    O
many    O
hormonal    O
and    O
behavioural    O
circadian    O
rhythms    O
,    O
complex    O
patterns    O
of    O
neuroendocrine    B-Cell102991711
outputs    O
,    O
complex    O
homeostatic    O
mechanisms    O
,    O
and    O
important    O
behaviours    O
.    O

Olfactory    O
stimuli    O
are    O
important    O
for    O
sexual    O
reproduction    O
and    O
neuroendocrine    B-Cell102991711
function    O
in    O
many    O
species    O
.    O

Granins    O
(    O
chromogranins    O
or    O
secretogranins    O
)    O
are    O
acidic    O
proteins    O
and    O
are    O
present    O
in    O
the    O
secretory    O
granules    O
of    O
a    O
wide    O
variety    O
of    O
endocrine    O
and    O
neuro-endocrine    B-Cell102991711
cells    O
.    O

There    O
is    O
also    O
evidence    O
that    O
CgA    O
,    O
and    O
perhaps    O
other    O
granins    O
,    O
regulate    O
the    O
biogenesis    O
of    O
dense    O
-    O
core    O
secretory    O
vesicles    O
and    O
hormone    O
sequestration    O
in    O
neuroendocrine    B-Cell102991711
cells    O
.    O

The    O
Pacak    O
-    O
Zhuang    O
syndrome    O
is    O
a    O
recently    O
described    O
disease    O
manifestation    O
in    O
females    O
that    O
includes    O
multiple    O
paragangliomas    O
and    O
somatostatinomas    O
(    O
in    O
some    O
)    O
,    O
both    O
neuroendocrine    B-Cell102991711
tumors    O
,    O
and    O
secondary    O
polycythemia    O
associated    O
with    O
high    O
erythropoietin    O
levels    O
.    O

Enterochromaffin    B-Cell102991711
cell    I-Cell102991711
are    O
enteroendocrine    O
and    O
neuroendocrine    B-Cell102991711
cell    I-Cell102991711
with    O
a    O
close    O
similarity    O
to    O
adrenomedullary    O
chromaffin    B-Cell102991711
cell    I-Cell102991711
secreting    O
serotonin    O
and    O
histamine    O
.    O

Neuroendocrine    B-Cell102991711
cell    I-Cell102991711

The    O
model    O
has    O
been    O
reported    O
to    O
result    O
in    O
long    O
lasting    O
changes    O
of    O
behavioral    O
,    O
neurochemical    O
,    O
neuroimmune    O
,    O
and    O
neuroendocrinological    B-Cell102991711
variables    O
resembling    O
reward    O
functions    O
including    O
decreased    O
intracranial    O
self    O
-    O
stimulation    O
,    O
reflecting    O
anhedonia    O
that    O
is    O
reversed    O
by    O
chronic    O
but    O
not    O
acute    O
antidepressant    O
treatment    O
.    O

It    O
also    O
reacts    O
with    O
neuroendocrine    B-Cell102991711
tumors    O
.    O

In    O
stomach    O
,    O
activation    O
of    O
receptors    O
on    O
enterochromaffine    O
-    O
like    O
cells    O
by    O
apelin    O
secreted    O
by    O
parietal    B-Cell102991711
cells    I-Cell102991711
can    O
inhibit    O
histamine    O
release    O
by    O
enterochromaffine    O
-    O
like    O
cells    O
,    O
which    O
in    O
turn    O
decreases    O
acid    O
secretion    O
by    O
parietal    O
cells    O
.    O

parietal    B-Cell102991711
cell    I-Cell102991711

Vitamin    O
B12    O
was    O
discovered    O
as    O
a    O
result    O
of    O
its    O
relationship    O
to    O
the    O
disease    O
pernicious    O
anemia    O
,    O
an    O
autoimmune    O
disease    O
in    O
which    O
parietal    B-Cell102991711
cell    I-Cell102991711
of    O
the    O
stomach    O
responsible    O
for    O
secreting    O
intrinsic    O
factor    O
are    O
destroyed    O
;    O
these    O
cells    O
are    O
also    O
responsible    O
for    O
secreting    O
acid    O
in    O
the    O
stomach    O
.    O

The    O
next    O
binding    O
protein    O
for    O
B12    O
is    O
intrinsic    O
factor    O
(    O
IF    O
)    O
,    O
a    O
protein    O
synthesized    O
by    O
gastric    O
parietal    B-Cell102991711
cell    I-Cell102991711
that    O
is    O
secreted    O
in    O
response    O
to    O
histamine    O
,    O
gastrin    O
and    O
pentagastrin    O
,    O
as    O
well    O
as    O
the    O
presence    O
of    O
food    O
.    O

Evidence    O
emerged    O
by    O
the    O
end    O
of    O
the    O
1970s    O
that    O
the    O
newly    O
discovered    O
proton    O
pump    O
(    O
H+/K+    O
ATPase    O
)    O
in    O
the    O
secretory    O
membrane    O
of    O
the    O
parietal    B-Cell102991711
cell    I-Cell102991711
was    O
the    O
final    O
step    O
in    O
acid    O
secretion    O
.    O

One    O
example    O
is    O
gastrin    O
,    O
which    O
stimulates    O
the    O
H    O
/    O
K    O
ATPase    O
in    O
the    O
parietal    B-Cell102991711
cell    I-Cell102991711
(    O
increased    O
gastric    O
acid    O
production    O
by    O
the    O
stomach    O
)    O
.    O

Vitamin    O
B12    O
can    O
then    O
bind    O
to    O
intrinsic    O
factor    O
(    O
IF    O
)    O
that    O
has    O
been    O
produced    O
by    O
parietal    B-Cell102991711
cells    I-Cell102991711
.    O

Parietal    B-Cell102991711
cell    I-Cell102991711
:    O
Produce    O
hydrochloric    O
acid    O
and    O
intrinsic    O
factor    O
.    O

Congenital    O
disorders    O
of    O
the    O
stomach    O
include    O
pernicious    O
anaemia    O
,    O
in    O
which    O
a    O
targeted    O
immune    O
response    O
against    O
parietal    B-Cell102991711
cell    I-Cell102991711
results    O
in    O
an    O
inability    O
to    O
absorb    O
vitamin    O
B12    O
.    O

Parietal    B-Cell102991711
cells    I-Cell102991711
,    O
stomach    O
epithelium    O
cells    O
that    O
secrete    O
gastric    O
acid    O
and    O
intrinsic    O
factor    O
to    O
aid    O
in    O
digestion    O
.    O

IL-17    O
acts    O
with    O
IL-22    O
(    O
produced    O
by    O
T    B-Cell102991711
helper    I-Cell102991711
17    I-Cell102991711
cells    O
)    O
to    O
induce    O
expression    O
of    O
antimicrobial    O
peptide    O
by    O
keratinocytes    B-Cell102991711
.    O

IL-17    O
function    O
is    O
also    O
essential    O
to    O
a    O
subset    O
of    O
CD4    O
+    O
T    O
-    O
Cells    O
called    O
T    B-Cell102991711
helper    I-Cell102991711
17    I-Cell102991711
(    O
Th17    O
)    O
cells    O
.    O

CD27    O
costimulation    O
is    O
known    O
to    O
suppresses    O
Th17    B-Cell102991711
effector    O
cell    O
function    O
.    O

The    O
immune    O
response    O
in    O
those    O
infected    O
with    O
HIV    O
is    O
typically    O
characterized    O
by    O
cellular    O
signals    O
from    O
Th2    B-Cell102991711
subset    I-Cell102991711
of    I-Cell102991711
CD4+    I-Cell102991711
helper    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
whereas    O
the    O
immune    O
response    O
in    O
psoriasis    O
vulgaris    O
is    O
characterized    O
by    O
a    O
pattern    O
of    O
cellular    O
signals    O
typical    O
of    O
Th1    B-Cell102991711
subset    I-Cell102991711
of    I-Cell102991711
CD4+    I-Cell102991711
helper    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
and    O
Th17    B-Cell102991711
helper    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
.    O

Many    O
novel    O
medications    O
being    O
researched    O
target    O
the    O
Th17    B-Cell102991711
axis    O
,    O
particularly    O
IL-23p19    O
inhibitors    O
,    O
as    O
IL-23p19    O
is    O
present    O
in    O
increased    O
concentrations    O
in    O
psoriasis    O
skin    O
lesions    O
while    O
contributing    O
less    O
to    O
protection    O
against    O
opportunistic    O
infections    O
.    O

In    O
addition    O
,    O
IL-21    O
expression    O
is    O
up    O
-    O
regulated    O
in    O
Th2    O
and    O
Th17    B-Cell102991711
subsets    O
of    O
T    B-Cell102991711
helper    I-Cell102991711
cell    I-Cell102991711
,    O
as    O
well    O
as    O
T    B-Cell102991711
follicular    I-Cell102991711
cell    I-Cell102991711
.    O

Uveitis    O
is    O
driven    O
by    O
the    O
Th17    B-Cell102991711
T    O
cell    O
sub    O
-    O
population    O
that    O
bear    O
T    O
-    O
cell    O
receptors    O
specific    O
for    O
proteins    O
found    O
in    O
the    O
eye    O
.    O

These    O
cells    O
produce    O
large    O
amounts    O
of    O
TGF    O
beta    O
and    O
other    O
suppressive    O
cytokines    O
,    O
including    O
IL-10    O
,    O
to    O
prevent    O
damage    O
to    O
the    O
eye    O
by    O
reducing    O
inflammation    O
and    O
causing    O
T    O
cells    O
to    O
differentiate    O
to    O
inducible    O
T    O
reg    O
cells    O
.    O
Innate    O
immune    O
stimulation    O
by    O
bacteria    O
and    O
cellular    O
stress    O
is    O
normally    O
suppressed    O
by    O
myeloid    O
suppression    O
while    O
inducible    O
Treg    B-Cell102991711
cells    O
prevent    O
activation    O
and    O
clonal    O
expansion    O
of    O
the    O
autoreactive    O
Th1    B-Cell102991711
and    O
Th17    B-Cell102991711
cells    O
that    O
possess    O
potential    O
to    O
cause    O
damage    O
to    O
the    O
eye    O
.    O

Prof    O
.    O
Golan    O
heads    O
a    O
research    O
group    O
working    O
in    O
the    O
area    O
of    O
nanomaterials    O
and    O
thin    B-Cell102991711
film    I-Cell102991711
.    O

Like    O
magnesium    O
fluoride    O
it    O
used    O
as    O
a    O
low    O
-    O
index    O
optical    O
thin    B-Cell102991711
film    I-Cell102991711
,    O
particularly    O
when    O
far    O
UV    O
transparency    O
is    O
required    O
.    O

The    O
solar    O
park    O
has    O
around    O
215,000    O
state    O
-    O
of    O
-    O
the    O
-    O
art    O
thin    B-Cell102991711
film    I-Cell102991711
PV    O
panels    O
for    O
a    O
total    O
nameplate    O
capacity    O
of    O
50-megawatts    O
,    O
and    O
was    O
finished    O
in    O
September    O
2013    O
.    O

The    O
solar    O
park    O
has    O
around    O
80,000    O
state    O
-    O
of    O
-    O
the    O
-    O
art    O
thin    B-Cell102991711
film    I-Cell102991711
PV    O
panels    O
for    O
a    O
total    O
nameplate    O
capacity    O
of    O
20-megawatts    O
,    O
and    O
was    O
finished    O
in    O
July    O
2013    O
.    O

In    O
2008    O
,    O
a    O
team    O
at    O
HP    O
Labs    O
claimed    O
to    O
have    O
found    O
Chua    O
's    O
missing    O
memristor    O
based    O
on    O
an    O
analysis    O
of    O
a    O
thin    B-Cell102991711
film    I-Cell102991711
of    O
titanium    O
dioxide    O
thus    O
connecting    O
the    O
operation    O
of    O
RRAM    O
devices    O
to    O
the    O
memristor    O
concept    O
.    O

Also    O
,    O
chemical    O
and    O
physical    O
methods    O
are    O
also    O
used    O
to    O
synthesize    O
other    O
materials    O
such    O
as    O
polymers    O
,    O
ceramics    O
,    O
thin    B-Cell102991711
film    I-Cell102991711
,    O
etc    O
.    O

Industrial    O
applications    O
of    O
materials    O
science    O
include    O
materials    O
design    O
,    O
cost    O
-    O
benefit    O
tradeoffs    O
in    O
industrial    O
production    O
of    O
materials    O
,    O
processing    O
methods    O
(    O
casting    O
,    O
rolling    O
,    O
welding    O
,    O
ion    O
implantation    O
,    O
crystal    O
growth    O
,    O
thin-film    B-Cell102991711
deposition    I-Cell102991711
,    O
sintering    O
,    O
glassblowing    O
,    O
etc    O
.    O
)    O
,    O
and    O
analytic    O
methods    O
(    O
characterization    O
methods    O
such    O
as    O
electron    O
microscopy    O
,    O
X    O
-    O
ray    O
diffraction    O
,    O
calorimetry    O
,    O
nuclear    O
microscopy    O
(    O
HEFIB    O
)    O
,    O
Rutherford    O
backscattering    O
,    O
neutron    O
diffraction    O
,    O
small    O
-    O
angle    O
X    O
-    O
ray    O
scattering    O
(    O
SAXS    O
)    O
,    O
etc    O
.    O
)    O
.    O

In    O
March    O
2008    O
,    O
Signet    O
Solar    O
Inc.    O
signed    O
a    O
memorandum    O
of    O
understanding    O
with    O
the    O
State    O
government    O
to    O
build    O
a    O
INR    O
20    O
billion    O
thin-film    B-Cell102991711
silicon    O
photovoltaic    O
module    O
manufacturing    O
plant    O
in    O
the    O
Sriperumbudur    O
Special    O
Economic    O
Zone    O
.    O

Thin    B-Cell102991711
film    I-Cell102991711
of    O
barium    O
borate    O
can    O
be    O
prepared    O
by    O
MOCVD    O
from    O
barium(II    O
)    O
hydro    O
-    O
tri(1-pyrazolyl)borate    O
.    O

Two    O
-    O
dimensional    O
(    O
thin    B-Cell102991711
film    I-Cell102991711
)    O
semi    O
-    O
ordered    O
lattices    O
have    O
been    O
studied    O
using    O
an    O
optical    O
microscope    O
,    O
as    O
well    O
as    O
those    O
collected    O
at    O
electrode    O
surfaces    O
.    O

Bottom    O
:    O
thin-film    B-Cell102991711
laminates    O
on    O
rooftops    O

A    O
thin    O
-    O
film    O
solar    O
cell    O
is    O
a    O
second    O
generation    O
solar    O
cell    O
that    O
is    O
made    O
by    O
depositing    O
one    O
or    O
more    O
thin    O
layers    O
,    O
or    O
thin    B-Cell102991711
film    I-Cell102991711
(    O
TF    O
)    O
of    O
photovoltaic    O
material    O
on    O
a    O
substrate    O
,    O
such    O
as    O
glass    O
,    O
plastic    O
or    O
metal    O
.    O

The    O
power    O
plant    O
will    O
be    O
a    O
2.4-megawatt    O
solar    O
power    O
system    O
using    O
state    O
-    O
of    O
-    O
the    O
-    O
art    O
thin    B-Cell102991711
film    I-Cell102991711
technology    O
,    O
and    O
should    O
be    O
finished    O
by    O
the    O
end    O
of    O
2012    O
.    O

The    O
power    O
plant    O
will    O
be    O
a    O
5    O
to    O
8-megawatt    O
solar    O
power    O
system    O
using    O
state    O
-    O
of    O
-    O
the    O
-    O
art    O
thin    B-Cell102991711
film    I-Cell102991711
technology    O
,    O
and    O
should    O
be    O
finished    O
by    O
the    O
end    O
of    O
2012    O
.    O

The    O
processes    O
used    O
for    O
crystal    O
growth    O
cover    O
both    O
bulk    O
crystal    O
growth    O
and    O
thin-film    B-Cell102991711
deposition    I-Cell102991711
.    O

His    O
fields    O
of    O
research    O
include    O
ultraviolet    O
photochemistry    O
,    O
optical    O
diagnostic    O
methods    O
implemented    O
on    O
microwave    O
-    O
activated    O
methane    O
/    O
hydrogen    O
plasmas    O
in    O
the    O
context    O
of    O
diamond    O
growth    O
via    O
chemical    O
vapour    O
deposition    O
,    O
diamond    O
thin    B-Cell102991711
film    I-Cell102991711
investigations    O
and    O
the    O
study    O
of    O
nanostructured    O
thin    O
films    O
.    O

Thin    B-Cell102991711
film    I-Cell102991711

Thin    B-Cell102991711
film    I-Cell102991711
of    O
barium    O
titanate    O
display    O
electrooptic    O
modulation    O
to    O
frequencies    O
over    O
40    O
GHz    O
.    O

Perakh    O
's    O
other    O
published    O
books    O
include    O
a    O
technical    O
volume    O
on    O
the    O
subject    O
of    O
thin    B-Cell102991711
films    I-Cell102991711
,    O
which    O
has    O
been    O
translated    O
into    O
eight    O
languages    O
,    O
and    O
the    O
novel    O
"    O
Man    O
in    O
a    O
Wire    O
Cage    O
"    O
(    O
originally    O
titled    O
by    O
the    O
author    O
"    O
Train    O
in    O
a    O
Wire    O
Cage    O
"    O
but    O
changed    O
by    O
the    O
publisher    O
)    O
(    O
1988    O
,    O
)    O
.    O

Coating    O
is    O
another    O
major    O
application    O
area    O
including    O
the    O
preparation    O
of    O
thin    B-Cell102991711
films    I-Cell102991711
,    O
printing    O
,    O
painting    O
and    O
adhesives    O
.    O

It    O
is    O
applied    O
as    O
a    O
process    O
for    O
adhering    O
two    O
multilayers    O
,    O
especially    O
a    O
substrate    O
and    O
deposited    B-Cell102991711
surface    O
layer    O
.    O

Elastic    O
Recoil    O
Detection    O
Analysis    O
(    O
ERDA    O
)    O
,    O
also    O
referred    O
to    O
as    O
forward    O
recoil    O
scattering    O
(    O
or    O
,    O
contextually    O
,    O
spectrometry    O
)    O
,    O
is    O
an    O
Ion    O
Beam    O
Analysis    O
technique    O
in    O
materials    O
science    O
to    O
obtain    O
elemental    O
concentration    O
depth    O
profiles    O
in    O
thin    B-Cell102991711
films    I-Cell102991711
.    O

When    O
deposited    O
as    O
a    O
thin    B-Cell102991711
film    I-Cell102991711
,    O
its    O
refractive    O
index    O
and    O
colour    O
make    O
it    O
an    O
excellent    O
reflective    O
optical    O
coating    O
for    O
dielectric    O
mirrors    O
and    O
some    O
gemstones    O
like    O
"    O
mystic    O
fire    O
topaz    O
"    O
.    O

Titanium    O
dioxide    O
,    O
in    O
thin    B-Cell102991711
film    I-Cell102991711
and    O
nanoparticle    O
form    O
has    O
potential    O
for    O
use    O
in    O
energy    O
production    O
:    O
as    O
a    O
photocatalyst    O
,    O
it    O
can    O
carry    O
out    O
hydrolysis    O
;    O
i.e.    O
,    O
break    O
water    O
into    O
hydrogen    O
and    O
oxygen    O
.    O

#    O
TiO2    O
can    O
be    O
supported    O
as    O
thin    B-Cell102991711
films    I-Cell102991711
on    O
suitable    O
reactor    O
substrates    O
,    O
which    O
can    O
be    O
readily    O
separated    O
from    O
treated    O
water    O
.    O

The    O
purpose    O
of    O
the    O
WSF    O
was    O
to    O
grow    B-Cell102991711
thin    I-Cell102991711
films    I-Cell102991711
in    O
a    O
near    O
perfect    O
vacuum    O
created    O
by    O
the    O
wake    O
of    O
the    O
satellite    O
as    O
it    O
moved    O
through    O
space    O
.    O

Hybrid    O
physical    O
-    O
chemical    O
vapor    O
deposition    O
(    O
HPCVD    O
)    O
is    O
a    O
thin-film    B-Cell102991711
deposition    I-Cell102991711
technique    O
,    O
that    O
combines    O
physical    O
vapor    O
deposition    O
(    O
PVD    O
)    O
with    O
chemical    O
vapor    O
deposition    O
(    O
CVD    O
)    O
.    O

Thin    B-Cell102991711
films    I-Cell102991711
are    O
prevalent    O
in    O
the    O
micro    O
and    O
nanoelectronics    O
industry    O
for    O
the    O
fabrication    O
of    O
sensors    O
,    O
actuators    O
and    O
transistors    O
;    O
thus    O
,    O
thermal    O
transport    O
properties    O
affect    O
the    O
performance    O
and    O
reliability    O
of    O
many    O
structures    O
such    O
as    O
transistors    O
,    O
solid    O
-    O
state    O
lasers    O
,    O
sensors    O
,    O
and    O
actuators    O
.    O

Surface    O
Engineering    O
and    O
Thin    B-Cell102991711
Films    I-Cell102991711
–    O
IST    O

Many    O
thin    B-Cell102991711
film    I-Cell102991711
metal    O
combinations    O
have    O
been    O
evaluated    O
for    O
their    O
adhesion    O
and    O
diffusion    O
barrier    O
properties    O
.    O

Thin-film    B-Cell102991711
deposition    I-Cell102991711

Sputter    O
deposition    O
is    O
a    O
physical    O
vapor    O
deposition    O
(    O
PVD    O
)    O
method    O
of    O
thin    B-Cell102991711
film    I-Cell102991711
deposition    O
by    O
sputtering    O
.    O

Energy    O
conservation    O
&    O
generation    O
:    O
low    O
emissivity    O
glass    O
coatings    O
,    O
solar    O
absorbing    O
coatings    O
,    O
mirrors    O
,    O
solar    O
thin    B-Cell102991711
film    I-Cell102991711
photovoltaic    O
cells    O
,    O
"    O
smart    O
"    O
films    O

A    O
thickness    O
of    O
less    O
than    O
one    O
micrometre    O
is    O
generally    O
called    O
a    O
thin    B-Cell102991711
film    I-Cell102991711
while    O
a    O
thickness    O
greater    O
than    O
one    O
micrometre    O
is    O
called    O
a    O
coating    O
.    O

He    O
gave    O
the    O
first    O
nonlinear    O
theory    O
of    O
film    O
rupture    O
by    O
instabilities    O
driven    O
by    O
van    O
der    O
Waals    O
attractions    O
and    O
the    O
first    O
coupling    O
of    O
evaporation    O
and    O
thin    B-Cell102991711
film    I-Cell102991711
instabilities    O
.    O

It    O
was    O
a    O
vacuum    O
-    O
deposited    O
thin    B-Cell102991711
film    I-Cell102991711
consisting    O
of    O
ceramic    O
layers    O
developed    O
by    O
the    O
Bank    O
of    O
Canada    O
and    O
the    O
National    O
Research    O
Council    O
of    O
Canada    O
in    O
the    O
early    O
1980s    O
and    O
was    O
manufactured    O
at    O
the    O
Bank    O
of    O
Canada    O
roll    O
-    O
coating    O
facility    O
.    O

Arrays    O
of    O
gold    O
nanobottles    O
have    O
been    O
fabricated    O
by    O
combining    O
optical    O
interference    O
lithography    O
with    O
thin    B-Cell102991711
film    I-Cell102991711
deposition    O
.    O

Frequent    O
topics    O
covered    O
by    O
the    O
journal    O
also    O
include    O
liquid    O
crystals    O
,    O
semiconductors    O
,    O
superconductors    O
,    O
optics    O
,    O
lasers    O
,    O
sensors    O
,    O
porous    O
materials    O
,    O
light    O
-    O
emitting    O
materials    O
,    O
magnetic    O
materials    O
,    O
thin    B-Cell102991711
films    I-Cell102991711
,    O
and    O
colloids    O
.    O

Four    O
-    O
point    O
probes    O
are    O
also    O
used    O
to    O
measure    O
sheet    O
resistance    O
of    O
thin    B-Cell102991711
film    I-Cell102991711
(    O
particularly    O
semiconductor    O
thin    O
films    O
)    O
.    O

It    O
is    O
mainly    O
used    O
for    O
the    O
manufacture    O
of    O
tantalum(V    O
)    O
oxide    O
thin-film    B-Cell102991711
materials    I-Cell102991711
by    O
approaches    O
including    O
chemical    O
vapor    O
deposition    O
,    O
atomic    O
layer    O
deposition    O
,    O
and    O
sol    O
-    O
gel    O
processing    O
.    O

Evaporation    O
suppressing    O
monolayers    O
are    O
materials    O
that    O
when    O
applied    O
to    O
the    O
air    O
/    O
water    O
interface    O
,    O
will    O
spread    O
(    O
or    O
self    O
-    O
assemble    O
)    O
and    O
form    O
a    O
thin    B-Cell102991711
film    I-Cell102991711
across    O
the    O
surface    O
of    O
the    O
water    O
.    O

A    O
patent    O
application    O
was    O
submitted    O
in    O
1991    O
suggesting    O
the    O
use    O
of    O
W(CH3)6    O
in    O
the    O
manufacture    O
of    O
semiconductor    O
devices    O
for    O
chemical    O
vapor    O
deposition    O
of    O
tungsten    O
thin    B-Cell102991711
films    I-Cell102991711
;    O
however    O
,    O
to    O
date    O
it    O
has    O
not    O
been    O
used    O
for    O
this    O
purpose    O
.    O

Merozygote    B-Cell102991711
is    O
a    O
state    O
when    O
a    O
cell    O
,    O
usually    O
bacterial    O
,    O
is    O
temporarily    O
partial    O
diploid    O
as    O
result    O
of    O
DNA    O
transfer    O
processes    O
like    O
conjugation    O
.    O

Enterochromaffin    B-Cell102991711
cell    I-Cell102991711
in    O
the    O
epithelia    O
lining    O
the    O
lumen    O
of    O
the    O
digestive    O
tract    O
secrete    O
serotonin    O
,    O
while    O
enterochromaffin    O
-    O
like    O
cells    O
at    O
the    O
stomach    O
glands    O
secrete    O
histamine    O
.    O

Enterochromaffin    B-Cell102991711
cell    I-Cell102991711
are    O
enteroendocrine    O
and    O
neuroendocrine    B-Cell102991711
cell    I-Cell102991711
with    O
a    O
close    O
similarity    O
to    O
adrenomedullary    O
chromaffin    B-Cell102991711
cell    I-Cell102991711
secreting    O
serotonin    O
and    O
histamine    O
.    O

Uroguanylin    O
is    O
a    O
16    O
amino    O
acid    O
peptide    O
that    O
is    O
secreted    O
by    O
enterochromaffin    B-Cell102991711
cells    I-Cell102991711
in    O
the    O
duodenum    O
and    O
proximal    O
small    O
intestine    O
.    O

Carcinoid    O
tumors    O
are    O
apudomas    O
that    O
arise    O
from    O
the    O
enterochromaffin    B-Cell102991711
cell    I-Cell102991711
throughout    O
the    O
gut    O
.    O

In    O
2014    O
,    O
OncoMed    O
entered    O
into    O
an    O
anti    O
-    O
cancer    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
therapeutic    O
development    O
agreement    O
with    O
Celgene    O
encompassing    O
demcizumab    O
and    O
five    O
other    O
biologics    O
from    O
OncoMed    O
's    O
pipeline    O
.    O

By    O
2014    O
,    O
the    O
list    O
of    O
firms    O
pursuing    O
therapies    O
targeting    O
cancer    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
had    O
grown    O
to    O
include    O
Boston    O
Biomedical    O
(    O
a    O
subsidiary    O
of    O
Dainippon    O
Sumitomo    O
Pharma    O
)    O
,    O
GlaxoSmithKline    O
,    O
Astellas    O
Pharma    O
,    O
Sanofi    O
(    O
the    O
American    O
subsidiary    O
)    O
and    O
Pfizer    O
;    O
however    O
,    O
Stemline    O
and    O
Verastem    O
remain    O
the    O
only    O
two    O
competitors    O
solely    O
focused    O
on    O
cancer    O
stem    O
cells    O
.    O

Some    O
view    O
cancer    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
as    O
units    O
of    O
selection    O
.    O

Some    O
of    O
the    O
most    O
notorious    O
forms    O
of    O
cancer    O
tumors    O
contain    O
cancer    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
(    O
CSC    O
)    O
,    O
which    O
makes    O
them    O
particularly    O
resistant    O
to    O
any    O
cancer    O
therapy    O
.    O

CD133    O
is    O
shown    O
to    O
be    O
a    O
marker    O
of    O
tumor    O
-    O
initiating    O
or    O
cancer    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
in    O
neuroblastoma    O
.    O

Notch    O
signaling    O
has    O
been    O
implicated    O
as    O
a    O
key    O
signaling    O
pathway    O
in    O
cancer    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
.    O

A    O
diagram    O
illustrating    O
the    O
distinction    O
between    O
cancer    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
targeted    O
and    O
conventional    O
cancer    O
therapies    O
.    O

In    O
particular    O
,    O
the    O
National    O
Cancer    O
Institute    O
’s    O
Gastrointestinal    O
Cancer    O
Steering    O
Committee    O
has    O
recently    O
place    O
major    O
emphasis    O
on    O
the    O
enhancement    O
of    O
"    O
research    O
to    O
identify    O
and    O
validate    O
the    O
relevant    O
targets    O
and    O
molecular    O
pathways    O
in    O
PDAC    O
,    O
cancer    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
,    O
and    O
the    O
microenvironment    O
"    O
;    O

Known    O
as    O
vitamin    B-Cell102991711
A2    I-Cell102991711
,    O
it    O
is    O
found    O
in    O
fish    O
liver    O
oils    O
.    O

Reed–Sternberg    B-Cell102991711
cell    I-Cell102991711

CD15    O
is    O
present    O
on    O
almost    O
all    O
Reed–Sternberg    B-Cell102991711
cell    I-Cell102991711
,    O
including    O
their    O
rare    O
mononuclear    O
variants    O
,    O
and    O
,    O
as    O
such    O
,    O
can    O
be    O
used    O
in    O
immunohistochemistry    O
to    O
identify    O
the    O
presence    O
of    O
such    O
cells    O
in    O
biopsies    O
.    O

In    O
Hodgkin    O
's    O
lymphoma    O
,    O
Reed-Sternberg    B-Cell102991711
cell    I-Cell102991711
harbor    O
amplification    O
of    O
chromosome    O
9p24.1    O
,    O
which    O
encodes    O
PD    O
-    O
L1    O
and    O
PD    O
-    O
L2    O
and    O
leads    O
to    O
their    O
constitutive    O
expression    O
.    O

As    O
an    O
example    O
of    O
its    O
dynamic    O
activity    O
,    O
14    O
-    O
3    O
-    O
3ζ    O
activates    O
autophagy    B-Cell102991711
under    O
hypoxic    O
conditions    O
by    O
binding    O
ATG9A    O
,    O
while    O
it    O
prevents    O
autophagy    O
under    O
hyperglycemic    O
conditions    O
by    O
binding    O
Vps34    O
.    O

On    O
the    O
other    O
hand    O
,    O
mitochondria    O
are    O
found    O
throughout    O
the    O
cytoplasm    O
along    O
with    O
the    O
organelles    O
involved    O
in    O
autophagy    B-Cell102991711
and    O
other    O
forms    O
of    O
catabolic    O
degradation    O
,    O
such    O
as    O
lysosomes    O
,    O
lipofuscin    O
granules    O
,    O
and    O
peroxisomes    O
.    O

is    O
a    O
Japanese    O
cell    O
biologist    O
specializing    O
in    O
autophagy    B-Cell102991711
,    O
the    O
process    O
that    O
cells    O
use    O
to    O
destroy    O
and    O
recycle    O
cellular    O
components    O
.    O

In    O
2016    O
he    O
was    O
awarded    O
the    O
Nobel    O
Prize    O
in    O
Physiology    O
or    O
Medicine    O
"    O
for    O
his    O
discoveries    O
of    O
mechanisms    O
for    O
autophagy    B-Cell102991711
"    O
.    O

Autophagy    B-Cell102991711
(    O
"    O
a.k.a    O
.    O
"    O

Trehalose    O
induces    O
autophagy    B-Cell102991711
via    O
an    O
mTOR    O
independent    O
pathway    O
.    O

Oral    O
trehalose    O
shows    O
antidepressant    O
properties    O
in    O
the    O
mouse    O
model    O
of    O
depression    O
,    O
possibly    O
through    O
reducing    O
p62/Beclin-1    O
ratio    O
and    O
increasing    O
autophagy    B-Cell102991711
in    O
the    O
frontal    O
cortex    O
.    O

Decreased    O
autophagy    B-Cell102991711
–    O
decreased    O
level    O
of    O
degradation    O
of    O
damaged    O
organelles    O
.    O

Autophagy    B-Cell102991711
then    O
occurs    O
at    O
an    O
accelerated    O
rate    O
.    O

Macroautophagy    B-Cell102991711
is    O
a    O
catabolic    O
process    O
involving    O
the    O
formation    O
of    O
double    O
-    O
membrane    O
bound    O
organelles    O
called    O
autophagosomes    O
,    O
which    O
aid    O
in    O
degradation    O
of    O
cellular    O
components    O
through    O
fusion    O
with    O
lysosomes    O
.    O

During    O
autophagy    B-Cell102991711
,    O
portions    O
of    O
the    O
cytoplasm    O
are    O
engulfed    O
by    O
a    O
cup    O
-    O
shaped    O
double    O
-    O
membrane    O
structure    O
called    O
a    O
phagophore    O
and    O
eventually    O
become    O
the    O
contents    O
of    O
the    O
fully    O
assembled    O
autophagosome    O
.    O

If    O
a    O
defective    O
mitochondria    O
it    O
is    O
cleared    O
in    O
the    O
cell    O
by    O
the    O
mechanism    O
of    O
autophagia    B-Cell102991711
.    O

Autophagy    B-Cell102991711
is    O
a    O
process    O
which    O
allows    O
cell    O
survival    O
under    O
stressed    O
conditions    O
but    O
can    O
also    O
lead    O
to    O
cell    O
death    O
.    O

Tubulin    O
acetylation    O
is    O
also    O
involved    O
in    O
regulating    O
autophagy    B-Cell102991711
.    O

Autophagy    B-Cell102991711

Together    O
,    O
these    O
three    O
proteins    O
form    O
the    O
Iml1-Npr2-Npr3    O
complex    O
and    O
are    O
involved    O
in    O
"    O
non    O
-    O
nitrogen    O
starvation    O
"    O
autophagy    B-Cell102991711
regulation    O
.    O

Microautophagy    O
(    O
unlike    O
Macroautophagy    B-Cell102991711
and    O
Chaperone    O
-    O
mediated    O
autophagy    O
)    O
is    O
the    O
type    O
of    O
autophagic    B-Cell102991711
pathway    I-Cell102991711
which    O
is    O
mediated    O
by    O
direct    O
lysosomal    O
(    O
mammals    O
)    O
or    O
vacuolar    O
(    O
plants    O
and    O
fungi    O
)    O
engulfment    O
of    O
the    O
cytoplasmic    O
cargo    O
.    O

Microautophagy    O
together    O
with    O
macroautophagy    B-Cell102991711
is    O
necessary    O
for    O
nutrient    O
recycling    O
under    O
starvation    O
.    O

Invagination    O
is    O
a    O
tubular    O
process    O
by    O
which    O
is    O
formed    O
the    O
autophagic    B-Cell102991711
tube    O
.    O

Formation    O
of    O
the    O
autophagic    B-Cell102991711
tubes    O
is    O
mediated    O
through    O
Atg7-dependent    O
ubiquitin    O
-    O
like    O
conjugation    O
(    O
Ublc    O
)    O
or    O
via    O
vacuolar    O
transporter    O
chaperone    O
(    O
VTC    O
)    O
molecular    O
complex    O
which    O
acts    O
through    O
calmodulin    O
-    O
dependent    O
manner    O
.    O

APCs    O
usually    O
internalise    O
exogenous    O
antigens    O
by    O
endocytosis    O
,    O
but    O
also    O
by    O
pinocytosis    O
,    O
macroautophagy    B-Cell102991711
,    O
endosomal    O
microautophagy    O
or    O
chaperone    O
-    O
mediated    O
autophagy    O
.    O

Alternative    O
pathway    O
of    O
endogenous    O
antigen    O
processing    O
and    O
presentation    O
over    O
MHC    O
-    O
II    O
molecules    O
exists    O
in    O
medulary    O
thymic    O
epithelial    O
cells    O
(    O
mTEC    O
)    O
via    O
the    O
process    O
of    O
autophagy    B-Cell102991711
.    O

Autophagy    B-Cell102991711
–    O

Treatment    O
from    O
this    O
compound    O
causes    O
autophagy    B-Cell102991711
in    O
the    O
cell    O
and    O
results    O
in    O
cell    O
death    O
.    O

The    O
genus    O
produces    O
akinete    B-Cell102991711
and    O
is    O
known    O
to    O
reproduce    O
with    O
hormogonia    O
.    O

Akinete    B-Cell102991711
are    O
not    O
known    O
,    O
and    O
the    O
members    O
of    O
the    O
family    O
are    O
known    O
to    O
reproduce    O
with    O
nonheterocystous    O
hormogonia    O
.    O

Angioblasts    O
or    O
endothelial    B-Cell102991711
progenitor    I-Cell102991711
cell    I-Cell102991711
(    O
EPC    O
)    O
.    O

Endothelial    B-Cell102991711
progenitor    I-Cell102991711
cell    I-Cell102991711

Vasculogenesis    O
can    O
also    O
occur    O
in    O
the    O
adult    O
organism    O
from    O
circulating    O
endothelial    B-Cell102991711
progenitor    I-Cell102991711
cell    I-Cell102991711
(    O
derivatives    O
of    O
stem    O
cells    O
)    O
able    O
to    O
contribute    O
,    O
albeit    O
to    O
varying    O
degrees    O
,    O
to    O
neovascularization    O
.    O

Endometriosis    O
-    O
It    O
appears    O
that    O
up    O
to    O
37%    O
of    O
the    O
microvascular    O
endothelium    O
of    O
the    O
ectopic    O
endometrial    O
tissue    O
originates    O
from    O
endothelial    B-Cell102991711
progenitor    I-Cell102991711
cell    I-Cell102991711
.    O

The    O
green    O
algae    O
,    O
including    O
the    O
characean    O
algae    O
,    O
have    O
served    O
as    O
model    O
experimental    O
organisms    O
to    O
understand    O
the    O
mechanisms    O
of    O
the    O
ionic    O
and    O
water    O
permeability    O
of    O
membranes    O
,    O
osmoregulation    O
,    O
turgor    O
regulation    O
,    O
salt    O
tolerance    O
,    O
cytoplasmic    B-Cell102991711
streaming    I-Cell102991711
,    O
and    O
the    O
generation    O
of    O
action    O
potentials    O
.    O

Myosin    O
XI    O
are    O
involved    O
in    O
cytoplasmic    B-Cell102991711
streaming    I-Cell102991711
,    O
wherein    O
movement    O
along    O
microfilament    O
networks    O
in    O
the    O
cell    O
allows    O
organelles    O
and    O
cytoplasm    O
to    O
stream    O
in    O
a    O
particular    O
direction    O
.    O

Cytoplasmic    B-Cell102991711
streaming    I-Cell102991711
–    O
Flowing    O
of    O
cytoplasm    O
in    O
eukaryotic    O
cells    O
.    O

The    O
capacitated    B-Cell102991711
spermatozoon    O
and    O
the    O
oocyte    O
meet    O
and    O
interact    O
in    O
the    O
"    O
ampulla    O
"    O
of    O
the    O
fallopian    O
tube    O
.    O

The    O
non    O
-    O
fertilising    O
sperm    O
help    O
the    O
fertilising    O
sperm    O
by    O
assisting    O
their    O
transport    O
or    O
capacitation    B-Cell102991711
(    O
i.e.    O
the    O
acquisition    O
of    O
fertilisation    O
competence    O
)    O
.    O

The    O
sperm    O
must    O
undergo    O
capacitation    B-Cell102991711
in    O
the    O
female    O
's    O
reproductive    O
tract    O
over    O
several    O
hours    O
,    O
which    O
increases    O
its    O
motility    O
and    O
destabilizes    O
its    O
membrane    O
,    O
preparing    O
it    O
for    O
the    O
acrosome    O
reaction    O
,    O
the    O
enzymatic    O
penetration    O
of    O
the    O
egg    O
's    O
tough    O
membrane    O
,    O
the    O
zona    O
pellucida    O
,    O
which    O
surrounds    O
the    O
oocyte    O
.    O

Chromophil    B-Cell102991711
cells    O
,    O
hormone    O
producing    O
cells    O
showing    O
"    O
chromaffin    O
granules    O
"    O
that    O
readily    O
absorb    O
chromium    O
stains    O
.    O

APUD    B-Cell102991711
cell    I-Cell102991711

APUD    B-Cell102991711
cells    I-Cell102991711
constitute    O
a    O
group    O
of    O
apparently    O
unrelated    O
endocrine    O
cells    O
,    O
which    O
were    O
named    O
by    O
the    O
scientist    O
A.G.E.    O
Pearse    O
,    O
who    O
developed    O
the    O
APUD    O
concept    O
in    O
the    O
early    O
1960s    O
.    O

The    O
activation    O
of    O
PDE3B    O
in    O
adipocytes    B-Cell102991711
is    O
associated    O
with    O
phosphorylation    O
of    O
serine    O
residue    O
by    O
an    O
insulin    O
-    O
stimulated    O
protein    O
serine    O
kinase    O
(    O
PDE3IK    O
)    O
.    O

NNMT    O
is    O
found    O
in    O
human    O
fat    B-Cell102991711
cell    I-Cell102991711
and    O
the    O
liver    O
.    O

These    O
proteins    O
are    O
found    O
in    O
hepatocyte    B-Cell102991711
,    O
adipocyte    B-Cell102991711
,    O
hematopoietic    O
cells    O
,    O
spleen    O
,    O
kidney    O
,    O
brain    O
,    O
and    O
many    O
other    O
organs    O
.    O

This    O
is    O
called    O
alcoholic    O
steato    B-Cell102991711
necrosis    O
and    O
the    O
inflammation    O
appears    O
to    O
predispose    O
to    O
liver    O
fibrosis    O
.    O

CRP    O
is    O
synthesized    O
by    O
the    O
liver    O
in    O
response    O
to    O
factors    O
released    O
by    O
macrophages    O
and    O
fat    O
cells    O
(    O
adipocytes    B-Cell102991711
)    O
.    O

This    O
acute    O
phase    O
response    O
occurs    O
as    O
a    O
result    O
of    O
a    O
rise    O
in    O
the    O
concentration    O
of    O
IL-6    O
,    O
which    O
is    O
produced    O
by    O
macrophages    O
as    O
well    O
as    O
adipocyte    B-Cell102991711
in    O
response    O
to    O
a    O
wide    O
range    O
of    O
acute    O
and    O
chronic    O
inflammatory    O
conditions    O
such    O
as    O
bacterial    O
,    O
viral    O
,    O
or    O
fungal    O
infections    O
;    O
rheumatic    O
and    O
other    O
inflammatory    O
diseases    O
;    O
malignancy    O
;    O
and    O
tissue    O
injury    O
and    O
necrosis    O
.    O

ACTH    O
receptors    O
are    O
also    O
expressed    O
in    O
the    O
skin    O
,    O
and    O
in    O
both    O
white    O
and    O
brown    B-Cell102991711
adipoctyes    I-Cell102991711
,    O
and    O
is    O
expressed    O
in    O
greater    O
concentrations    O
when    O
adipose    O
cells    O
differentiate    O
.    O

Adipocytes    B-Cell102991711
lack    O
glycerol    O
kinase    O
so    O
they    O
can    O
not    O
metabolize    O
the    O
glycerol    O
produced    O
during    O
triacyl    O
glycerol    O
degradation    O
.    O

The    O
main    O
cellular    O
component    O
of    O
this    O
tissue    O
is    O
the    O
adipocyte    B-Cell102991711
,    O
or    O
fat    O
cell    O
.    O

Apelin    O
is    O
expressed    O
and    O
secreted    O
by    O
adipocyte    B-Cell102991711
,    O
and    O
its    O
production    O
is    O
increased    O
during    O
adipocyte    O
differentiation    O
and    O
is    O
stimulated    O
by    O
insulin    O
.    O

PEComas    O
are    O
rare    O
and    O
can    O
have    O
myriad    O
features    O
;    O
therefore    O
,    O
they    O
can    O
be    O
confused    O
with    O
carcinomas    O
,    O
smooth    O
muscle    O
tumours    O
,    O
adipocytic    B-Cell102991711
tumours    O
,    O
clear    O
cell    O
sarcomas    O
,    O
melanomas    O
and    O
gastrointestinal    O
stromal    O
tumours    O
(    O
GIST    O
)    O
.    O

It    O
regulates    O
the    O
metabolism    O
of    O
carbohydrates    O
,    O
fats    O
and    O
protein    O
by    O
promoting    O
the    O
absorption    O
of    O
,    O
especially    O
,    O
glucose    O
from    O
the    O
blood    O
into    O
fat    B-Cell102991711
,    O
liver    O
and    O
skeletal    O
muscle    O
cells    O
.    O

In    O
insulin    O
-    O
resistant    O
adipocyte    B-Cell102991711
,    O
patterns    O
of    O
insulin    O
-    O
induced    O
enzyme    O
expression    O
is    O
disturbed    O
in    O
a    O
manner    O
consistent    O
with    O
elevated    O
EC    O
synthesis    O
and    O
reduced    O
EC    O
degradation    O
.    O

An    O
angiomyolipoma    O
is    O
composed    O
of    O
varying    O
proportions    O
of    O
vascular    O
cells    O
,    O
immature    O
smooth    O
muscle    O
cells    O
and    O
fat    B-Cell102991711
cell    I-Cell102991711
.    O

Obese    O
Zucker    O
rats    O
have    O
high    O
levels    O
of    O
lipids    O
and    O
cholesterol    O
in    O
their    O
bloodstream    O
,    O
are    O
resistant    O
to    O
insulin    O
without    O
being    O
hyperglycemic    O
,    O
and    O
gain    O
weight    O
from    O
an    O
increase    O
in    O
both    O
the    O
size    O
and    O
number    O
of    O
fat    B-Cell102991711
cells    I-Cell102991711
.    O

β3    O
receptors    O
,    O
which    O
are    O
presumed    O
to    O
be    O
involved    O
in    O
fatty    O
acid    O
metabolism    O
,    O
are    O
located    O
in    O
the    O
adipocyte    B-Cell102991711
.    O

Leptin    O
(    O
from    O
Greek    O
λεπτός    O
"    O
leptos    O
"    O
,    O
"    O
thin    O
"    O
)    O
,    O
the    O
"    O
satiety    O
hormone    O
"    O
,    O
is    O
a    O
hormone    O
made    O
by    O
adipose    B-Cell102991711
cells    I-Cell102991711
that    O
helps    O
to    O
regulate    O
energy    O
balance    O
by    O
inhibiting    O
hunger    O
.    O

The    O
"    O
energy    O
expenditure    O
hormone    O
"    O
leptin    O
is    O
made    O
by    O
adipose    B-Cell102991711
cells    I-Cell102991711
,    O
thus    O
it    O
is    O
labeled    O
"    O
fat    O
cell    O
-    O
specific    O
"    O
.    O
Leptin    O
acts    O
"    O
directly    O
"    O
on    O
leptin    O
receptors    O
in    O
the    O
cell    O
membrane    O
of    O
different    O
types    O
of    O
cells    O
in    O
the    O
human    O
body    O
in    O
particular    O
,    O
and    O
in    O
vertebrates    O
in    O
general    O
.    O

(    O
This    O
insulin    O
-    O
leptin    O
relationship    O
is    O
notably    O
similar    O
to    O
insulin    O
's    O
effect    O
on    O
the    O
increase    O
of    O
IL-6    O
gene    O
expression    O
and    O
secretion    O
from    O
preadipocytes    B-Cell102991711
in    O
a    O
time-    O
and    O
dose    O
-    O
dependent    O
manner    O
.    O
)    O

The    O
two    O
types    O
of    O
bone    O
marrow    O
are    O
"    O
red    O
marrow    O
"    O
,    O
which    O
consists    O
mainly    O
of    O
hematopoietic    O
tissue    O
,    O
and    O
"    O
yellow    O
marrow    O
"    O
,    O
which    O
is    O
mainly    O
made    O
up    O
of    O
fat    B-Cell102991711
cells    I-Cell102991711
.    O

In    O
turn    O
,    O
transferrin    O
transports    O
Cr3    O
+    O
to    O
insulin    O
sensitive    O
cells    O
(    O
i.e.    O
adipocytes    B-Cell102991711
)    O
where    O
it    O
binds    O
to    O
apochromodulin    O
to    O
form    O
holochromodulin    O
.    O

A    O
fat    B-Cell102991711
pad    I-Cell102991711
(    O
aka    O
haversian    B-Cell102991711
gland    I-Cell102991711
)    O
is    O
a    O
mass    O
of    O
closely    O
packed    O
fat    B-Cell102991711
cell    I-Cell102991711
surrounded    O
by    O
fibrous    O
tissue    O
septa    O
.    O

In    O
humans    O
,    O
via    O
white    O
adipocyte    B-Cell102991711
(    O
fat    O
cells    O
)    O
,    O
production    O
of    O
the    O
hormone    O
leptin    O
(    O
an    O
adipokine    O
)    O
acts    O
on    O
the    O
hypothalamus    O
where    O
reproductive    O
hormone    O
Gonadotrophin    O
-    O
releasing    O
hormone    O
(    O
GnRH    O
)    O
is    O
produced    O
.    O

Abdominal    O
fat    O
accumulation    O
with    O
the    O
formation    O
of    O
enlarged    O
lipid    O
engorged    O
adipocyte    B-Cell102991711
has    O
emerged    O
as    O
the    O
key    O
risk    O
factor    O
for    O
the    O
onset    O
of    O
type    O
2    O
diabetes    O
,    O
which    O
is    O
often    O
a    O
manifestation    O
of    O
a    O
broader    O
underlying    O
metabolic    O
disorder    O
termed    O
as    O
metabolic    O
syndrome    O
.    O

Severe    O
combined    O
immunodeficiency    O
(    O
SCID    O
)    O
with    O
low    O
T-cell    B-Cell102991711
and    O
B-cell    B-Cell102991711
numbers    O

Severe    O
combined    O
immunodeficiency    O
(    O
SCID    O
)    O
with    O
low    O
or    O
normal    O
B-cell    B-Cell102991711
numbers    O

Poly    O
I    O
:    O
C    O
is    O
known    O
to    O
interact    O
with    O
toll    O
-    O
like    O
receptor    O
3    O
(    O
TLR3    O
)    O
,    O
which    O
is    O
expressed    O
in    O
the    O
membrane    O
of    O
B-cells    B-Cell102991711
,    O
macrophages    O
and    O
dendritic    B-Cell102991711
cells    I-Cell102991711
.    O

The    O
B    B-Cell102991711
cell    I-Cell102991711
can    O
present    O
antigens    O
to    O
helper    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
.    O

CD40    O
is    O
constitutively    O
expressed    O
by    O
antigen    O
presenting    O
cells    O
,    O
including    O
dendritic    B-Cell102991711
cells    I-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
and    O
macrophages    O
.    O

Through    O
binding    O
to    O
the    O
interleukin-5    O
receptor    O
,    O
interleukin    O
5    O
stimulates    O
B    B-Cell102991711
cell    I-Cell102991711
growth    O
and    O
increases    O
immunoglobulin    O
secretion    O
.    O

The    O
IL-19    O
gene    O
is    O
expressed    O
in    O
resting    O
monocytes    O
and    O
B    B-Cell102991711
cells    I-Cell102991711
.    O

(    O
This    O
is    O
in    O
contrast    O
to    O
the    O
lymphoid    O
portions    O
of    O
the    O
white    O
pulp    O
,    O
where    O
B    B-Cell102991711
cell    I-Cell102991711
predominate    O
.    O
)    O

Blast    O
cells    O
are    O
involved    O
in    O
generation    O
of    O
B-    B-Cell102991711
and    O
T-lymphocytes    B-Cell102991711
,    O
which    O
participate    O
in    O
immune    O
responses    O
.    O

In    O
addition    O
,    O
histological    O
analysis    O
revealed    O
that    O
the    O
meningeal    O
lymphatics    O
constitutively    O
contain    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
MHC    O
class    O
II    O
-    O
expressing    O
myeloid    O
cells    O
,    O
demonstrating    O
that    O
meningeal    O
lymphatic    O
vessels    O
are    O
capable    O
of    O
carrying    O
immune    O
cells    O
.    O

Dock11    O
was    O
identified    O
as    O
a    O
protein    O
which    O
is    O
highly    O
expressed    O
in    O
Germinal    O
center    O
B    B-Cell102991711
lymphocytes    I-Cell102991711
.    O

FMS    O
-    O
like    O
tyrosine    O
kinase    O
3    O
ligand    O
(    O
FLT3L    O
)    O
is    O
an    O
endogenous    O
small    O
molecule    O
that    O
functions    O
as    O
a    O
cytokine    O
and    O
growth    O
factor    O
that    O
increases    O
the    O
number    O
of    O
immune    O
cells    O
(    O
lymphocytes    O
(    O
B    B-Cell102991711
cell    I-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
)    O
)    O
by    O
activating    O
the    O
hematopoietic    O
progenitors    O
.    O

The    O
"    O
MIR155HG    O
"    O
was    O
initially    O
identified    O
as    O
a    O
gene    O
that    O
was    O
transcriptionally    O
activated    O
by    O
promoter    O
insertion    O
at    O
a    O
common    O
retroviral    O
integration    O
site    O
in    O
B-cell    B-Cell102991711
lymphomas    O
and    O
was    O
formerly    O
called    O
BIC    O
(    O
B    O
-    O
cell    O
Integration    O
Cluster    O
)    O
.    O

Sequence    O
analysis    O
of    O
small    O
RNA    O
clone    O
libraries    O
comparing    O
miRNA    O
expression    O
to    O
all    O
other    O
organ    O
systems    O
examined    O
established    O
that    O
miR-155    O
-    O
5p    O
was    O
one    O
of    O
five    O
miRNAs    O
(    O
i.e.    O
miR-142    O
,    O
miR-144    O
,    O
miR-150    O
,    O
miR-155    O
,    O
and    O
miR-223    O
)    O
that    O
was    O
specific    O
for    O
hematopoietic    O
cells    O
including    O
B-cells    B-Cell102991711
,    O
T-cells    B-Cell102991711
,    O
monocytes    O
and    O
granulocytes    O
.    O

CLPs    O
subsequently    O
differentiate    O
into    O
B-cells    B-Cell102991711
and    O
T-cells    B-Cell102991711
in    O
a    O
process    O
designated    O
lymphopoiesis    O
.    O

Riniker    O
syndrome    O
,    O
severe    O
mixed    O
immunodeficiency    O
syndrome    O
,    O
and    O
thymic    O
alymphoplasia    O
,    O
is    O
a    O
rare    O
genetic    O
disorder    O
characterized    O
by    O
the    O
disturbed    O
development    O
of    O
functional    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
B    B-Cell102991711
cells    I-Cell102991711
caused    O
by    O
numerous    O
genetic    O
mutations    O
that    O
result    O
in    O
heterogeneous    O
clinical    O
presentations    O
.    O

SCID    O
involves    O
defective    O
antibody    O
response    O
due    O
to    O
either    O
direct    O
involvement    O
with    O
B    B-Cell102991711
lymphocytes    I-Cell102991711
or    O
through    O
improper    O
B    O
lymphocyte    O
activation    O
due    O
to    O
non    O
-    O
functional    O
T-helper    B-Cell102991711
cell    I-Cell102991711
.    O

Consequently    O
,    O
both    O
"    O
arms    O
"    O
(    O
B    B-Cell102991711
cell    I-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
)    O
of    O
the    O
adaptive    O
immune    O
system    O
are    O
impaired    O
due    O
to    O
a    O
defect    O
in    O
one    O
of    O
several    O
possible    O
genes    O
.    O

An    O
Fc    O
receptor    O
is    O
a    O
protein    O
found    O
on    O
the    O
surface    O
of    O
certain    O
cells    O
–    O
including    O
,    O
among    O
others    O
,    O
B    B-Cell102991711
lymphocytes    I-Cell102991711
,    O
follicular    O
dendritic    O
cells    O
,    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
,    O
macrophages    O
,    O
neutrophils    O
,    O
eosinophils    O
,    O
basophils    O
,    O
human    O
platelets    O
,    O
and    O
mast    O
cells    O
–    O
that    O
contribute    O
to    O
the    O
protective    O
functions    O
of    O
the    O
immune    O
system    O
.    O

Fc    O
receptors    O
are    O
found    O
on    O
a    O
number    O
of    O
cells    O
in    O
the    O
immune    O
system    O
including    O
phagocytes    O
like    O
macrophages    O
and    O
monocytes    O
,    O
granulocytes    O
like    O
neutrophils    O
and    O
eosinophils    O
,    O
and    O
lymphocytes    O
of    O
the    O
innate    O
immune    O
system    O
(    O
natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
)    O
or    O
adaptive    O
immune    O
system    O
(    O
e.g.    O
,    O
B    B-Cell102991711
cell    I-Cell102991711
)    O
.    O

Specific    O
allergen    O
exposure    O
(    O
e.g.    O
,    O
dust    O
mites    O
)    O
under    O
the    O
influence    O
of    O
helper    O
T2    O
lymphocytes    O
leads    O
to    O
B-lymphocyte    B-Cell102991711
elaboration    O
of    O
immunoglobulin    O
E    O
(    O
IgE    O
)    O
antibodies    O
specific    O
to    O
that    O
allergen    O
.    O

Autoimmunity    O
has    O
been    O
proposed    O
to    O
be    O
a    O
factor    O
in    O
CFS    O
;    O
however    O
,    O
the    O
only    O
relevant    O
finding    O
is    O
a    O
subset    O
of    O
patients    O
with    O
increased    O
B    B-Cell102991711
Cell    I-Cell102991711
activity    O
and    O
autoantibodies    O
,    O
possibly    O
as    O
a    O
result    O
of    O
decreased    O
NK    B-Cell102991711
cell    I-Cell102991711
regulation    O
or    O
viral    O
mimicry    O
.    O

Cell    O
CANARY    O
(    O
Cellular    O
Analysis    O
and    O
Notification    O
of    O
Antigen    O
Risks    O
and    O
Yields    O
)    O
is    O
a    O
recent    O
technology    O
that    O
uses    O
genetically    O
engineered    O
B    B-Cell102991711
cells    I-Cell102991711
to    O
identify    O
pathogens    O
.    O

VG-1    O
is    O
a    O
B    B-Cell102991711
cell    O
line    O
which    O
was    O
derived    O
from    O
primary    O
effusion    O
lymphoma    O
(    O
PEL    O
)    O
.    O

The    O
human    O
immune    O
system    O
typically    O
produces    O
both    O
T-cells    B-Cell102991711
and    O
B-cells    B-Cell102991711
that    O
are    O
capable    O
of    O
being    O
reactive    O
with    O
self    O
-    O
antigens    O
,    O
but    O
these    O
self    O
-    O
reactive    O
cells    O
are    O
usually    O
either    O
killed    O
prior    O
to    O
becoming    O
active    O
within    O
the    O
immune    O
system    O
,    O
placed    O
into    O
a    O
state    O
of    O
anergy    O
(    O
silently    O
removed    O
from    O
their    O
role    O
within    O
the    O
immune    O
system    O
due    O
to    O
over    O
-    O
activation    O
)    O
,    O
or    O
removed    O
from    O
their    O
role    O
within    O
the    O
immune    O
system    O
by    O
regulatory    O
cells    O
.    O

B    B-Cell102991711
cell    I-Cell102991711
and    O
T    O
cells    O
are    O
the    O
major    O
types    O
of    O
lymphocytes    O
and    O
are    O
derived    O
from    O
hematopoietic    O
stem    O
cells    O
in    O
the    O
bone    O
marrow    O
.    O

A    O
B    B-Cell102991711
cell    I-Cell102991711
identifies    O
pathogens    O
when    O
antibodies    O
on    O
its    O
surface    O
bind    O
to    O
a    O
specific    O
foreign    O
antigen    O
.    O

The    O
activation    O
of    O
a    O
resting    O
helper    O
T    O
cell    O
causes    O
it    O
to    O
release    O
cytokines    O
and    O
other    O
stimulatory    O
signals    O
(    O
green    O
arrows    O
)    O
that    O
stimulate    O
the    O
activity    O
of    O
macrophages    O
,    O
killer    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
and    O
B    B-Cell102991711
cell    I-Cell102991711
,    O
the    O
latter    O
producing    O
antibodies    O
.    O

Antibodies    O
are    O
specific    O
proteins    O
released    O
from    O
a    O
certain    O
class    O
of    O
immune    O
cells    O
known    O
as    O
B    B-Cell102991711
lymphocyte    I-Cell102991711
,    O
while    O
antigens    O
are    O
defined    O
as    O
anything    O
that    O
elicits    O
the    O
generation    O
of    O
antibodies    O
(    O
"    O
anti"body    O
"    O
gen"erators    O
)    O
.    O

CLL    O
affects    O
B    B-Cell102991711
cell    I-Cell102991711
lymphocytes    O
,    O
which    O
originate    O
in    O
the    O
bone    O
marrow    O
,    O
develop    O
in    O
the    O
lymph    O
nodes    O
,    O
and    O
normally    O
fight    O
infection    O
by    O
producing    O
antibodies    O
.    O

They    O
found    O
consistent    O
stress    O
-    O
related    O
increases    O
in    O
numbers    O
of    O
total    O
white    O
blood    O
cells    O
,    O
as    O
well    O
as    O
decreases    O
in    O
the    O
numbers    O
of    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
suppressor    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
Natural    B-Cell102991711
killer    I-Cell102991711
cells    O
(    O
NK    O
)    O
.    O

V(D)J    O
recombination    O
is    O
the    O
rearrangement    O
of    O
multiple    O
,    O
distinct    O
gene    O
segments    O
in    O
germ    O
-    O
line    O
DNA    O
to    O
produce    O
the    O
unique    O
protein    O
domains    O
of    O
immune    O
cells    O
,    O
B    B-Cell102991711
cells    I-Cell102991711
and    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
that    O
will    O
specifically    O
recognize    O
foreign    O
antigens    O
such    O
as    O
viruses    O
,    O
bacteria    O
,    O
and    O
pathogenic    O
eukaryotes    O
.    O

Conditional    O
(    O
CD21-cre    O
-    O
mediated    O
)    O
deletion    O
of    O
the    O
XRCC4    O
NHEJ    O
gene    O
in    O
p53-deficient    O
peripheral    O
mouse    O
B    B-Cell102991711
cell    I-Cell102991711
resulted    O
in    O
surface    O
Ig    O
-    O
negative    O
B    O
-    O
cell    O
lymphomas    O
,    O
and    O
these    O
lymphomas    O
often    O
had    O
a    O
"    O
reciprocal    O
chromosomal    O
translocation    O
"    O
fusing    O
IgH    O
to    O
Myc    O
(    O
and    O
also    O
had    O
"    O
large    O
chromosomal    O
deletions    O
or    O
translocations    O
"    O
involving    O
IgK    O
or    O
IgL    O
,    O
with    O
IgL    O
"    O
fusing    O
"    O
to    O
oncogenes    O
or    O
to    O
IgH    O
)    O
.    O

CCDC109B    O
is    O
expressed    O
in    O
B-cells    B-Cell102991711
,    O
Dendritic    O
Cells    O
,    O
T-Cells    B-Cell102991711
,    O
and    O
Natural    B-Cell102991711
Killer    I-Cell102991711
Cells    I-Cell102991711
.    O

TH2-type    O
lymphocytes    O
are    O
activated    O
,    O
with    O
an    O
increase    O
in    O
T    B-Cell102991711
cell    I-Cell102991711
expressing    O
CD25    O
(    O
IL-2R    O
)    O
,    O
and    O
B    B-Cell102991711
cell    I-Cell102991711
expressing    O
CD    O
23    O
,    O
causing    O
increased    O
production    O
of    O
IgE.    O
After    O
exercise    O
,    O
the    O
conditions    O
will    O
fade    O
within    O
one    O
to    O
three    O
minutes    O
.    O

Promoters    O
are    O
associated    O
with    O
a    O
wide    O
variety    O
of    O
tissues    O
including    O
B-lymphocyes    B-Cell102991711
,    O
germ    O
cells    O
,    O
muscle    O
,    O
neurons    O
&    O
prostate    O
.    O

He    O
is    O
famous    O
for    O
having    O
discovered    O
the    O
function    O
of    O
the    O
thymus    O
and    O
for    O
the    O
identification    O
,    O
in    O
mammalian    O
species    O
of    O
the    O
two    O
major    O
subsets    O
of    O
lymphocytes    O
(    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
B    B-Cell102991711
cells    I-Cell102991711
)    O
and    O
their    O
function    O
.    O

ZAP-70    O
in    O
B    B-Cell102991711
cell    I-Cell102991711
is    O
used    O
as    O
a    O
prognostic    O
marker    O
in    O
identifying    O
different    O
forms    O
of    O
chronic    O
lymphocytic    O
leukemia    O
(    O
CLL    O
)    O
.    O

In    O
contrast    O
,    O
FADD    O
has    O
no    O
effect    O
on    O
the    O
proliferation    O
of    O
B    B-Cell102991711
cells    I-Cell102991711
induced    O
by    O
stimulation    O
of    O
the    O
B    O
cell    O
receptor    O
.    O

The    O
combination    O
of    O
this    O
cytokine    O
and    O
IL12    O
has    O
been    O
shown    O
to    O
inhibit    O
IL-4    O
dependent    O
IgE    O
and    O
IgG1    O
production    O
,    O
and    O
enhance    O
IgG2a    O
production    O
in    O
B    B-Cell102991711
cell    I-Cell102991711
.    O

Activation    O
of    O
EP2    O
contributes    O
to    O
regulating    O
B    B-Cell102991711
cell    I-Cell102991711
immunoglobulin    O
class    O
switching    O
,    O
maturation    O
of    O
T    O
lymphocyte    O
CD4−CD8−    O
cells    O
to    O
CD4+CD8    O
+    O
cells    O
,    O
and    O
the    O
function    O
of    O
Antigen-presenting    B-Cell102991711
cell    I-Cell102991711
,    O
particularly    O
Dendritic    B-Cell102991711
cells    I-Cell102991711
.    O

There    O
was    O
no    O
coexpression    O
of    O
CD5    O
or    O
CD23    O
by    O
the    O
monoclonal    O
B-cell    B-Cell102991711
population    O
.    O
"    O

Further    O
subtypes    O
can    O
be    O
classified    O
;    O
for    O
example    O
,    O
among    O
lymphocytes    O
,    O
there    O
are    O
B    B-Cell102991711
cell    I-Cell102991711
,    O
T    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
NK    B-Cell102991711
cells    I-Cell102991711
.    O

B    B-Cell102991711
cell    I-Cell102991711
:    O
releases    O
antibodies    O
and    O
assists    O
activation    O
of    O
T    O
cells    O

B    B-Cell102991711
cell    I-Cell102991711
make    O
antibodies    O
that    O
can    O
bind    O
to    O
pathogens    O
,    O
block    O
pathogen    O
invasion    O
,    O
activate    O
the    O
complement    O
system    O
,    O
and    O
enhance    O
pathogen    O
destruction    O
.    O

A    O
decline    O
in    O
humoral    O
immunity    O
caused    O
by    O
a    O
reduction    O
in    O
the    O
population    O
of    O
antibody    O
producing    O
B-cells    B-Cell102991711
along    O
with    O
a    O
smaller    O
immunoglobulin    O
diversity    O
and    O
affinity    O
.    O

impaired    O
development    O
of    O
CD4    O
+    O
T    B-Cell102991711
follicular    I-Cell102991711
helper    I-Cell102991711
cells    I-Cell102991711
,    O
which    O
are    O
specialized    O
in    O
facilitating    O
peripheral    O
B    B-Cell102991711
cell    I-Cell102991711
maturation    O
,    O
and    O
the    O
generation    O
of    O
antibody    O
-    O
producing    O
plasma    O
cells    O
and    O
memory    B-Cell102991711
B    I-Cell102991711
cell    I-Cell102991711

It    O
interacts    O
with    O
interferon    O
regulatory    O
factor-4    O
and    O
plays    O
an    O
important    O
role    O
in    O
immunoregulatory    O
gene    O
expression    O
in    O
B    B-Cell102991711
and    O
T    B-Cell102991711
lymphocyte    I-Cell102991711
.    O

After    O
completing    O
her    O
studies    O
in    O
mathematics    O
and    O
biology    O
at    O
the    O
University    O
of    O
Bonn    O
and    O
the    O
University    O
of    O
Heidelberg    O
,    O
Maria    O
Leptin    O
worked    O
for    O
her    O
PhD    O
at    O
the    O
Basel    O
Institute    O
for    O
Immunology    O
,    O
Switzerland    O
,    O
(    O
1979    O
-    O
1983    O
)    O
studying    O
B-lymphocyte    B-Cell102991711
activation    O
under    O
the    O
supervision    O
of    O
Fritz    O
Melchers    O
.    O

It    O
inhibits    O
activation    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
B    B-Cell102991711
cells    I-Cell102991711
by    O
reducing    O
the    O
production    O
of    O
interleukin-2    O
(    O
IL-2    O
)    O
.    O

Sirolimus    O
inhibits    O
IL-2    O
and    O
other    O
cytokines    O
receptor    O
-    O
dependent    O
signal    O
transduction    O
mechanisms    O
,    O
via    O
action    O
on    O
mTOR    O
,    O
and    O
thereby    O
blocks    O
activation    O
of    O
T    B-Cell102991711
and    O
B    B-Cell102991711
cell    I-Cell102991711
.    O

Lymphocytes    O
of    O
specific    O
immunity    O
T    B-Cell102991711
cell    I-Cell102991711
—    O
including    O
the    O
subclasses    O
helper    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
and    O
killer    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
—    O
and    O
B    B-Cell102991711
cell    I-Cell102991711
.    O

Post    O
-    O
transplant    O
lymphoproliferative    O
disorder    O
(    O
PTLD    O
)    O
is    O
the    O
name    O
given    O
to    O
a    O
B-cell    B-Cell102991711
proliferation    O
due    O
to    O
therapeutic    O
immunosuppression    O
after    O
organ    O
transplantation    O
.    O

Some    O
of    O
these    O
B-cells    B-Cell102991711
may    O
undergo    O
mutations    O
which    O
will    O
render    O
them    O
malignant    O
,    O
giving    O
rise    O
to    O
a    O
lymphoma    O
.    O

In    O
some    O
patients    O
,    O
the    O
malignant    O
cell    O
clone    O
can    O
become    O
the    O
dominant    O
proliferating    O
cell    O
type    O
,    O
leading    O
to    O
frank    O
lymphoma    O
,    O
a    O
group    O
of    O
B    B-Cell102991711
cell    I-Cell102991711
lymphomas    O
occurring    O
in    O
immunosuppressed    O
patients    O
following    O
organ    O
transplant    O
.    O

It    O
inhibits    O
an    O
enzyme    O
needed    O
for    O
the    O
growth    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
B    B-Cell102991711
cells    I-Cell102991711
.    O

Glucocorticoids    O
cause    O
immunosuppression    O
,    O
and    O
the    O
therapeutic    O
component    O
of    O
this    O
effect    O
is    O
mainly    O
the    O
decreases    O
in    O
the    O
function    O
and    O
numbers    O
of    O
lymphocytes    O
,    O
including    O
both    O
B    B-Cell102991711
cell    I-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
.    O

Glucocorticoids    O
cause    O
B    B-Cell102991711
cell    I-Cell102991711
to    O
express    O
smaller    O
amounts    O
of    O
IL-2    O
and    O
of    O
IL-2    O
receptors    O
.    O

Glucocorticoids    O
cause    O
immunosuppression    O
,    O
decreasing    O
the    O
function    O
and/or    O
numbers    O
of    O
neutrophils    O
,    O
lymphocytes    O
(    O
including    O
both    O
B    B-Cell102991711
cell    I-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
)    O
,    O
monocytes    O
,    O
macrophages    O
,    O
and    O
the    O
anatomical    O
barrier    O
function    O
of    O
the    O
skin    O
.    O

A    O
centrocyte    O
generally    O
refers    O
to    O
a    O
B    B-Cell102991711
cell    I-Cell102991711
with    O
a    O
cleaved    O
nucleus    O
,    O
as    O
may    O
appear    O
in    O
e.g.    O
follicular    O
lymphoma    O
.    O

EBV    O
infects    O
B    B-Cell102991711
cells    I-Cell102991711
of    O
the    O
immune    O
system    O
and    O
epithelial    O
cells    O
.    O

EBV    O
can    O
infect    O
different    O
cell    O
types    O
,    O
including    O
B    B-Cell102991711
cells    I-Cell102991711
and    O
epithelial    O
cells    O
.    O

EBV    O
can    O
infect    O
both    O
B    B-Cell102991711
cells    I-Cell102991711
and    O
epithelial    O
cells    O
.    O

EBV    O
can    O
latently    O
persist    O
within    O
B    B-Cell102991711
cells    I-Cell102991711
and    O
epithelial    O
cells    O
,    O
but    O
different    O
latency    O
programs    O
are    O
possible    O
in    O
the    O
two    O
types    O
of    O
cell    O
.    O

CD100    O
increases    O
PMA    O
,    O
CD3    O
and    O
CD2    O
induced    O
T    O
cell    O
proliferation    O
,    O
increases    O
CD45    O
induced    O
T    O
cell    O
adhesion    O
,    O
induces    O
B    O
cell    O
homotypic    O
adhesion    O
and    O
down    O
-    O
regulates    O
B    B-Cell102991711
cell    I-Cell102991711
expression    O
of    O
CD23    O
.    O

NHL    O
affects    O
two    O
particular    O
types    O
of    O
white    O
blood    O
cells    O
:    O
B-cells    B-Cell102991711
and    O
T    O
-    O
cells    O
.    O

Cutaneous    O
B    O
-    O
cell    O
lymphomas    O
constitute    O
a    O
group    O
of    O
diseases    O
that    O
occur    O
less    O
commonly    O
than    O
cutaneous    O
T    O
-    O
cell    O
lymphoma    O
,    O
and    O
are    O
characterized    O
histologically    O
by    O
B-cell    B-Cell102991711
that    O
appear    O
similar    O
to    O
those    O
normally    O
found    O
in    O
germinal    O
centers    O
of    O
lymph    O
nodes    O
.    O

Instead    O
of    O
having    O
platelets    O
,    O
non    O
-    O
mammalian    O
vertebrates    O
have    O
thrombocytes    O
,    O
which    O
have    O
a    O
nucleus    O
and    O
resemble    O
B    B-Cell102991711
lymphocyte    I-Cell102991711
in    O
morphology    O
.    O

It    O
is    O
found    O
on    O
mature    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
activated    O
macrophages    O
,    O
eosinophils    O
,    O
follicular    O
dendritic    O
cells    O
,    O
and    O
platelets    O
.    O

Osteopontin    O
(    O
OPN    O
)    O
is    O
expressed    O
in    O
a    O
range    O
of    O
immune    O
cells    O
,    O
including    O
macrophages    O
,    O
neutrophils    O
,    O
dendritic    O
cells    O
,    O
and    O
T    B-Cell102991711
and    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
with    O
varying    O
kinetics    O
.    O

Atacicept    O
is    O
a    O
recombinant    O
fusion    O
protein    O
designed    O
to    O
inhibit    O
B    B-Cell102991711
cell    I-Cell102991711
,    O
thereby    O
suppressing    O
autoimmune    O
disease    O
.    O

XMEN    O
patients    O
generally    O
have    O
chronically    O
high    O
levels    O
of    O
EBV    O
with    O
increased    O
EBV    O
-    O
infected    O
cells    O
,    O
diminished    O
thymic    O
output    O
of    O
CD4    O
+    O
cells    O
,    O
reduced    O
CD4:CD8    O
ratio    O
,    O
moderately    O
high    O
B    B-Cell102991711
cell    I-Cell102991711
counts    O
,    O
and    O
mild    O
neutropenia    O
.    O

The    O
process    O
is    O
similar    O
to    O
T    B-Cell102991711
and    O
B    B-Cell102991711
cell    I-Cell102991711
signaling    O
through    O
their    O
specific    O
receptors    O
TCR    O
or    O
BCR    O
.    O

They    O
become    O
activated    O
and    O
start    O
to    O
secrete    O
cytokines    O
,    O
substances    O
that    O
activate    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
lymphocytes    I-Cell102991711
(    O
CTL    O
)    O
,    O
antibody    O
-    O
secreting    O
B    B-Cell102991711
cell    I-Cell102991711
,    O
macrophages    O
and    O
other    O
particles    O
.    O

Tumor    O
antigens    O
can    O
appear    O
on    O
the    O
surface    O
of    O
the    O
tumor    O
in    O
the    O
form    O
of    O
,    O
for    O
example    O
,    O
a    O
mutated    O
receptor    O
,    O
in    O
which    O
case    O
they    O
are    O
recognized    O
by    O
B    B-Cell102991711
cells    I-Cell102991711
.    O

T    B-Cell102991711
cell    I-Cell102991711
can    O
not    O
bind    O
native    O
antigens    O
,    O
but    O
require    O
that    O
they    O
be    O
processed    O
by    O
APCs    O
,    O
whereas    O
B    B-Cell102991711
cell    I-Cell102991711
can    O
be    O
activated    O
by    O
native    O
ones    O
.    O

Antibodies    O
are    O
secreted    O
by    O
B    B-Cell102991711
cell    I-Cell102991711
of    O
the    O
adaptive    O
immune    O
system    O
,    O
mostly    O
by    O
differentiated    O
B    O
cells    O
called    O
plasma    O
cells    O
.    O

The    O
antibody    O
isotype    O
of    O
a    O
B    B-Cell102991711
cell    I-Cell102991711
changes    O
during    O
cell    O
development    B-Cell102991711
and    O
activation    O
.    O

Signalling    O
from    O
these    O
receptors    O
normally    O
promotes    O
growth    O
and    O
differentiation    O
of    O
T-cells    B-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
,    O
glial    O
cells    O
,    O
and    O
cells    O
of    O
the    O
monocyte    O
lineage    O
,    O
depending    O
on    O
the    O
cell    O
type    O
and    O
receptor    O
activated    O
.    O

A    O
healthy    O
immune    O
system    O
should    O
contain    O
large    O
amounts    O
of    O
lymphocytes    O
,    O
but    O
individuals    O
with    O
X    O
-    O
SCID    O
will    O
contain    O
unusually    O
small    O
amounts    O
of    O
T    O
-    O
cells    O
,    O
non    O
-    O
functional    O
B-cells    B-Cell102991711
,    O
and    O
some    O
natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
.    O

A    O
study    O
that    O
investigated    O
the    O
methylome    O
of    O
B    B-Cell102991711
cell    I-Cell102991711
along    O
their    O
differentiation    O
cycle    O
,    O
using    O
whole    O
-    O
genome    O
bisulfite    O
sequencing    O
(    O
WGBS    O
)    O
,    O
showed    O
that    O
there    O
is    O
a    O
hypomethylation    O
from    O
the    O
earliest    O
stages    O
to    O
the    O
most    O
differentiated    O
stages    O
.    O

Only    O
APCs    O
do    O
express    O
the    O
class    O
II    O
of    O
MHC    O
molecules    O
on    O
the    O
surface    O
in    O
large    O
quantity    O
,    O
such    O
as    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
B    B-Cell102991711
cell    I-Cell102991711
or    O
macrophages    O
,    O
so    O
expression    O
of    O
MHC    O
-    O
II    O
molecules    O
is    O
more    O
cell    O
-    O
specific    O
than    O
MHC    O
-    O
I.    O

B    O
-    O
cell    O
receptors    O
on    O
the    O
surface    O
of    O
B    B-Cell102991711
cell    I-Cell102991711
bind    O
to    O
intact    O
native    O
and    O
undigested    O
antigens    O
of    O
structural    O
nature    O
,    O
rather    O
than    O
to    O
a    O
linear    O
sequence    O
of    O
a    O
peptide    O
which    O
has    O
been    O
digested    O
into    O
small    O
fragments    O
and    O
presented    O
by    O
MHC    O
molecules    O
.    O

Large    O
complexes    O
of    O
intact    O
antigen    O
are    O
presented    O
in    O
lymph    O
nodes    O
to    O
B    B-Cell102991711
cell    I-Cell102991711
by    O
follicular    O
dendritic    O
cells    O
in    O
the    O
form    O
of    O
immune    O
complexes    O
.    O

Allelic    O
exclusion    O
has    O
been    O
observed    O
most    O
often    O
in    O
genes    O
for    O
cell    O
surface    O
receptors    O
and    O
has    O
been    O
extensively    O
studied    O
in    O
immune    O
cells    O
such    O
as    O
B    B-Cell102991711
lymphocyte    I-Cell102991711
.    O

In    O
the    O
classical    O
pathway    O
,    O
the    O
microbial    O
pathogen    O
is    O
coated    O
in    O
antibodies    O
(    O
IgG    O
and    O
IgM    O
)    O
released    O
by    O
B    B-Cell102991711
cell    I-Cell102991711
.    O

BENTA    O
stands    O
for    O
"    O
B    B-Cell102991711
cell    I-Cell102991711
expansion    O
with    O
NF-κB    O
and    O
T    B-Cell102991711
cell    I-Cell102991711
anergy    O
"    O
and    O
is    O
caused    O
by    O
germline    O
heterozygous    O
gain    O
-    O
of    O
-    O
function    O
mutations    O
in    O
the    O
gene    O
CARD11    O
(    O
see    O
OMIM    O
entry    O
#    O
607210    O
)    O
.    O

T    B-Cell102991711
cells    I-Cell102991711
,    O
part    O
of    O
the    O
components    O
of    O
the    O
immune    O
system    O
along    O
with    O
B    B-Cell102991711
cells    I-Cell102991711

These    O
temporary    O
cells    O
are    O
called    O
progenitor    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
are    O
intermediate    O
cell    O
types    O
which    O
disappear    O
during    O
embryogenesis    O
by    O
turning    O
into    O
other    O
progenitor    O
cells    O
,    O
or    O
into    O
mature    O
adult    O
somatic    O
cell    O
types    O
,    O
or    O
which    O
disappear    O
due    O
to    O
programmed    O
cell    O
death    O
(    O
apoptosis    O
)    O
.    O

During    O
this    O
process    O
there    O
is    O
an    O
increase    O
in    O
the    O
restriction    O
of    O
cell    O
fate    O
that    O
begins    O
with    O
earlier    O
progenitors    B-Cell102991711
giving    O
rise    O
to    O
any    O
cell    O
type    O
in    O
the    O
cortex    O
and    O
later    O
progenitors    O
giving    O
rise    O
only    O
to    O
neurons    O
of    O
superficial    O
layers    O
.    O

A    O
progenitor    B-Cell102991711
cell    I-Cell102991711
is    O
a    O
biological    O
cell    O
that    O
,    O
like    O
a    O
stem    O
cell    O
,    O
has    O
a    O
tendency    O
to    O
differentiate    O
into    O
a    O
specific    O
type    O
of    O
cell    O
,    O
but    O
is    O
already    O
more    O
specific    O
than    O
a    O
stem    O
cell    O
and    O
is    O
pushed    O
to    O
differentiate    O
into    O
its    O
"    O
target    O
"    O
cell    O
.    O

The    O
term    O
"    O
regenerative    O
medicine    O
"    O
is    O
often    O
used    O
synonymously    O
with    O
tissue    O
engineering    O
,    O
although    O
those    O
involved    O
in    O
regenerative    O
medicine    O
place    O
more    O
emphasis    O
on    O
the    O
use    O
of    O
stem    O
cells    O
or    O
progenitor    B-Cell102991711
cells    I-Cell102991711
to    O
produce    O
tissues    O
.    O

Brpf1    O
"    O
shares    O
phenotypes    O
with    O
transcription    O
factors    O
"    O
Sox2    O
"    O
,    O
"    O
Tlx    O
"    O
and    O
"    O
Tbr2    O
"    O
in    O
dentate    O
gyrus    O
development    O
and    O
has    O
potential    O
link    O
to    O
neural    O
stem    O
cells    O
and    O
progenitors    B-Cell102991711
.    O

Since    O
all    O
three    O
components    O
of    O
an    O
angiomyolipoma    O
(    O
vascular    O
cells    O
,    O
immature    O
smooth    O
muscle    O
cells    O
and    O
fat    O
cells    O
)    O
contain    O
a    O
"    O
second    O
hit    O
"    O
mutation    O
,    O
they    O
are    O
believed    O
to    O
have    O
derived    O
from    O
a    O
common    O
progenitor    B-Cell102991711
cell    I-Cell102991711
that    O
suffered    O
the    O
common    O
second    O
hit    O
mutation    O
.    O

Hemopoietic    O
growth    O
factors    O
regulate    O
the    O
differentiation    O
and    O
proliferation    O
of    O
particular    O
progenitor    B-Cell102991711
cell    I-Cell102991711
.    O

HSC    O
=    O
Hematopoietic    O
stem    O
cell    O
,    O
Progenitor    O
=    O
Progenitor    B-Cell102991711
cell    I-Cell102991711
,    O
L    O
-    O
blast    O
=    O
Lymphoblast    O
,    O
Lymphocyte    O
,    O
Mo    O
-    O
blast    O
=    O
Monoblast    O
,    O
Monocyte    O
,    O
Myeloblast    O
,    O
Pro    O
-    O
M    O
=    O
Promyelocyte    O
,    O
Myelocyte    O
,    O
Meta    O
-    O
M    O
=    O
Metamyelocyte    O
,    O
Neutrophil    O
,    O
Eosinophil    O
,    O
Basophil    O
,    O
Pro    O
-    O
E    O
=    O
Proerythroblast    O
,    O
Baso    O
-    O
E    O
=    O
Basophilic    O
erythroblast    O
,    O
poly    O
-    O
E    O
=    O
Polychromatic    O
erythroblast    O
,    O
Ortho    O
-    O
E    O
=    O
Orthochromatic    O
erythroblast    O
,    O
Erythrocyte    O
,    O
Promegakaryocyte    O
,    O
Megakaryocyte    O
,    O
Platelet    O
.    O

Rabbit    O
ATG    O
has    O
been    O
used    O
in    O
two    O
randomised    O
trials    O
to    O
reduce    O
acute    O
Graft    O
versus    O
Host    O
(    O
aGVH    O
)    O
disease    O
in    O
recipients    O
receiving    O
progenitor    B-Cell102991711
cell    I-Cell102991711
transplants    O
.    O

In    O
this    O
approach    O
,    O
transcription    O
factors    O
from    O
progenitor    B-Cell102991711
cell    I-Cell102991711
of    O
the    O
target    O
cell    O
type    O
are    O
transfected    O
into    O
a    O
somatic    O
cell    O
to    O
induce    O
transdifferentiation    O
.    O

The    O
red    O
bone    O
marrow    O
is    O
a    O
key    O
element    O
of    O
the    O
lymphatic    O
system    O
,    O
being    O
one    O
of    O
the    O
primary    O
lymphoid    O
organs    O
that    O
generate    O
lymphocytes    O
from    O
immature    O
hematopoietic    O
progenitor    B-Cell102991711
cell    I-Cell102991711
.    O

Atacicept    O
is    O
thought    O
to    O
selectively    O
impair    O
mature    O
B    O
cells    O
and    O
plasma    O
cells    O
with    O
less    O
impact    O
on    O
progenitor    B-Cell102991711
cell    I-Cell102991711
and    O
memory    B-Cell102991711
B    I-Cell102991711
cell    I-Cell102991711
.    O

It    O
is    O
thought    O
that    O
early    O
scleraxis    O
-    O
expressing    O
progenitor    B-Cell102991711
cell    I-Cell102991711
lead    O
to    O
the    O
eventual    O
formation    O
of    O
tendon    O
tissue    O
and    O
other    O
muscle    O
attachments    O
.    O

Neuroepithelial    O
cells    O
undergo    O
mitosis    O
generating    O
more    O
neuroepithelial    O
cells    O
,    O
radial    O
glial    O
cells    O
or    O
progenitor    B-Cell102991711
cells    I-Cell102991711
,    O
the    O
latter    O
two    O
differentiating    O
into    O
either    O
neurons    O
or    O
glial    O
cells    O
.    O

In    O
an    O
attempt    O
to    O
identify    O
the    O
key    O
features    O
that    O
differentiate    O
neuroepithelial    O
cells    O
from    O
their    O
progenitor    B-Cell102991711
cell    I-Cell102991711
,    O
researchers    O
identified    O
an    O
intermediate    O
filament    O
that    O
was    O
expressed    O
by    O
98%    O
of    O
the    O
neuroepithelial    O
cells    O
of    O
the    O
neural    O
tube    O
,    O
but    O
none    O
of    O
their    O
progenitor    O
cells    O
.    O

Organoid    O
formation    O
generally    O
requires    O
culturing    O
the    O
stem    O
cells    O
or    O
progenitor    B-Cell102991711
cells    I-Cell102991711
in    O
a    O
3D    O
media    O
.    O

Neurotrophins    O
also    O
induce    O
differentiation    O
of    O
progenitor    B-Cell102991711
cells    I-Cell102991711
,    O
to    O
form    O
neurons    O
.    O

Oxyphil    B-Cell102991711
cell    I-Cell102991711

Today    O
his    O
name    O
is    O
associated    O
with    O
the    O
eponymous    O
"    O
Bottcher    B-Cell102991711
cells    I-Cell102991711
"    O
,    O
which    O
are    O
cells    O
of    O
the    O
basilar    O
membrane    O
of    O
the    O
cochlea    O
.    O

CYGB    O
expression    O
can    O
be    O
used    O
as    O
a    O
specific    O
marker    O
with    O
which    O
hepatic    B-Cell102991711
stellate    I-Cell102991711
cell    I-Cell102991711
can    O
be    O
distinguished    O
from    O
portal    O
myofibroblast    B-Cell102991711
in    O
the    O
damaged    O
human    O
liver    O
.    O

Acetaldehyde    O
may    O
be    O
responsible    O
for    O
alcohol    O
-    O
induced    O
fibrosis    O
by    O
stimulating    O
collagen    O
deposition    O
by    O
hepatic    B-Cell102991711
stellate    I-Cell102991711
cell    I-Cell102991711
.    O

The    O
perisinusoidal    O
space    O
also    O
contains    O
hepatic    B-Cell102991711
stellate    I-Cell102991711
cell    I-Cell102991711
(    O
also    O
known    O
as    O
cells    O
of    O
Ito    O
)    O
,    O
which    O
store    O
fat    O
or    O
fat    O
soluble    O
vitamins    O
including    O
vitamin    O
A    O
)    O
.    O

Hepatic    B-Cell102991711
stellate    I-Cell102991711
cells    I-Cell102991711
(    O
here    O
HSC    B-Cell102991711
)    O
,    O
also    O
known    O
as    O
perisinusoidal    B-Cell102991711
cells    I-Cell102991711
or    O
Ito    B-Cell102991711
cells    I-Cell102991711
(    O
earlier    O
"    O
lipocytes    O
"    O
or    O
"    O
fat    O
-    O
storing    O
cells    O
"    O
)    O
,    O
are    O
pericyte    B-Cell102991711
found    O
in    O
the    O
perisinusoidal    O
space    O
of    O
the    O
liver    O
,    O
also    O
known    O
as    O
the    O
space    O
of    O
Disse    O
(    O
a    O
small    O
area    O
between    O
the    O
sinusoids    O
and    O
hepatocyte    B-Cell102991711
)    O
.    O

This    O
fibrous    O
connective    O
tissue    O
bundles    O
have    O
cartilage    O
cells    O
between    O
them    O
;    O
these    O
cells    O
to    O
a    O
certain    O
extent    O
resemble    O
tendon    B-Cell102991711
cell    I-Cell102991711
.    O

H.    O
poeyi    O
"    O
is    O
the    O
only    O
species    O
of    O
"    O
Halichoeres    O
"    O
where    O
the    O
larvae    O
develop    O
internal    O
,    O
specialised    O
,    O
chromatophores    B-Cell102991711
.    O

Chromatophore    B-Cell102991711

Melanopsin    O
was    O
first    O
discovered    O
by    O
Ignacio    O
Provencio    O
as    O
a    O
novel    O
opsin    O
in    O
the    O
melanophores    B-Cell102991711
,    O
or    O
light    O
-    O
sensitive    O
skin    O
cells    O
,    O
of    O
the    O
African    O
clawed    O
frog    O
in    O
1998    O
.    O

The    O
pigment    O
cells    O
,    O
called    O
chromatophore    B-Cell102991711
,    O
are    O
derived    O
from    O
the    O
neural    O
crest    O
.    O

The    O
coloration    O
is    O
pinkish    O
-    O
white    O
to    O
translucent    O
,    O
with    O
varying    O
numbers    O
of    O
grayish    O
-    O
brown    O
to    O
black    O
chromatophore    B-Cell102991711
on    O
the    O
upper    O
sides    O
of    O
the    O
body    O
.    O

By    O
this    O
stage    O
,    O
their    O
bodies    O
are    O
covered    O
by    O
melanophores    B-Cell102991711
.    O

Known    O
for    O
his    O
research    O
in    O
the    O
field    O
of    O
cellular    O
anatomy    O
,    O
he    O
made    O
valuable    O
contributions    O
in    O
his    O
studies    O
of    O
chromatophore    B-Cell102991711
(    O
pigment    O
cells    O
)    O
.    O

"    O
Zur    O
Kenntnis    O
der    O
Chromatophoren    O
der    O
Cephalopoden    O
u.    O
ihrer    O
Adnexa    O
"    O
,    O
1898    O
-    O
To    O
the    O
understanding    O
of    O
the    O
chromatophore    B-Cell102991711
of    O
cephalopods    O
and    O
their    O
appendages    O
.    O

It    O
has    O
a    O
distinctive    O
pattern    O
of    O
melanophore    B-Cell102991711
.    O

Instead    O
,    O
the    O
colour    O
of    O
the    O
skin    O
is    O
largely    O
due    O
to    O
chromatophore    B-Cell102991711
in    O
the    O
dermis    O
,    O
which    O
,    O
in    O
addition    O
to    O
melanin    O
,    O
may    O
contain    O
guanine    O
or    O
carotenoid    O
pigments    O
.    O

Many    O
species    O
,    O
such    O
as    O
flounders    O
,    O
change    O
the    O
colour    O
of    O
their    O
skin    O
by    O
adjusting    O
the    O
relative    O
size    O
of    O
their    O
chromatophores    B-Cell102991711
.    O

The    O
background    O
color    O
of    O
the    O
body    O
is    O
translucent    O
with    O
a    O
large    O
number    O
of    O
tiny    O
dark    O
chromatophores    B-Cell102991711
.    O

Those    O
later    O
are    O
widely    O
distributed    O
on    O
all    O
the    O
body    O
from    O
arms    O
,    O
head    O
,    O
ventral    O
and    O
dorsal    O
areas    O
of    O
the    O
mantle    O
,    O
except    O
the    O
pair    O
of    O
lateral    O
fins    O
which    O
only    O
the    O
border    O
with    O
the    O
mantle    O
has    O
chromatophores    B-Cell102991711
.    O

It    O
has    O
very    O
small    O
eyes    O
and    O
near    O
the    O
jaws    O
are    O
star    O
-    O
shaped    O
melanophore    B-Cell102991711
which    O
are    O
more    O
numerous    O
in    O
older    O
specimens    O
.    O

The    O
body    O
is    O
transparent    O
and    O
melanophore    B-Cell102991711
and    O
silvery    O
patches    O
are    O
found    O
on    O
the    O
abdomen    O
,    O
which    O
contains    O
a    O
large    O
swim    O
bladder    O
.    O

The    O
color    O
of    O
"    O
D.    O
opalescens    O
"    O
can    O
range    O
from    O
white    O
to    O
brown    O
,    O
with    O
the    O
animals    O
able    O
to    O
change    O
their    O
color    O
shades    O
using    O
chromatophore    B-Cell102991711
depending    O
on    O
mood    O
and    O
for    O
camouflage    O
.    O

In    O
addition    O
to    O
the    O
small    O
difference    O
in    O
size    O
,    O
males    O
differ    O
from    O
females    O
in    O
colouration    O
,    O
for    O
example    O
by    O
having    O
a    O
cream    O
-    O
coloured    O
belly    O
(    O
versus    O
orangish    O
yellow    O
in    O
females    O
)    O
and    O
a    O
light    O
pink    O
throat    O
dotted    O
with    O
melanophore    B-Cell102991711
(    O
pure    O
orangish    O
yellow    O
in    O
females    O
)    O
.    O

It    O
is    O
characterised    O
by    O
several    O
unique    O
morphological    O
features    O
:    O
the    O
tentacle    O
bases    O
are    O
narrower    O
than    O
adjacent    O
arm    O
bases    O
,    O
the    O
proximal    O
tentacle    O
lacks    O
suckers    O
but    O
possesses    O
glandular    O
structures    O
,    O
and    O
the    O
animal    O
's    O
pigment    O
is    O
contained    O
mostly    O
in    O
functional    O
chromatophore    B-Cell102991711
.    O

It    O
is    O
characterised    O
by    O
its    O
dark    O
epidermal    O
pigmentation    O
,    O
which    O
is    O
epithelial    O
,    O
as    O
opposed    O
to    O
the    O
chromatophoral    B-Cell102991711
pigmentation    O
found    O
in    O
other    O
"    O
Magnapinna    O
"    O
species    O
.    O

It    O
is    O
characterised    O
by    O
several    O
morphological    O
features    O
:    O
the    O
proximal    O
tentacles    O
are    O
more    O
slender    O
than    O
arm    O
pair    O
IV    O
,    O
pigmentation    O
is    O
contained    O
in    O
the    O
chromatophore    B-Cell102991711
,    O
and    O
"    O
white    O
nodules    O
"    O
are    O
absent    O
from    O
the    O
fins    O
and    O
glandular    O
regions    O
of    O
the    O
proximal    O
tentacles    O
.    O

The    O
colour    O
changes    O
are    O
instantaneous    O
and    O
made    O
by    O
chromatophore    B-Cell102991711
under    O
direct    O
control    O
of    O
the    O
brain    O
.    O

These    O
ultimately    O
leave    O
the    O
trabecular    O
sheaths    O
,    O
and    O
terminate    O
in    O
the    O
proper    O
substance    O
of    O
the    O
spleen    O
in    O
small    O
tufts    O
or    O
pencils    O
of    O
minute    O
arterioles    O
,    O
which    O
open    O
into    O
the    O
interstices    O
of    O
the    O
reticulum    O
formed    O
by    O
the    O
branched    O
sustentacular    B-Cell102991711
cell    I-Cell102991711
.    O

The    O
carotid    O
body    O
is    O
made    O
up    O
of    O
two    O
types    O
of    O
cells    O
,    O
called    O
glomus    O
cells    O
:    O
glomus    O
type    O
I    O
cells    O
are    O
peripheral    O
chemoreceptors    O
,    O
and    O
glomus    O
type    O
II    O
cells    O
are    O
sustentacular    B-Cell102991711
supportive    O
cells    O
.    O

:    O
:    O
A    O
fragmented    O
red    O
blood    O
cell    O
is    O
known    O
as    O
a    O
schistocyte    B-Cell102991711
and    O
is    O
generally    O
the    O
result    O
of    O
an    O
intracellular    O
mechanical    O
injury    O
to    O
the    O
red    O
blood    O
cell    O
.    O

Vessels    O
feature    O
intimal    O
thickening    O
,    O
fibrinoid    O
necrosis    O
,    O
red    B-Cell102991711
blood    I-Cell102991711
cell    I-Cell102991711
fragmentation    I-Cell102991711
,    O
extravasation    O
,    O
thrombosis    O
.    O

The    O
proventricle    O
possesses    O
15    O
to    O
17    O
muscle    B-Cell102991711
cell    I-Cell102991711
rows    O
.    O

Its    O
proventricle    O
is    O
barrel    O
-    O
shaped    O
,    O
long    O
and    O
wide    O
(    O
spanning    O
4    O
segments    O
)    O
,    O
with    O
about    O
22    O
muscle    B-Cell102991711
cell    I-Cell102991711
rows    O
.    O

Its    O
proventricle    O
is    O
barrel    O
-    O
shaped    O
,    O
long    O
and    O
wide    O
(    O
spanning    O
3    O
segments    O
)    O
,    O
with    O
about    O
26    O
muscle    B-Cell102991711
cell    I-Cell102991711
rows    O
.    O

Its    O
proventricle    O
is    O
long    O
and    O
wide    O
,    O
barrel    O
-    O
shaped    O
,    O
spanning    O
3    O
to    O
4    O
segments    O
,    O
with    O
18    O
-    O
20    O
muscle    B-Cell102991711
cell    I-Cell102991711
rows    O
.    O

Dock11    O
is    O
expressed    O
at    O
lower    O
levels    O
in    O
NIH-3T3    O
fibroblasts    O
,    O
C2C12    O
myoblast    B-Cell102991711
and    O
Neuro-2A    O
neuroblastoma    O
cells    O
.    O

Various    O
cell    O
types    O
were    O
inserted    O
into    O
the    O
ECM    O
core    O
,    O
including    O
myocytes    B-Cell102991711
,    O
endothelial    O
cells    O
,    O
nerve    O
cell    O
fibers    O
,    O
and    O
epithelial    O
cell    O
fibers    O
.    O

Increases    O
heart    O
rate    O
and    O
the    O
contractility    O
of    O
cardiac    O
cells    O
(    O
myocytes    B-Cell102991711
)    O
,    O
thereby    O
providing    O
a    O
mechanism    O
for    O
enhanced    O
blood    O
flow    O
to    O
skeletal    O
muscles    O

The    O
diad    B-Cell102991711
is    O
a    O
structure    O
in    O
the    O
cardiac    O
myocyte    B-Cell102991711
located    O
at    O
the    O
sarcomere    O
Z    O
-    O
line    O
.    O

In    O
the    O
heart    O
Foxp1    O
has    O
3    O
vital    O
roles    O
,    O
these    O
include    O
the    O
regulation    O
of    O
cardiac    O
myocyte    B-Cell102991711
maturation    O
and    O
proliferation    O
,    O
outflow    O
tract    O
separation    O
of    O
the    O
pulmonary    O
artery    O
and    O
aorta    O
,    O
and    O
expression    O
of    O
Sox4    O
in    O
cushions    O
and    O
myocardium    O
.    O

A    O
few    O
of    O
these    O
defects    O
include    O
myocyte    B-Cell102991711
maturation    O
and    O
proliferation    O
defects    O
that    O
cause    O
a    O
thin    O
ventricular    O
myocardial    O
compact    O
zone    O
,    O
non    O
-    O
separation    O
of    O
the    O
pulmonary    O
artery    O
and    O
aorta    O
,    O
and    O
cardiomyocyte    O
proliferation    O
increase    O
and    O
defective    O
differentiation    O
.    O

Undifferentiated    O
myoblast    B-Cell102991711
primarily    O
express    O
talin-1    O
,    O
and    O
both    O
mRNA    O
and    O
protein    O
expression    O
of    O
talin-2    O
is    O
upregulated    O
during    O
differentiation    O
;    O
ectopic    O
expression    O
of    O
talin-2    O
in    O
undifferentiated    O
myoblast    B-Cell102991711
dysregulates    O
the    O
actin    O
cytoskeleton    O
,    O
demonstrating    O
that    O
the    O
timing    O
of    O
talin-2    O
expression    O
during    O
development    O
is    O
critical    O
.    O

Talin-2    O
appears    O
to    O
play    O
a    O
role    O
in    O
skeletal    O
muscle    O
development    O
;    O
specifically    O
,    O
in    O
myoblast    B-Cell102991711
fusion    O
,    O
sarcomere    O
assembly    O
,    O
and    O
the    O
integrity    O
of    O
myotendinous    O
junctions    O
.    O

Ablation    O
of    O
both    O
talin    O
isoforms    O
,    O
talin-2    O
and    O
talin-1    O
prevented    O
normal    O
myoblast    B-Cell102991711
fusion    O
and    O
sarcomere    O
assembly    O
,    O
as    O
well    O
as    O
assembly    O
of    O
integrin    O
adhesion    O
complexes    O
,    O
which    O
was    O
attributed    O
to    O
disrupted    O
interactions    O
between    O
integrins    O
and    O
the    O
actin    O
cytoskeleton    O
.    O

When    O
injected    O
with    O
myoblast    B-Cell102991711
transplants    O
,    O
laminin–111    O
decreased    O
degeneration    O
and    O
inflammatory    O
reactions    O
and    O
increased    O
the    O
success    O
of    O
the    O
transplantation    O
.    O

Myoglobin    O
,    O
found    O
in    O
high    O
concentrations    O
in    O
muscle    O
tissue    O
,    O
can    O
then    O
transfer    O
the    O
oxygen    O
to    O
muscle    O
muscle    B-Cell102991711
fiber    I-Cell102991711
,    O
where    O
it    O
will    O
be    O
used    O
in    O
the    O
generation    O
of    O
energy    O
to    O
fuel    O
muscle    O
contraction    O
.    O

The    O
majority    O
of    O
CMD    O
cases    O
result    O
from    O
a    O
genetic    O
mutation    O
in    O
laminin-α2    O
,    O
a    O
subunit    O
of    O
the    O
laminin-211    O
protein    O
,    O
which    O
serves    O
as    O
an    O
essential    O
mechanical    O
link    O
between    O
basement    O
membrane    O
and    O
muscle    B-Cell102991711
fiber    I-Cell102991711
in    O
skeletal    O
and    O
heart    O
muscle    O
.    O

Myocyte    B-Cell102991711
are    O
small    O
muscular    O
cells    O
that    O
open    O
and    O
close    O
the    O
porocytes    O
.    O

A    O
motor    O
unit    O
is    O
defined    O
as    O
one    O
motor    O
neuron    O
and    O
all    O
of    O
the    O
muscle    B-Cell102991711
fibers    I-Cell102991711
it    O
innervates    O
.    O

;    O
Physiology    O
:    O
In    O
skeletal    O
muscle    O
cells    O
(    O
a.k.a    O
.    O
muscle    B-Cell102991711
fibers    I-Cell102991711
)    O
,    O
the    O
term    O
"    O
isotropic    O
"    O
refers    O
to    O
the    O
light    O
bands    O
(    O
I    O
bands    O
)    O
that    O
contribute    O
to    O
the    O
striated    O
pattern    O
of    O
the    O
cells    O
.    O

Muscle    B-Cell102991711
fiber    I-Cell102991711
–    O

For    O
whole    O
brain    O
simulation    O
,    O
this    O
network    O
map    O
should    O
show    O
the    O
connectivity    O
of    O
the    O
whole    O
nervous    O
system    O
,    O
including    O
the    O
spinal    O
cord    O
,    O
sensory    O
receptors    O
,    O
and    O
muscle    B-Cell102991711
cells    I-Cell102991711
.    O

A    O
double    O
sucrose    O
-    O
gap    O
is    O
generally    O
advantageous    O
when    O
used    O
to    O
electrically    O
isolate    O
smaller    O
segments    O
of    O
nerve    O
fibers    O
than    O
would    O
be    O
possible    O
with    O
a    O
single    O
sucrose    O
-    O
gap    O
,    O
as    O
was    O
done    O
in    O
studies    O
on    O
membrane    O
potentials    O
and    O
currents    O
in    O
sheep    O
and    O
calf    O
ventricular    O
muscle    B-Cell102991711
fibers    I-Cell102991711
.    O

myocyte    B-Cell102991711

Fast    B-Cell102991711
twitch    I-Cell102991711
muscle    I-Cell102991711
units    O
and    O
slow    B-Cell102991711
twitch    I-Cell102991711
muscle    I-Cell102991711
units    O
differ    O
in    O
their    O
ability    O
to    O
produce    O
force    O
and    O
resist    O
fatigue    O
.    O

They    O
have    O
the    O
potential    O
to    O
provide    O
additional    O
myonuclei    B-Cell102991711
to    O
their    O
parent    O
muscle    O
fiber    O
,    O
or    O
return    O
to    O
a    O
quiescent    O
state    O
.    O

More    O
specifically    O
,    O
upon    O
activation    O
,    O
satellite    O
cells    O
can    O
re    O
-    O
enter    O
the    O
cell    O
cycle    O
to    O
proliferate    O
and    O
differentiate    O
into    O
myoblast    B-Cell102991711
.    O

Satellite    O
cells    O
are    O
able    O
to    O
differentiate    O
and    O
fuse    O
to    O
augment    O
existing    O
muscle    B-Cell102991711
fibers    I-Cell102991711
and    O
to    O
form    O
new    O
fibers    O
.    O

In    O
response    O
to    O
mechanical    O
strain    O
,    O
satellite    O
cells    O
become    O
"    O
activated    O
"    O
.    O
Activated    O
satellite    O
cells    O
initially    O
proliferate    O
as    O
skeletal    O
myoblast    B-Cell102991711
before    O
undergoing    O
myogenic    O
differentiation    O
.    O

Chief    O
among    O
these    O
is    O
a    O
preponderance    O
of    O
natural    O
fast    B-Cell102991711
twitch    I-Cell102991711
muscle    I-Cell102991711
fibers    O
,    O
which    O
aid    O
in    O
quicker    O
reaction    O
times    O
.    O

This    O
in    O
turn    O
is    O
a    O
function    O
of    O
slim    O
body    O
morphology    O
and    O
slender    O
legs    O
,    O
a    O
preponderance    O
of    O
slow    B-Cell102991711
twitch    I-Cell102991711
muscle    I-Cell102991711
fibers    O
,    O
a    O
low    O
heart    O
rate    O
gained    O
from    O
living    O
at    O
high    O
-    O
altitude    O
,    O
as    O
well    O
as    O
a    O
culture    O
of    O
running    O
to    O
school    O
from    O
a    O
young    O
age    O
.    O

The    O
introduced    O
transgene    O
causes    O
green    O
fluorescence    O
to    O
appear    O
in    O
fast    B-Cell102991711
twitch    I-Cell102991711
muscle    I-Cell102991711
fibres    O
early    O
in    O
development    O
which    O
persist    O
throughout    O
life    O
.    O

While    O
at    O
Duke    O
University    O
,    O
his    O
laboratory    O
discovered    O
key    O
genes    O
,    O
proteins    O
and    O
pathways    O
involved    O
in    O
the    O
development    O
and    O
proliferation    O
of    O
cardiac    O
and    O
skeletal    O
muscle    O
cells    O
(    O
or    O
myocytes    B-Cell102991711
researchers    O
insight    O
into    O
early    O
heart    O
development    O
.    O

Lactic    O
acid    O
fermentation    O
is    O
used    O
by    O
human    O
muscle    B-Cell102991711
cells    I-Cell102991711
as    O
a    O
means    O
of    O
generating    O
ATP    O
during    O
strenuous    O
exercise    O
where    O
oxygen    O
consumption    O
is    O
higher    O
than    O
the    O
supplied    O
oxygen    O
.    O

Forcing    O
mouse    O
embryonic    O
fibroblasts    O
to    O
express    O
MyoD    O
was    O
found    O
to    O
be    O
sufficient    O
to    O
turn    O
those    O
cells    O
into    O
myoblast    B-Cell102991711
.    O

MSCs    O
have    O
been    O
shown    O
to    O
differentiate    O
,    O
in    O
vitro    O
or    O
in    O
vivo    O
,    O
into    O
osteoblasts    O
,    O
chondrocyte    B-Cell102991711
,    O
myocyte    B-Cell102991711
,    O
marrow    O
adipocytes    O
and    O
beta    O
-    O
pancreatic    O
islets    O
cells    O
.    O

Osteopontin    O
is    O
biosynthesized    O
by    O
a    O
variety    O
of    O
tissue    O
types    O
including    O
cardiac    O
fibroblasts    O
,    O
preosteoblasts    O
,    O
osteoblasts    O
,    O
osteocytes    O
,    O
odontoblasts    O
,    O
some    O
bone    O
marrow    O
cells    O
,    O
hypertrophic    O
chondrocytes    B-Cell102991711
,    O
dendritic    B-Cell102991711
cells    I-Cell102991711
,    O
macrophages    O
,    O
smooth    O
muscle    O
,    O
skeletal    O
muscle    O
myoblasts    B-Cell102991711
,    O
endothelial    O
cells    O
,    O
and    O
extraosseous    O
(    O
non    O
-    O
bone    O
)    O
cells    O
in    O
the    O
inner    O
ear    O
,    O
brain    O
,    O
kidney    O
,    O
deciduum    O
,    O
and    O
placenta    O
.    O

In    O
March    O
1902    O
,    O
he    O
provided    O
the    O
first    O
accurate    O
description    O
of    O
the    O
reticular    O
network    O
(    O
sarcoplasmic    O
reticulum    O
)    O
in    O
skeletal    O
muscle    B-Cell102991711
fiber    I-Cell102991711
.    O

Additionally    O
,    O
if    O
muscle    B-Cell102991711
fibre    I-Cell102991711
are    O
stretched    O
excessively    O
,    O
they    O
lose    O
their    O
ability    O
to    O
contract    O
,    O
rendering    O
them    O
ineffective    O
.    O

In    O
the    O
body    O
,    O
a    O
possible    O
role    O
in    O
myoblast    B-Cell102991711
development    O
has    O
been    O
described    O
.    O

In    O
the    O
case    O
of    O
muscle    B-Cell102991711
fiber    I-Cell102991711
,    O
the    O
individual    O
muscle    O
fiber    O
does    O
not    O
respond    O
at    O
all    O
if    O
the    O
stimulus    O
is    O
too    O
weak    O
.    O

Muscle    O
cells    O
are    O
amassed    O
into    O
muscle    B-Cell102991711
fibers    I-Cell102991711
and    O
then    O
into    O
the    O
functional    O
unit    O
,    O
the    O
muscle    O
.    O

Cardiac    O
myoblast    B-Cell102991711
and    O
blood    O
islands    O
in    O
the    O
splanchnopleuric    O
mesenchyme    O
on    O
each    O
side    O
of    O
the    O
neural    O
plate    O
,    O
give    O
rise    O
to    O
the    O
cardiogenic    O
region    O
.    O

Dystrobrevin    O
is    O
a    O
protein    O
that    O
binds    O
to    O
dystrophin    O
in    O
the    O
costamere    O
of    O
skeletal    O
muscle    B-Cell102991711
cell    I-Cell102991711
.    O

The    O
cardiac    O
muscle    O
is    O
composed    O
of    O
myocytes    B-Cell102991711
which    O
initiate    O
their    O
own    O
contraction    O
without    O
the    O
help    O
of    O
external    O
nerves    O
(    O
with    O
the    O
exception    O
of    O
modifying    O
the    O
heart    O
rate    O
due    O
to    O
metabolic    O
demand    O
)    O
.    O

It    O
is    O
characterised    O
by    O
deposits    O
of    O
IgA    O
in    O
the    O
space    B-Cell102991711
between    I-Cell102991711
glomerular    I-Cell102991711
capillaries    I-Cell102991711
.    O

Immunofluorescence    O
(    O
right    O
)    O
demonstrated    O
C3    O
positive    O
staining    O
in    O
mesangial    B-Cell102991711
area    I-Cell102991711
.    O

It    O
is    O
characterized    O
by    O
glomerular    O
basement    O
membrane    O
thickening    O
(    O
referred    O
to    O
as    O
"    O
tram    O
-    O
tracking    O
of    O
the    O
basement    O
membrane    O
"    O
)    O
,    O
increased    O
mesangial    B-Cell102991711
matrix    I-Cell102991711
and    O
segmental    O
and    O
global    O
glomerulosclerosis    O
.    O

Chaperone    B-Cell102991711
(protein)    I-Cell102991711

It    O
binds    O
to    O
the    O
5'UTR    O
of    O
mRNA    O
encoding    O
the    O
hfq2    O
chaperone    B-Cell102991711
protein    I-Cell102991711
.    O

molecular    B-Cell102991711
chaperone    I-Cell102991711
,    O
they    O
identified    O
a    O
domain    O
in    O
the    O
protein    O
that    O
acts    O
as    O
a    O
signal    O
for    O
nuclear    O
entry    O
.    O

Her    O
research    O
is    O
largely    O
focuses    O
on    O
molecular    B-Cell102991711
chaperones    I-Cell102991711
and    O
protein    O
misfolding    O
.    O

STag    O
and    O
LTag    O
share    O
a    O
common    O
N    O
-    O
terminal    O
domain    O
called    O
the    O
J    O
domain    O
,    O
which    O
is    O
around    O
80    O
-    O
90    O
residues    O
long    O
,    O
has    O
homology    O
to    O
DnaJ    O
proteins    O
,    O
and    O
functions    O
as    O
a    O
molecular    B-Cell102991711
chaperone    I-Cell102991711
.    O

In    O
the    O
bacterial    O
cytosol    O
,    O
ATP    O
-    O
dependent    O
protein    O
degradation    O
is    O
performed    O
by    O
several    O
different    O
chaperone    B-Cell102991711
-    O
protease    O
pairs    O
,    O
including    O
ClpAP    O
.    O

ClpS    O
directly    O
influences    O
the    O
ClpAP    O
machine    O
by    O
binding    O
to    O
the    O
N    O
-    O
terminal    O
domain    O
of    O
the    O
chaperone    B-Cell102991711
ClpA.    O
The    O
degradation    O
of    O
ClpAP    O
substrates    O
,    O
both    O
SsrA    O
-    O
tagged    O
proteins    O
and    O
ClpA    O
itself    O
,    O
is    O
specifically    O
inhibited    O
by    O
ClpS.    O
ClpS    O
modifies    O
ClpA    O
substrate    O
specificity    O
,    O
potentially    O
redirecting    O
degradation    O
by    O
ClpAP    O
toward    O
aggregated    O
proteins    O
.    O

CobW    O
-    O
like    O
proteins    O
include    O
P47    O
K    O
,    O
a    O
"    O
Pseudomonas    O
chlororaphis    O
"    O
protein    O
needed    O
for    O
nitrile    O
hydratase    O
expression    O
,    O
and    O
urease    O
accessory    O
protein    O
UreG    O
,    O
which    O
acts    O
as    O
a    O
chaperone    B-Cell102991711
in    O
the    O
activation    O
of    O
urease    O
upon    O
insertion    O
of    O
nickel    O
into    O
the    O
active    O
site    O
.    O

The    O
ER    O
provides    O
an    O
oxidizing    O
environment    O
(    O
for    O
formation    O
of    O
disulfide    O
bonds    O
)    O
and    O
the    O
necessary    O
chaperone    B-Cell102991711
(    O
folding    O
assisting    O
agents    O
that    O
are    O
not    O
part    O
of    O
the    O
final    O
protein    O
)    O
.    O

CCT    O
is    O
a    O
group    O
II    O
cytosolic    O
molecular    B-Cell102991711
chaperone    I-Cell102991711
(    O
or    O
chaperonin    O
,    O
a    O
protein    O
that    O
assists    O
in    O
the    O
folding    O
of    O
other    O
macromolecular    O
structures    O
)    O
.    O

Ribbon    O
model    O
of    O
the    O
apical    O
γ-domain    O
of    O
the    O
chaperonin    B-Cell102991711
CCT    O
.    O

GroEL    O
belongs    O
to    O
the    O
chaperonin    O
family    O
of    O
molecular    B-Cell102991711
chaperones    I-Cell102991711
,    O
and    O
is    O
found    O
in    O
a    O
large    O
number    O
of    O
bacteria    O
.    O

It    O
functions    O
as    O
a    O
co    O
-    O
chaperone    O
which    O
reversibly    O
links    O
together    O
the    O
protein    O
chaperone    B-Cell102991711
Hsp70    O
and    O
Hsp90    O
.    O

Hop    O
belongs    O
to    O
the    O
large    O
group    O
of    O
co    O
-    O
chaperones    O
,    O
which    O
regulate    O
and    O
assist    O
the    O
major    O
chaperone    B-Cell102991711
(    O
mainly    O
heat    O
shock    O
proteins    O
)    O
.    O

As    O
a    O
member    O
of    O
the    O
heat    O
shock    O
protein    O
70    O
family    O
and    O
a    O
chaperone    B-Cell102991711
protein    I-Cell102991711
,    O
it    O
facilitates    O
the    O
proper    O
folding    O
of    O
newly    O
translated    O
and    O
misfolded    O
proteins    O
,    O
as    O
well    O
as    O
stabilize    O
or    O
degrade    O
mutant    O
proteins    O
.    O

For    O
instance    O
,    O
14    O
-    O
3    O
-    O
3ζ    O
controls    O
cellular    O
senescence    O
by    O
complexing    O
with    O
BIS    O
to    O
chaperone    B-Cell102991711
protein    O
folding    O
of    O
STAT3    O
and    O
activate    O
the    O
signaling    O
pathway    O
.    O

Nucleoplasmin    O
,    O
the    O
first    O
identified    O
molecular    B-Cell102991711
chaperone    I-Cell102991711
is    O
a    O
thermostable    O
acidic    O
protein    O
with    O
a    O
pentameric    O
structure    O
.    O

He    O
found    O
one    O
of    O
the    O
first    O
examples    O
of    O
self    O
-    O
regulation    O
of    O
a    O
gene    O
(    O
"    O
cI    O
"    O
,    O
the    O
repressor    O
gene    O
of    O
lambda    O
phage    O
)    O
and    O
later    O
did    O
pioneering    O
work    O
on    O
molecular    B-Cell102991711
chaperones    I-Cell102991711
.    O

LEA    O
proteins    O
function    O
by    O
mechanisms    O
which    O
are    O
distinct    O
from    O
those    O
displayed    O
by    O
heat    O
shock    O
molecular    B-Cell102991711
chaperones    I-Cell102991711
.    O

does    O
not    O
belong    O
to    O
the    O
holin    O
class    O
of    O
proteins    O
,    O
but    O
it    O
shares    O
several    O
characteristics    O
with    O
molecular    B-Cell102991711
chaperones    I-Cell102991711
.    O

In    O
this    O
scenario    O
,    O
the    O
UPR    O
has    O
three    O
aims    O
:    O
initially    O
to    O
restore    O
normal    O
function    O
of    O
the    O
cell    O
by    O
halting    O
protein    O
translation    O
,    O
degrading    O
misfolded    O
proteins    O
,    O
and    O
activating    O
the    O
signalling    O
pathways    O
that    O
lead    O
to    O
increasing    O
the    O
production    O
of    O
molecular    O
chaperones    B-Cell102991711
involved    O
in    O
protein    O
folding    O
.    O

On    O
the    O
other    O
hand    O
,    O
the    O
unfolded    O
proteins    O
are    O
corrected    O
by    O
the    O
production    O
of    O
chaperone    B-Cell102991711
,    O
which    O
are    O
induced    O
by    O
the    O
activating    O
transcription    O
factor    O
6    O
(    O
ATF6    O
)    O
.    O

Archease    O
genes    O
are    O
generally    O
located    O
adjacent    O
to    O
genes    O
encoding    O
proteins    O
involved    O
in    O
DNA    O
or    O
RNA    O
processing    O
and    O
therefore    O
been    O
predicted    O
to    O
be    O
modulators    O
or    O
chaperones    B-Cell102991711
involved    O
in    O
DNA    O
or    O
RNA    O
metabolism    O
.    O

The    O
function    O
of    O
this    O
family    O
of    O
archeases    O
as    O
chaperone    B-Cell102991711
is    O
supported    O
by    O
structural    O
analysis    O
of    O
the    O
archease    O
from    O
"    O
Methanobacterium    O
thermoautotrophicum    O
"    O
,    O
which    O
shows    O
homology    O
to    O
heat    O
shock    O
protein    O
33    O
,    O
a    O
chaperone    B-Cell102991711
protein    I-Cell102991711
that    O
inhibits    O
the    O
aggregation    O
of    O
partially    O
denatured    O
proteins    O
.    O

These    O
proteins    O
have    O
histone    O
chaperone    B-Cell102991711
activity    O
.    O

In    O
molecular    O
biology    O
,    O
BAG    O
domains    O
are    O
protein    O
domains    O
found    O
in    O
proteins    O
which    O
are    O
modulators    O
of    O
chaperone    B-Cell102991711
activity    O
,    O
they    O
bind    O
to    O
HSP70/HSC70    O
proteins    O
and    O
promote    O
substrate    O
release    O
.    O

It    O
has    O
a    O
similar    O
function    O
to    O
the    O
human    O
chaperone    B-Cell102991711
α-crystallin    O
.    O

C    O
terminus    O
-    O
cancer    O
-    O
candidate    O
gene    O
-    O
Canonical    O
sequence    O
-    O
cap    O
-    O
cap    O
site    O
-    O
carboxyl    O
terminus    O
-    O
carcinoma    O
-    O
carrier    O
-    O
CAT    O
assay    O
-    O
CCAAT    O
box    O
-    O
cDNA    O
-    O
cDNA    O
clone    O
-    O
cDNA    O
library    O
-    O
cell    O
-    O
centimorgan    O
-    O
centromere    O
-    O
chain    O
terminator    O
-    O
chaperone    B-Cell102991711
protein    I-Cell102991711
-    O
chromosome    O
-    O
Chromosomal    O
translocation    O
-    O
chromosome    O
walking    O
-    O
CIS    O
-    O
cistron    O
-    O
clone    O
(    O
genetics    O
)    O
-    O
clone    O
(    O
noun    O
)    O
-    O
clone    O
(    O
verb    O
)    O
-    O
cloning    O
-    O
coding    O
sequence    O
-    O
coding    O
strand    O
-    O
codon    O
-    O
codon    O
usage    O
bias    O
-    O
competent    O
-    O
complementary    O
-    O
conformational    O
epitope    O
-    O
congenital    O
-    O
consensus    O
sequence    O
-    O
conservative    O
substitution    O
-    O
conserved    O
-    O
contig    O
-    O
cosmid    O
-    O
craniosynostosis    O
-    O
cystic    O
fibrosis    O
-    O
cytogenetic    O
map    O
-    O
cytosine    O
-    O

Faggot    B-Cell102991711
cell    I-Cell102991711
,    O
blast    O
cell    O
type    O
found    O
in    O
acute    O
promyelocytic    O
leukemia    O

Pancreatic    B-Cell102991711
stellate    I-Cell102991711
cell    I-Cell102991711

Except    O
for    O
crystalline    O
silicon    O
wafers    O
or    O
cadmium    B-Cell102991711
telluride    I-Cell102991711
photovoltaics    I-Cell102991711
or    O
Float    O
-    O
zone    O
silicon    O
,    O
nearly    O
80    O
percent    O
of    O
solar    O
-    O
panel    O
weight    O
is    O
flat    O
glass    O
.    O

288,132    O
thin-film    B-Cell102991711
modules    I-Cell102991711
using    O
cadmium    B-Cell102991711
telluride    I-Cell102991711
photovoltaics    I-Cell102991711
(    O
CdTe    O
PV    O
)    O
manufactured    O
by    O
U.S.    O
company    O
First    O
Solar    O

Lab    O
efficiencies    O
of    O
26.6    O
percent    O
for    O
(    O
heterojunction    O
back    O
-    O
contact    O
type    O
)    O
mono    O
-    O
Si    O
cells    O
are    O
the    O
highest    O
in    O
the    O
commercial    O
PV    O
market    O
,    O
ahead    O
of    O
polysilicon    O
with    O
21.3    O
percent    O
and    O
all    O
established    O
thin-film    B-Cell102991711
technologies    I-Cell102991711
namely    O
,    O
CIGS    O
cells    O
(    O
22.6%    O
)    O
,    O
CdTe    B-Cell102991711
cells    I-Cell102991711
(    O
22.1%    O
)    O
,    O
and    O
a    O
-    O
Si    O
cells    O
(    O
14.0%    O
)    O
.    O

Cadmium    B-Cell102991711
telluride    I-Cell102991711
solar    I-Cell102991711
cell    I-Cell102991711
(    O
CdTe    O
)    O

Middle    O
:    O
CIGS    O
solar    O
cell    O
on    O
a    O
flexible    O
plastic    O
backing    O
and    O
rigid    O
CdTe    B-Cell102991711
panels    I-Cell102991711
mounted    O
on    O
a    O
supporting    O
structure    O

Thin    O
-    O
film    O
solar    O
cells    O
are    O
commercially    O
used    O
in    O
several    O
technologies    O
,    O
including    O
cadmium    B-Cell102991711
telluride    I-Cell102991711
(    O
CdTe    O
)    O
,    O
copper    O
indium    O
gallium    O
diselenide    O
(    O
CIGS    O
)    O
,    O
and    O
amorphous    O
thin    O
-    O
film    O
silicon    O
(    O
a    O
-    O
Si    O
,    O
TF    O
-    O
Si    O
)    O
.    O

In    O
2012    O
Abound    O
Solar    O
,    O
a    O
manufacturer    O
of    O
cadmium    B-Cell102991711
telluride    I-Cell102991711
modules    I-Cell102991711
,    O
went    O
bankrupt    O
.    O

The    O
solar    O
park    O
has    O
about    O
1.4    O
million    O
thin-film    B-Cell102991711
PV    I-Cell102991711
panels    I-Cell102991711
based    O
on    O
CdTe    B-Cell102991711
technology    I-Cell102991711
made    O
by    O
the    O
US    O
company    O
First    O
Solar    O
.    O

Transketolase    O
is    O
abundantly    O
expressed    O
in    O
the    O
mammalian    O
cornea    O
by    O
the    O
stromal    B-Cell102991711
keratocytes    I-Cell102991711
and    O
epithelial    O
cells    O
and    O
is    O
reputed    O
to    O
be    O
one    O
of    O
the    O
corneal    O
crystallins    O
.    O

Long    O
-    O
term    O
wear    O
of    O
rigid    O
contacts    O
is    O
associated    O
with    O
decreased    O
corneal    B-Cell102991711
keratocyte    I-Cell102991711
density    O
and    O
increased    O
number    O
of    O
epithelial    O
Langerhans    O
cells    O
.    O

The    O
diad    B-Cell102991711
is    O
a    O
structure    O
in    O
the    O
cardiac    O
myocyte    B-Cell102991711
located    O
at    O
the    O
sarcomere    O
Z    O
-    O
line    O
.    O

Arbuscular    O
mycorrhizal    O
fungi    O
have    O
(    O
possibly    O
)    O
been    O
asexual    O
for    O
many    O
millions    O
of    O
years    O
and    O
,    O
unusually    O
,    O
individuals    O
can    O
contain    O
many    O
genetically    O
different    O
nuclei    O
(    O
a    O
phenomenon    O
called    O
heterokaryosis    B-Cell102991711
)    O
.    O

For    O
example    O
,    O
exposure    O
of    O
the    O
heterokaryotic    B-Cell102991711
mycelium    O
to    O
light    O
is    O
required    O
for    O
fruit    O
to    O
occur    O
,    O
and    O
furthermore    O
,    O
this    O
light    O
needs    O
to    O
be    O
at    O
a    O
wavelength    O
of    O
less    O
than    O
530    O
nm    O
.    O

heterokaryon    B-Cell102991711
(    O
adj    O
.    O
heterokaryotic    B-Cell102991711
)    O

While    O
wild    O
strains    O
are    O
highly    O
adaptable    O
and    O
may    O
be    O
heterokaryotic    B-Cell102991711
(    O
contain    O
nuclei    O
of    O
dissimilar    O
genotype    O
within    O
a    O
single    O
organism    O
,    O
and    O
hence    O
highly    O
variable    O
)    O
,    O
strains    O
used    O
for    O
biocontrol    O
in    O
commercial    O
agriculture    O
are    O
,    O
or    O
should    O
be    O
,    O
homokaryotic    O
(    O
nuclei    O
are    O
all    O
genetically    O
similar    O
or    O
identical    O
)    O
.    O

cytotoxic    O
activity    O
of    O
Natural    B-Cell102991711
Killer    I-Cell102991711
T-cells    I-Cell102991711
(    O
NKTs    O
)    O
decreases    O

Recent    O
evidence    O
suggests    O
a    O
role    O
as    O
a    O
liver    O
-    O
resident    O
antigen-presenting    B-Cell102991711
cell    I-Cell102991711
,    O
presenting    O
lipid    O
antigens    O
to    O
and    O
stimulating    O
proliferation    O
of    O
NKT    B-Cell102991711
cells    I-Cell102991711
.    O

Like    O
other    O
'    O
unconventional    O
'    O
T    O
cell    O
subsets    O
bearing    O
invariant    O
TCRs    O
,    O
such    O
as    O
CD1d    O
-    O
restricted    O
Natural    B-Cell102991711
Killer    I-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
,    O
gamma    O
delta    O
T    O
cells    O
exhibit    O
several    O
characteristics    O
that    O
place    O
them    O
at    O
the    O
border    O
between    O
the    O
more    O
evolutionarily    O
primitive    O
innate    O
immune    O
system    O
that    O
permits    O
a    O
rapid    O
beneficial    O
response    O
to    O
a    O
variety    O
of    O
foreign    O
agents    O
,    O
and    O
the    O
adaptive    O
immune    O
system    O
,    O
where    O
B    O
and    O
T    O
cells    O
coordinate    O
a    O
slower    O
but    O
highly    O
antigen    O
-    O
specific    O
immune    O
response    O
leading    O
to    O
long    O
-    O
lasting    O
memory    O
against    O
subsequent    O
challenges    O
by    O
the    O
same    O
antigen    O
.    O

Natural    B-Cell102991711
killer    I-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711

Group    O
2    O
CD1    O
molecules    O
activate    O
a    O
group    O
of    O
T    O
cells    O
,    O
known    O
as    O
Natural    B-Cell102991711
killer    I-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
because    O
of    O
their    O
expression    O
of    O
NK    O
surface    O
markers    O
such    O
as    O
CD161    O
.    O

Thus    O
,    O
mice    O
have    O
been    O
used    O
extensively    O
to    O
characterize    O
the    O
role    O
of    O
CD1d    O
and    O
CD1d    O
-    O
dependent    O
NKT    B-Cell102991711
cell    I-Cell102991711
in    O
a    O
variety    O
of    O
disease    O
models    O
.    O

As    O
in    O
nonbiological    O
examples    O
of    O
ultrafiltration    O
,    O
pressure    O
(    O
in    O
this    O
case    O
blood    O
pressure    O
)    O
and    O
concentration    O
gradients    O
lead    O
to    O
a    O
separation    O
through    O
a    O
semipermeable    O
membrane    O
(    O
provided    O
by    O
the    O
podocyte    B-Cell102991711
)    O
.    O

The    O
visceral    O
layer    O
,    O
composed    O
of    O
modified    O
simple    O
squamous    O
epithelium    O
,    O
is    O
lined    O
by    O
podocyte    B-Cell102991711
.    O

Blood    O
is    O
filtered    O
as    O
it    O
passes    O
through    O
three    O
layers    O
:    O
the    O
endothelial    O
cells    O
of    O
the    O
capillary    O
wall    O
,    O
its    O
basement    O
membrane    O
,    O
and    O
between    O
the    O
foot    O
processes    O
of    O
the    O
podocyte    B-Cell102991711
of    O
the    O
lining    O
of    O
the    O
capsule    O
.    O

The    O
filtering    O
structure    O
(    O
glomerular    O
filtration    O
barrier    O
)    O
has    O
three    O
layers    O
composed    O
of    O
endothelial    O
cells    O
,    O
a    O
basement    O
membrane    O
,    O
and    O
podocyte    B-Cell102991711
(    O
foot    O
processes    O
)    O
.    O

It    O
is    O
composed    O
of    O
a    O
visceral    O
inner    O
layer    O
formed    O
by    O
specialized    O
cells    O
called    O
podocyte    B-Cell102991711
,    O
and    O
a    O
parietal    O
outer    O
layer    O
composed    O
of    O
simple    O
squamous    O
epithelium    O
.    O

Inflammation    O
that    O
affects    O
the    O
cells    O
surrounding    O
the    O
glomerulus    O
,    O
podocyte    B-Cell102991711
,    O
increases    O
the    O
permeability    O
to    O
proteins    O
,    O
resulting    O
in    O
an    O
increase    O
in    O
excreted    O
proteins    O
.    O

Although    O
no    O
changes    O
may    O
be    O
visible    O
by    O
light    O
microscopy    O
,    O
changes    O
on    O
electron    O
microscopy    O
within    O
the    O
glomerules    O
may    O
show    O
a    O
fusion    O
of    O
the    O
foot    O
processes    O
of    O
the    O
podocyte    B-Cell102991711
(    O
cells    O
lining    O
the    O
basement    O
membrane    O
of    O
the    O
capillaries    O
of    O
glomerulus    O
)    O
.    O

Podocyte    B-Cell102991711
,    O
cells    O
which    O
line    O
the    O
glomerulus    O
,    O
are    O
negatively    O
charged    O
and    O
have    O
small    O
gaps    O
,    O
preventing    O
the    O
filtration    O
of    O
large    O
molecules    O
.    O

:    O
:*    O
Lymph    B-Cell102991711
node    I-Cell102991711
stromal    I-Cell102991711
cell    I-Cell102991711

In    O
this    O
case    O
,    O
the    O
NFAT    O
pathway    O
activates    O
another    O
transcription    O
factor    O
-    O
FOXP3    O
that    O
is    O
a    O
marker    O
of    O
T-regs    B-Cell102991711
and    O
participates    O
in    O
their    O
genetic    O
program    O
.    O

Increased    O
concentration    O
of    O
IL-6    O
alters    O
the    O
epidermal    O
environment    O
by    O
decreasing    O
the    O
ability    O
of    O
T    B-Cell102991711
regulatory    I-Cell102991711
cells    I-Cell102991711
to    O
control    O
the    O
behavior    O
of    O
Th17    O
cells    O
.    O

Regulatory    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
and    O
mutations    O
of    O
FOXP3    O

Finally    O
,    O
it    O
was    O
established    O
that    O
regulatory    O
T    O
-    O
cell    O
(    O
Tregs    B-Cell102991711
)    O
development    O
required    O
miR-155    O
-    O
5p    O
and    O
this    O
miRNA    O
was    O
shown    O
to    O
play    O
a    O
role    O
in    O
Treg    O
homeostasis    O
and    O
overall    O
survival    O
by    O
directly    O
targeting    O
SOCS1    O
,    O
a    O
negative    O
regulator    O
for    O
IL-2    O
signaling    O
.    O

In    O
addition    O
there    O
are    O
regulatory    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
which    O
have    O
a    O
role    O
in    O
modulating    O
immune    O
response    O
.    O

Key    O
actors    O
include    O
macrophages    O
and    O
neutrophils    O
,    O
but    O
other    O
cellular    O
actors    O
,    O
including    O
γδ    O
T    O
cells    O
,    O
innate    O
lymphoid    O
cells    O
(    O
ILCs    O
)    O
,    O
and    O
regulatory    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
(    O
Tregs    O
)    O
,    O
are    O
also    O
important    O
.    O

In    O
2005    O
,    O
the    O
PCRF    O
lab    O
at    O
Columbia    O
University    O
reported    O
the    O
critical    O
differences    O
in    O
cord    O
blood    O
compared    O
to    O
adult    O
peripheral    O
blood    O
regulatory    B-Cell102991711
T-cells    I-Cell102991711
that    O
may    O
account    O
for    O
the    O
significantly    O
different    O
responses    O
after    O
cord    O
blood    O
transplantation    O
.    O

They    O
found    O
consistent    O
stress    O
-    O
related    O
increases    O
in    O
numbers    O
of    O
total    O
white    O
blood    O
cells    O
,    O
as    O
well    O
as    O
decreases    O
in    O
the    O
numbers    O
of    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
suppressor    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
Natural    B-Cell102991711
killer    I-Cell102991711
cells    O
(    O
NK    O
)    O
.    O

Regulatory    B-Cell102991711
(suppressor)    I-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
:    O
Returns    O
the    O
functioning    O
of    O
the    O
immune    O
system    O
to    O
normal    O
operation    O
after    O
infection    O
;    O
prevents    O
autoimmunity    O

Tregitopes    O
”    O
,    O
that    O
are    O
shown    O
to    O
activate    O
regulatory    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
and    O
suppress    O
the    O
immune    O
response    O
.    O
De    O
Groot    O
,    O
Martin    O
and    O
Moise    O
also    O
developed    O
the    O
JanusMatrix    O
tool    O
,    O
that    O
identifies    O
regions    O
of    O
"    O
immune    O
camouflage    O
"    O
used    O
by    O
pathogens    O
to    O
escape    O
immune    O
response    O
.    O

Regulatory    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711

The    O
approach    O
seeks    O
to    O
eliminate    O
the    O
immune    O
response    O
directed    O
at    O
insulin    O
that    O
is    O
present    O
in    O
patients    O
with    O
the    O
disease    O
by    O
generating    O
antigen    O
-    O
specific    O
Tregs    O
(    O
regulatory    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
)    O
in    O
response    O
to    O
the    O
antigens    O
of    O
interest    O
rather    O
than    O
try    O
to    O
eliminate    O
the    O
autoreactive    O
destructive    O
cells    O
.    O

It    O
can    O
also    O
precipitate    O
autoimmune    O
disease    O
through    O
the    O
suppression    O
of    O
suppressor    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
populations    O
and/or    O
the    O
emergence    O
of    O
autoreactive    O
B    O
-    O
cells    O
.    O

These    O
cells    O
produce    O
large    O
amounts    O
of    O
TGF    O
beta    O
and    O
other    O
suppressive    O
cytokines    O
,    O
including    O
IL-10    O
,    O
to    O
prevent    O
damage    O
to    O
the    O
eye    O
by    O
reducing    O
inflammation    O
and    O
causing    O
T    O
cells    O
to    O
differentiate    O
to    O
inducible    O
T    O
reg    O
cells    O
.    O
Innate    O
immune    O
stimulation    O
by    O
bacteria    O
and    O
cellular    O
stress    O
is    O
normally    O
suppressed    O
by    O
myeloid    O
suppression    O
while    O
inducible    O
Treg    B-Cell102991711
cells    O
prevent    O
activation    O
and    O
clonal    O
expansion    O
of    O
the    O
autoreactive    O
Th1    B-Cell102991711
and    O
Th17    B-Cell102991711
cells    O
that    O
possess    O
potential    O
to    O
cause    O
damage    O
to    O
the    O
eye    O
.    O

Successful    O
treatment    O
of    O
active    O
uveitis    O
increases    O
T-regulatory    B-Cell102991711
cell    I-Cell102991711
in    O
the    O
eye    O
,    O
which    O
likely    O
contributes    O
to    O
disease    O
regression    O
.    O

VISTA    O
is    O
produced    O
at    O
high    O
levels    O
in    O
tumor    O
-    O
infiltrating    O
lymphocytes    O
,    O
such    O
as    O
myeloid    O
-    O
derived    O
suppressor    O
cells    O
and    O
regulatory    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
,    O
and    O
its    O
blockade    O
with    O
an    O
antibody    O
results    O
in    O
delayed    O
tumor    O
growth    O
in    O
mouse    O
models    O
of    O
melanoma    O
and    O
squamous    O
cell    O
carcinoma    O
.    O

These    O
were    O
foundational    O
studies    O
and    O
represented    O
some    O
of    O
the    O
seminal    O
work    O
on    O
regulatory    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
(    O
Treg    O
)    O
.    O

piRNA    O
and    O
PIWI    O
protein    O
complexes    O
are    O
a    O
common    O
defense    O
mechanism    O
against    O
retrotransposons    O
in    O
the    O
germline    B-Cell102991711
—    O
sperm    O
or    O
egg    O
cells--    O
,    O
cells    O
that    O
are    O
extremely    O
vulnerable    O
to    O
retrotransposon    O
induced    O
mutations    O
.    O

L1    O
is    O
transcribed    O
and    O
retrotransposed    O
most    O
frequently    O
in    O
the    O
germ-line    B-Cell102991711
and    O
during    O
early    O
development    O
;    O
as    O
a    O
result    O
SINEs    O
move    O
around    O
the    O
genome    O
most    O
during    O
these    O
periods    O
.    O

These    O
mutations    O
,    O
which    O
are    O
identical    O
to    O
the    O
ones    O
present    O
in    O
SGS    O
as    O
germ    B-Cell102991711
line    I-Cell102991711
mutations    O
,    O
impair    O
the    O
degradation    O
of    O
SETBP1    O
and    O
therefore    O
cause    O
increased    O
cellular    O
levels    O
of    O
the    O
protein    O
.    O

The    O
macronuclei    O
,    O
or    O
somatic    O
nuclei    O
,    O
are    O
the    O
site    O
of    O
transcription    O
,    O
while    O
the    O
smaller    O
micronuclei    O
,    O
or    O
germline    B-Cell102991711
nuclei    O
,    O
are    O
only    O
active    O
during    O
sexual    O
reproduction    O
,    O
where    O
they    O
first    O
undergo    O
meiosis    O
to    O
form    O
gametic    O
nuclei    O
,    O
which    O
are    O
exchanged    O
when    O
two    O
mating    O
cells    O
conjugate    O
.    O

The    O
frequency    O
of    O
mutations    O
in    O
mouse    O
somatic    O
tissue    O
(    O
brain    O
,    O
liver    O
,    O
Sertoli    B-Cell102991711
cell    I-Cell102991711
)    O
was    O
compared    O
to    O
the    O
mutation    O
frequency    O
in    O
male    O
germline    B-Cell102991711
cells    O
at    O
sequential    O
stages    O
of    O
spermatogenesis    O
.    O

These    O
piRNA    O
complexes    O
(    O
piRCs    O
)    O
have    O
been    O
linked    O
to    O
transcriptional    O
gene    O
silencing    O
of    O
retrotransposons    O
and    O
other    O
genetic    O
elements    O
in    O
germ    B-Cell102991711
line    I-Cell102991711
cells    O
,    O
particularly    O
those    O
in    O
spermatogenesis    O
.    O

Germ-line    B-Cell102991711
mutations    O
in    O
miR-16    O
-    O
1    O
and    O
miR-15    O
primary    O
precursors    O
have    O
been    O
shown    O
to    O
be    O
much    O
more    O
frequent    O
in    O
patients    O
with    O
chronic    O
lymphocytic    O
leukemia    O
compared    O
to    O
control    O
populations    O
.    O

Germ    B-Cell102991711
line    I-Cell102991711
cells    O
develop    O
into    O
eggs    O
and    O
sperm    O
and    O
the    O
associated    O
inherited    O
material    O
can    O
be    O
passed    O
down    O
to    O
future    O
generations    O
.    O

Germline    B-Cell102991711

Most    O
NGS    O
based    O
methods    O
for    O
SNV    O
detection    O
are    O
designed    O
to    O
detect    O
germline    B-Cell102991711
variations    O
in    O
the    O
individual    O
's    O
genome    O
.    O

In    O
addition    O
to    O
methods    O
that    O
align    O
reads    O
from    O
individual    O
sample(s    O
)    O
to    O
a    O
reference    O
genome    O
in    O
order    O
to    O
detect    O
germline    B-Cell102991711
genetic    O
variants    O
,    O
reads    O
from    O
multiple    O
tissue    O
samples    O
within    O
a    O
single    O
individual    O
can    O
be    O
aligned    O
and    O
compared    O
in    O
order    O
to    O
detect    O
somatic    O
variants    O
.    O

All    O
oogonial    O
stem    O
cells    O
in    O
"    O
C.    O
elegans    O
"    O
are    O
derived    O
from    O
one    O
distal    O
-    O
tip    O
cell    O
(    O
DTC    O
)    O
,    O
which    O
acts    O
as    O
a    O
niche    O
to    O
ensure    O
that    O
germline    B-Cell102991711
proliferation    O
continues    O
.    O

gel    O
electrophoresis    O
-    O
gel    O
shift    O
-    O
gel    O
shift    O
assay    O
-    O
gene    O
-    O
gene    O
amplification    O
-    O
gene    O
conversion    O
-    O
gene    O
expression    O
-    O
gene    O
mapping    O
-    O
gene    O
pool    O
-    O
gene    O
therapy    O
-    O
gene    O
transfer    O
-    O
genetic    O
code    O
-    O
genetic    O
counseling    O
-    O
genetic    O
map    O
-    O
genetic    O
marker    O
-    O
genetic    O
screening    O
-    O
genetically    O
modified    O
mouse    O
-    O
genome    O
-    O
genomic    O
blot    O
-    O
genomic    O
clone    O
-    O
genomic    O
library    O
-    O
genotype    O
-    O
germ    B-Cell102991711
line    I-Cell102991711
-    O
glycoprotein    O
-    O
glycosylation    O
-    O
Golgi    O
apparatus    O
-    O
GRE    O
-    O
guanine    O
-    O

Somatic    O
cell    O
–    O
any    O
cells    O
forming    O
the    O
body    O
of    O
an    O
organism    O
,    O
as    O
opposed    O
to    O
germline    B-Cell102991711
cells    O
.    O

PTCs    O
can    O
arise    O
in    O
cells    O
through    O
various    O
mechanisms    O
:    O
germline    B-Cell102991711
mutations    O
in    O
DNA    O
;    O
somatic    O
mutations    O
in    O
DNA    O
;    O
errors    O
in    O
transcription    O
;    O
or    O
errors    O
in    O
post    O
transcriptional    O
mRNA    O
processing    O
.    O

BENTA    O
disease    O
is    O
caused    O
by    O
germline    B-Cell102991711
-    O
encoded    O
gain    O
-    O
of    O
-    O
function    O
mutations    O
in    O
the    O
gene    O
CARD11    O
.    O

Somatic    O
mutations    O
are    O
those    O
that    O
occur    O
in    O
non    O
-    O
germline    B-Cell102991711
cells    O
that    O
are    O
not    O
inherited    O
by    O
children    O
.    O

These    O
include    O
all    O
types    O
of    O
crystalline    O
silicon    O
panels    O
(    O
either    O
mono    O
-    O
Si    O
,    O
or    O
multi    O
-    O
Si    O
)    O
and    O
all    O
types    O
of    O
thin    B-Cell102991711
film    I-Cell102991711
panels    I-Cell102991711
(    O
amorphous    O
silicon    O
,    O
CdTe    O
,    O
CIGS    O
,    O
microcrystalline    O
)    O
.    O

On    O
the    O
other    O
hand    O
,    O
thin-film    B-Cell102991711
solar    I-Cell102991711
cell    I-Cell102991711
are    O
made    O
of    O
direct    O
band    O
gap    O
materials    O
(    O
such    O
as    O
CdTe    O
,    O
CIGS    O
or    O
CZTS    O
)    O
,    O
which    O
absorb    O
the    O
light    O
in    O
a    O
much    O
thinner    O
region    O
,    O
and    O
consequently    O
can    O
be    O
made    O
with    O
a    O
very    O
thin    O
active    O
layer    O
(    O
often    O
less    O
than    O
1    O
micron    O
thick    O
)    O
.    O

High    O
-    O
volume    O
applications    O
such    O
as    O
DRAM    O
computer    O
memory    O
production    O
,    O
the    O
manufacturing    O
of    O
flat    O
panel    O
displays    O
and    O
the    O
large    O
-    O
scale    O
production    O
of    O
thin-film    B-Cell102991711
solar    I-Cell102991711
cell    I-Cell102991711
.    O

It    O
is    O
possible    O
to    O
use    O
any    O
type    O
of    O
solar    O
thermal    O
panel    O
(    O
sheet    O
and    O
tubes    O
,    O
roll    O
-    O
bond    O
,    O
heat    O
pipe    O
,    O
thermal    O
plates    O
)    O
or    O
hybrid    O
(    O
mono    O
/    O
polycrystalline    O
,    O
thin    B-Cell102991711
film    I-Cell102991711
)    O
in    O
combination    O
with    O
the    O
heat    O
pump    O
.    O

Satu    O
Mare    O
Solar    O
Park    O
,    O
a    O
large    O
thin-film    B-Cell102991711
photovoltaic    I-Cell102991711
(    O
PV    O
)    O
power    O
system    O
,    O
is    O
being    O
built    O
on    O
a    O
15    O
ha    O
plot    O
of    O
land    O
near    O
the    O
Satu    O
Mare    O
city    O
in    O
Romania    O
.    O

Some    O
solar    O
photovoltaics    O
use    O
Monocrystalline    O
silicon    O
or    O
polycrystalline    O
silicon    O
panels    O
,    O
while    O
newer    O
technologies    O
have    O
used    O
thin-film    B-Cell102991711
solar    I-Cell102991711
cell    I-Cell102991711
.    O

The    O
solar    O
park    O
has    O
about    O
1.4    O
million    O
thin-film    B-Cell102991711
PV    I-Cell102991711
panels    I-Cell102991711
based    O
on    O
CdTe    B-Cell102991711
technology    I-Cell102991711
made    O
by    O
the    O
US    O
company    O
First    O
Solar    O
.    O

It    O
is    O
best    O
known    O
as    O
the    O
material    O
for    O
CIGS    O
solar    O
cells    O
a    O
thin-film    B-Cell102991711
technology    I-Cell102991711
used    O
in    O
the    O
photovoltaic    O
industry    O
.    O

In    O
particular    O
,    O
the    O
technique    O
can    O
be    O
applied    O
to    O
lower    O
cost    O
thin-film    B-Cell102991711
solar    I-Cell102991711
cell    I-Cell102991711
using    O
amorphous    O
silicon    O
,    O
as    O
opposed    O
to    O
conventional    O
crystalline    O
silicon    O
,    O
to    O
produce    O
a    O
cell    O
with    O
about    O
10%    O
efficiency    O
that    O
is    O
lightweight    O
and    O
flexible    O
.    O

There    O
are    O
four    O
main    O
categories    O
of    O
photovoltaic    O
cells    O
:    O
conventional    O
mono    O
and    O
multi    O
crystalline    O
silicon    O
(    O
c    O
-    O
Si    O
)    O
cells    O
,    O
thin    B-Cell102991711
film    I-Cell102991711
solar    I-Cell102991711
cell    I-Cell102991711
(    O
a    O
-    O
Si    O
,    O
CIGS    O
and    O
CdTe    O
)    O
,    O
and    O
multi    O
-    O
junction    O
(    O
MJ    O
)    O
solar    O
cells    O
.    O

Physically    O
,    O
the    O
main    O
property    O
of    O
a    O
MJ    O
solar    O
cell    O
is    O
having    O
more    O
than    O
one    O
pn    O
junction    O
in    O
order    O
to    O
catch    O
a    O
larger    O
photon    O
energy    O
spectrum    O
while    O
the    O
main    O
property    O
of    O
the    O
thin    B-Cell102991711
film    I-Cell102991711
solar    I-Cell102991711
cell    I-Cell102991711
is    O
to    O
use    O
thin    O
films    O
instead    O
of    O
thick    O
layers    O
in    O
order    O
to    O
decrease    O
the    O
cost    O
efficiency    O
ratio    O
.    O

TEL    O
Solar    O
,    O
formerly    O
Oerlikon    O
Solar    O
,    O
is    O
a    O
manufacturer    O
of    O
production    O
equipment    O
for    O
the    O
manufacturing    O
of    O
thin-film    B-Cell102991711
silicon    I-Cell102991711
cell    I-Cell102991711
,    O
headquartered    O
in    O
Trübbach    O
,    O
Switzerland    O
,    O
near    O
the    O
border    O
to    O
Liechtenstein    O
.    O

Adams    O
'    O
team    O
at    O
ASU    O
works    O
in    O
the    O
field    O
of    O
computational    O
and    O
materials    O
science    O
,    O
studying    O
semiconductor    O
processing    O
and    O
the    O
ideal    O
coatings    O
for    O
tools    O
used    O
for    O
aluminum    O
processing    O
using    O
computer    O
simulations    O
,    O
as    O
well    O
as    O
silicon    B-Cell102991711
thin-film    I-Cell102991711
cell    I-Cell102991711
.    O

#    O
Photovoltaics    O
,    O
especially    O
development    O
of    O
thin    B-Cell102991711
film    I-Cell102991711
solar    I-Cell102991711
cells    I-Cell102991711

Third    B-Cell102991711
generation    I-Cell102991711
solar    I-Cell102991711
cell    I-Cell102991711

The    O
main    O
application    O
of    O
this    O
novel    O
material    O
is    O
in    O
the    O
field    O
of    O
silicon    O
thin    B-Cell102991711
film    I-Cell102991711
solar    I-Cell102991711
cell    I-Cell102991711
.    O

A    O
Solar    O
backpack    O
is    O
a    O
backpack    O
(    O
a    O
cloth    O
sack    O
carried    O
on    O
one    O
's    O
back    O
and    O
secured    O
with    O
two    O
straps    O
that    O
go    O
over    O
the    O
shoulders    O
)    O
,    O
equipped    O
with    O
thin    B-Cell102991711
film    I-Cell102991711
solar    I-Cell102991711
cell    I-Cell102991711
and    O
batteries    O
.    O

He    O
currently    O
focuses    O
on    O
low    O
-    O
cost    O
methods    O
to    O
develop    O
thin    B-Cell102991711
film    I-Cell102991711
solar    I-Cell102991711
cells    I-Cell102991711
based    O
on    O
electrodeposited    O
copper    O
indium    O
gallium    O
selenide    O
materials    O
,    O
where    O
he    O
has    O
reported    O
efficiencies    O
of    O
15.9%    O
to    O
date    O
,    O
compared    O
with    O
the    O
highest    O
value    O
of    O
19.5%    O
reported    O
by    O
NREL    O
[    O
4    O
]    O
using    O
more    O
expensive    O
techniques    O
.    O

This    O
includes    O
a    O
range    O
of    O
alternatives    O
to    O
cells    O
made    O
of    O
semiconducting    O
p    O
-    O
n    O
junctions    O
(    O
"    O
first    O
generation    O
"    O
)    O
and    O
thin    B-Cell102991711
film    I-Cell102991711
cells    I-Cell102991711
(    O
"    O
second    O
generation    O
"    O
)    O
.    O

The    O
HTCE    O
also    O
hosts    O
several    O
publicly    O
funded    O
research    O
institutes    O
as    O
well    O
as    O
collaborative    O
entities    O
such    O
as    O
Solliance    O
,    O
a    O
cooperation    O
between    O
ECN    O
,    O
TNO    O
,    O
Holst    O
Centre    O
and    O
TU    O
/    O
e    O
,    O
established    O
to    O
do    O
research    O
into    O
thin    B-Cell102991711
film    I-Cell102991711
solar    I-Cell102991711
cells    I-Cell102991711
.    O

The    O
middle    B-Cell102991711
lamella    I-Cell102991711
(    O
a    O
glue    O
-    O
like    O
layer    O
containing    O
pectin    O
)    O
develops    O
from    O
the    O
cell    O
plate    O
,    O
serving    O
to    O
bind    O
the    O
cell    O
walls    O
of    O
adjoining    O
cells    O
together    O
.    O

Middle    B-Cell102991711
lamella    I-Cell102991711

Paracrine    B-Cell102991711
signal    I-Cell102991711
transduction    I-Cell102991711
abnormalities    O

As    O
mentioned    O
above    O
,    O
prostacyclin    O
(    O
PGI2    O
)    O
is    O
released    O
by    O
healthy    O
endothelial    O
cells    O
and    O
performs    O
its    O
function    O
through    O
a    O
paracrine    B-Cell102991711
signaling    O
cascade    O
that    O
involves    O
G    O
protein    O
-    O
coupled    O
receptors    O
on    O
nearby    O
platelets    O
and    O
endothelial    O
cells    O
.    O

Endothelial    O
cells    O
secrete    O
angiopoietin-2    O
for    O
autocrine    O
signaling    O
while    O
parenchymal    O
cells    O
of    O
the    O
extravascular    O
tissue    O
secrete    O
angiopoietin-2    O
onto    O
endothelial    O
cells    O
for    O
paracrine    B-Cell102991711
signaling    I-Cell102991711
,    O
which    O
then    O
binds    O
to    O
the    O
extracellular    O
matrix    O
and    O
is    O
stored    O
within    O
the    O
endothelial    O
cells    O
.    O

It    O
binds    O
Bone    O
morphogenetic    O
proteins    O
,    O
members    O
of    O
the    O
TGF    O
beta    O
superfamily    O
of    O
ligands    O
,    O
which    O
are    O
involved    O
in    O
paracrine    B-Cell102991711
signalling    I-Cell102991711
.    O

Somatomedins    O
are    O
produced    O
in    O
many    O
tissues    O
and    O
have    O
autocrine    O
and    O
paracrine    B-Cell102991711
actions    O
in    O
addition    O
to    O
their    O
endocrine    O
action    O
.    O

The    O
sEH    O
pathway    O
acts    O
rapidly    O
and    O
is    O
by    O
far    O
the    O
predominant    O
pathway    O
of    O
EDP    O
inactivation    O
;    O
its    O
operation    O
causes    O
EDPs    O
to    O
function    O
as    O
short    O
-    O
lived    O
mediators    O
whose    O
actions    O
are    O
limited    O
to    O
their    O
parent    O
and    O
nearby    O
cells    O
,    O
i.e.    O
they    O
are    O
autocrine    O
and    O
paracrine    B-Cell102991711
signaling    O
agents    O
,    O
respectively    O
.    O

By    O
definition    O
of    O
being    O
hormones    O
,    O
they    O
are    O
secreted    O
into    O
the    O
circulation    O
for    O
systemic    O
effect    O
,    O
but    O
they    O
can    O
also    O
have    O
a    O
role    O
of    O
neurotransmitter    O
or    O
other    O
roles    O
such    O
as    O
autocrine    O
(    O
self    O
)    O
or    O
paracrine    B-Cell102991711
(    O
local    O
)    O
messenger    O
.    O

The    O
Wnt    O
signalling    O
pathway    O
family    O
refers    O
to    O
a    O
group    O
of    O
secreted    O
paracrine    B-Cell102991711
signaling    I-Cell102991711
proteins    O
.    O

The    O
exact    O
function(s    O
)    O
of    O
these    O
proteins    O
is    O
not    O
yet    O
settled    O
but    O
there    O
is    O
evidence    O
that    O
granins    O
function    O
as    O
pro    O
-    O
hormones    O
,    O
giving    O
rise    O
to    O
an    O
array    O
of    O
peptide    O
fragments    O
for    O
which    O
autocrine    O
,    O
paracrine    B-Cell102991711
,    O
and    O
endocrine    O
activities    O
have    O
been    O
demonstrated    O
in    O
vitro    O
and    O
in    O
vivo    O
.    O

Keratinocyte    O
growth    O
factor    O
(    O
KGF    O
or    O
FGF7    O
)    O
is    O
a    O
paracrine    B-Cell102991711
growth    O
factor    O
produced    O
by    O
the    O
underlying    O
dermal    O
fibroblasts    O
in    O
which    O
the    O
proliferation    B-Cell102991711
of    O
basal    O
cells    O
is    O
regulated    O
.    O

They    O
produce    O
gastrointestinal    O
hormones    O
or    O
peptides    O
in    O
response    O
to    O
various    O
stimuli    O
and    O
release    O
them    O
into    O
the    O
bloodstream    O
for    O
systemic    O
effect    O
,    O
diffuse    O
them    O
as    O
local    B-Cell102991711
messengers    I-Cell102991711
,    O
or    O
transmit    O
them    O
to    O
the    O
enteric    O
nervous    O
system    O
to    O
activate    O
nervous    O
responses    O
.    O

The    O
corpus    O
luteum    O
continues    O
this    O
paracrine    B-Cell102991711
action    O
for    O
the    O
remainder    O
of    O
the    O
menstrual    O
cycle    O
,    O
maintaining    O
the    O
endometrium    O
,    O
before    O
disintegrating    O
into    O
scar    O
tissue    O
during    O
menses    O
.    O

Activated    O
T    B-Cell102991711
cells    I-Cell102991711
can    O
either    O
induce    O
their    O
own    O
proliferation    O
and    O
differentiation    O
(    O
autocrine    O
signalling    O
)    O
,    O
or    O
that    O
of    O
other    O
T    B-Cell102991711
cells    I-Cell102991711
(    O
paracrine    B-Cell102991711
signalling    O
)    O
–    O
both    O
involve    O
IL-2    O
binding    O
to    O
the    O
IL-2    O
receptor    O
on    O
T    B-Cell102991711
cells    I-Cell102991711
(    O
upregulated    O
upon    O
cell    O
activation    O
,    O
under    O
the    O
induction    O
of    O
macrophage    O
-    O
secreted    O
IL-1    O
)    O
.    O

They    O
appear    O
to    O
act    O
as    O
hormone    O
-    O
like    O
autocrine    O
and    O
paracrine    B-Cell102991711
signalling    I-Cell102991711
agents    O
that    O
are    O
involved    O
in    O
regulating    O
inflammatory    O
and    O
perhaps    O
other    O
response    O
.    O

The    O
hormone    O
acts    O
in    O
endocrine    O
,    O
autocrine    O
and    O
paracrine    B-Cell102991711
manner    O
through    O
the    O
prolactin    O
receptor    O
and    O
a    O
large    O
number    O
of    O
cytokine    O
receptors    O
.    O

Extrapituitary    O
production    O
of    O
prolactin    O
is    O
thought    O
to    O
be    O
special    O
to    O
humans    O
and    O
primates    O
and    O
may    O
serve    O
mostly    O
tissue    O
specific    O
paracrine    B-Cell102991711
and    O
autocrine    O
purposes    O
.    O

The    O
surgery    O
may    O
not    O
be    O
the    O
only    O
or    O
main    O
culprit    O
:    O
the    O
disseminated    O
disease    O
may    O
also    O
be    O
the    O
result    O
of    O
predisposition    O
,    O
reduced    O
paracrine    B-Cell102991711
feedback    O
,    O
or    O
metastasis    O
independent    O
of    O
surgery    O
.    O

Urticating    B-Cell102991711
hair    I-Cell102991711
are    O
present    O
in    O
both    O
genders    O
.    O

"    O
Hapalotremus    O
"    O
has    O
red    O
or    O
white    O
Type    O
III    O
urticating    B-Cell102991711
hair    I-Cell102991711
,    O
i.e.    O
relatively    O
long    O
,    O
thin    O
hairs    O
,    O
up    O
to    O
1.2    O
mm    O
,    O
with    O
a    O
fine    O
point    O
and    O
barbs    O
along    O
at    O
least    O
half    O
of    O
the    O
lower    O
part    O
.    O

Some    O
of    O
the    O
species    O
have    O
urticating    B-Cell102991711
hair    I-Cell102991711
.    O

"    O
B.    O
vagans    O
"    O
is    O
frequently    O
kept    O
and    O
bred    O
in    O
captivity    O
.    O
They    O
are    O
typically    O
docile    O
,    O
though    O
they    O
can    O
be    O
skittish    O
and    O
prone    O
to    O
releasing    O
urticating    B-Cell102991711
hair    I-Cell102991711
.    O

Like    O
the    O
banded    O
wooly    O
bear    O
,    O
its    O
hairs    O
are    O
not    O
urticant    B-Cell102991711
and    O
do    O
not    O
typically    O
cause    O
irritation    O
.    O

The    O
backs    O
of    O
older    O
caterpillars    O
(    O
3rd    O
to    O
6th    O
instars    O
)    O
are    O
covered    O
with    O
up    O
to    O
63,000    O
pointed    O
defensive    O
bristles    O
containing    O
an    O
urticating    B-Cell102991711
toxin    O
(    O
thaumetopoein    O
or    O
closely    O
related    O
compounds    O
)    O
.    O

The    O
larvae    O
,    O
like    O
most    O
hemileucines    O
,    O
are    O
covered    O
with    O
urticating    B-Cell102991711
hair    I-Cell102991711
,    O
but    O
these    O
caterpillars    O
possess    O
a    O
uniquely    O
potent    O
anticoagulant    O
venom    O
.    O

"    O
Ami    O
"    O
species    O
have    O
modified    O
Type    O
I    O
urticating    B-Cell102991711
hair    I-Cell102991711
on    O
the    O
abdomen    O
,    O
similar    O
to    O
those    O
of    O
"    O
Proshapalopus    O
"    O
and    O
"    O
Citharacanthus    O
livingstoni    O
"    O
.    O

They    O
almost    O
always    O
have    O
urticating    B-Cell102991711
hair    I-Cell102991711
,    O
often    O
on    O
bumps    O
in    O
the    O
epidermis    O
.    O

The    O
cause    O
of    O
Senior    O
–    O
Løken    O
syndrome    O
type    O
5    O
has    O
been    O
identified    O
to    O
mutation    O
in    O
the    O
NPHP1    O
gene    O
which    O
adversely    O
affects    O
the    O
protein    O
formation    O
mechanism    O
of    O
the    O
cilia    B-Cell102991711
.    O

A    O
ciliopathy    O
is    O
a    O
genetic    O
disorder    O
of    O
the    O
cellular    O
cilia    B-Cell102991711
or    O
the    O
cilia    O
anchoring    O
structures    O
,    O
the    O
basal    O
bodies    O
,    O
or    O
of    O
ciliary    O
function    O
.    O

Although    O
ciliopathies    O
are    O
usually    O
considered    O
to    O
involve    O
proteins    O
that    O
localize    O
to    O
motile    O
and/or    O
immotile    O
(    O
primary    O
)    O
cilia    B-Cell102991711
or    O
centrosomes    O
,    O
it    O
is    O
possible    O
for    O
ciliopathies    O
to    O
be    O
associated    O
with    O
proteins    O
such    O
as    O
XPNPEP3    O
,    O
which    O
localizes    O
to    O
mitochondria    O
but    O
is    O
believed    O
to    O
affect    O
ciliary    O
function    O
through    O
proteolytic    O
cleavage    O
of    O
ciliary    O
proteins    O
.    O

By    O
Day    O
1    O
the    O
embryo    O
has    O
hatched    O
as    O
a    O
ciliated    B-Cell102991711
gastrula    O
stage    O
(    O
photograph    O
)    O
.    O

An    O
abundance    O
of    O
cilia    B-Cell102991711
and    O
centrioles    O
has    O
also    O
been    O
found    O
in    O
these    O
Type    O
2    O
cells    O
of    O
the    O
pineal    O
gland    O
.    O

Both    O
types    O
of    O
cells    O
have    O
similar    O
features    O
,    O
including    O
cilia    B-Cell102991711
,    O
folded    O
membranes    O
,    O
and    O
polarity    O
.    O

Subsequently    O
,    O
a    O
different    O
,    O
heterotrimeric    O
plus    O
-    O
end    O
-    O
directed    O
MT    O
-    O
based    O
motor    O
named    O
kinesin-2    O
,    O
consisting    O
of    O
2    O
distinct    O
KHC    O
-    O
related    O
motor    O
subunits    O
and    O
an    O
accessory    O
"    O
KAP    O
"    O
subunit    O
,    O
was    O
purified    O
from    O
echinoderm    O
egg    O
/    O
embryo    O
extracts    O
and    O
is    O
best    O
known    O
for    O
its    O
role    O
in    O
transporting    O
protein    O
complexes    O
(    O
IFT    O
particles    O
)    O
along    O
axonemes    O
during    O
cilium    B-Cell102991711
biogenesis    O
.    O

Intraflagellar    O
transport    O
along    O
cilia    B-Cell102991711

Dynein    O
transports    O
various    O
cellular    O
cargos    O
,    O
provides    O
forces    O
and    O
displacements    O
important    O
in    O
mitosis    O
,    O
and    O
drives    O
the    O
beat    O
of    O
eukaryotic    O
cilia    B-Cell102991711
and    O
flagella    O
.    O

Axonemal    O
dynein    O
causes    O
sliding    O
of    O
microtubules    O
in    O
the    O
axoneme    B-Cell102991711
of    O
cilia    B-Cell102991711
and    O
flagella    O
and    O
is    O
found    O
only    O
in    O
cells    O
that    O
have    O
those    O
structures    O
.    O

Axonemal    O
dyneins    O
come    O
in    O
multiple    O
forms    O
that    O
contain    O
either    O
one    O
,    O
two    O
or    O
three    O
non    O
-    O
identical    O
heavy    O
chains    O
(    O
depending    O
upon    O
the    O
organism    O
and    O
location    O
in    O
the    O
cilium    B-Cell102991711
)    O
.    O

2,5-Dimethylfuran    O
has    O
been    O
identified    O
as    O
one    O
of    O
the    O
components    O
of    O
cigar    O
smoke    O
with    O
low    O
cilatoxicity    O
(    O
ability    O
to    O
adversely    O
affect    O
the    O
cilia    B-Cell102991711
in    O
the    O
respiratory    O
tract    O
that    O
are    O
responsible    O
for    O
removing    O
foreign    O
particles    O
)    O
.    O

The    O
parapodia    O
are    O
also    O
covered    O
with    O
cilia    B-Cell102991711
,    O
which    O
produce    O
a    O
minute    O
water    O
current    O
that    O
pushes    O
the    O
planktonic    O
food    O
to    O
the    O
mouth    O
of    O
the    O
animal    O
.    O

Infection    O
at    O
an    O
early    O
age    O
may    O
permanently    O
damage    O
nasal    O
and    O
sinus    O
tissue    O
,    O
causing    O
a    O
disruption    O
of    O
cilia    B-Cell102991711
clearance    O
of    O
mucus    O
and    O
bacteria    O
,    O
and    O
predispose    O
these    O
cats    O
to    O
chronic    O
bacterial    O
infections    O
.    O

It    O
uses    O
its    O
cilia    B-Cell102991711
to    O
pull    O
water    O
into    O
its    O
shell    O
cavity    O
through    O
an    O
incurrent    O
siphon    O
and    O
it    O
is    O
here    O
that    O
desirable    O
particulate    O
matter    O
is    O
removed    O
.    O

A    O
typical    O
myzostomid    O
has    O
a    O
flattened    O
,    O
rounded    O
shape    O
,    O
with    O
a    O
thin    O
edge    O
drawn    O
out    O
into    O
delicate    O
radiating    O
hairs    O
called    O
cirri    B-Cell102991711
.    O

There    O
are    O
two    O
types    O
of    O
bulbous    O
shaped    O
sensory    O
papillae    O
on    O
the    O
surface    O
,    O
each    O
measuring    O
10    O
-    O
15    O
µ    O
in    O
diameter    O
at    O
the    O
base    O
with    O
nipple    O
-    O
like    O
tips    O
;    O
one    O
has    O
a    O
short    O
cilia    B-Cell102991711
on    O
top    O
.    O

Structural    O
inheritance    O
has    O
also    O
been    O
seen    O
in    O
the    O
orientation    O
of    O
cilia    B-Cell102991711
in    O
protozoans    O
such    O
as    O
"    O
Paramecium    O
"    O
and    O
"    O
Tetrahymena    O
"    O
,    O
and    O
'    O
handedness    O
'    O
of    O
the    O
spiral    O
of    O
the    O
cell    O
in    O
"    O
Tetrahymena    O
"    O
,    O
and    O
shells    O
of    O
snails    O
.    O

Other    O
enzymes    O
or    O
organelles    O
such    O
as    O
cilia    B-Cell102991711
can    O
be    O
anchored    O
to    O
this    O
scaffolding    O
in    O
order    O
to    O
control    O
the    O
deformation    O
of    O
the    O
external    O
cell    O
membrane    O
,    O
which    O
allows    O
endocytosis    O
and    O
cytokinesis    O
.    O

These    O
strict    O
guidelines    O
require    O
the    O
animal    O
be    O
killed    O
by    O
a    O
single    O
cut    O
across    O
the    O
throat    O
to    O
a    O
precise    O
depth    O
,    O
severing    O
both    O
carotid    O
arteries    O
,    O
both    O
jugular    O
veins    O
,    O
both    O
vagus    O
nerves    O
,    O
the    O
trachea    O
and    O
the    O
esophagus    O
,    O
no    O
higher    O
than    O
the    O
epiglottis    O
and    O
no    O
lower    O
than    O
where    O
cilia    B-Cell102991711
begin    O
inside    O
the    O
trachea    O
,    O
causing    O
the    O
animal    O
to    O
bleed    O
to    O
death    O
.    O

Cercomonads    O
are    O
flagellates    O
that    O
glide    O
on    O
their    O
posterior    O
cilium    B-Cell102991711
and/or    O
generate    O
filopodia    O
.    O

The    O
bundle    O
of    O
cilia    B-Cell102991711
that    O
projects    O
from    O
the    O
surface    O
of    O
the    O
hair    O
cell    O
is    O
the    O
organelle    O
which    O
participates    O
in    O
mechanosensation    O
.    O

Within    O
the    O
biological    O
and    O
medical    O
disciplines    O
,    O
recent    O
discoveries    O
have    O
noted    O
that    O
"    O
primary    O
cilia    B-Cell102991711
"    O
in    O
many    O
types    O
of    O
cells    O
within    O
eukaryotes    O
serve    O
as    O
"    O
cellular    O
antennae    O
"    O
.    O

In    O
some    O
SGCs    O
of    O
the    O
sensory    O
ganglia    O
researchers    O
have    O
seen    O
a    O
single    O
cilium    B-Cell102991711
that    O
extends    O
outward    O
from    O
the    O
cell    O
surface    O
near    O
the    O
nucleus    O
and    O
into    O
the    O
extracellular    O
space    O
of    O
a    O
deep    O
indentation    O
in    O
the    O
plasma    O
membrane    O
.    O

The    O
direction    O
of    O
asymmetry    O
is    O
established    O
much    O
earlier    O
during    O
embryonic    O
development    O
,    O
possibly    O
by    O
the    O
clockwise    O
rotation    O
of    O
cilia    B-Cell102991711
,    O
and    O
leads    O
to    O
sided    O
expression    O
of    O
Pitx2    O
.    O

It    O
carries    O
two    O
densely    O
cilia    B-Cell102991711
nuchal    O
organs    O
.    O

Microscopically    O
,    O
the    O
cyst    O
lining    O
consists    O
of    O
a    O
simple    O
epithelium    O
with    O
cilia    B-Cell102991711
that    O
may    O
be    O
columnar    O
or    O
flat    O
.    O

The    O
radioles    O
are    O
bipinnate    O
and    O
covered    O
with    O
fine    O
cilia    B-Cell102991711
.    O

Smoking    O
can    O
also    O
cause    O
damage    O
to    O
the    O
cilia    B-Cell102991711
that    O
protect    O
the    O
Eustachian    O
tube    O
from    O
mucus    O
,    O
which    O
can    O
result    O
in    O
the    O
clogging    O
of    O
the    O
tube    O
and    O
a    O
buildup    O
of    O
bacteria    O
in    O
the    O
ear    O
,    O
leading    O
to    O
a    O
middle    O
ear    O
infection    O
.    O

Cilia    B-Cell102991711
pull    O
the    O
food    O
through    O
the    O
mouth    O
in    O
a    O
stream    O
of    O
mucus    O
and    O
through    O
the    O
oesophagus    O
,    O
where    O
it    O
is    O
partially    O
digested    O
by    O
enzymes    O
from    O
a    O
pair    O
of    O
large    O
pharyngeal    O
glands    O
.    O

Bronchiectasis    O
may    O
result    O
from    O
congenital    O
disorders    O
that    O
affect    O
cilia    B-Cell102991711
motility    O
or    O
ion    O
transport    O
.    O

Kartagener    O
syndrome    O
is    O
one    O
such    O
disorder    O
of    O
cilia    B-Cell102991711
motility    O
linked    O
to    O
the    O
development    O
of    O
bronchiectasis    O
.    O

All    O
but    O
1    O
species    O
of    O
platyctenids    O
do    O
not    O
possess    O
the    O
iconic    O
ctene    O
rows    O
(    O
the    O
cilia    B-Cell102991711
comb    O
-    O
rows    O
)    O
that    O
distinguishes    O
the    O
Ctenophores    O
but    O
they    O
still    O
possess    O
the    O
pair    O
of    O
tentilla    O
-    O
bearing    O
tentacles    O
and    O
adhesive    O
collocytes    O
that    O
also    O
characterize    O
the    O
phylum    O
in    O
pores    O
along    O
the    O
dorsal    O
surface    O
.    O

Functional    O
considerations    O
suggest    O
that    O
the    O
surface    O
of    O
the    O
bilaterian    O
was    O
probably    O
covered    O
with    O
cilia    B-Cell102991711
,    O
which    O
it    O
could    O
have    O
used    O
for    O
locomotion    O
or    O
feeding    O
.    O

Cilium    B-Cell102991711
–    O
projections    O
from    O
living    O
cells    O
that    O
have    O
locomotive    O
or    O
sensory    O
functions    O

Behe    O
argued    O
that    O
irreducibly    O
complex    O
biological    O
mechanisms    O
include    O
the    O
bacterial    O
flagellum    O
of    O
"    O
E.    O
coli    O
''    O
,    O
the    O
blood    O
clotting    O
cascade    O
,    O
cilia    B-Cell102991711
,    O
and    O
the    O
adaptive    O
immune    O
system    O
.    O

Behe    O
's    O
original    O
examples    O
of    O
irreducibly    O
complex    O
mechanisms    O
included    O
the    O
bacterial    O
flagellum    O
of    O
"    O
E.    O
coli    O
"    O
,    O
the    O
blood    O
clotting    O
cascade    O
,    O
cilia    B-Cell102991711
,    O
and    O
the    O
adaptive    O
immune    O
system    O
.    O

The    O
cilium    B-Cell102991711
construction    O
of    O
axoneme    B-Cell102991711
microtubules    O
movement    O
by    O
the    O
sliding    O
of    O
dynein    O
protein    O
was    O
cited    O
by    O
Behe    O
as    O
an    O
example    O
of    O
irreducible    O
complexity    O
.    O

The    O
cilia    B-Cell102991711
of    O
the    O
respiratory    O
epithelium    O
move    O
the    O
secreted    O
mucus    O
and    O
particulate    O
matter    O
posteriorly    O
towards    O
the    O
pharynx    O
where    O
it    O
passes    O
into    O
the    O
esophagus    O
and    O
is    O
digested    O
in    O
the    O
stomach    O
.    O

Cilia    B-Cell102991711
and    O
mucus    O
along    O
the    O
inside    O
wall    O
of    O
the    O
nasal    O
cavity    O
traps    O
and    O
removes    O
dust    O
and    O
pathogens    O
from    O
the    O
air    O
as    O
it    O
flows    O
through    O
the    O
nasal    O
cavity    O
.    O

Planarians    O
move    O
by    O
beating    O
cilia    B-Cell102991711
on    O
the    O
ventral    O
dermis    O
,    O
allowing    O
them    O
to    O
glide    O
along    O
on    O
a    O
film    O
of    O
mucus    O
.    O

After    O
entering    O
the    O
oviduct    O
,    O
the    O
oocyte    O
is    O
pushed    O
along    O
by    O
cilia    B-Cell102991711
,    O
beginning    O
its    O
journey    O
toward    O
the    O
uterus    O
.    O

Cilia    B-Cell102991711

The    O
sperm    O
tail    O
is    O
a    O
specialized    O
type    O
of    O
cilium    B-Cell102991711
(    O
aka    O
flagella    O
)    O
.    O

The    O
simplest    O
propulsive    O
systems    O
are    O
composed    O
of    O
cilia    B-Cell102991711
and    O
flagella    O
.    O

Ciliates    O
use    O
small    O
flagella    O
called    O
cilia    B-Cell102991711
to    O
move    O
through    O
the    O
water    O
.    O

Each    O
cell    O
has    O
one    O
or    O
more    O
cilia    B-Cell102991711
and    O
their    O
beating    O
inside    O
the    O
protonephridial    O
tube    O
creates    O
an    O
outward    O
going    O
current    O
and    O
hence    O
a    O
partial    O
pressurization    O
in    O
the    O
blind    O
of    O
the    O
tube    O
.    O
Because    O
of    O
this    O
,    O
pressurization    O
drives    O
waste    O
fluids    O
from    O
the    O
inside    O
of    O
the    O
animal    O
,    O
and    O
they    O
are    O
pulled    O
through    O
small    O
perforations    O
in    O
the    O
terminal    O
cells    O
and    O
into    O
the    O
protonephridium    O
.    O

These    O
tubules    O
bear    O
a    O
tuft    O
of    O
cilia    B-Cell102991711
or    O
flagellum    O
.    O

Many    O
cilia    B-Cell102991711

cilium    B-Cell102991711

An    O
oocyte    O
is    O
released    O
from    O
the    O
ovary    O
into    O
the    O
peritoneal    O
cavity    O
and    O
the    O
cilia    B-Cell102991711
of    O
the    O
fimbriae    O
sweep    O
the    O
ovum    O
into    O
the    O
Fallopian    O
tube    O
.    O

Volume    O
22    O
:    O
British    O
and    O
Other    O
Freshwater    O
Ciliated    B-Cell102991711
Protozoa    O
(    O
Part    O
1    O
)    O
Ciliophora    O
:    O
Kinetofragminophora    O
(    O
CR    O
Curds    O
)    O
1982    O

This    O
last    O
study    O
allowed    O
to    O
reveal    O
the    O
intracellular    O
distribution    O
of    O
ATAT1    O
in    O
ciliated    B-Cell102991711
cells    I-Cell102991711
of    O
some    O
tissues    O
.    O

The    O
Lorentz    O
reciprocal    O
theorem    O
can    O
also    O
be    O
used    O
to    O
relate    O
the    O
swimming    O
speed    O
of    O
a    O
microorganism    O
,    O
such    O
as    O
cyanobacterium    O
,    O
to    O
the    O
surface    O
velocity    O
which    O
is    O
prescribed    O
by    O
deformations    O
of    O
the    O
body    O
shape    O
via    O
cilia    B-Cell102991711
or    O
flagella    O
.    O

It    O
lacks    O
the    O
pincers    O
or    O
pedicellariae    O
that    O
most    O
starfish    O
use    O
to    O
clean    O
the    O
skin    O
surface    O
of    O
debris    O
,    O
but    O
its    O
small    O
,    O
moving    O
hairs    O
or    O
cilia    B-Cell102991711
may    O
create    O
enough    O
of    O
a    O
water    O
current    O
to    O
keep    O
the    O
surface    O
of    O
its    O
skin    O
clean    O
.    O

The    O
lateral    O
cilia    B-Cell102991711
create    O
a    O
water    O
current    O
and    O
fine    O
plankton    O
are    O
transported    O
down    O
the    O
tentacles    O
to    O
the    O
brachial    O
groove    O
and    O
into    O
the    O
mouth    O
.    O

Most    O
cells    O
in    O
human    O
body    O
possess    O
one    O
primary    O
cilium    B-Cell102991711
,    O
a    O
relatively    O
small    O
protrusion    O
of    O
the    O
cell    O
membrane    O
that    O
looks    O
like    O
a    O
stick    O
or    O
a    O
finger    O
under    O
the    O
electron    O
microscope    O
.    O

These    O
include    O
muscle    O
contraction    O
,    O
neuronal    O
transmission    O
as    O
in    O
an    O
excitatory    O
synapse    O
,    O
cellular    O
motility    O
(    O
including    O
the    O
movement    O
of    O
flagella    O
and    O
cilia    B-Cell102991711
)    O
,    O
fertilisation    O
,    O
cell    B-Cell102991711
growth    I-Cell102991711
or    O
proliferation    O
,    O
neurogenesis    O
,    O
learning    O
and    O
memory    O
as    O
with    O
synaptic    O
plasticity    O
,    O
and    O
secretion    O
of    O
saliva    O
.    O

Leaves    O
are    O
narrowly    O
lanceolate    O
,    O
tapering    O
at    O
the    O
tip    O
,    O
up    O
to    O
12    O
cm    O
long    O
,    O
sometimes    O
with    O
cilia    B-Cell102991711
(    O
=    O
long    O
soft    O
hairs    O
)    O
along    O
the    O
margins    O
.    O

Other    O
characters    O
found    O
in    O
all    O
neodermatans    O
are    O
related    O
to    O
the    O
anatomy    O
of    O
the    O
protonephridium    O
and    O
the    O
rootlets    O
of    O
epidermal    O
locomotory    O
cilia    B-Cell102991711
.    O

From    O
1829    O
to    O
1836    O
Sharpey    O
was    O
engaged    O
in    O
scientific    O
work    O
,    O
of    O
which    O
the    O
earliest    O
outcome    O
was    O
his    O
paper    O
on    O
ciliary    B-Cell102991711
motion    I-Cell102991711
,    O
published    O
in    O
1830    O
.    O

A    O
metachronal    O
rhythm    O
or    O
metachronal    O
wave    O
refers    O
to    O
wavy    O
movements    O
produced    O
by    O
the    O
sequential    O
action    O
(    O
as    O
opposed    O
to    O
synchronized    O
)    O
of    O
structures    O
such    O
as    O
cilia    B-Cell102991711
,    O
segments    O
of    O
worms    O
or    O
legs    O
.    O

Similarly    O
to    O
the    O
iPhone    O
4    O
and    O
iPhone    O
4s    O
,    O
the    O
frame    O
of    O
the    O
phone    O
serves    O
as    O
its    O
antenna    B-Cell102991711
;    O
the    O
device    O
optimizes    O
antenna    O
usage    O
to    O
ensure    O
that    O
it    O
does    O
not    O
lose    O
cellular    O
reception    O
if    O
it    O
is    O
held    O
in    O
certain    O
ways    O
.    O

Langhans    B-Cell102991711
giant    I-Cell102991711
cell    I-Cell102991711

This    O
formation    O
is    O
often    O
referred    O
to    O
as    O
multinucleated    O
giant    O
cells    O
in    O
which    O
the    O
nuclei    O
form    O
a    O
circle    O
or    O
semicircle    O
related    O
to    O
the    O
shape    O
of    O
a    O
horseshoe    O
away    O
from    O
the    O
center    O
of    O
the    O
cell    O
.    O
Langhans    B-Cell102991711
giant    I-Cell102991711
cell    I-Cell102991711
is    O
said    O
to    O
be    O
related    O
to    O
tuberculosis    O
and    O
it    O
occurs    O
in    O
many    O
types    O
of    O
granulomatous    O
diseases    O
.    O

Pancreatic    O
polypeptide    O
(    O
PP    O
)    O
is    O
a    O
polypeptide    O
secreted    O
by    O
PP    B-Cell102991711
cell    I-Cell102991711
in    O
the    O
endocrine    O
pancreas    O
predominantly    O
in    O
the    O
head    O
of    O
the    O
pancreas    O
.    O

Gamma    B-Cell102991711
delta    I-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
(    O
γδ    O
T    O
cells    O
)    O
possess    O
an    O
alternative    O
T    O
-    O
cell    O
receptor    O
(    O
TCR    O
)    O
as    O
opposed    O
to    O
CD4    O
+    O
and    O
CD8    O
+    O
(    O
αβ    O
)    O
T    O
cells    O
and    O
share    O
the    O
characteristics    O
of    O
helper    O
T    O
cells    O
,    O
cytotoxic    O
T    O
cells    O
and    O
NK    O
cells    O
.    O

γδ    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
:    O
bridge    O
between    O
innate    O
and    O
adaptive    O
immune    O
responses    O
;    O
phagocytosis    O

γδ    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
possess    O
an    O
alternative    O
T    O
cell    O
receptor    O
(    O
different    O
from    O
the    O
αβ    O
TCR    O
found    O
on    O
conventional    O
CD4    O
+    O
and    O
CD8    O
+    O
T    O
cells    O
)    O
.    O

Gamma    B-Cell102991711
delta    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
(    O
γδ    O
T    O
cells    O
)    O
are    O
T    B-Cell102991711
cell    I-Cell102991711
that    O
have    O
a    O
distinctive    O
T    O
-    O
cell    O
receptor    O
(    O
TCR    O
)    O
on    O
their    O
surface    O
.    O

The    O
nodes    O
are    O
encapsulated    O
by    O
microvilli    B-Cell102991711
stemming    O
from    O
the    O
outer    O
aspect    O
of    O
the    O
Schwann    O
cell    O
membrane    O
in    O
the    O
PNS    O
,    O
or    O
by    O
perinodal    O
extensions    O
from    O
astrocytes    O
in    O
the    O
CNS    O
.    O

Ezrin    O
,    O
a    O
component    O
of    O
the    O
undercoat    O
of    O
the    O
microvilli    B-Cell102991711
plasma    O
membrane    O
.    O

Microvilli    B-Cell102991711
are    O
present    O
in    O
the    O
canaliculi    O
but    O
are    O
sparse    O
.    O

Some    O
sensory    O
neurons    O
have    O
small    O
projections    O
called    O
microvilli    B-Cell102991711
that    O
extend    O
outward    O
from    O
their    O
cell    O
surfaces    O
.    O

Some    O
of    O
them    O
have    O
an    O
apical    O
tuft    O
of    O
rigid    O
microvilli    B-Cell102991711
(    O
brush    O
cells    O
)    O
.    O

Microvilli    B-Cell102991711
of    O
hepatocytes    O
extend    O
into    O
this    O
space    O
,    O
allowing    O
proteins    O
and    O
other    O
plasma    O
components    O
from    O
the    O
sinusoids    O
to    O
be    O
absorbed    O
by    O
the    O
hepatocytes    O
.    O

Microvilli    B-Cell102991711
(    O
singular    O
:    O
microvillus    B-Cell102991711
)    O
are    O
microscopic    O
cellular    O
membrane    O
protrusions    O
that    O
increase    O
the    O
surface    O
area    O
for    O
diffusion    O
and    O
minimize    O
any    O
increase    O
in    O
volume    O
,    O
and    O
are    O
involved    O
in    O
a    O
wide    O
variety    O
of    O
functions    O
,    O
including    O
absorption    O
,    O
secretion    O
,    O
cellular    B-Cell102991711
adhesion    I-Cell102991711
,    O
and    O
mechanotransduction    O
.    O

The    O
luminal    O
surface    O
of    O
the    O
epithelial    O
cells    O
of    O
this    O
segment    O
of    O
the    O
nephron    O
is    O
covered    O
with    O
densely    O
packed    O
microvilli    B-Cell102991711
forming    O
a    O
border    O
readily    O
visible    O
under    O
the    O
light    O
microscope    O
giving    O
the    O

The    O
gallbladder    O
wall    O
's    O
innermost    O
surface    O
is    O
lined    O
by    O
a    O
single    O
layer    O
of    O
columnar    O
cells    O
with    O
a    O
brush    O
border    O
of    O
microvilli    B-Cell102991711
,    O
very    O
similar    O
to    O
intestinal    O
absorptive    O
cells    O
.    O

The    O
mucosa    O
,    O
the    O
outer    O
portion    O
of    O
the    O
gallbladder    O
wall    O
,    O
consists    O
of    O
a    O
lining    O
of    O
a    O
single    O
layer    O
of    O
columnar    O
cells    O
,    O
with    O
cells    O
possessing    O
small    O
hair    O
-    O
like    O
attachments    O
called    O
microvilli    B-Cell102991711
.    O

Microscopic    O
projections    O
from    O
the    O
mid    O
-    O
gut    O
wall    O
,    O
called    O
microvilli    B-Cell102991711
,    O
increase    O
surface    O
area    O
and    O
allow    O
for    O
maximum    O
absorption    O
of    O
nutrients    O
.    O

Pulmonary    O
surfactant    O
is    O
a    O
complex    O
system    O
of    O
lipids    O
,    O
proteins    O
and    O
glycoproteins    O
that    O
are    O
produced    O
in    O
specialized    O
lung    O
cells    O
called    O
Type    O
II    O
cells    O
or    O
Type    B-Cell102991711
II    I-Cell102991711
pneumocyte    I-Cell102991711
.    O

Pneumocytic    O
hyperplasia    O
is    O
an    O
hyperplasia    O
of    O
pneumocyte    B-Cell102991711
lining    O
pulmonary    O
alveoli    O
.    O

Multifocal    O
micronodular    O
pneumocyte    O
hyperplasia    O
(    O
MMPH    O
)    O
is    O
a    O
subtype    O
of    O
pneumocytic    O
hyperplasia    O
(    O
hyperplasia    O
of    O
pneumocyte    B-Cell102991711
lining    O
pulmonary    O
alveoli    O
)    O
.    O

It    O
is    O
formed    O
by    O
the    O
type    O
1    O
pneumocytes    B-Cell102991711
of    O
the    O
alveolar    O
wall    O
,    O
the    O
endothelial    O
cells    O
of    O
the    O
capillaries    O
and    O
the    O
basement    O
membrane    O
between    O
the    O
two    O
cells    O
.    O

This    O
is    O
significant    O
because    O
cortisol    O
induces    O
type    B-Cell102991711
II    I-Cell102991711
pneumocytes    I-Cell102991711
of    O
the    O
lungs    O
to    O
synthesize    O
and    O
secrete    O
pulmonary    O
surfactant    O
;    O
without    O
pulmonary    O
surfactant    O
to    O
reduce    O
the    O
alveolar    O
surface    O
tension    O
,    O
premature    O
neonates    O
may    O
die    O
of    O
neonatal    O
respiratory    O
distress    O
syndrome    O
.    O

Identified    O
by    O
methenamine    O
silver    O
stain    O
of    O
lung    O
tissue    O
,    O
type    B-Cell102991711
I    I-Cell102991711
pneumocyte    I-Cell102991711
,    O
and    O
type    B-Cell102991711
II    I-Cell102991711
pneumocyte    I-Cell102991711
over    O
-    O
replicate    O
and    O
damage    O
alveolar    O
epithelium    O
,    O
causing    O
death    O
by    O
asphyxiation    O
.    O

M    O
cells    O
in    O
the    O
LGN    O
receive    O
input    O
from    O
parasol    B-Cell102991711
ganglion    I-Cell102991711
cells    I-Cell102991711
(    O
which    O
some    O
neuroscientists    O
call    O
M    O
cells    O
)    O
,    O
and    O
P    O
cells    O
receive    O
input    O
from    O
midget    B-Cell102991711
retinal    I-Cell102991711
ganglion    I-Cell102991711
cells    I-Cell102991711
(    O
which    O
some    O
neuroscientists    O
call    O
P    O
cells    O
)    O
.    O

Ossicles    O
are    O
created    O
intracellularly    O
by    O
specialised    O
secretory    O
cells    O
known    O
as    O
sclerocyte    B-Cell102991711
in    O
the    O
dermis    O
of    O
the    O
body    O
wall    O
of    O
echinoderms    O
.    O

EPEC    O
/    O
EHEC    O
inhibit    O
both    O
transcytosis    O
through    O
M    B-Cell102991711
cells    I-Cell102991711
and    O
internalization    O
by    O
phagocytes    O
.    O

Microfold    B-Cell102991711
cell    I-Cell102991711

In    O
the    O
1990s    O
MMRL    O
researchers    O
discovered    O
the    O
M    B-Cell102991711
cell    I-Cell102991711
,    O
confirming    O
that    O
the    O
heart    O
is    O
made    O
of    O
several    O
different    O
cell    O
types    O
.    O

These    O
genes    O
include    O
cancer    O
marker    O
genes    O
and    O
genes    O
involved    O
in    O
cell    B-Cell102991711
adhesion    I-Cell102991711
,    O
migration    O
,    O
and    O
metastasis    O
.    O

In    O
1967    O
,    O
S.    O
B.    O
Carter    O
reported    O
the    O
use    O
of    O
shadow    O
-    O
evaporated    O
palladium    O
islands    O
for    O
cell    B-Cell102991711
attachment    I-Cell102991711
.    O

Poiseuille    O
flow    O
in    O
microfluidics    O
allows    O
shear    O
stresses    O
to    O
be    O
varied    O
systematically    O
using    O
channel    O
geometry    O
and    O
flow    O
rate    O
via    O
micropumps    O
,    O
as    O
demonstrated    O
by    O
using    O
arrays    O
of    O
perfusion    O
chambers    O
for    O
mesenchymal    O
stem    O
cells    O
and    O
fibroblast    O
cell    B-Cell102991711
adhesion    I-Cell102991711
studies    O
.    O

It    O
has    O
been    O
found    O
by    O
using    O
micro    O
-    O
contact    O
printing    O
to    O
control    O
cell    B-Cell102991711
attachment    I-Cell102991711
area    O
that    O
that    O
switch    O
in    O
osteogenic    O
/    O
adipogenic    O
lineage    O
in    O
human    O
mesenchymal    O
stem    O
cells    O
can    O
be    O
cell    O
shape    O
dependent    O
.    O

Surface    O
modification    O
can    O
also    O
affect    O
properties    O
that    O
promote    O
cell    B-Cell102991711
adhesion    I-Cell102991711
.    O

Studies    O
have    O
also    O
shown    O
that    O
"    O
TLN2    O
"    O
is    O
a    O
direct    O
target    O
of    O
miR-132    O
,    O
which    O
is    O
epigenetically    O
silenced    O
in    O
prostate    O
cancer    O
,    O
suggesting    O
that    O
talin-2    O
may    O
play    O
a    O
role    O
in    O
modulating    O
cell    B-Cell102991711
adhesion    I-Cell102991711
in    O
prostate    O
cancer    O
.    O

During    O
EMT    O
,    O
cells    O
lose    O
adhesion    B-Cell102991711
and    O
increase    O
in    O
motility    O
.    O

For    O
example    O
,    O
Znf    O
-    O
containing    O
proteins    O
function    O
in    O
gene    O
transcription    O
,    O
translation    O
,    O
mRNA    O
trafficking    O
,    O
cytoskeleton    O
organization    O
,    O
epithelial    O
development    O
,    O
cell    B-Cell102991711
adhesion    I-Cell102991711
,    O
protein    O
folding    O
,    O
chromatin    O
remodeling    O
,    O
and    O
zinc    O
sensing    O
,    O
to    O
name    O
but    O
a    O
few    O
.    O

In    O
cell    B-Cell102991711
adhesion    I-Cell102991711
laminin-111    O
and    O
other    O
isoforms    O
are    O
important    O
proteins    O
that    O
anchor    O
cells    O
to    O
the    O
extracellular    O
matrix    O
(    O
ECM    O
)    O
.    O

These    O
GWAS    O
studies    O
yield    O
a    O
number    O
of    O
implicated    O
genes    O
,    O
although    O
many    O
of    O
them    O
code    O
for    O
seemingly    O
unrelated    O
proteins    O
in    O
processes    O
such    O
as    O
cell    B-Cell102991711
adhesion    I-Cell102991711
,    O
transcriptional    O
regulation    O
,    O
cell    O
structure    O
determination    O
,    O
and    O
RNA    O
,    O
DNA    O
,    O
and    O
protein    O
handling    O
/    O
modifying    O
.    O

All    O
living    O
surfaces    O
are    O
decorated    O
with    O
a    O
diverse    O
range    O
of    O
complex    O
molecules    O
,    O
which    O
are    O
key    O
modulators    O
of    O
chemical    O
communications    O
and    O
other    O
functions    O
such    O
as    O
protection    O
,    O
adhesion    B-Cell102991711
,    O
infectivity    O
,    O
apoptosis    O
,    O
etc    O
.    O

The    O
attachment    O
of    O
the    O
cell    O
takes    O
place    O
through    O
formation    O
of    O
cell    B-Cell102991711
adhesion    I-Cell102991711
complexes    O
,    O
which    O
consist    O
of    O
integrins    O
and    O
many    O
cytoplasmic    O
proteins    O
,    O
such    O
as    O
talin    O
,    O
vinculin    O
,    O
paxillin    O
,    O
and    O
alpha    O
-    O
actinin    O
.    O

Microvilli    B-Cell102991711
(    O
singular    O
:    O
microvillus    B-Cell102991711
)    O
are    O
microscopic    O
cellular    O
membrane    O
protrusions    O
that    O
increase    O
the    O
surface    O
area    O
for    O
diffusion    O
and    O
minimize    O
any    O
increase    O
in    O
volume    O
,    O
and    O
are    O
involved    O
in    O
a    O
wide    O
variety    O
of    O
functions    O
,    O
including    O
absorption    O
,    O
secretion    O
,    O
cellular    B-Cell102991711
adhesion    I-Cell102991711
,    O
and    O
mechanotransduction    O
.    O

Suppress    O
cell    B-Cell102991711
adhesion    I-Cell102991711
,    O
antigen    O
presentation    O
,    O
chemotaxis    O
&    O
cytotoxicity    O
.    O

Cell    B-Cell102991711
adhesion    I-Cell102991711

Cell    B-Cell102991711
adhesion    I-Cell102991711

EP2    O
also    O
activates    O
the    O
a    O
)    O
GSK-3    O
pathway    O
which    O
regulates    O
cell    O
migratory    O
responses    O
and    O
innate    O
immune    O
responses    O
including    O
pro    O
-    O
inflammatory    O
cytokine    O
and    O
interleukin    O
production    O
and    O
b    O
)    O
Beta    O
-    O
catenin    O
pathway    O
which    O
regulates    O
not    O
only    O
cell–cell    B-Cell102991711
adhesion    I-Cell102991711
but    O
also    O
activates    O
the    O
Wnt    O
signaling    O
pathway    O
which    O
,    O
in    O
turn    O
,    O
stimulates    O
the    O
transcription    O
of    O
genes    O
responsible    O
for    O
regulating    O
cell    O
migration    O
and    O
proliferation    O
.    O

It    O
is    O
postulated    O
that    O
these    O
proteins    O
are    O
receptors    O
involved    O
in    O
contact    O
-    O
mediated    O
communication    O
,    O
with    O
cadherin    O
domains    O
acting    O
as    O
homophilic    O
binding    O
regions    O
and    O
the    O
EGF    O
-    O
like    O
domains    O
involved    O
in    O
cell    B-Cell102991711
adhesion    I-Cell102991711
and    O
receptor    O
-    O
ligand    O
interactions    O
.    O

Caveolins    O
are    O
found    O
in    O
the    O
majority    O
of    O
adherent    B-Cell102991711
,    O
mammalian    O
cells    O
.    O

The    O
dynamic    O
mechanical    O
behavior    O
of    O
cell    O
-    O
ECM    O
and    O
cell    O
-    O
cell    O
interactions    O
is    O
known    O
to    O
influence    O
a    O
vast    O
range    O
of    O
cellular    O
functions    O
,    O
including    O
necrosis    O
,    O
differentiation    O
,    O
adhesion    B-Cell102991711
,    O
migration    O
,    O
locomotion    O
,    O
and    O
growth    B-Cell102991711
.    O

both    O
suppresses    O
phospholipase    O
A2    O
,    O
thereby    O
blocking    O
eicosanoid    O
production    O
,    O
and    O
inhibits    O
various    O
leukocyte    O
inflammatory    O
events    O
(    O
epithelial    O
adhesion    B-Cell102991711
,    O
emigration    O
,    O
chemotaxis    O
,    O
phagocytosis    O
,    O
respiratory    O
burst    O
,    O
etc    O
.    O
)    O
.    O

Cell    B-Cell102991711
adhesion    I-Cell102991711
is    O
the    O
process    O
by    O
which    O
cells    O
interact    O
and    O
attach    O
to    O
a    O
surface    O
,    O
substrate    O
or    O
another    O
cell    O
,    O
mediated    O
by    O
interactions    O
between    O
molecules    O
of    O
the    O
cell    O
surface    O
.    O

Therefore    O
,    O
the    O
three    O
-    O
dimensional    O
structure    O
,    O
including    O
the    O
establishment    O
of    O
complex    O
cell    B-Cell102991711
adhesion    I-Cell102991711
and    O
paracrine    O
signaling    O
within    O
the    O
EB    O
microenvironment    O
,    O
enables    O
differentiation    O
and    O
morphogenesis    O
which    O
yields    O
microtissues    O
that    O
are    O
similar    O
to    O
native    O
tissue    O
structures    O
.    O

They    O
play    O
important    O
roles    O
in    O
cell    B-Cell102991711
adhesion    I-Cell102991711
,    O
forming    O
adherens    O
junctions    O
to    O
bind    O
cells    O
within    O
tissues    O
together    O
.    O

The    O
homodimeric    O
cadherins    O
create    O
cell-cell    B-Cell102991711
adhesion    I-Cell102991711
with    O
cadherins    O
present    O
in    O
the    O
membranes    O
of    O
other    O
cells    O
through    O
changing    O
conformation    O
from    O
"    O
cis    O
"-    O
dimers    O
to    O
"    O
trans    O
"-    O
dimers    O
.    O

It    O
also    O
functions    O
as    O
an    O
adhesion    O
protein    O
,    O
involved    O
in    O
cell    B-Cell102991711
attachment    I-Cell102991711
and    O
wound    O
healing    O
.    O

The    O
primary    O
roles    O
of    O
hyaladherins    O
are    O
cell    B-Cell102991711
adhesion    I-Cell102991711
,    O
structural    O
support    O
of    O
the    O
extracellular    O
matrix    O
(    O
ECM    O
)    O
and    O
cell    O
signalling    O
.    O

Currently    O
,    O
four    O
desmoglein    O
subfamily    O
members    O
have    O
been    O
identified    O
and    O
all    O
are    O
members    O
of    O
the    O
cadherin    O
cell    B-Cell102991711
adhesion    I-Cell102991711
molecule    O
superfamily    O
.    O

Cell    B-Cell102991711
adhesion    I-Cell102991711
–    O
Holding    O
together    O
cells    O
and    O
tissues    O
.    O

Functional    O
roles    O
of    O
lipids    O
are    O
in    O
fact    O
many    O
:    O
They    O
serve    O
as    O
regulatory    O
agents    O
in    O
cell    B-Cell102991711
growth    I-Cell102991711
and    O
adhesion    B-Cell102991711
.    O

Disc    B-Cell102991711
shedding    I-Cell102991711
is    O
the    O
process    O
by    O
which    O
photoreceptors    O
in    O
the    O
eye    O
are    O
renewed    O
.    O

A    O
peg    B-Cell102991711
cell    I-Cell102991711
is    O
a    O
non    O
-    O
ciliated    B-Cell102991711
epithelial    O
cell    O
within    O
the    O
uterine    O
tube    O
(    O
oviduct    O
or    O
Fallopian    O
tube    O
)    O
.    O

Tumor    O
cells    O
can    O
be    O
fibroblastic    O
,    O
myxoid    O
,    O
or    O
pericytic    B-Cell102991711
.    O

In    O
adults    O
,    O
EPO    O
is    O
synthesized    O
mainly    O
by    O
interstitial    O
cells    O
in    O
the    O
peritubular    O
capillary    O
bed    O
of    O
the    O
renal    O
cortex    O
,    O
with    O
additional    O
amounts    O
being    O
produced    O
in    O
the    O
liver    O
,    O
and    O
the    O
pericytes    B-Cell102991711
in    O
the    O
brain    O
.    O

Angiomyolipomas    O
are    O
tumours    O
consisting    O
of    O
perivascular    B-Cell102991711
epithelioid    B-Cell102991711
cells    O
(    O
cells    O
which    O
are    O
found    O
surrounding    O
blood    O
vessels    O
and    O
which    O
resemble    O
epithelial    O
cells    O
)    O
.    O

However    O
,    O
other    O
cells    O
in    O
the    O
body    O
such    O
as    O
pericytes    B-Cell102991711
and    O
hematopoietic    O
stem    O
cells    O
have    O
all    O
been    O
shown    O
to    O
be    O
able    O
to    O
contribute    O
to    O
muscle    O
repair    O
in    O
a    O
similar    O
manner    O
to    O
the    O
endogenous    O
satellite    O
cell    O
.    O

Hepatic    B-Cell102991711
stellate    I-Cell102991711
cells    I-Cell102991711
(    O
here    O
HSC    B-Cell102991711
)    O
,    O
also    O
known    O
as    O
perisinusoidal    B-Cell102991711
cells    I-Cell102991711
or    O
Ito    B-Cell102991711
cells    I-Cell102991711
(    O
earlier    O
"    O
lipocytes    O
"    O
or    O
"    O
fat    O
-    O
storing    O
cells    O
"    O
)    O
,    O
are    O
pericyte    B-Cell102991711
found    O
in    O
the    O
perisinusoidal    O
space    O
of    O
the    O
liver    O
,    O
also    O
known    O
as    O
the    O
space    O
of    O
Disse    O
(    O
a    O
small    O
area    O
between    O
the    O
sinusoids    O
and    O
hepatocyte    B-Cell102991711
)    O
.    O

Two    O
populations    O
of    O
pericytes    B-Cell102991711
arise    O
from    O
the    O
mesoderm    O
and    O
the    O
neuroectoderm    O
and    O
form    O
at    O
the    O
approximate    O
location    O
of    O
the    O
portal    O
system    O
in    O
what    O
will    O
eventually    O
become    O
the    O
mature    O
brain    O
.    O

The    O
stria    O
vascularis    O
also    O
contains    O
pericyte    B-Cell102991711
,    O
melanocyte    O
,    O
and    O
endothelial    O
cells    O
.    O

In    O
regards    O
to    O
his    O
discovery    O
of    O
"    O
Kupffer    O
cells    O
"    O
in    O
1876    O
,    O
he    O
initially    O
suggested    O
that    O
this    O
type    O
of    O
cell    O
belonged    O
to    O
a    O
group    O
of    O
perivascular    B-Cell102991711
cell    I-Cell102991711
(    O
pericytes    B-Cell102991711
)    O
of    O
the    O
connective    O
tissues    O
or    O
to    O
the    O
adventitial    O
cells    O
.    O

Chloragogen    B-Cell102991711
cells    I-Cell102991711
,    O
also    O
called    O
as    O
"    O
y    O
cells    O
"    O
,    O
are    O
cells    O
in    O
annelids    O
that    O
function    O
similarly    O
to    O
the    O
liver    O
in    O
vertebrates    O
.    O

Sentinel    B-Cell102991711
cell    I-Cell102991711
in    O
"    O
Dictyostelium    O
discoideum    O
"    O
are    O
phagocytic    O
cells    O
responsible    O
for    O
removing    O
toxic    O
material    O
from    O
the    O
slug    O
stage    O
of    O
the    O
social    O
cycle    O
.    O

T-cell    B-Cell102991711
receptor    I-Cell102991711
excision    I-Cell102991711
circles    I-Cell102991711
(    O
TRECs    O
)    O
are    O
small    O
circles    O
of    O
DNA    O
created    O
in    O
T-cell    B-Cell102991711
during    O
their    O
passage    O
through    O
the    O
thymus    O
as    O
they    O
rearrange    O
their    O
TCR    O
genes    O
.    O

The    O
synthesis    O
of    O
pyocyanin    O
is    O
primarily    O
controlled    O
by    O
the    O
quorum    B-Cell102991711
sensing    I-Cell102991711
process    O
.    O

Ajoene    O
inhibits    O
genes    O
controlled    O
by    O
quorum    B-Cell102991711
sensing    I-Cell102991711
.    O

In    O
July    O
2013    O
α-pyrones    O
were    O
identified    O
as    O
a    O
new    O
class    O
of    O
signalling    O
molecule    O
in    O
bacterial    O
communication    O
,    O
similar    O
to    O
quorum    B-Cell102991711
sensing    I-Cell102991711
.    O

Chemical    O
signaling    O
in    O
bacteria    O
via    O
histidine    O
kinase    O
-    O
mediated    O
two    O
component    O
signal    O
transduction    O
systems    O
,    O
systems    O
that    O
function    O
both    O
intraspecifically    O
(    O
e.g.    O
,    O
in    O
chemotaxis    O
and    O
quorum    B-Cell102991711
sensing    I-Cell102991711
)    O
and    O
interspecifically    O
(    O
e.g.    O
,    O
in    O
pathogenesis    O
and    O
virulence    O
responses    O
)    O
;    O

Furthermore    O
,    O
LuxS    O
is    O
involved    O
in    O
the    O
synthesis    O
of    O
autoinducer    O
AI-2    O
(    O
autoinducer-2    O
)    O
,    O
which    O
plays    O
a    O
role    O
in    O
quorum    B-Cell102991711
sensing    I-Cell102991711
in    O
a    O
certain    O
number    O
of    O
bacterial    O
species    O
.    O

Quorum    B-Cell102991711
sensing    I-Cell102991711
behavior    O
in    O
bacteria    O
is    O
a    O
commonly    O
cited    O
example    O
of    O
a    O
modulon    O
or    O
stimulon    O
,    O
though    O
some    O
sources    O
describe    O
this    O
type    O
of    O
intercellular    O
auto    O
-    O
induction    O
as    O
a    O
separate    O
form    O
of    O
regulation    O
.    O

AI-2    O
is    O
a    O
signaling    O
molecules    O
found    O
in    O
quorum    B-Cell102991711
sensing    I-Cell102991711
.    O

Allison    O
Adonizio    O
and    O
colleagues    O
screened    O
"    O
F.    O
aurea    O
"    O
for    O
anti    O
-    O
quorum    B-Cell102991711
sensing    I-Cell102991711
activity    O
(    O
as    O
a    O
possible    O
means    O
of    O
anti    O
-    O
bacterial    O
action    O
)    O
,    O
but    O
found    O
no    O
such    O
activity    O
.    O

Quorum    B-Cell102991711
sensing    I-Cell102991711
,    O
a    O
system    O
of    O
stimulus    O
and    O
response    O
correlated    O
to    O
population    O
density    O

In    O
2015    O
,    O
he    O
was    O
a    O
co    O
-    O
recipient    O
of    O
the    O
Shaw    O
Prize    O
in    O
Life    O
Science    O
and    O
Medicine    O
for    O
his    O
distinguished    O
work    O
in    O
quorum    B-Cell102991711
sensing    I-Cell102991711
.    O

While    O
he    O
was    O
a    O
professor    O
at    O
Iowa    O
,    O
in    O
1994    O
,    O
he    O
and    O
his    O
colleagues    O
coined    O
the    O
term    O
quorum    B-Cell102991711
sensing    I-Cell102991711
,    O
a    O
process    O
of    O
cell    O
-    O
to    O
-    O
cell    O
bacterial    O
communication    O
.    O

Quorum    B-Cell102991711
sensing    I-Cell102991711
is    O
a    O
system    O
of    O
stimuli    O
and    O
response    O
correlated    O
to    O
population    O
density    O
.    O

As    O
the    O
density    O
of    O
quorum    B-Cell102991711
sensing    I-Cell102991711
bacterial    O
cells    O
increases    O
so    O
does    O
the    O
concentration    O
of    O
the    O
autoinducer    O
.    O

|rowspan=2|    O
Mononuclear    B-Cell102991711
leukocytes    I-Cell102991711
(    O
Lymphocytes    O
+    O
monocytes    O
)    O

Two    O
pairs    O
of    O
broadest    O
categories    O
classify    O
them    O
either    O
by    O
structure    O
(    O
granulocytes    O
or    O
agranulocyte    B-Cell102991711
)    O
or    O
by    O
cell    O
division    O
lineage    O
(    O
myeloid    O
cells    O
or    O
lymphoid    O
cells    O
)    O
.    O

Two    O
pairs    O
of    O
broadest    O
categories    O
classify    O
them    O
either    O
by    O
structure    O
(    O
granulocytes    O
or    O
agranulocyte    B-Cell102991711
)    O
or    O
by    O
cell    O
lineage    O
(    O
myeloid    O
cells    O
or    O
lymphoid    O
cells    O
)    O
.    O

Scotch    O
bonnets    O
are    O
predators    O
;    O
they    O
search    O
for    O
their    O
food    O
on    O
sandy    O
stretches    O
of    O
the    O
ocean    O
floor    O
,    O
where    O
they    O
consume    O
echinoderms    O
such    O
as    O
sand    O
dollars    O
,    O
sea    O
biscuits    O
,    O
and    O
other    O
sea    O
urchins    O
(    O
such    O
as    O
"    O
Echinocardium    O
cordatum    O
"    O
)    O
,    O
drilling    O
into    O
their    O
tests    B-Cell102991711
with    O
the    O
aid    O
of    O
sulfuric    O
acid    O
.    O

After    O
this    O
point    O
,    O
organisms    O
such    O
as    O
sponges    O
extracted    O
silica    O
from    O
the    O
oceans    O
in    O
order    O
to    O
construct    O
test    B-Cell102991711
(    O
skeletons    O
)    O
,    O
with    O
the    O
result    O
that    O
the    O
surface    O
oceans    O
no    O
longer    O
became    O
supersaturated    O
with    O
respect    O
to    O
silica    O
when    O
evaporation    O
condensed    O
the    O
mineral    O
.    O

Appendicularians    O
have    O
greatly    O
improved    O
the    O
efficiency    O
of    O
food    O
intake    O
by    O
producing    O
a    O
test    B-Cell102991711
(    O
a    O
kind    O
of    O
skeleton    O
)    O
known    O
as    O
a    O
"    O
house    O
"    O
of    O
protein    O
and    O
cellulose    O
that    O
,    O
in    O
most    O
cases    O
,    O
surrounds    O
the    O
animal    O
like    O
a    O
bubble    O
,    O
and    O
which    O
contains    O
a    O
complicated    O
arrangement    O
of    O
filters    O
that    O
allow    O
food    O
in    O
the    O
surrounding    O
water    O
to    O
be    O
brought    O
in    O
and    O
concentrated    O
prior    O
to    O
feeding    O
.    O

The    O
smallest    O
sea    O
urchin    O
,    O
"    O
Echinocyamus    O
scaber    O
"    O
,    O
has    O
a    O
test    B-Cell102991711
only    O
6    O
mm    O
across    O
.    O

Arcellinida    O
species    O
produce    O
shells    O
or    O
tests    B-Cell102991711
from    O
mineral    O
particles    O
or    O
biogeonic    O
elements    O
(    O
e.g.    O
diatom    O
frustules    O
)    O
and    O
are    O
thus    O
commonly    O
referred    O
to    O
as    O
testate    O
amoebae    O
or    O
shelled    O
amoebae    O
.    O

Test    B-Cell102991711
(    O
hard    O
shell    O
)    O
of    O
the    O
sea    O
potato    O
.    O

They    O
produce    O
hyaline    O
calcareous    O
tests    B-Cell102991711
,    O
and    O
are    O
known    O
as    O
fossils    O
from    O
the    O
Jurassic    O
period    O
onwards    O
.    O

"    O
Echinus    O
tylodes    O
"    O
has    O
a    O
subglobular    O
test    B-Cell102991711
about    O
two    O
-    O
thirds    O
as    O
high    O
as    O
it    O
is    O
wide    O
and    O
grows    O
to    O
a    O
diameter    O
of    O
.    O

Pedicellariae    O
are    O
compound    O
ossicles    O
that    O
articulate    O
with    O
other    O
ossicles    O
and    O
protrude    O
from    O
the    O
aboral    O
(    O
upper    O
)    O
surface    O
of    O
some    O
sea    O
stars    O
(    O
and    O
also    O
the    O
test    B-Cell102991711
of    O
sea    O
urchins    O
)    O
.    O

Sea    O
urchins    O
are    O
covered    O
with    O
plates    O
which    O
are    O
usually    O
fused    O
together    O
to    O
give    O
a    O
rigid    O
test    B-Cell102991711
,    O
but    O
in    O
the    O
order    O
Echinothurioida    O
,    O
the    O
test    O
is    O
leathery    O
because    O
the    O
plates    O
are    O
separate    O
.    O

It    O
produces    O
an    O
organic    O
test    B-Cell102991711
,    O
which    O
is    O
ovoid    O
or    O
lobed    O
and    O
may    O
exceed    O
one    O
millimetre    O
in    O
size    O
;    O
this    O
resembles    O
a    O
small    O
grape    O
,    O
in    O
that    O
its    O
centre    O
is    O
fluid    O
-    O
filled    O
but    O
lacks    O
organic    O
matter    O
,    O
which    O
is    O
concentrated    O
in    O
its    O
translucent    O
test    O
and    O
underlying    O
sediment    O
,    O
making    O
the    O
organism    O
almost    O
neutrally    O
buoyant    O
.    O

This    O
species    O
grows    O
to    O
25    O
cm    O
in    O
diameter    O
,    O
with    O
articulated    O
plates    O
making    O
the    O
test    B-Cell102991711
quite    O
flexible    O
and    O
accounting    O
for    O
its    O
binomen    O
.    O

Targets    O
of    O
this    O
cytokine    O
are    O
mostly    O
non    O
-    O
hematopoietic    O
cells    O
such    O
as    O
hepatocytes    B-Cell102991711
,    O
keratinocytes    B-Cell102991711
,    O
and    O
lung    O
and    O
intestinal    O
epithelial    O
cells    O
.    O
Pancreatic    O
islets    O
also    O
express    O
high    O
levels    O
of    O
IL-22    O
receptor    O
.    O

Furthermore    O
,    O
PC    O
made    O
via    O
PEMT    O
plays    O
a    O
wide    O
range    O
of    O
physiological    O
roles    O
,    O
utilized    O
in    O
choline    O
synthesis    O
,    O
hepatocyte    B-Cell102991711
membrane    O
structure    O
,    O
bile    O
secretion    O
,    O
and    O
very    O
-    O
low    O
-    O
density    O
lipoprotein    O
(    O
VLDL    O
)    O
secretion    O
.    O

Upon    O
ingestion    O
,    O
it    O
binds    O
to    O
the    O
RNA    O
polymerase    O
II    O
enzyme    O
,    O
effectively    O
causing    O
cytolysis    O
of    O
hepatocyte    B-Cell102991711
(    O
liver    O
cells    O
)    O
.    O

Upon    O
ingestion    O
,    O
it    O
binds    O
to    O
the    O
RNA    O
polymerase    O
II    O
enzyme    O
,    O
effectively    O
causing    O
cytolysis    O
of    O
hepatocyte    B-Cell102991711
(    O
liver    O
cells    O
)    O
.    O

Upon    O
ingestion    O
,    O
it    O
binds    O
to    O
the    O
RNA    O
polymerase    O
II    O
enzyme    O
which    O
completely    O
prevents    O
mRNA    O
synthesis    O
,    O
effectively    O
causing    O
cytolysis    O
of    O
hepatocyte    B-Cell102991711
(    O
liver    O
cells    O
)    O
and    O
kidney    O
cells    O
.    O

These    O
proteins    O
are    O
found    O
in    O
hepatocyte    B-Cell102991711
,    O
adipocyte    B-Cell102991711
,    O
hematopoietic    O
cells    O
,    O
spleen    O
,    O
kidney    O
,    O
brain    O
,    O
and    O
many    O
other    O
organs    O
.    O

Specifically    O
,    O
hepatocyte    B-Cell102991711
have    O
been    O
patterned    O
to    O
co    O
-    O
culture    O
at    O
specific    O
cell    O
densities    O
with    O
fibroblasts    O
to    O
maintain    O
liver    O
-    O
specific    O
functions    O
such    O
as    O
albumin    O
secretion    O
,    O
urea    O
synthesis    O
,    O
and    O
p450    O
detoxification    O
.    O

Additionally    O
,    O
the    O
liver    O
has    O
tremendous    O
capacity    O
to    O
regenerate    O
and    O
even    O
when    O
75%    O
of    O
hepatocytes    B-Cell102991711
are    O
dead    O
,    O
it    O
continues    O
to    O
function    O
as    O
normal    O
.    O

Fatty    O
change    O
,    O
or    O
steatosis    O
is    O
the    O
accumulation    O
of    O
fatty    O
acids    O
in    O
liver    B-Cell102991711
cells    I-Cell102991711
.    O

Bioartificial    O
liver    O
device    O
:    O
several    O
research    O
efforts    O
have    O
produced    O
hepatic    O
assist    O
devices    O
utilizing    O
living    O
hepatocyte    B-Cell102991711
.    O

The    O
toxin    O
naturally    O
accumulates    O
in    O
liver    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
the    O
ensuing    O
disruption    O
of    O
metabolism    O
accounts    O
for    O
the    O
severe    O
liver    O
dysfunction    O
cause    O
by    O
amatoxins    O
.    O

In    O
cultured    O
cells    O
,    O
InlA    O
is    O
necessary    O
to    O
facilitate    O
Listeria    O
entry    O
into    O
human    O
epithelial    O
cells    O
,    O
while    O
InlB    O
is    O
necessary    O
for    O
Listeria    O
internalisation    O
in    O
several    O
other    O
cell    O
types    O
,    O
including    O
hepatocyte    B-Cell102991711
,    O
fibroblasts    O
,    O
and    O
epithelioid    O
cells    O
.    O

Marth    O
and    O
colleagues    O
discovered    O
the    O
first    O
physiological    O
purpose    O
of    O
the    O
Ashwell    O
-    O
Morell    O
Receptor    O
(    O
AMR    O
)    O
,    O
a    O
hepatocyte    B-Cell102991711
lectin    O
discovered    O
by    O
Gilbert    O
Ashwell    O
and    O
Anatol    O
Morell    O
.    O

"    O
Struktur    O
der    O
Leberzelle    O
"    O
,    O
1899    O
-    O
Structure    O
of    O
the    O
liver    B-Cell102991711
cell    I-Cell102991711
.    O

Similar    O
to    O
other    O
filoviruses    O
,    O
EBOV    O
replicates    O
very    O
efficiently    O
in    O
many    O
cells    O
,    O
producing    O
large    O
amounts    O
of    O
virus    O
in    O
monocytes    O
,    O
macrophages    O
,    O
dendritic    B-Cell102991711
cell    I-Cell102991711
and    O
other    O
cells    O
including    O
liver    B-Cell102991711
cells    I-Cell102991711
,    O
fibroblasts    O
,    O
and    O
adrenal    O
gland    O
cells    O
.    O

The    O
perisinusoidal    O
space    O
(    O
or    O
space    O
of    O
Disse    O
)    O
is    O
a    O
location    O
in    O
the    O
liver    O
between    O
a    O
hepatocyte    B-Cell102991711
and    O
a    O
sinusoid    O
.    O

In    O
the    O
smaller    O
portal    O
triads    O
,    O
the    O
four    O
vessels    O
lie    O
in    O
a    O
network    O
of    O
connective    O
tissue    O
and    O
are    O
surrounded    O
on    O
all    O
sides    O
by    O
hepatocyte    B-Cell102991711
.    O

In    O
type    O
2    O
diabetic    O
rats    O
,    O
chronic    O
exposure    O
of    O
β-cells    O
to    O
glucose    O
due    O
to    O
peripheral    O
insulin    O
resistance    O
results    O
in    O
decreased    O
PC    O
enzyme    O
activity    O
and    O
decreased    O
pyruvate    O
cycling    O
The    O
continued    O
overproduction    O
of    O
glucose    O
by    O
hepatocytes    B-Cell102991711
causes    O
dramatic    O
alteration    O
of    O
β-cell    O
gene    O
expression    O
with    O
large    O
increases    O
in    O
normally    O
suppressed    O
genes    O
,    O
and    O
equivalent    O
decreases    O
in    O
expression    O
of    O
mRNA    O
for    O
insulin    O
,    O
ion    O
pumps    O
necessary    O
for    O
insulin    O
secretion    O
,    O
and    O
metabolic    O
enzymes    O
related    O
to    O
insulin    O
secretion    O
,    O
including    O
pyruvate    O
carboxylase    O

Hepatic    B-Cell102991711
stellate    I-Cell102991711
cells    I-Cell102991711
(    O
here    O
HSC    B-Cell102991711
)    O
,    O
also    O
known    O
as    O
perisinusoidal    B-Cell102991711
cells    I-Cell102991711
or    O
Ito    B-Cell102991711
cells    I-Cell102991711
(    O
earlier    O
"    O
lipocytes    O
"    O
or    O
"    O
fat    O
-    O
storing    O
cells    O
"    O
)    O
,    O
are    O
pericyte    B-Cell102991711
found    O
in    O
the    O
perisinusoidal    O
space    O
of    O
the    O
liver    O
,    O
also    O
known    O
as    O
the    O
space    O
of    O
Disse    O
(    O
a    O
small    O
area    O
between    O
the    O
sinusoids    O
and    O
hepatocyte    B-Cell102991711
)    O
.    O

Stem    O
cells    O
are    O
by    O
definition    O
pluripotent    O
,    O
able    O
to    O
differentiate    O
into    O
several    O
cell    O
types    O
such    O
as    O
neurons    O
,    O
cardiomyocytes    O
,    O
hepatocytes    B-Cell102991711
,    O
etc    O
.    O

Clinically    O
-    O
relevant    O
cell    O
types    O
i.e.    O
cell    O
type    O
affected    O
in    O
diseases    O
are    O
a    O
major    O
focus    O
of    O
research    O
,    O
this    O
includes    O
hepatocytes    B-Cell102991711
,    O
Langerhans    O
islet    O
beta    O
-    O
cells    O
,    O
cardiomyocytes    O
and    O
neurons    O
.    O

MC2    O
Biotek    O
has    O
also    O
developed    O
a    O
3D    O
ProtoTissue™    O
Bioreactor    O
,    O
which    O
allows    O
cells    O
from    O
an    O
immortal    O
human    O
hepatocyte    B-Cell102991711
line    O
to    O
grow    O
into    O
3D    O
spheroids    O
.    O

Schematic    O
model    O
of    O
the    O
hepatocyte    B-Cell102991711
-    O
to    O
-    O
beta    O
cell    O
transdifferentiation    O
process    O
.    O

HCV    O
is    O
a    O
positive    O
-    O
sense    O
single    O
-    O
stranded    O
RNA    O
virus    O
that    O
has    O
been    O
demonstrated    O
to    O
replicate    O
in    O
the    O
hepatocyte    B-Cell102991711
of    O
both    O
humans    O
and    O
chimpanzees    O
.    O

The    O
interaction    O
of    O
both    O
substances    O
might    O
also    O
influence    O
apoptosis    O
and    O
necrosis    O
in    O
hepatocyte    B-Cell102991711
.    O

Bile    O
is    O
formed    O
in    O
the    O
liver    O
by    O
hepatocyte    B-Cell102991711
(    O
liver    O
cells    O
)    O
and    O
excreted    O
into    O
the    O
common    O
hepatic    O
duct    O
.    O

Hepatocytes    B-Cell102991711
are    O
separated    O
from    O
the    O
sinusoids    O
by    O
the    O
space    O
of    O
Disse    O
.    O

Estrogens    O
,    O
and    O
particularly    O
glucuronides    O
such    O
as    O
estradiol-17β-D    O
-    O
glucuronide    O
,    O
have    O
been    O
shown    O
to    O
cause    O
cholestasis    O
in    O
animal    O
studies    O
,    O
by    O
reducing    O
bile    O
acid    O
uptake    O
by    O
hepatocyte    B-Cell102991711
.    O

HCC    O
is    O
a    O
cancer    O
formed    O
by    O
liver    O
cells    O
,    O
known    O
as    O
hepatocyte    B-Cell102991711
,    O
that    O
become    O
malignant    O
.    O

Each    O
heavy    O
chain    O
has    O
a    O
globular    O
motor    O
domain    O
with    O
a    O
doughnut    O
-    O
shaped    O
structure    O
believed    O
to    O
resemble    O
that    O
of    O
other    O
AAA    O
proteins    O
,    O
a    O
coiled    O
coil    O
"    O
stalk    O
"    O
that    O
binds    O
to    O
the    O
microtubule    O
,    O
and    O
an    O
extended    O
tail    O
(    O
or    O
"    O
stem    O
"    O
)    O
that    O
attaches    O
to    O
a    O
neighboring    O
microtubule    O
of    O
the    O
same    O
axoneme    B-Cell102991711
.    O

The    O
cilium    B-Cell102991711
construction    O
of    O
axoneme    B-Cell102991711
microtubules    O
movement    O
by    O
the    O
sliding    O
of    O
dynein    O
protein    O
was    O
cited    O
by    O
Behe    O
as    O
an    O
example    O
of    O
irreducible    O
complexity    O
.    O

In    O
many    O
animals    O
the    O
sperm    O
tail    O
is    O
formed    O
in    O
a    O
unique    O
way    O
,    O
which    O
is    O
named    O
Cytosolic    O
ciliogenesis    O
,    O
since    O
all    O
or    O
part    O
of    O
axoneme    B-Cell102991711
of    O
the    O
sperm    O
tail    O
is    O
formed    O
in    O
the    O
cytoplasm    O
or    O
get    O
exposed    O
to    O
the    O
cytoplasm    O
.    O

Moreover    O
,    O
ATAT1    O
is    O
thought    O
to    O
be    O
associated    O
not    O
only    O
with    O
the    O
connecting    O
cilia    O
and    O
the    O
axoneme    B-Cell102991711
of    O
the    O
outer    O
segment    O
(    O
OS    O
)    O
,    O
but    O
also    O
with    O
the    O
entire    O
inner    O
segment    O
(    O
IS    O
)    O
and    O
the    O
entire    O
outer    O
segment    O
(    O
OS    O
)    O
.    O

Apicomplexa    O
–    O
parasitic    O
protozoa    O
that    O
lack    O
axonemal    B-Cell102991711
locomotive    O
structures    O
except    O
in    O
gametes    O

Extraglomerular    O
mesangial    O
cells    O
are    O
part    O
of    O
the    O
juxtaglomerular    O
apparatus    O
,    O
along    O
with    O
the    O
macula    B-Cell102991711
densa    I-Cell102991711
cells    O
of    O
the    O
distal    O
convoluted    O
tubule    O
and    O
the    O
juxtaglomerular    B-Cell102991711
cells    I-Cell102991711
of    O
the    O
afferent    O
arteriole    O
.    O

It    O
contains    O
three    O
components    O
:    O
the    O
macula    B-Cell102991711
densa    I-Cell102991711
,    O
juxtaglomerular    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
extraglomerular    B-Cell102991711
mesangial    I-Cell102991711
cell    I-Cell102991711
.    O

Juxtaglomerular    O
cells    O
secrete    O
renin    O
in    O
response    O
to    O
a    O
drop    O
in    O
pressure    O
detected    O
by    O
stretch    O
receptors    O
in    O
the    O
vascular    O
walls    O
,    O
or    O
when    O
stimulated    O
by    O
macula    B-Cell102991711
densa    I-Cell102991711
cells    O
.    O

Gorgonia    O
flabellum    O
,    O
also    O
known    O
as    O
the    O
Venus    O
fan    O
,    O
Venus    O
sea    O
fan    O
,    O
common    O
sea    O
fan    O
,    O
West    O
Indian    O
sea    O
fan    O
and    O
purple    O
gorgonian    O
seafan    O
,    O
is    O
a    O
species    O
of    O
sea    O
fan    O
,    O
a    O
sessile    O
colonial    B-Cell102991711
soft    O
coral    O
.    O

The    O
Venus    O
sea    O
fan    O
is    O
a    O
delicate    O
-    O
looking    O
colonial    B-Cell102991711
soft    O
coral    O
in    O
the    O
form    O
of    O
a    O
fan    O
composed    O
of    O
a    O
lattice    O
of    O
branches    O
in    O
a    O
single    O
plane    O
.    O

Atriolum    O
robustum    O
is    O
a    O
colonial    B-Cell102991711
tunicate    O
or    O
sea    O
squirt    O
in    O
the    O
family    O
"    O
Didemnidae    O
"    O
.    O

"    O
C.    O
innocuum    O
"    O
forms    O
white    O
,    O
glossy    O
,    O
raised    O
colonies    B-Cell102991711
and    O
exhibits    O
a    O
chartreuse    O
fluorescence    O
.    O

Biological    O
filters    O
provide    O
a    O
medium    O
specially    O
designed    O
for    O
colonization    B-Cell102991711
by    O
the    O
desired    O
nitrifying    O
bacteria    O
.    O

Unlike    O
most    O
other    O
bee    O
species    O
,    O
honey    O
bees    O
have    O
perennial    O
colonies    B-Cell102991711
which    O
persist    O
year    O
after    O
year    O
.    O
Because    O
of    O
this    O
high    O
degree    O
of    O
sociality    O
and    O
permanence    O
,    O
honey    O
bee    O
colonies    O
can    O
be    O
considered    O
superorganisms    O
,    O
meaning    O
that    O
reproduction    O
of    O
the    O
colony    O
,    O
rather    O
than    O
individual    O
bees    O
,    O
is    O
the    O
biologically    O
significant    O
unit    O
.    O

The    O
honey    O
bee    O
is    O
a    O
colonial    B-Cell102991711
insect    O
which    O
is    O
housed    O
,    O
fed    O
and    O
transported    O
by    O
beekeepers    O
.    O

A    O
coenobium    O
(    O
plural    O
coenobia    O
)    O
is    O
a    O
colony    B-Cell102991711
containing    O
a    O
fixed    O
number    O
of    O
cells    O
,    O
with    O
little    O
or    O
no    O
specialization    O
.    O

It    O
is    O
found    O
on    O
the    O
eastern    O
coasts    O
of    O
North    O
America    O
and    O
the    O
Caribbean    O
Sea    O
where    O
it    O
feeds    O
on    O
colonial    B-Cell102991711
sea    O
squirts    O
.    O

It    O
forms    O
small    O
white    O
colonies    B-Cell102991711
on    O
a    O
Wilkins    O
-    O
Chalgren    O
agar    O
plate    O
.    O

"    O
Porites    O
furcata    O
"    O
is    O
a    O
colonial    B-Cell102991711
coral    O
forming    O
clumps    O
of    O
short    O
,    O
slender    O
lobes    O
with    O
rounded    O
tips    O
,    O
often    O
densely    O
packed    O
together    O
.    O

The    O
behaviour    O
of    O
insects    O
that    O
live    O
in    O
colonies    B-Cell102991711
,    O
such    O
as    O
ants    O
,    O
bees    O
,    O
wasps    O
and    O
termites    O
,    O
has    O
always    O
been    O
a    O
source    O
of    O
fascination    O
for    O
children    O
,    O
naturalists    O
and    O
artists    O
.    O

Partially    O
inspired    O
by    O
colonies    B-Cell102991711
of    I-Cell102991711
insects    I-Cell102991711
such    O
as    O
ants    O
and    O
bees    O
,    O
researchers    O
are    O
modelling    O
the    O
behaviour    O
of    O
swarms    O
of    O
thousands    O
of    O
tiny    O
robots    O
which    O
together    O
perform    O
a    O
useful    O
task    O
,    O
such    O
as    O
finding    O
something    O
hidden    O
,    O
cleaning    O
,    O
or    O
spying    O
.    O

They    O
lay    O
small    O
,    O
spherical    O
,    O
initially    O
transparent    O
eggs    O
and    O
many    O
species    O
spin    O
silk    O
webbing    O
to    O
help    O
protect    O
the    O
colony    B-Cell102991711
from    O
predators    O
;    O
they    O
get    O
the    O
"    O
spider    O
"    O
part    O
of    O
their    O
common    O
name    O
from    O
this    O
webbing    O
.    O

The    O
larvae    O
of    O
"    O
Lomechusa    O
pubicollis    O
"    O
live    O
inside    O
colonies    B-Cell102991711
of    O
the    O
European    O
red    O
wood    O
ant    O
"    O
Formica    O
polyctena    O
"    O
,    O
or    O
the    O
red    O
wood    O
ant    O
"    O
Formica    O
rufa    O
"    O
.    O

"    O
P.    O
damicornis    O
"    O
is    O
a    O
colonial    B-Cell102991711
coral    O
and    O
can    O
grow    O
into    O
clumps    O
up    O
to    O
high    O
.    O

"    O
Pocillopora    O
verrucosa    O
"    O
is    O
a    O
colonial    B-Cell102991711
coral    O
and    O
grows    O
into    O
hemispherical    O
clumps    O
up    O
to    O
in    O
diameter    O
.    O

When    O
grown    O
in    O
culture    O
,    O
"    O
B.    O
mallei    O
"    O
grows    O
in    O
smooth    O
,    O
grey    O
,    O
translucent    O
colonies    B-Cell102991711
.    O

It    O
does    O
not    O
nest    O
colonially    B-Cell102991711
but    O
may    O
nest    O
with    O
other    O
birds    O
such    O
as    O
river    O
terns    O
(    O
"    O
Sterna    O
aurantia    O
"    O
)    O
,    O
pratincoles    O
(    O
"    O
Glareola    O
"    O
spp    O
.    O
)    O
and    O
Indian    O
skimmers    O
(    O
"    O
Rynchops    O
albicollis    O
"    O
)    O
.    O

They    O
produce    O
grey    O
spore    O
masses    O
and    O
grey    O
-    O
yellow    O
reverse    O
pigments    O
when    O
they    O
grow    O
as    O
colonies    B-Cell102991711
.    O

Psammoactinia    O
antarctica    O
was    O
an    O
encrusting    O
,    O
colonial    B-Cell102991711
cnidarian    O
in    O
the    O
family    O
Hydractiniidae    O
that    O
lived    O
in    O
the    O
Cretaceous    O
Antarctic    O
.    O

The    O
local    O
church    O
,    O
built    O
on    O
a    O
small    O
hill    O
above    O
the    O
village    O
,    O
is    O
dedicated    O
to    O
Saint    O
Acacius    O
and    O
is    O
home    O
to    O
an    O
important    O
colony    B-Cell102991711
of    O
the    O
lesser    O
horseshoe    O
bat    O
.    O

A    O
honey    O
bee    O
(    O
or    O
honeybee    O
)    O
is    O
any    O
member    O
of    O
the    O
genus    O
Apis    O
,    O
primarily    O
distinguished    O
by    O
the    O
production    O
and    O
storage    O
of    O
honey    O
and    O
the    O
construction    O
of    O
perennial    O
,    O
colonial    B-Cell102991711
nests    O
from    O
wax    O
.    O

Solenosmilia    O
variabilis    O
is    O
a    O
species    O
of    O
colonial    B-Cell102991711
coral    O
in    O
the    O
family    O
Caryophylliidae    O
.    O

Fire    O
corals    O
are    O
colonial    B-Cell102991711
coral    O
-    O
like    O
organisms    O
that    O
secrete    O
calcareous    O
skeletons    O
.    O

'    O
"    O
colony    B-Cell102991711

Colony    B-Cell102991711
(biology)    I-Cell102991711

Botrylloides    O
leachii    O
is    O
a    O
colonial    B-Cell102991711
tunicate    O
of    O
the    O
genus    O
"    O
Botrylloides    O
"    O
.    O

Breeding    O
happens    O
in    O
colonies    B-Cell102991711
and    O
normally    O
begins    O
in    O
late    O
May    O
or    O
June    O
.    O

"    O
Dichocoenia    O
stokesi    O
"    O
is    O
a    O
massive    O
colonial    B-Cell102991711
coral    O
that    O
forms    O
rounded    O
humps    O
up    O
to    O
in    O
diameter    O
.    O

"    O
Dichocoenia    O
stellaris    O
"    O
is    O
a    O
massive    O
colonial    B-Cell102991711
coral    O
that    O
forms    O
thick    O
plates    O
.    O

Meandrina    O
meandrites    O
,    O
commonly    O
known    O
as    O
maze    O
coral    O
,    O
is    O
a    O
species    O
of    O
colonial    B-Cell102991711
stony    O
coral    O
in    O
the    O
family    O
Meandrinidae    O
.    O

Meandrina    O
is    O
a    O
genus    O
of    O
colonial    B-Cell102991711
stony    O
coral    O
in    O
the    O
family    O
Meandrinidae    O
.    O

Colonies    B-Cell102991711
are    O
initiated    O
in    O
March    O
and    O
the    O
cycle    O
lasts    O
eight    O
months    O
.    O

"    O
Savalia    O
savaglia    O
"    O
forms    O
a    O
large    O
,    O
tree    O
-    O
like    O
colony    B-Cell102991711
.    O

It    O
may    O
form    O
expansive    O
colonies    B-Cell102991711
.    O

Coniochaeta    O
hoffmannii    O
"    O
colonies    B-Cell102991711
range    O
in    O
colour    O
from    O
a    O
pale    O
salmon    O
to    O
a    O
pallid    O
orange    O
,    O
with    O
degenerate    O
strains    O
presenting    O
a    O
creamy    O
white    O
colour    O
.    O

Sessile    O
animals    O
such    O
as    O
sponges    O
are    O
asymmetrical    O
alongside    O
coral    O
colonies    B-Cell102991711
(    O
with    O
the    O
exception    O
of    O
the    O
individual    O
polyps    O
that    O
exhibit    O
radial    O
symmetry    O
)    O
;    O
alpheidae    O
claws    O
that    O
lack    O
pincers    O
;    O
and    O
some    O
copepods    O
,    O
polyopisthocotyleans    O
,    O
and    O
monogeneans    O
which    O
parasitize    O
by    O
attachment    O
or    O
residency    O
within    O
the    O
gill    O
chamber    O
of    O
their    O
fish    O
hosts    O
)    O
.    O

In    O
biology    O
,    O
a    O
colony    B-Cell102991711
is    O
composed    O
of    O
two    O
or    O
more    O
conspecific    O
individuals    O
living    O
in    O
close    O
association    O
with    O
,    O
or    O
connected    O
to    O
,    O
one    O
another    O
,    O
usually    O
for    O
mutual    O
benefit    O
such    O
as    O
stronger    O
defense    O
or    O
the    O
ability    O
to    O
attack    O
bigger    O
prey    O
.    O

"    O
Lobophyllia    O
hemprichii    O
"    O
is    O
a    O
colonial    B-Cell102991711
species    O
of    O
coral    O
that    O
may    O
form    O
hemispherical    O
or    O
flattened    O
mounds    O
up    O
to    O
in    O
diameter    O
.    O

They    O
live    O
in    O
colonies    B-Cell102991711
,    O
and    O
show    O
a    O
primitive    O
level    O
of    O
cellular    O
specialization    O
for    O
different    O
tasks    O
.    O

In    O
this    O
role    O
the    O
colonies    B-Cell102991711
often    O
grow    O
extensive    O
mycelia    O
,    O
like    O
a    O
fungus    O
would    O
,    O
and    O
the    O
name    O
of    O
an    O
important    O
order    O
of    O
the    O
phylum    O
,    O
Actinomycetales    O
(    O
the    O
actinomycetes    O
)    O
,    O
reflects    O
that    O
they    O
were    O
long    O
believed    O
to    O
be    O
fungi    O
.    O

Seriatopora    O
is    O
a    O
genus    O
of    O
colonial    B-Cell102991711
stony    O
corals    O
in    O
the    O
family    O
Pocilloporidae    O
.    O

Due    O
to    O
decreased    O
quantities    O
of    O
seaweed    O
,    O
marine    O
iguanas    O
will    O
often    O
seek    O
food    O
on    O
the    O
land    O
,    O
taking    O
over    O
the    O
food    O
source    O
from    O
the    O
colonies    B-Cell102991711
of    O
land    O
iguanas    O
.    O

It    O
is    O
a    O
colonial    B-Cell102991711
species    O
and    O
forms    O
aggregations    O
on    O
the    O
lower    O
shore    O
near    O
low    O
-    O
water    O
mark    O
.    O

Even    O
among    O
the    O
workers    O
of    O
a    O
colony    B-Cell102991711
,    O
there    O
is    O
a    O
considerable    O
degree    O
of    O
variation    O
in    O
colouring    O
but    O
none    O
of    O
these    O
variations    O
seems    O
to    O
be    O
taxonomically    O
significant    O
.    O

It    O
is    O
normally    O
found    O
in    O
large    O
colonies    B-Cell102991711
,    O
and    O
is    O
usually    O
abundant    O
wherever    O
it    O
occurs    O
.    O

It    O
nests    O
in    O
colonies    B-Cell102991711
in    O
secluded    O
areas    O
,    O
often    O
on    O
islands    O
,    O
vegetated    O
land    O
among    O
sand    O
dunes    O
,    O
thickets    O
of    O
shrubs    O
and    O
trees    O
,    O
and    O
mangroves    O
.    O

It    O
is    O
a    O
colonial    O
species    O
,    O
with    O
some    O
colonies    B-Cell102991711
maintained    O
for    O
many    O
years    O
.    O

Many    O
bumblebees    O
are    O
social    O
insects    O
that    O
form    O
colonies    B-Cell102991711
with    O
a    O
single    O
queen    O
.    O

Most    O
form    O
colonies    B-Cell102991711
of    O
between    O
50    O
and    O
400    O
individuals    O
,    O
but    O
colonies    O
have    O
been    O
documented    O
as    O
small    O
as    O
~20    O
individuals    O
and    O
as    O
large    O
as    O
1700    O
.    O

It    O
is    O
readily    O
identifiable    O
by    O
distinctive    O
orange    O
/    O
red    O
colonies    B-Cell102991711
when    O
grown    O
on    O
SDA    O
(    O
Sabouraud    O
's    O
Dextrose    O
Agar    O
)    O
.    O

Acropora    O
prolifera    O
,    O
the    O
fused    O
staghorn    O
coral    O
,    O
is    O
a    O
branching    O
,    O
colonial    B-Cell102991711
,    O
stony    O
coral    O
found    O
in    O
shallow    O
parts    O
of    O
the    O
Caribbean    O
Sea    O
,    O
the    O
Bahamas    O
and    O
southern    O
Florida    O
.    O

When    O
grown    O
in    O
pure    O
culture    O
conditions    O
on    O
a    O
petri    O
dish    O
at    O
a    O
temperature    O
of    O
,    O
"    O
Rhopalomyces    O
elegans    O
"    O
produces    O
hyaline    O
(    O
translucent    O
)    O
,    O
partially    O
submerged    O
colonies    B-Cell102991711
that    O
fill    O
the    O
plate    O
in    O
about    O
six    O
days    O
.    O

"    O
Mussa    O
angulosa    O
"    O
is    O
a    O
colonial    B-Cell102991711
species    O
and    O
the    O
whole    O
clump    O
forms    O
a    O
low    O
dome    O
that    O
may    O
reach    O
across    O
.    O

"    O
Scolymia    O
lacera    O
"    O
is    O
a    O
coral    O
with    O
a    O
single    O
,    O
solitary    O
polyp    O
and    O
does    O
not    O
increase    O
in    O
size    O
by    O
budding    O
as    O
do    O
colonial    B-Cell102991711
species    O
of    O
coral    O
.    O

The    O
same    O
study    O
also    O
showed    O
that    O
transfection    O
of    O
the    O
Dock6    O
DHR2    O
domain    O
into    O
N1E-115    O
neuroblastoma    O
cells    O
promoted    O
Rac-    O
and    O
Cdc42-dependent    O
neurite    B-Cell102991711
outgrowth    O
,    O
although    O
the    O
physiological    O
significance    O
of    O
this    O
has    O
yet    O
to    O
be    O
demonstrated    O
.    O

N    O
-    O
type    O
calcium    O
channels    O
have    O
been    O
shown    O
to    O
play    O
a    O
part    O
in    O
the    O
localization    O
of    O
neurite    B-Cell102991711
growth    O
in    O
the    O
sympathetic    O
nervous    O
system    O
and    O
the    O
skin    O
and    O
spinal    O
cord    O
.    O

Regeneration    O
of    O
injured    O
axons    O
at    O
neuromuscular    O
junctions    O
is    O
regulated    O
by    O
extra    O
-    O
cellular    O
protein    O
factors    O
that    O
promote    O
neurite    B-Cell102991711
outgrowth    O
.    O

The    O
activated    O
GTPase    O
then    O
activates    O
Cdc42    O
which    O
further    O
activates    O
c    O
-    O
Jun    O
kinases    O
and    O
phosphorylation    O
of    O
Jun.    O
Activation    O
of    O
c    O
-    O
Jun    O
kinases    O
leads    O
to    O
high    O
levels    O
of    O
c    O
-    O
Jun    O
expression    O
which    O
results    O
in    O
neurite    B-Cell102991711
outgrowth    O
.    O

N    O
-    O
cadherin    O
agonists    O
have    O
been    O
identified    O
and    O
observed    O
to    O
stimulate    O
neurite    B-Cell102991711
growth    O
and    O
cell    O
migration    O
,    O
key    O
aspects    O
of    O
promoting    O
axon    O
growth    O
and    O
remyelination    O
after    O
injury    O
or    O
disease    O
.    O

Neurite    B-Cell102991711

The    O
term    O
"    O
neurotrophic    O
"    O
means    O
"    O
relating    O
to    O
the    O
nutrition    O
and    O
maintenance    O
of    O
nerve    O
tissue    O
"    O
and    O
the    O
device    O
gets    O
its    O
name    O
from    O
the    O
fact    O
that    O
it    O
is    O
coated    O
with    O
Matrigel    O
and    O
nerve    O
growth    O
factor    O
to    O
encourage    O
the    O
expansion    O
of    O
neurites    B-Cell102991711
through    O
its    O
tip    O
.    O

When    O
the    O
neurites    B-Cell102991711
reach    O
the    O
back    O
end    O
of    O
the    O
cone    O
,    O
they    O
rejoin    O
with    O
the    O
neuropil    O
on    O
that    O
side    O
,    O
which    O
anchors    O
the    O
glass    O
cone    O
in    O
place    O
.    O

In    O
vitro    O
and    O
in    O
vivo    O
results    O
show    O
that    O
Neuroaid    O
makes    O
cells    O
more    O
resistant    O
against    O
glutamate    O
aggression    O
,    O
increases    O
neurite    B-Cell102991711
outgrowth    O
and    O
connectivity    O
as    O
well    O
as    O
reduces    O
the    O
infarct    O
volume    O
.    O

Tissue    O
-    O
like    O
structures    O
are    O
often    O
exhibited    O
within    O
EBs    O
,    O
including    O
the    O
appearance    O
of    O
blood    O
islands    O
reminiscent    O
of    O
early    O
blood    O
vessel    O
structures    O
in    O
the    O
developing    O
embryo    O
,    O
as    O
well    O
as    O
the    O
patterning    O
of    O
neurite    B-Cell102991711
extensions    O
(    O
indicative    O
of    O
neuron    O
organization    O
)    O
and    O
spontaneous    O
contractile    O
activity    O
(    O
indicative    O
of    O
cardiomyocyte    O
differentiation    O
)    O
when    O
EBs    O
are    O
plated    O
onto    O
adhesive    O
substrates    O
such    O
as    O
gelatin    O
.    O

Abnormal    O
neurites    B-Cell102991711
in    O
senile    O
plaques    O
are    O
composed    O
primarily    O
of    O
paired    O
helical    O
filaments    O
,    O
a    O
component    O
of    O
neurofibrillary    O
tangles    O
.    O

The    O
encoded    O
protein    O
appears    O
to    O
promote    O
Neurite    B-Cell102991711
.    O

Slit    O
LRR    O
domains    O
are    O
thought    O
to    O
assist    O
in    O
controlling    O
neurite    B-Cell102991711
outgrowth    O
.    O

The    O
carriers    O
in    O
the    O
electron    O
transport    O
chain    O
use    O
some    O
of    O
the    O
electron    O
's    O
energy    O
to    O
actively    O
transport    O
protons    O
from    O
the    O
stroma    B-Cell102991711
to    O
the    O
lumen    O
.    O

The    O
resulting    O
chemiosmotic    O
potential    O
between    O
the    O
lumen    O
and    O
stroma    B-Cell102991711
is    O
high    O
enough    O
to    O
drive    O
ATP    O
synthesis    O
using    O
the    O
ATP    O
synthase    O
.    O

It    O
is    O
well    O
recognized    O
that    O
tumors    O
are    O
a    O
complex    O
and    O
dynamic    O
population    O
of    O
cells    O
composed    O
of    O
transformed    O
cells    O
as    O
well    O
as    O
stromal    B-Cell102991711
cell    I-Cell102991711
,    O
blood    O
vessels    O
,    O
tissue    O
macrophages    O
,    O
and    O
other    O
immune    O
infiltrates    O
.    O

Classically    O
it    O
is    O
biphasic    O
and    O
is    O
characterized    O
by    O
an    O
admixture    O
of    O
polygonal    O
epithelial    O
and    O
spindle    O
-    O
shaped    O
myoepithelial    O
elements    O
in    O
a    O
variable    O
background    O
stroma    B-Cell102991711
that    O
may    O
be    O
mucoid    O
,    O
myxoid    O
,    O
cartilaginous    O
or    O
hyaline    O
.    O

Uterine    O
adenosarcoma    O
have    O
,    O
by    O
definition    O
,    O
a    O
malignant    O
stroma    B-Cell102991711
and    O
benign    O
glandular    O
elements    O
.    O

co    O
-    O
culture    O
with    O
stromal    B-Cell102991711
cells    I-Cell102991711
or    O
feeder    O
cells    O
,    O
and    O
on    O
specific    O
culture    O
substrates    O
:    O

Corneal    O
dystrophy    O
is    O
also    O
epithelian    O
instead    O
of    O
being    O
stromal    B-Cell102991711
.    O

The    O
stroma    B-Cell102991711
of    O
the    O
bone    O
marrow    O
is    O
all    O
tissue    O
not    O
directly    O
involved    O
in    O
the    O
marrow    O
's    O
primary    O
function    O
of    O
hematopoiesis    O
.    O

An    O
endometrial    O
stromal    O
nodule    O
is    O
a    O
noninfiltrative    O
,    O
circumscribed    O
proliferation    O
of    O
endometrial    O
stromal    B-Cell102991711
cells    I-Cell102991711
and    O
is    O
a    O
benign    O
subtype    O
of    O
endometrial    O
stromal    O
tumor    O
.    O

This    O
ingression    O
sees    O
the    O
cells    O
from    O
the    O
epiblast    O
move    O
into    O
the    O
primitive    O
streak    O
in    O
an    O
epithelial-mesenchymal    B-Cell102991711
transition    I-Cell102991711
;    O
epithelial    O
cells    O
become    O
mesenchymal    O
stem    O
cells    O
,    O
multipotent    O
stromal    B-Cell102991711
cells    O
that    O
can    O
differentiate    O
into    O
various    O
cell    O
types    O
.    O

Particularly    O
successful    O
recently    O
has    O
been    O
the    O
delivery    O
of    O
mesoangioblast    B-Cell102991711
cells    O
into    O
the    O
Golden    O
Retriever    O
dog    O
model    O
of    O
Duchenne    O
muscular    O
dystrophy    O
,    O
which    O
effectively    O
cured    O
the    O
disease    O
.    O

PECs    O
consist    O
of    O
perivascular    O
epithelioid    B-Cell102991711
cells    O
with    O
a    O
clear    O
/    O
granular    O
cytoplasm    O
and    O
central    O
round    O
nucleus    O
without    O
prominent    O
nucleoli    O
.    O

Angiomyolipomas    O
are    O
tumours    O
consisting    O
of    O
perivascular    B-Cell102991711
epithelioid    B-Cell102991711
cells    O
(    O
cells    O
which    O
are    O
found    O
surrounding    O
blood    O
vessels    O
and    O
which    O
resemble    O
epithelial    O
cells    O
)    O
.    O

The    O
nodules    O
are    O
composed    O
of    O
epithelioid    B-Cell102991711
cell    I-Cell102991711
and    O
giant    B-Cell102991711
cell    I-Cell102991711
surrounded    O
by    O
lymphocytes    O
.    O

MDA-MB-468    B-Cell102991711
(    O
breast    O
cancer    O
)    O

Enzymatic    O
activity    O
excising    O
8-oxoguanine    O
from    O
DNA    O
(    O
OGG    O
activity    O
)    O
was    O
reduced    O
in    O
peripheral    B-Cell102991711
blood    I-Cell102991711
mononuclear    I-Cell102991711
cell    I-Cell102991711
(    O
PBMCs    O
)    O
,    O
and    O
in    O
paired    O
lung    O
tissue    O
,    O
from    O
patients    O
with    O
non    O
–    O
small    O
cell    O
lung    O
cancer    O
.    O

Additionally    O
,    O
there    O
are    O
descriptions    O
of    O
the    O
presence    O
of    O
papillomavirus    O
DNA    O
in    O
the    O
blood    O
and    O
in    O
the    O
peripheral    B-Cell102991711
blood    I-Cell102991711
mononuclear    I-Cell102991711
cell    I-Cell102991711
.    O

CCL17    O
is    O
expressed    O
constitutively    O
in    O
thymus    O
,    O
but    O
only    O
transiently    O
in    O
phytohemagglutinin    O
-    O
stimulated    O
peripheral    B-Cell102991711
blood    I-Cell102991711
mononuclear    I-Cell102991711
cells    I-Cell102991711
.    O

One    O
difference    O
in    O
the    O
function    O
of    O
hIL-10    O
and    O
cmvIL-10    O
is    O
that    O
hIL-10    O
causes    O
human    O
peripheral    O
blood    O
mononuclear    O
cells    O
(    O
PBMC    B-Cell102991711
)    O
to    O
both    O
increase    O
and    O
decrease    O
in    O
proliferation    O
whereas    O
cmvIL-10    O
only    O
causes    O
a    O
decrease    O
in    O
proliferation    O
of    O
PBMCs    O
.    O

The    O
majority    O
of    O
patient    O
peripheral    B-Cell102991711
blood    I-Cell102991711
mononucleated    I-Cell102991711
cells    I-Cell102991711
are    O
polyclonal    O
naïve    O
mature    O
B    O
cells    O
,    O
with    O
a    O
significant    O
increase    O
in    O
immature    O
,    O
transitional    O
B    O
cell    O
numbers    O
(    O
identified    O
as    O
CD10    O
+    O
)    O
.    O

Neurons    O
are    O
particularly    O
vulnerable    O
to    O
channel    O
-    O
forming    O
toxins    O
because    O
of    O
their    O
reliance    O
on    O
maintenance    O
of    O
strict    O
Na+    O
,    O
K+    O
,    O
and    O
Ca2    O
+    O
concentration    O
gradients    O
and    O
membrane    B-Cell102991711
potential    I-Cell102991711
for    O
proper    O
functioning    O
and    O
action    O
potential    O
propagation    O
.    O

Membrane    B-Cell102991711
potential    I-Cell102991711

It    O
is    O
primarily    O
driven    O
by    O
the    O
mitochondrial    O
membrane    B-Cell102991711
potential    I-Cell102991711
.    O

This    O
can    O
initiate    O
calcium    O
spikes    O
or    O
calcium    O
waves    O
with    O
large    O
changes    O
in    O
the    O
membrane    B-Cell102991711
potential    I-Cell102991711
.    O

Regulation    O
of    O
the    O
membrane    B-Cell102991711
potential    I-Cell102991711

Typically    O
these    O
are    O
sodium    O
-    O
dependent    O
voltage    O
-    O
sensitive    O
oscillations    O
in    O
membrane    B-Cell102991711
potential    I-Cell102991711
at    O
near    O
-    O
action    O
potential    O
voltages    O
(    O
Alonso    O
&    O
Llinás    O
,    O
1989    O
)    O
.    O

Margatoxin    O
significantly    O
reduces    O
outward    O
currents    O
of    O
Kv1.3    O
channels    O
and    O
depolarized    O
resting    O
membrane    B-Cell102991711
potential    I-Cell102991711
.    O

These    O
heterotetramers    O
plays    O
a    O
role    O
in    O
regulating    O
the    O
membrane    B-Cell102991711
potential    I-Cell102991711
of    O
macrophages    O
on    O
different    O
stages    O
of    O
macrophage    O
activation    O
by    O
lymphocytes    O
.    O

The    O
membrane    B-Cell102991711
potential    I-Cell102991711
exerts    O
powerful    O
effects    O
on    O
the    O
lymphocyte    O
activation    O
.    O

This    O
hyperpolarization    O
causes    O
the    O
membrane    B-Cell102991711
potential    I-Cell102991711
to    O
become    O
more    O
negative    O
.    O

In    O
the    O
TC    O
neurons    O
this    O
is    O
generated    O
by    O
the    O
"    O
slow    O
oscillation    O
"    O
and    O
is    O
dependent    O
on    O
membrane    B-Cell102991711
potential    I-Cell102991711
bistability    O
,    O
a    O
property    O
of    O
these    O
neurons    O
due    O
to    O
an    O
electrophysiological    O
component    O
known    O
as    O
"    O
I    O
t    O
window    O
"    O
.    O

As    O
in    O
all    O
other    O
cells    O
,    O
the    O
resting    O
potential    B-Cell102991711
of    O
a    O
pacemaker    O
cell    O
(    O
-60mV    O
to    O
-70mV    O
)    O
is    O
caused    O
by    O
a    O
continuous    O
outflow    O
or    O
"    O
leak    O
"    O
of    O
potassium    O
ions    O
through    O
ion    O
channel    O
proteins    O
in    O
the    O
membrane    O
that    O
surrounds    O
the    O
cells    O
.    O

PTPIP51    O
has    O
been    O
observed    O
to    O
induce    O
apoptosis    O
by    O
disrupting    O
the    O
mitochondrial    O
membrane    B-Cell102991711
potential    I-Cell102991711
,    O
resulting    O
in    O
the    O
release    O
of    O
cytochrome    O
c.    O

As    O
kidney    O
failure    O
progresses    O
,    O
with    O
a    O
consequent    O
decline    O
of    O
excretory    O
function    O
,    O
potassium    O
is    O
likely    O
to    O
accumulate    O
with    O
probable    O
harmful    O
effects    O
on    O
the    O
cellular    O
membrane    B-Cell102991711
potential    I-Cell102991711
and    O
cardiac    O
arrhythmias    O
as    O
the    O
primary    O
symptom    O
.    O

The    O
electrical    O
source    O
is    O
the    O
muscle    O
membrane    B-Cell102991711
potential    I-Cell102991711
of    O
about    O
–90    O
mV.    O
Measured    O
EMG    O
potentials    O
range    O
between    O
less    O
than    O
50    O
μV    O
and    O
up    O
to    O
20    O
to    O
30    O
mV    O
,    O
depending    O
on    O
the    O
muscle    O
under    O
observation    O
.    O

Voltage    O
-    O
gated    O
ion    O
channels    O
open    O
and    O
close    O
in    O
response    O
to    O
membrane    B-Cell102991711
potential    I-Cell102991711
.    O

Membrane    B-Cell102991711
potential    I-Cell102991711

However    O
,    O
as    O
the    O
function    O
of    O
brain    O
tissue    O
is    O
partially    O
determined    O
by    O
molecular    O
events    O
(    O
particularly    O
at    O
synapses    O
,    O
but    O
also    O
at    O
other    O
places    O
on    O
the    O
neuron    O
's    O
cell    O
membrane    B-Cell102991711
)    O
,    O
this    O
may    O
not    O
suffice    O
for    O
capturing    O
and    O
simulating    O
neuron    O
functions    O
.    O

Michaelis    O
demonstrated    O
the    O
membrane    B-Cell102991711
potential    I-Cell102991711
(    O
1926    O
)    O
and    O
proposed    O
that    O
it    O
was    O
related    O
to    O
the    O
distribution    O
of    O
ions    O
across    O
the    O
membrane    O
.    O

The    O
tremendous    O
success    O
of    O
Hodgkin    O
,    O
Huxley    O
,    O
and    O
Katz    O
in    O
the    O
development    O
of    O
the    O
membrane    O
theory    O
of    O
cellular    B-Cell102991711
membrane    I-Cell102991711
potentials    I-Cell102991711
,    O
with    O
differential    O
equations    O
that    O
modeled    O
the    O
phenomena    O
correctly    O
,    O
provided    O
even    O
more    O
support    O
for    O
the    O
membrane    O
pump    O
hypothesis    O
.    O

This    O
method    O
is    O
also    O
useful    O
in    O
studying    O
the    O
changes    O
in    O
membrane    B-Cell102991711
potential    I-Cell102991711
in    O
response    O
to    O
different    O
pharmacologically    O
active    O
agents    O
,    O
which    O
can    O
be    O
introduced    O
in    O
the    O
test    O
chamber    O
.    O

Synchronous    O
arrival    O
of    O
these    O
two    O
inputs    O
may    O
push    O
the    O
membrane    B-Cell102991711
potential    I-Cell102991711
of    O
a    O
target    O
neuron    O
over    O
the    O
threshold    O
required    O
to    O
create    O
an    O
action    O
potential    O
.    O

Consequently    O
,    O
there    O
is    O
a    O
difference    O
in    O
electric    O
potentials    O
between    O
the    O
cell    O
interior    O
and    O
a    O
fluid    O
bulk    O
,    O
known    O
as    O
the    O
transmembrane    B-Cell102991711
potential    I-Cell102991711
.    O

This    O
reduction    O
in    O
the    O
membrane    B-Cell102991711
potential    I-Cell102991711
opens    O
voltage    O
-    O
gated    O
calcium    O
channels    O
,    O
which    O
causes    O
a    O
rise    O
in    O
intracellular    O
calcium    O
concentration    O
.    O

This    O
difference    O
in    O
charge    O
is    O
called    O
the    O
cell    O
's    O
membrane    B-Cell102991711
potential    I-Cell102991711
.    O

Membrane    B-Cell102991711
potential    I-Cell102991711

When    O
stimulated    O
by    O
a    O
change    O
in    O
transmembrane    B-Cell102991711
voltage    I-Cell102991711
,    O
this    O
segment    O
moves    O
toward    O
the    O
extracellular    O
side    O
of    O
the    O
cell    O
membrane    O
,    O
allowing    O
the    O
channel    O
to    O
become    O
permeable    O
to    O
ions    O
.    O

If    O
enough    O
channels    O
open    O
when    O
there    O
is    O
a    O
change    O
in    O
the    O
cell    O
's    O
membrane    B-Cell102991711
potential    I-Cell102991711
,    O
a    O
small    O
but    O
significant    O
number    O
of    O
Na+    O
ions    O
will    O
move    O
into    O
the    O
cell    O
down    O
their    O
electrochemical    O
gradient    O
,    O
further    O
depolarizing    O
the    O
cell    O
.    O

Individual    O
cells    O
consistently    O
get    O
excited    B-Cell102991711
by    O
sounds    O
at    O
specific    O
frequencies    O
,    O
or    O
multiples    O
of    O
that    O
frequency    O
.    O

The    O
primary    O
auditory    O
cortex    O
is    O
subject    O
to    O
modulation    O
by    O
numerous    O
neurotransmitters    O
,    O
including    O
norepinephrine    O
,    O
which    O
has    O
been    O
shown    O
to    O
decrease    O
cellular    B-Cell102991711
excitability    I-Cell102991711
in    O
all    O
layers    O
of    O
the    O
temporal    O
cortex    O
.    O

Lacosamide    O
makes    O
this    O
inactivation    O
happen    O
at    O
less    O
depolarized    O
membrane    B-Cell102991711
potential    I-Cell102991711
.    O

The    O
specialized    O
keratins    O
of    O
hair    O
and    O
nail    O
are    O
known    O
as    O
"    O
hard    O
keratins    O
"    O
or    O
"    O
trichocyte    B-Cell102991711
keratins    O
"    O
.    O

It    O
is    O
also    O
an    O
avid    O
biofilm    B-Cell102991711
grazer    O
,    O
ingesting    O
microorganisms    O
,    O
as    O
well    O
as    O
algae    O
.    O

Plants    O
also    O
provide    O
surfaces    O
to    O
graze    O
on    O
biofilm    B-Cell102991711
.    O

Thus    O
,    O
coral    O
reefs    O
and    O
microbial    B-Cell102991711
mats    I-Cell102991711
are    O
spared    O
much    O
of    O
the    O
impact    O
of    O
these    O
plumes    O
and    O
are    O
growing    O
nearby    O
,    O
complete    O
with    O
thriving    O
tropical    O
fish    O
.    O

They    O
are    O
also    O
used    O
for    O
devices    O
where    O
gas    O
and    O
liquid    O
are    O
put    O
in    O
contact    O
for    O
purposes    O
of    O
gas    O
absorption    O
,    O
stripping    O
or    O
chemical    O
reaction    O
,    O
and    O
as    O
a    O
support    O
for    O
biofilm    B-Cell102991711
in    O
biological    O
reactors    O
.    O

The    O
rotating    O
cell    O
biofilm    O
reactor    O
(    O
RCBR    O
)    O
is    O
a    O
new    O
type    O
of    O
biological    O
process    O
based    O
on    O
biofilm    B-Cell102991711
active    O
sludge    O
used    O
in    O
wastewaters    O
treatment    O
.    O

Biofilms    B-Cell102991711
are    O
an    O
example    O
of    O
microbe    O
-    O
microbe    O
interactions    O
and    O
are    O
thought    O
to    O
be    O
associated    O
with    O
up    O
to    O
80%    O
of    O
human    O
infections    O
.    O

It    O
is    O
currently    O
believed    O
that    O
bacterial    O
biofilms    B-Cell102991711
play    O
an    O
integral    O
role    O
in    O
the    O
harboring    O
of    O
chronic    O
infection    O
by    O
tonsil    O
and    O
adenoid    O
tissue    O
so    O
contributing    O
to    O
recurrent    O
sinusitis    O
and    O
recurrent    O
or    O
persistent    O
ear    O
disease    O
.    O

Chryseobacterium    O
molle    O
is    O
a    O
Gram    O
-    O
negative    O
,    O
rod    O
-    O
shaped    O
,    O
non    O
-    O
spore    O
-    O
forming    O
and    O
non    O
-    O
motile    O
bacteria    O
from    O
the    O
genus    O
of    O
Chryseobacterium    O
which    O
has    O
been    O
isolated    O
from    O
biofilm    B-Cell102991711
of    O
a    O
beer    O
bottling    O
plant    O
in    O
Germany    O
.    O

Biofilm    B-Cell102991711
that    O
may    O
contain    O
a    O
mixture    O
of    O
bacteria    O
and    O
fungi    O
have    O
the    O
potential    O
to    O
damage    O
electronic    O
equipment    O
by    O
oxidising    O
various    O
components    O
e.g.    O
copper    O
cables    O
.    O

Uhrich    O
has    O
collaborated    O
with    O
Professor    O
Michael    O
Tchikindas    O
in    O
the    O
Rutgers    O
Food    O
Science    O
department    O
to    O
investigate    O
PolyAspirin    O
and    O
other    O
plant    O
-    O
based    O
polymers    O
as    O
a    O
method    O
for    O
prevention    O
of    O
biofilm    B-Cell102991711
formation    O
by    O
microbes    O
such    O
as    O
"    O
E.    O
coli    O
"    O
and    O
"    O
Salmonella    O
"    O
in    O
food    O
.    O

Medically    O
,    O
Cellulase    O
is    O
used    O
as    O
a    O
treatment    O
for    O
phytobezoars    O
,    O
a    O
form    O
of    O
cellulose    O
bezoar    O
found    O
in    O
the    O
human    O
stomach    O
,    O
and    O
it    O
has    O
exhibited    O
efficacy    O
in    O
degrading    O
polymicrobial    O
bacterial    O
biofilm    B-Cell102991711
by    O
hydrolyzing    O
the    O
β(1    O
-    O
4    O
)    O
glycosidic    O
linkages    O
within    O
the    O
structural    O
,    O
matrix    O
exopolysaccharides    O
of    O
the    O
extracellular    O
polymeric    O
substance    O
(    O
EPS    O
)    O
.    O

It    O
is    O
commonly    O
found    O
in    O
the    O
biofilm    B-Cell102991711
and    O
cell    O
wall    O
of    O
various    O
fungal    O
species    O
.    O

It    O
is    O
particularly    O
interesting    O
that    O
it    O
took    O
so    O
long    O
to    O
discover    O
the    O
marine    O
microbial    O
symbiosis    O
because    O
nearly    O
every    O
surface    O
submerged    O
in    O
the    O
oceans    O
becomes    O
covered    O
with    O
biofilm    B-Cell102991711
,    O
including    O
a    O
large    O
number    O
of    O
living    O
organisms    O
.    O

As    O
of    O
June    O
2015    O
,    O
he    O
is    O
a    O
professor    O
at    O
the    O
University    O
of    O
Washington    O
and    O
his    O
lab    O
studies    O
fields    O
such    O
as    O
quorum    O
sensing    O
and    O
biofilm    B-Cell102991711
.    O

Implants    O
,    O
made    O
of    O
synthetic    O
materials    O
,    O
are    O
naturally    O
coated    O
by    O
a    O
biofilm    B-Cell102991711
by    O
the    O
body    O
,    O
which    O
may    O
function    O
as    O
a    O
favorable    O
medium    O
for    O
bacteria    O
growth    O
.    O

Some    O
bacteria    O
form    O
biofilm    B-Cell102991711
to    O
protect    O
themselves    O
from    O
the    O
cells    O
and    O
proteins    O
of    O
the    O
immune    O
system    O
.    O

One    O
of    O
the    O
most    O
important    O
causes    O
of    O
starvation    O
induced    O
tolerance    O
in    O
vivo    O
is    O
biofilm    B-Cell102991711
growth    O
,    O
which    O
occurs    O
in    O
many    O
chronic    O
infections    O
.    O

A    O
biofilm    B-Cell102991711
is    O
a    O
colony    O
of    O
microorganisms    O
often    O
comprising    O
several    O
species    O
,    O
with    O
properties    O
and    O
capabilities    O
greater    O
than    O
the    O
aggregate    O
of    O
capabilities    O
of    O
the    O
individual    O
organisms    O
.    O

The    O
opportunistic    O
pathogen    O
"    O
Pseudomonas    O
aeruginosa    O
"    O
uses    O
quorum    O
sensing    O
to    O
coordinate    O
the    O
formation    O
of    O
biofilms    B-Cell102991711
,    O
swarming    O
motility    O
,    O
exopolysaccharide    O
production    O
,    O
virulence    O
,    O
and    O
cell    O
aggregation    O
.    O

Then    O
they    O
become    O
aggressive    O
,    O
developing    O
to    O
the    O
point    O
at    O
which    O
their    O
numbers    O
are    O
sufficient    O
to    O
overcome    O
the    O
host    O
's    O
immune    O
system    O
,    O
and    O
form    O
a    O
biofilm    B-Cell102991711
,    O
leading    O
to    O
disease    O
within    O
the    O
host    O
as    O
the    O
biofilm    O
is    O
a    O
protective    O
layer    O
encasing    O
the    O
bacteria    O
population    O
.    O

These    O
proteins    O
are    O
known    O
to    O
regulate    O
and    O
influence    O
biofilm    B-Cell102991711
formation    O
by    O
releasing    O
DNA    O
from    O
lysed    O
cells    O
which    O
contributes    O
to    O
the    O
biofilm    O
matrix    O
.    O

Microfluidic    O
techniques    O
have    O
been    O
used    O
to    O
follow    O
gene    O
expression    O
temporally    O
and    O
spatially    O
during    O
biofilm    B-Cell102991711
formation    O
,    O
revealing    O
that    O
both    O
"    O
cidA    O
"    O
and    O
"    O
lrgA    O
"    O
are    O
expressed    O
mostly    O
in    O
the    O
interior    O
of    O
tower    O
structures    O
in    O
the    O
biofilms    O
,    O
regulated    O
by    O
oxygen    O
availability    O
.    O

The    O
MBBR    O
system    O
consists    O
of    O
an    O
aeration    O
tank    O
(    O
similar    O
to    O
a    O
activated    O
sludge    O
tank    O
)    O
with    O
special    O
plastic    O
carriers    O
that    O
provide    O
a    O
surface    O
where    O
a    O
biofilm    B-Cell102991711
can    O
grow    O
.    O

Whilst    O
drug    O
resistance    O
typically    O
involves    O
microbes    O
chemically    O
inactivating    O
an    O
antimicrobial    O
drug    O
or    O
a    O
cell    O
mechanically    O
stopping    O
the    O
uptake    O
of    O
a    O
drug    O
,    O
another    O
form    O
of    O
drug    O
resistance    O
can    O
arise    O
from    O
the    O
formation    O
of    O
biofilm    B-Cell102991711
.    O

Dental    O
plaque    O
is    O
a    O
biofilm    B-Cell102991711
or    O
mass    O
of    O
bacteria    O
that    O
grows    O
on    O
surfaces    O
within    O
the    O
mouth    O
.    O

Over    O
time    O
,    O
biofilm    B-Cell102991711
develop    O
on    O
the    O
pipes    O
of    O
the    O
drainage    O
field    O
,    O
which    O
can    O
lead    O
to    O
blockage    O
.    O

The    O
bacterium    O
forms    O
a    O
biofilm    B-Cell102991711
which    O
is    O
resistant    O
to    O
chemical    O
and    O
antimicrobial    O
treatments    O
,    O
including    O
chlorine    O
.    O

The    O
primary    O
waste    O
liquids    O
cleaning    O
and    O
purification    O
action    O
in    O
a    O
drain    O
field    O
is    O
performed    O
by    O
a    O
biofilm    B-Cell102991711
in    O
the    O
loose    O
fill    O
surrounding    O
the    O
perforated    O
drain    O
tile    O
.    O

Blastochloris    O
gulmargensis    O
is    O
a    O
gram    O
-    O
negative    O
,    O
motile    O
bacteria    O
from    O
the    O
genus    O
of    O
Blastochloris    O
which    O
was    O
isolated    O
from    O
biofilm    B-Cell102991711
in    O
a    O
cold    O
sulfur    O
spring    O
in    O
Gulmarg    O
in    O
India    O
.    O

It    O
occurs    O
through    O
the    O
formation    O
of    O
slimes    B-Cell102991711
and    O
capsules    O
,    O
and    O
with    O
a    O
preference    O
for    O
binding    O
to    O
the    O
phosphate    O
and    O
phosphoryl    O
groups    O
(    O
although    O
it    O
also    O
occurs    O
with    O
carboxyl    O
,    O
amine    O
or    O
sulfhydryl    O
groups    O
)    O

In    O
"    O
Citrobacter    O
"    O
and    O
"    O
Serratia    O
"    O
genera    O
,    O
this    O
cleavage    O
liberates    O
inorganic    O
phosphates    O
(    O
HPO42−    O
)    O
that    O
precipitates    O
with    O
uranyl    O
ion    O
(    O
UO22    O
+    O
)    O
and    O
cause    O
deposition    O
of    O
polycrystalline    O
minerals    O
around    O
the    O
cell    O
wall    O
.    O
"    O
Serratia    O
"    O
also    O
form    O
biofilms    B-Cell102991711
that    O
promote    O
precipitation    O
of    O
chernikovite    O
(    O
rich    O
in    O
uranium    O
)    O
and    O
additionally    O
,    O
remove    O
up    O
to    O
85%    O
of    O
cobalt-60    O
and    O
97%    O
of    O
cesium-137    O
by    O
proton    O
substitution    O
of    O
this    O
mineral    O
.    O

Ethanol    O
is    O
also    O
used    O
in    O
soil    O
injection    O
systems    O
with    O
hydraulic    O
recirculations    O
:    O
it    O
raises    O
the    O
pH    O
and    O
promotes    O
the    O
growth    O
of    O
denitrifying    O
and    O
radionuclide    O
-    O
reducing    O
bacteria    O
,    O
that    O
produce    O
biofilms    B-Cell102991711
and    O
achieve    O
almost    O
90%    O
decrease    O
in    O
the    O
concentration    O
of    O
radioactive    O
uranium    O
.    O

Arthrobacter    O
tumbae    O
is    O
a    O
bacterium    O
species    O
from    O
the    O
genus    O
of    O
"    O
Arthrobacter    O
"    O
which    O
has    O
been    O
isolated    O
from    O
a    O
biofilm    B-Cell102991711
which    O
covered    O
a    O
Servilia    O
tomb    O
in    O
the    O
Roman    O
necropolis    O
of    O
Carmona    O
in    O
Carmona    O
in    O
Spain    O
.    O

It    O
is    O
often    O
seen    O
in    O
biofilm    B-Cell102991711
on    O
chronic    O
ulcers    O
such    O
as    O
in    O
diabetic    O
foot    O
or    O
decubitus    O
ulcers    O
.    O

Additionally    O
,    O
nanowires    O
can    O
facilitate    O
long    O
-    O
range    O
electron    O
transfer    O
across    O
thick    O
"    O
biofilm    B-Cell102991711
"    O
layers    O
.    O

Harmful    O
bacteria    O
and    O
viruses    O
are    O
reduced    O
by    O
filtration    O
and    O
adsorption    O
by    O
biofilm    B-Cell102991711
on    O
the    O
gravel    O
or    O
sand    O
media    O
in    O
subsurface    O
flow    O
and    O
vertical    O
flow    O
systems    O
.    O

Water    O
stagnating    O
in    O
a    O
hose    O
between    O
uses    O
,    O
especially    O
when    O
warmed    O
by    O
the    O
sun    O
,    O
can    O
host    O
the    O
growth    O
and    O
interaction    O
of    O
"    O
Legionella    O
"    O
and    O
free    O
-    O
living    O
amoebae    O
(    O
FLA    O
)    O
as    O
biofilm    B-Cell102991711
on    O
the    O
inner    O
surface    O
of    O
the    O
hose    O
.    O

Some    O
show    O
promise    O
,    O
such    O
as    O
to    O
affect    O
the    O
formation    O
of    O
biofilm    B-Cell102991711
on    O
surfaces    O
or    O
medical    O
equipment    O
,    O
and    O
in    O
other    O
"    O
in    O
vitro    O
"    O
situations    O
.    O

It    O
normally    O
produces    O
slime    B-Cell102991711
but    O
not    O
capsules    O
.    O

Scientists    O
have    O
successfully    O
engineered    O
it    O
to    O
create    O
a    O
biofilm    B-Cell102991711
which    O
produce    O
electricity    O
.    O

Hilary    O
Margaret    O
Lappin    O
-    O
Scott    O
(    O
born    O
1955    O
)    O
is    O
a    O
British    O
microbiologist    O
who    O
studies    O
the    O
function    O
of    O
microbial    O
biofilms    B-Cell102991711
.    O

When    O
dentures    O
are    O
worn    O
in    O
the    O
mouth    O
,    O
a    O
biofilm    B-Cell102991711
develops    O
which    O
may    O
be    O
similar    O
to    O
dental    O
plaque    O
.    O

Several    O
microbes    O
can    O
be    O
a    O
source    O
for    O
VA    O
,    O
including    O
"    O
Acetobacter    O
"    O
,    O
"    O
Brettanomyces    O
"    O
,    O
and    O
film    B-Cell102991711
yeast    I-Cell102991711
such    O
as    O
"    O
Candida    O
"    O
,    O
as    O
well    O
as    O
LAB    O
.    O

Such    O
activities    O
include    O
symbiosis    O
,    O
virulence    O
,    O
motility    O
,    O
antibiotic    O
production    O
,    O
and    O
biofilm    B-Cell102991711
formation    O
.    O

It    O
feeds    O
on    O
algae    O
and    O
other    O
materials    O
that    O
occur    O
in    O
the    O
organic    B-Cell102991711
film    I-Cell102991711
which    O
is    O
found    O
on    O
the    O
surface    O
of    O
plants    O
and    O
debris    O
.    O

This    O
study    O
will    O
allow    O
researchers    O
to    O
begin    O
to    O
determine    O
whether    O
biofilms    B-Cell102991711
are    O
forming    O
on    O
the    O
plastic    O
particles    O
,    O
whether    O
the    O
microbes    O
living    O
on    O
the    O
particles    O
are    O
different    O
from    O
the    O
free    O
-    O
living    O
planktonic    O
organisms    O
,    O
and    O
what    O
effect    O
these    O
communities    O
might    O
have    O
on    O
the    O
oceanic    O
carbon    O
cycle    O
and    O
nitrogen    O
cycle    O
.    O

A    O
2012    O
"    O
in    O
vitro    O
"    O
study    O
found    O
that    O
miltefosine    O
had    O
promising    O
activity    O
against    O
C.    O
albicans    O
biofilm    B-Cell102991711
.    O

Aloke    O
Kumar    O
-    O
Canada    O
Research    O
Chair    O
in    O
Biofilm    B-Cell102991711
and    O
pioneer    O
of    O
Optoelectrofluidics    O

Essential    O
amino    O
acids    O
are    O
provided    O
to    O
aphids    O
by    O
bacterial    O
endosymbionts    O
,    O
harboured    O
in    O
special    O
cells    O
,    O
bacteriocyte    B-Cell102991711
.    O

Aphids    O
harbour    O
a    O
vertically    O
transmitted    O
(    O
from    O
parent    O
to    O
its    O
offspring    O
)    O
obligate    O
symbiosis    O
with    O
"    O
Buchnera    O
aphidicola    O
"    O
(    O
Buchner    O
)    O
(    O
Proteobacteria    O
:    O
Enterobacteriaceae    O
)    O
,    O
referred    O
to    O
as    O
the    O
primary    O
symbiont    O
,    O
which    O
is    O
located    O
inside    O
specialised    O
cells    O
,    O
the    O
bacteriocytes    B-Cell102991711
.    O

[    O
A    O
]    O
Gram    O
-    O
negative    O
with    O
a    O
peptidoglycan    O
cell    O
wall    O
like    O
Chlorosome    B-Cell102991711
.    O

They    O
contain    O
bacteriochlorophyll    O
c    O
and    O
chlorosome    B-Cell102991711
.    O

In    O
sponges    O
,    O
amebocytes    O
,    O
also    O
known    O
as    O
archaeocyte    B-Cell102991711
,    O
are    O
cells    O
found    O
in    O
the    O
mesohyl    O
that    O
can    O
transform    O
into    O
any    O
of    O
the    O
animal    O
's    O
more    O
specialized    O
cell    O
types    O
.    O

Embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711

The    O
cells    O
of    O
the    O
inner    O
cell    O
mass    O
(    O
embryoblast    O
)    O
,    O
which    O
are    O
known    O
as    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
(    O
hESCs    O
)    O
,    O
will    O
further    O
differentiate    O
to    O
form    O
four    O
structures    O
:    O
the    O
amnion    O
,    O
the    O
yolk    O
sac    O
,    O
the    O
allantois    O
,    O
and    O
the    O
embryo    O
itself    O
.    O

Meisner    O
is    O
an    O
advocate    O
for    O
easing    O
restrictions    O
on    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
.    O

A    O
fully    O
automated    O
microfluidic    O
cell    O
culture    O
system    O
has    O
been    O
developed    O
to    O
study    O
osteogenic    O
differentiation    O
of    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
.    O

It    O
was    O
shown    O
that    O
the    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
(    O
ESC)-specific    O
isoform    O
of    O
FOXP1    O
stimulates    O
the    O
expression    O
of    O
transcription    O
factor    O
genes    O
required    O
for    O
pluripotency    O
,    O
including    O
OCT4    O
,    O
NANOG    O
,    O
NR5A2    O
,    O
and    O
GDF3    O
,    O
while    O
concomitantly    O
repressing    O
genes    O
required    O
for    O
ESC    O
differentiation    O
.    O

The    O
film    O
follows    O
Dr.    O
Jack    O
Kessler    O
of    O
Northwestern    O
University    O
in    O
his    O
search    O
for    O
a    O
cure    O
for    O
spinal    O
cord    O
injuries    O
using    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
.    O

VSHL    O
works    O
opposes    O
abortion    O
,    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
,    O
and    O
euthanasia    O
in    O
Virginia    O
with    O
the    O
ultimate    O
goal    O
of    O
ending    O
those    O
practices    O
in    O
the    O
state    O
and    O
nationwide    O
.    O

In    O
2013    O
,    O
BioTime    O
acquired    O
the    O
stem    O
-    O
cell    O
assets    O
of    O
Geron    O
Corporation    O
,    O
with    O
the    O
aim    O
of    O
restarting    O
its    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
-    O
based    O
clinical    O
trial    O
for    O
spinal    O
cord    O
injury    O
.    O

In    O
November    O
2014    O
,    O
the    O
company    O
received    O
FDA    O
clearance    O
to    O
start    O
a    O
15-patient    O
Phase    O
1/2a    O
human    O
clinical    O
trial    O
using    O
human    B-Cell102991711
embryonic    I-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
-    O
derived    O
retinal    O
pigment    O
epithelial    O
cells    O
to    O
treat    O
age    O
-    O
related    O
macular    O
degeneration    O
(    O
AMD    O
)    O
.    O

mRNA    O
is    O
expressed    O
in    O
multiple    O
tissues    O
,    O
including    O
cardiac    O
muscle    O
,    O
mouse    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
,    O
brain    O
,    O
lung    O
,    O
skeletal    O
muscle    O
,    O
kidney    O
and    O
testis    O
;    O
however    O
expression    O
is    O
highest    O
in    O
cardiac    O
muscle    O
.    O

Several    O
target    O
genes    O
of    O
miR-137    O
have    O
been    O
documented    O
and    O
shown    O
to    O
play    O
important    O
roles    O
in    O
various    O
human    O
cancers    O
,    O
cell    O
cycle    O
signalling    O
and    O
mouse    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
development    O
.    O

The    O
use    O
of    O
CBEs    O
could    O
potentially    O
eliminate    O
the    O
ethical    O
difficulties    O
associated    O
with    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
(    O
ESCs    O
)    O
.    O

For    O
example    O
,    O
the    O
PI3K    O
/    O
AKT    O
pathway    O
is    O
used    O
by    O
laminin-111    O
(    O
promotes    O
cell    O
-    O
survival    O
)    O
,    O
511    O
(    O
prevents    O
apoptosis    O
with    O
laminin    O
521    O
)    O
,    O
and    O
521    O
(    O
stabilizes    O
pluripotency    O
of    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
)    O
.    O

KIAA1958    O
was    O
also    O
overexpressed    O
in    O
Stat5/ab    O
and    O
stat    O
3    O
which    O
are    O
transcription    O
factors    O
reported    O
to    O
be    O
critical    O
for    O
the    O
growth    O
and    O
viability    O
of    O
prostate    O
cancer    O
cells    O
and    O
both    O
the    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
and    O
the    O
pluripotent    O
stem    O
cell    O
.    O

The    O
Food    O
and    O
Drug    O
Administration    O
(    O
FDA    O
)    O
approved    O
the    O
first    O
clinical    O
trial    O
in    O
the    O
United    O
States    O
involving    O
human    B-Cell102991711
embryonic    I-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
on    O
January    O
23    O
,    O
2009    O
.    O

BioTime    O
indicated    O
that    O
it    O
plans    O
to    O
re    O
-    O
start    O
the    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
-    O
based    O
clinical    O
trial    O
for    O
spinal    O
cord    O
injury    O
.    O

He    O
voted    O
in    O
favor    O
of    O
expanding    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
.    O

Axordia    O
,    O
a    O
University    O
spinout    O
company    O
dealing    O
with    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
(    O
hESC    O
)    O
also    O
works    O
out    O
of    O
the    O
building    O
although    O
their    O
offices    O
are    O
in    O
the    O
Sheffield    O
Bioincubator    O
.    O

On    O
October    O
24    O
,    O
2006    O
,    O
he    O
was    O
featured    O
in    O
a    O
political    O
advertisement    O
opposing    O
an    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
bill    O
in    O
Missouri    O
.    O

As    O
recently    O
as    O
2004    O
,    O
the    O
hospital    O
did    O
perform    O
research    O
using    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
.    O

Matrigel    O
is    O
also    O
used    O
as    O
an    O
attachment    O
substrate    O
in    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
culture    O
.    O

However    O
,    O
Bush    O
did    O
not    O
support    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    O
.    O

Rat    O
strains    O
are    O
generally    O
not    O
transgenic    O
,    O
or    O
genetically    O
modified    O
,    O
because    O
the    O
gene    O
knockout    O
and    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
techniques    O
that    O
work    O
in    O
mice    O
are    O
relatively    O
difficult    O
in    O
rats    O
.    O

The    O
National    O
Academies    O
called    O
for    O
the    O
establishment    O
of    O
Embryonic    O
Stem    O
Cell    O
Research    O
Oversight    O
(    O
ESCRO    O
)    O
Committees    O
in    O
its    O
2005    O
"    O
Guidelines    O
for    O
Human    O
Embryonic    O
Stem    O
Cell    O
Research    O
"    O
to    O
manage    O
the    O
ethical    O
and    O
legal    O
concerns    O
in    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
.    O

Because    O
of    O
the    O
complexity    O
and    O
novelty    O
of    O
many    O
of    O
the    O
issues    O
involved    O
in    O
that    O
research    O
,    O
the    O
Guidelines    O
committee    O
believes    O
that    O
all    O
research    O
institutions    O
engaged    O
in    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
should    O
create    O
and    O
maintain    O
these    O
committees    O
at    O
the    O
local    O
level    O
.    O

The    O
National    O
Academies    O
'    O
Guidelines    O
make    O
clear    O
that    O
activities    O
related    O
to    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
should    O
be    O
overseen    O
by    O
an    O
ESCRO    O
committee    O
.    O

The    O
composition    O
of    O
ESCRO    O
committees    O
was    O
specified    O
to    O
include    O
representatives    O
of    O
the    O
public    O
and    O
people    O
with    O
expertise    O
in    O
developmental    O
biology    O
,    O
stem    O
cell    O
research    O
,    O
molecular    O
biology    O
,    O
assisted    O
reproduction    O
,    O
and    O
ethical    O
and    O
legal    O
issues    O
in    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
.    O

review    O
compliance    O
of    O
all    O
in    O
-    O
house    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
with    O
all    O
relevant    O
regulations    O
and    O
these    O
guidelines    O

maintain    O
registries    O
of    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
conducted    O
at    O
the    O
institution    O
and    O
hES    O
cell    O
lines    O
derived    O
or    O
imported    O
by    O
institutional    O
investigators    O

facilitate    O
education    O
of    O
investigators    O
involved    O
in    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
.    O

Since    O
the    O
discovery    O
of    O
embryonic    B-Cell102991711
stem    I-Cell102991711
(    O
ES    O
)    O
cells    O
(    O
1981    O
)    O
and    O
induced    O
pluripotent    O
stem    O
(    O
iPS    O
)    O
cells    O
(    O
2006    O
)    O
,    O
source    O
material    O
is    O
potentially    O
unlimited    O
.    O

Krauthammer    O
is    O
a    O
supporter    O
of    O
abortion    O
legalization    O
but    O
opposes    O
euthanasia    O
;    O
an    O
opponent    O
of    O
capital    O
punishment    O
;    O
a    O
critic    O
of    O
the    O
intelligent    O
design    O
movement    O
and    O
an    O
advocate    O
for    O
the    O
scientific    O
consensus    O
on    O
evolution    O
,    O
calling    O
the    O
religion    O
-    O
science    O
controversy    O
a    O
"    O
false    O
conflict    O
;    O
"    O
a    O
supporter    O
of    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
using    O
embryos    O
discarded    O
by    O
fertility    O
clinics    O
with    O
restrictions    O
in    O
its    O
applications    O
;    O
and    O
a    O
longtime    O
advocate    O
of    O
radically    O
higher    O
energy    O
taxes    O
to    O
induce    O
conservation    O
.    O

Hescheler    O
has    O
been    O
working    O
with    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
since    O
the    O
late    O
80    O
’s    O
.    O

He    O
became    O
the    O
first    O
researcher    O
to    O
accomplish    O
an    O
electrophysiological    O
characterisation    O
of    O
stem    O
cells    O
and    O
was    O
also    O
among    O
the    O
first    O
scientists    O
in    O
Germany    O
obtaining    O
permission    O
to    O
do    O
research    O
on    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
.    O

He    O
has    O
been    O
appointed    O
as    O
the    O
Coordinator    O
of    O
various    O
pan    O
-    O
European    O
consortia    O
including    O
the    O
large    O
-    O
scale    O
integrated    O
EU    O
-    O
projects    O
FunGenES    O
(    O
"    O
Functional    O
Genomics    O
of    O
Engineered    O
Embryonic    B-Cell102991711
Stem    I-Cell102991711
Cells    I-Cell102991711
)    O
,    O
CRYSTAL    O
(    O
"    O
Cryo    O
-    O
banking    O
of    O
stem    O
cells    O
for    O
human    O
Therapeutic    O
Application    O
"    O
)    O
,    O
ESNATS    O
(    O
"    O
Embryonic    O
stem    O
cell    O
-    O
based    O
Novel    O
Alternative    O
Testing    O
Strategies    O
"    O
)    O
,    O
and    O
DETECTIVE    O
-    O
Detection    O
of    O
endpoints    O
and    O
biomarkers    O
for    O
repeated    O
dose    O
toxicity    O
using    O
in    O
vitro    O
systems    O
.    O

Hescheler    O
has    O
been    O
working    O
with    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
ever    O
since    O
the    O
late    O
1980s    O
.    O

He    O
achieved    O
a    O
first    O
functional    O
characterization    O
of    O
cardiomyocytes    O
developed    O
from    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
which    O
is    O
an    O
important    O
prerequisite    O
for    O
their    O
subsequent    O
use    O
in    O
regenerative    O
medicine    O
.    O

In    O
2002    O
,    O
he    O
was    O
among    O
the    O
first    O
scientists    O
in    O
Germany    O
to    O
obtain    O
permission    O
to    O
work    O
with    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
.    O

O'Donnell    O
opposes    O
human    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
,    O
human    O
cloning    O
,    O
and    O
research    O
into    O
cloning    O
monkey    O
embryos    O
.    O

The    O
pluripotent    O
cell    O
types    O
that    O
comprise    O
embryoid    O
bodies    O
include    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
(    O
ESCs    O
)    O
derived    O
from    O
the    O
blastocyst    O
stage    O
of    O
embryos    O
from    O
mouse    O
(    O
mESC    O
)    O
,    O
primate    O
,    O
and    O
human    O
(    O
hESC    O
)    O
sources    O
.    O

At    O
Geron    O
,    O
West    O
initiated    O
and    O
managed    O
programs    O
in    O
telomere    O
biology    O
relating    O
to    O
aging    O
,    O
cancer    O
and    O
human    B-Cell102991711
embryonic    I-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
technology    O
.    O

embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711

Recent    O
examples    O
of    O
tensions    O
have    O
been    O
the    O
creation    O
-    O
evolution    O
controversy    O
,    O
controversies    O
over    O
the    O
use    O
of    O
birth    O
control    O
,    O
opposition    O
to    O
research    O
into    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
,    O
or    O
theological    O
objections    O
to    O
vaccination    O
,    O
anesthesia    O
,    O
and    O
blood    O
transfusion    O
.    O

nanOg    O
)    O
is    O
a    O
transcription    O
factor    O
critically    O
involved    O
with    O
self    O
-    O
renewal    O
of    O
undifferentiated    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
.    O

NANOG    O
is    O
a    O
transcription    O
factor    O
in    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
(    O
ESCs    O
)    O
and    O
is    O
thought    O
to    O
be    O
a    O
key    O
factor    O
in    O
maintaining    O
pluripotency    O
.    O

Knockdown    O
of    O
NANOG    O
in    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
results    O
in    O
a    O
reduction    O
of    O
Rex1    O
expression    O
,    O
while    O
forced    O
expression    O
of    O
NANOG    O
stimulates    O
Rex1    O
expression    O
.    O

Researchers    O
have    O
been    O
able    O
to    O
create    O
neural    O
chimeras    O
by    O
combining    O
neurons    O
that    O
developed    O
from    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
with    O
glial    O
cells    O
that    O
were    O
also    O
derived    O
from    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cells    I-Cell102991711
.    O

They    O
are    O
derived    O
from    O
one    O
or    O
a    O
few    O
cells    O
from    O
a    O
tissue    O
,    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
or    O
induced    O
pluripotent    O
stem    O
cells    O
,    O
which    O
can    O
self    O
-    O
organize    O
in    O
three    O
-    O
dimensional    O
culture    O
owing    O
to    O
their    O
self    O
-    O
renewal    O
and    O
differentiation    O
capacities    O
.    O

In    O
2014    O
,    O
Artem    O
Shkumatov    O
et    O
al    O
.    O
at    O
the    O
University    O
of    O
Illinois    O
at    O
Urbana    O
-    O
Champaign    O
demonstrated    O
that    O
cardiovascular    O
organoids    O
can    O
be    O
formed    O
from    O
ES    B-Cell102991711
cells    I-Cell102991711
through    O
modulation    O
of    O
the    O
substrate    O
stiffness    O
,    O
to    O
which    O
they    O
adhere    O
.    O

Cord    O
blood    O
contains    O
hematopoietic    O
stem    O
cells    O
(    O
which    O
can    O
differentiate    O
only    O
into    O
blood    O
cells    O
)    O
,    O
and    O
should    O
not    O
be    O
confused    O
with    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
or    O
pluripotent    O
stem    O
cells    O
,    O
which    O
can    O
differentiate    O
into    O
any    O
cell    O
in    O
the    O
body    O
.    O

In    O
March    O
2009    O
,    O
he    O
described    O
President    O
Barack    O
Obama    O
's    O
lifting    O
of    O
George    O
W.    O
Bush    O
's    O
restrictions    O
on    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
as    O
"    O
a    O
sad    O
victory    O
of    O
politics    O
over    O
science    O
and    O
ethics    O
.    O
"    O

PPFA    O
notes    O
that    O
LDI    O
is    O
opposed    O
to    O
abortion    O
,    O
fetal    O
tissue    O
and    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
research    I-Cell102991711
,    O
Planned    O
Parenthood    O
,    O
and    O
the    O
International    O
Planned    O
Parenthood    O
Federation    O
.    O

Research    O
has    O
been    O
conducted    O
concerning    O
the    O
use    O
of    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
(    O
ESCs    O
)    O
in    O
regenerative    O
medicine    O
.    O

While    O
a    O
fellow    O
at    O
the    O
Imperial    O
Cancer    O
Research    O
Fund    O
,    O
(    O
now    O
Cancer    O
Research    O
UK    O
)    O
laboratory    O
in    O
Oxford    O
,    O
Beddington    O
and    O
Elizabeth    O
Robertson    O
recognised    O
the    O
potential    O
of    O
embryonic    B-Cell102991711
stem    I-Cell102991711
cell    I-Cell102991711
for    O
the    O
study    O
of    O
genetic    O
manipulation    O
after    O
demonstrating    O
the    O
ability    O
of    O
these    O
cells    O
to    O
colonise    O
developing    O
embryos    O
.    O

It    O
was    O
later    O
recognized    O
that    O
the    O
animal    O
's    O
blood    O
cells    O
,    O
mobile    O
cells    O
called    O
amoebocyte    B-Cell102991711
,    O
contain    O
granules    O
with    O
a    O
clotting    O
factor    O
known    O
as    O
coagulogen    O
;    O
this    O
is    O
released    O
outside    O
the    O
cell    O
when    O
bacterial    O
endotoxin    O
is    O
encountered    O
.    O

An    O
amebocyte    B-Cell102991711
or    O
amoebocyte    B-Cell102991711
is    O
a    O
mobile    O
cell    O
(    O
moving    O
like    O
an    O
amoeba    O
)    O
in    O
the    O
body    O
of    O
invertebrates    O
including    O
echinoderms    O
,    O
molluscs    O
,    O
tunicates    O
,    O
sponges    O
and    O
some    O
chelicerates    O
.    O

Cell    B-Cell102991711
sorting    I-Cell102991711

CD28    O
is    O
the    O
only    O
B7    O
receptor    O
constitutively    O
expressed    O
on    O
naive    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
.    O

Association    O
of    O
the    O
TCR    O
of    O
a    O
naive    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
with    O
MHC    O
:    O
antigen    O
complex    O
without    O
CD28:B7    O
interaction    O
results    O
in    O
a    O
T    O
cell    O
that    O
is    O
anergic    O
.    O

Naive    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711

The    O
MHC    O
can    O
not    O
reach    O
the    O
cell    O
surface    O
and    O
therefore    O
can    O
not    O
activate    O
the    O
T    B-Cell102991711
cell    I-Cell102991711
response    O
.    O

B7    O
is    O
a    O
type    O
of    O
peripheral    O
membrane    O
protein    O
found    O
on    O
activated    O
antigen    B-Cell102991711
presenting    I-Cell102991711
cell    I-Cell102991711
(    O
APC    O
)    O
that    O
,    O
when    O
paired    O
with    O
either    O
a    O
CD28    O
or    O
CD152    O
(    O
CTLA-4    O
)    O
surface    O
protein    O
on    O
a    O
T    B-Cell102991711
cell    I-Cell102991711
,    O
can    O
produce    O
a    O
costimulatory    O
signal    O
or    O
a    O
coinhibitory    O
signal    O
to    O
enhance    O
or    O
decrease    O
the    O
activity    O
of    O
a    O
MHC    O
-    O
TCR    O
signal    O
between    O
the    O
APC    O
and    O
the    O
T    O
cell    O
,    O
respectively    O
.    O

In    O
the    O
macrophage    O
,    O
the    O
primary    O
signal    O
for    O
activation    O
is    O
IFN-γ    O
from    O
Th1    O
type    O
CD4    O
T    B-Cell102991711
cell    I-Cell102991711
.    O

If    O
an    O
activated    O
T    B-Cell102991711
cell    I-Cell102991711
recognizes    O
the    O
peptide    O
presented    O
by    O
the    O
B    O
cell    O
,    O
the    O
CD40L    O
on    O
the    O
T    O
cell    O
binds    O
to    O
the    O
B    O
cell    O
's    O
CD40    O
receptor    O
,    O
causing    O
B    O
cell    O
activation    O
.    O

IL-22    O
is    O
produced    O
by    O
activated    O
NK    B-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
and    O
initiates    O
innate    O
immune    O
responses    O
against    O
bacterial    O
pathogens    O
especially    O
in    O
epithelial    O
cells    O
such    O
as    O
respiratory    O
and    O
gut    O
epithelial    O
cells    O
.    O

An    O
important    O
physiological    O
role    O
of    O
the    O
IK    O
channel    O
is    O
to    O
help    O
maintain    O
large    O
electrical    O
gradients    O
for    O
the    O
sustained    O
transport    O
of    O
ions    O
such    O
as    O
Ca2    O
+    O
that    O
controls    O
T    B-Cell102991711
lymphocyte    I-Cell102991711
(    O
T    O
cell    O
)    O
proliferation    O
.    O

Originally    O
,    O
Th17    O
was    O
identified    O
in    O
1993    O
by    O
Rouvier    O
"    O
et    O
al    O
.    O
"    O
who    O
isolated    O
IL17    O
transcript    O
from    O
a    O
rodent    O
T-cell    B-Cell102991711
hybridoma    O
.    O

The    O
expression    O
of    O
IL-17A    O
and    O
IL-17F    O
appear    O
to    O
be    O
restricted    O
to    O
a    O
small    O
group    O
of    O
activated    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
upregulated    O
during    O
inflammation    O
.    O

Although    O
IL-23    O
is    O
not    O
required    O
for    O
IL-17    O
expression    O
in    O
this    O
situation    O
,    O
IL-23    O
may    O
play    O
a    O
role    O
in    O
promoting    O
survival    O
and/or    O
proliferation    O
of    O
the    O
IL-17    O
producing    O
T-cell    B-Cell102991711
.    O

Cytokines    O
released    O
from    O
DCs    O
stimulate    O
dying    O
keratinocytes    O
to    O
secrete    O
TNF    O
-    O
alpha    O
,    O
IL-1    O
and    O
IL-6    O
leading    O
to    O
the    O
chemotaxis    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
and    O
monocytes    O
to    O
the    O
epidermis    O
.    O

It    O
can    O
be    O
absorbed    O
by    O
cells    O
that    O
are    O
not    O
infected    O
with    O
HIV    O
,    O
and    O
can    O
act    O
directly    O
as    O
a    O
toxin    O
producing    O
cell    O
death    O
via    O
apoptosis    O
in    O
uninfected    O
"    O
bystander    O
"    O
T    B-Cell102991711
cell    I-Cell102991711
,    O
assisting    O
in    O
progression    O
toward    O
AIDS    O
.    O

They    O
are    O
populated    O
largely    O
by    O
T    B-Cell102991711
cell    I-Cell102991711
and    O
surround    O
central    O
arteries    O
within    O
the    O
spleen    O
;    O
the    O
PALS    O
T    O
-    O
cells    O
are    O
presented    O
with    O
blood    O
borne    O
antigens    O
via    O
myeloid    B-Cell102991711
dendritic    I-Cell102991711
cells    I-Cell102991711
.    O

Immunosuppressive    O
effects    O
are    O
mediated    O
by    O
suppressing    O
delayed    O
hypersensitivity    O
reactions    O
by    O
direct    O
action    O
on    O
T-lymphocytes    B-Cell102991711
.    O

Bird    O
taxa    O
that    O
are    O
capable    O
of    O
exerting    O
stronger    O
antiparasitic    O
defense    O
—    O
such    O
as    O
stronger    O
T    B-Cell102991711
cell    I-Cell102991711
immune    O
response    O
or    O
larger    O
uropygial    O
glands    O
—    O
harbor    O
more    O
taxa    O
of    O
Amblyceran    O
lice    O
than    O
others    O
.    O

Blast    O
cells    O
are    O
involved    O
in    O
generation    O
of    O
B-    B-Cell102991711
and    O
T-lymphocytes    B-Cell102991711
,    O
which    O
participate    O
in    O
immune    O
responses    O
.    O

The    O
receptor    O
is    O
commonly    O
found    O
on    O
the    O
cell    O
surfaces    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
.    O

These    O
carbohydrates    O
include    O
members    O
of    O
the    O
Lewis    O
X    O
and    O
Lewis    O
A    O
families    O
found    O
on    O
monocytes    O
,    O
granulocytes    O
,    O
and    O
T-lymphocyte    B-Cell102991711
.    O

In    O
addition    O
,    O
histological    O
analysis    O
revealed    O
that    O
the    O
meningeal    O
lymphatics    O
constitutively    O
contain    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
MHC    O
class    O
II    O
-    O
expressing    O
myeloid    O
cells    O
,    O
demonstrating    O
that    O
meningeal    O
lymphatic    O
vessels    O
are    O
capable    O
of    O
carrying    O
immune    O
cells    O
.    O

It    O
is    O
an    O
acute    O
-    O
phase    O
protein    O
of    O
hepatic    O
origin    O
that    O
increases    O
following    O
interleukin-6    O
secretion    O
by    O
macrophages    O
and    O
T    B-Cell102991711
cell    I-Cell102991711
.    O

It    O
should    O
not    O
be    O
confused    O
with    O
the    O
term    O
"    O
Downey    B-Cell102991711
bodies    I-Cell102991711
"    O
,    O
which    O
refers    O
to    O
a    O
type    O
of    O
T    B-Cell102991711
cell    I-Cell102991711
observed    O
in    O
infectious    O
mononucleosis    O
.    O

FMS    O
-    O
like    O
tyrosine    O
kinase    O
3    O
ligand    O
(    O
FLT3L    O
)    O
is    O
an    O
endogenous    O
small    O
molecule    O
that    O
functions    O
as    O
a    O
cytokine    O
and    O
growth    O
factor    O
that    O
increases    O
the    O
number    O
of    O
immune    O
cells    O
(    O
lymphocytes    O
(    O
B    B-Cell102991711
cell    I-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
)    O
)    O
by    O
activating    O
the    O
hematopoietic    O
progenitors    O
.    O

This    O
outcome    O
has    O
been    O
associated    O
with    O
an    O
immunodominant    O
T    B-Cell102991711
cell    I-Cell102991711
epitope    O
of    O
outer    O
-    O
surface    O
protein    O
A    O
(    O
OspA    O
)    O
of    O
the    O
spirochete    O
.    O

Schwann    O
cells    O
are    O
involved    O
in    O
many    O
important    O
aspects    O
of    O
peripheral    O
nerve    O
biology    O
—    O
the    O
conduction    O
of    O
nervous    O
impulses    O
along    O
axons    O
,    O
nerve    O
development    O
and    O
regeneration    O
,    O
trophic    O
support    O
for    O
neurons    O
,    O
production    O
of    O
the    O
nerve    O
extracellular    O
matrix    O
,    O
modulation    O
of    O
neuromuscular    O
synaptic    O
activity    O
,    O
and    O
presentation    O
of    O
antigens    O
to    O
T-lymphocytes    B-Cell102991711
.    O

Nivolumab    O
works    O
as    O
a    O
checkpoint    O
inhibitor    O
,    O
blocking    O
a    O
signal    O
that    O
would    O
have    O
prevented    O
activated    O
T    B-Cell102991711
cells    I-Cell102991711
from    O
attacking    O
the    O
cancer    O
,    O
thus    O
allowing    O
the    O
immune    O
system    O
to    O
clear    O
the    O
cancer    O
.    O

Nivolumab    O
acts    O
by    O
blocking    O
a    O
negative    O
regulator    O
of    O
T-cell    B-Cell102991711
activation    O
and    O
response    O
,    O
thus    O
allowing    O
the    O
immune    O
system    O
to    O
attack    O
the    O
tumor    O
.    O

It    O
offers    O
an    O
explanation    O
for    O
how    O
TCR    O
binding    O
to    O
its    O
ligand    O
triggers    O
T-cell    B-Cell102991711
activation    O
,    O
based    O
on    O
size    O
-    O
sensitivity    O
for    O
the    O
molecules    O
involved    O
.    O
Simon    O
J.    O
Davis    O
and    O
Anton    O
van    O
der    O
Merwe    O
,    O
University    O
of    O
Oxford    O
,    O
proposed    O
this    O
model    O
in    O
1996    O
.    O

It    O
has    O
a    O
signaling    O
role    O
,    O
as    O
a    O
GPI    O
anchored    O
molecule    O
,    O
in    O
T    B-Cell102991711
cell    I-Cell102991711
activation    O
and    O
appears    O
to    O
have    O
some    O
role    O
in    O
cell    O
adhesion    O
through    O
CD2    O
(    O
controversial    O
)    O
.    O

Sequence    O
analysis    O
of    O
small    O
RNA    O
clone    O
libraries    O
comparing    O
miRNA    O
expression    O
to    O
all    O
other    O
organ    O
systems    O
examined    O
established    O
that    O
miR-155    O
-    O
5p    O
was    O
one    O
of    O
five    O
miRNAs    O
(    O
i.e.    O
miR-142    O
,    O
miR-144    O
,    O
miR-150    O
,    O
miR-155    O
,    O
and    O
miR-223    O
)    O
that    O
was    O
specific    O
for    O
hematopoietic    O
cells    O
including    O
B-cells    B-Cell102991711
,    O
T-cells    B-Cell102991711
,    O
monocytes    O
and    O
granulocytes    O
.    O

CLPs    O
subsequently    O
differentiate    O
into    O
B-cells    B-Cell102991711
and    O
T-cells    B-Cell102991711
in    O
a    O
process    O
designated    O
lymphopoiesis    O
.    O

CD4    O
+    O
T    O
cells    O
are    O
the    O
helper    O
T    B-Cell102991711
cell    I-Cell102991711
which    O
detect    O
foreign    O
particles    O
in    O
the    O
body    O
,    O
and    O
call    O
CD8    O
+    O
T    O
cells    O
to    O
facilitate    O
death    O
of    O
the    O
foreign    O
particles    O
.    O

Anti    O
-    O
RA33    O
antibodies    O
and    O
T    B-Cell102991711
cells    I-Cell102991711
directed    O
against    O
RA33    O
might    O
contribute    O
to    O
autoimmunity    O
and    O
inflammation    O
by    O
immune    O
complex    O
formation    O
or    O
by    O
virtue    O
of    O
secretion    O
of    O
cytokines    O
that    O
may    O
initiate    O
and    O
drive    O
the    O
pathogenic    O
process    O
.    O

He    O
described    O
the    O
immunopathology    O
of    O
idiopathic    O
demyelinating    O
neuropathy    O
showing    O
T    B-Cell102991711
cell    I-Cell102991711
subsets    O
,    O
mononuclear    O
cells    O
and    O
Human    O
Leukocyte    O
Antigen    O
class    O
I    O
and    O
II    O
expression    O
within    O
nerve    O
,    O
demonstrating    O
the    O
possibility    O
of    O
an    O
immunological    O
role    O
for    O
Schwann    O
cells    O
,    O
and    O
challenging    O
the    O
dogma    O
that    O
nerve    O
was    O
an    O
immunologically    O
privileged    O
site    O
.    O

A    O
membrane    O
nanotube    O
or    O
tunnelling    O
nanotube    O
is    O
a    O
term    O
that    O
has    O
been    O
applied    O
to    O
protrusions    O
that    O
extend    O
from    O
the    O
plasma    O
membrane    O
that    O
enable    O
different    O
animal    O
cells    O
to    O
touch    O
over    O
long    O
distances    O
,    O
sometimes    O
over    O
100    O
μm    O
between    O
T    B-Cell102991711
cells    I-Cell102991711
.    O

Riniker    O
syndrome    O
,    O
severe    O
mixed    O
immunodeficiency    O
syndrome    O
,    O
and    O
thymic    O
alymphoplasia    O
,    O
is    O
a    O
rare    O
genetic    O
disorder    O
characterized    O
by    O
the    O
disturbed    O
development    O
of    O
functional    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
B    B-Cell102991711
cells    I-Cell102991711
caused    O
by    O
numerous    O
genetic    O
mutations    O
that    O
result    O
in    O
heterogeneous    O
clinical    O
presentations    O
.    O

Consequently    O
,    O
both    O
"    O
arms    O
"    O
(    O
B    B-Cell102991711
cell    I-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
)    O
of    O
the    O
adaptive    O
immune    O
system    O
are    O
impaired    O
due    O
to    O
a    O
defect    O
in    O
one    O
of    O
several    O
possible    O
genes    O
.    O

ARGX-115    O
is    O
a    O
first    O
-    O
in    O
-    O
class    O
immunotherapy    O
targeting    O
GARP    O
(    O
glycoprotein    O
A    O
repetitions    O
predominant    O
)    O
,    O
a    O
membrane    O
protein    O
believed    O
to    O
enhance    O
the    O
immunosuppressive    O
effects    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
.    O

Acquired    O
immune    O
system    O
cells    O
called    O
T-cells    B-Cell102991711
are    O
known    O
to    O
be    O
present    O
at    O
the    O
site    O
of    O
lesions    O
.    O

Severe    O
combined    O
immunodeficiency    O
(    O
SCID    O
)    O
caused    O
by    O
T-cell    B-Cell102991711
deficiency    O
is    O
a    O
disorder    O
that    O
was    O
recently    O
added    O
to    O
newborn    O
screening    O
programs    O
in    O
some    O
regions    O
of    O
the    O
United    O
States    O
.    O

It    O
is    O
phosphorylated    O
in    O
T    B-Cell102991711
cell    I-Cell102991711
and    O
other    O
HIV    O
target    O
cells    O
into    O
its    O
active    O
triphosphate    O
form    O
,    O
ddCTP    O
.    O

Many    O
cancers    O
protect    O
themselves    O
from    O
the    O
immune    O
system    O
by    O
inhibiting    O
the    O
T    B-Cell102991711
cell    I-Cell102991711
signal    O
.    O

This    O
is    O
caused    O
by    O
the    O
synchronous    O
division    O
of    O
T    B-Cell102991711
cell    I-Cell102991711
over    O
time    O
,    O
with    O
T    O
-    O
effector    O
cells    O
boosting    O
immune    O
activity    O
followed    O
by    O
T    O
-    O
regulatory    O
cells    O
suppressing    O
the    O
immune    O
response    O
.    O

Natural    B-Cell102991711
killer    I-Cell102991711
('NK')    I-Cell102991711
cells    I-Cell102991711
are    O
cytotoxic    O
innate    O
effector    O
cells    O
analogous    O
to    O
the    O
cytotoxic    O
T    B-Cell102991711
cells    I-Cell102991711
of    O
the    O
adaptive    O
immune    O
system    O
.    O

Although    O
not    O
confirmed    O
as    O
yet    O
,    O
this    O
system    O
presumably    O
will    O
be    O
where    O
naive    O
(    O
unstimulated    O
)    O
T    B-Cell102991711
cells    I-Cell102991711
accumulate    O
while    O
waiting    O
to    O
encounter    O
an    O
antigen    O
.    O

There    O
are    O
two    O
major    O
mechanisms    O
of    O
immune    O
evasion    O
such    O
as    O
induction    O
of    O
immune    O
suppressive    O
IL-10    O
responses    O
and    O
the    O
generation    O
of    O
poor    O
and    O
functionally    O
impaired    O
CD8(+    O
)    O
T-cell    B-Cell102991711
responses    O
.    O

Direct    O
evidence    O
from    O
transfer    O
of    O
disease    O
-    O
causing    O
antibody    O
or    O
disease    O
-    O
causing    O
T    B-Cell102991711
lymphocyte    I-Cell102991711
white    I-Cell102991711
blood    I-Cell102991711
cells    I-Cell102991711

The    O
human    O
immune    O
system    O
typically    O
produces    O
both    O
T-cells    B-Cell102991711
and    O
B-cells    B-Cell102991711
that    O
are    O
capable    O
of    O
being    O
reactive    O
with    O
self    O
-    O
antigens    O
,    O
but    O
these    O
self    O
-    O
reactive    O
cells    O
are    O
usually    O
either    O
killed    O
prior    O
to    O
becoming    O
active    O
within    O
the    O
immune    O
system    O
,    O
placed    O
into    O
a    O
state    O
of    O
anergy    O
(    O
silently    O
removed    O
from    O
their    O
role    O
within    O
the    O
immune    O
system    O
due    O
to    O
over    O
-    O
activation    O
)    O
,    O
or    O
removed    O
from    O
their    O
role    O
within    O
the    O
immune    O
system    O
by    O
regulatory    O
cells    O
.    O

Dendritic    O
cells    O
serve    O
as    O
a    O
link    O
between    O
the    O
bodily    O
tissues    O
and    O
the    O
innate    O
and    O
adaptive    O
immune    O
systems    O
,    O
as    O
they    O
present    O
antigens    O
to    O
T    B-Cell102991711
cell    I-Cell102991711
,    O
one    O
of    O
the    O
key    O
cell    O
types    O
of    O
the    O
adaptive    O
immune    O
system    O
.    O

These    O
reactions    O
are    O
mediated    O
by    O
T    B-Cell102991711
cell    I-Cell102991711
,    O
monocytes    O
,    O
and    O
macrophages    O
.    O

The    O
most    O
well    O
-    O
known    O
disease    O
that    O
affects    O
the    O
immune    O
system    O
itself    O
is    O
AIDS    O
,    O
an    O
immunodeficiency    O
characterized    O
by    O
the    O
suppression    O
of    O
CD4    O
+    O
(    O
"    O
helper    O
"    O
)    O
T    B-Cell102991711
cell    I-Cell102991711
,    O
dendritic    B-Cell102991711
cells    I-Cell102991711
and    O
macrophages    O
by    O
the    O
Human    O
Immunodeficiency    O
Virus    O
(    O
HIV    O
)    O
.    O

In    O
addition    O
,    O
ion    O
channels    O
are    O
key    O
components    O
in    O
a    O
wide    O
variety    O
of    O
biological    O
processes    O
that    O
involve    O
rapid    O
changes    O
in    O
cells    O
,    O
such    O
as    O
cardiac    O
,    O
skeletal    O
,    O
and    O
smooth    O
muscle    O
contraction    O
,    O
epithelial    O
transport    O
of    O
nutrients    O
and    O
ions    O
,    O
T-cell    B-Cell102991711
activation    O
and    O
pancreatic    O
beta    O
-    O
cell    O
insulin    O
release    O
.    O

The    O
inflammation    O
aspect    O
is    O
characterized    O
by    O
the    O
cloning    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
that    O
appear    O
to    O
be    O
driven    O
by    O
specific    O
antigens    O
to    O
invade    O
muscle    O
fibers    O
.    O

Dalakas    O
(    O
2006    O
)    O
suggested    O
that    O
a    O
chain    O
of    O
events    O
causes    O
IBM    O
—    O
some    O
sort    O
of    O
virus    O
,    O
likely    O
a    O
retrovirus    O
,    O
triggers    O
the    O
cloning    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
.    O

This    O
process    O
is    O
called    O
antigen    O
presentation    O
and    O
it    O
leads    O
to    O
activation    O
of    O
T    B-Cell102991711
lymphocyte    I-Cell102991711
,    O
which    O
then    O
mount    O
a    O
specific    O
immune    O
response    O
against    O
the    O
antigen    O
.    O

Researchers    O
at    O
the    O
Abramson    O
Cancer    O
Center    O
of    O
the    O
University    O
of    O
Pennsylvania    O
School    O
of    O
Medicine    O
reported    O
preliminary    O
success    O
in    O
the    O
use    O
of    O
gene    O
therapy    O
,    O
through    O
genetically    O
modified    O
T    B-Cell102991711
cell    I-Cell102991711
,    O
to    O
treat    O
CLL    O
.    O

Naturalistic    O
stressors    O
were    O
associated    O
with    O
increases    O
in    O
number    O
of    O
circulating    O
neutrophils    O
,    O
decreases    O
in    O
number    O
and    O
percentages    O
of    O
total    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
helper    B-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
and    O
decreases    O
in    O
percentages    O
of    O
Natural    B-Cell102991711
killer    I-Cell102991711
cell    I-Cell102991711
(    O
NK    O
)    O
cells    O
and    O
cytotoxic    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
lymphocytes    O
.    O

They    O
can    O
restore    O
the    O
response    O
of    O
purified    O
T    B-Cell102991711
lymphocytes    I-Cell102991711
to    O
Con    O
A.    O

V(D)J    O
recombination    O
is    O
the    O
rearrangement    O
of    O
multiple    O
,    O
distinct    O
gene    O
segments    O
in    O
germ    O
-    O
line    O
DNA    O
to    O
produce    O
the    O
unique    O
protein    O
domains    O
of    O
immune    O
cells    O
,    O
B    B-Cell102991711
cells    I-Cell102991711
and    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
that    O
will    O
specifically    O
recognize    O
foreign    O
antigens    O
such    O
as    O
viruses    O
,    O
bacteria    O
,    O
and    O
pathogenic    O
eukaryotes    O
.    O

CXCL16    O
is    O
produced    O
by    O
dendritic    B-Cell102991711
cell    I-Cell102991711
found    O
in    O
the    O
T    B-Cell102991711
cell    I-Cell102991711
zones    O
of    O
lymphoid    O
organs    O
,    O
and    O
by    O
cells    O
found    O
in    O
the    O
red    O
pulp    O
of    O
the    O
spleen    O
.    O

Most    O
of    O
the    O
identified    O
genes    O
relate    O
to    O
the    O
immune    O
system    O
,    O
particularly    O
the    O
major    O
histocompatibility    O
complex    O
(    O
MHC    O
)    O
and    O
T    B-Cell102991711
cells    I-Cell102991711
.    O

These    O
changes    O
are    O
believed    O
to    O
stem    O
from    O
the    O
premature    O
maturation    O
of    O
keratinocytes    B-Cell102991711
induced    O
by    O
an    O
inflammatory    O
cascade    O
in    O
the    O
dermis    O
involving    O
dendritic    B-Cell102991711
cell    I-Cell102991711
,    O
macrophages    O
,    O
and    O
T    B-Cell102991711
cell    I-Cell102991711
(    O
three    O
subtypes    O
of    O
white    O
blood    O
cells    O
)    O
.    O

CCDC109B    O
is    O
expressed    O
in    O
B-cells    B-Cell102991711
,    O
Dendritic    O
Cells    O
,    O
T-Cells    B-Cell102991711
,    O
and    O
Natural    B-Cell102991711
Killer    I-Cell102991711
Cells    I-Cell102991711
.    O

TH2-type    O
lymphocytes    O
are    O
activated    O
,    O
with    O
an    O
increase    O
in    O
T    B-Cell102991711
cell    I-Cell102991711
expressing    O
CD25    O
(    O
IL-2R    O
)    O
,    O
and    O
B    B-Cell102991711
cell    I-Cell102991711
expressing    O
CD    O
23    O
,    O
causing    O
increased    O
production    O
of    O
IgE.    O
After    O
exercise    O
,    O
the    O
conditions    O
will    O
fade    O
within    O
one    O
to    O
three    O
minutes    O
.    O

When    O
the    O
immune    O
system    O
is    O
fighting    O
pathogens    O
,    O
cytokines    O
signal    O
immune    O
cells    O
such    O
as    O
T-cell    B-Cell102991711
and    O
macrophages    O
to    O
travel    O
to    O
the    O
site    O
of    O
infection    O
.    O

A    O
2003    O
report    O
in    O
the    O
"    O
Journal    O
of    O
Experimental    O
Medicine    O
"    O
published    O
by    O
researchers    O
at    O
Imperial    O
College    O
London    O
demonstrates    O
the    O
possibility    O
of    O
preventing    O
a    O
cytokine    O
storm    O
by    O
inhibiting    O
or    O
disabling    O
T    B-Cell102991711
cell    I-Cell102991711
response    O
.    O

Davis    O
well    O
known    O
for    O
identifying    O
the    O
first    O
T-cell    B-Cell102991711
receptor    O
genes    O
,    O
which    O
are    O
responsible    O
for    O
T    O
lymphocytes    O
ability    O
to    O
“    O
see    O
”    O
foreign    O
entities    O
,    O
solving    O
a    O
major    O
mystery    O
in    O
immunology    O
at    O
that    O
time    O
.    O

He    O
is    O
famous    O
for    O
having    O
discovered    O
the    O
function    O
of    O
the    O
thymus    O
and    O
for    O
the    O
identification    O
,    O
in    O
mammalian    O
species    O
of    O
the    O
two    O
major    O
subsets    O
of    O
lymphocytes    O
(    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
B    B-Cell102991711
cells    I-Cell102991711
)    O
and    O
their    O
function    O
.    O

ZAP-70    O
(    O
Zeta    O
-    O
chain    O
-    O
associated    O
protein    O
kinase    O
70    O
)    O
is    O
a    O
protein    O
normally    O
expressed    O
near    O
the    O
surface    O
membrane    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
.    O

FADD    O
is    O
thought    O
to    O
have    O
a    O
role    O
in    O
regulating    O
the    O
cell    O
cycle    O
of    O
T    B-Cell102991711
lymphocytes    I-Cell102991711
.    O

FADD    O
is    O
essential    O
for    O
T    B-Cell102991711
cell    I-Cell102991711
proliferation    O
when    O
the    O
T    O
cell    O
receptor    O
is    O
stimulated    O
by    O
antigen    O
.    O

IL-15    O
was    O
discovered    O
in    O
1994    O
by    O
two    O
different    O
laboratories    O
,    O
and    O
characterized    O
as    O
T    B-Cell102991711
cell    I-Cell102991711
growth    O
factor    O
.    O

IL-15    O
regulates    O
the    O
activation    O
and    O
proliferation    O
of    O
T    B-Cell102991711
and    O
natural    B-Cell102991711
killer    I-Cell102991711
(    O
NK    O
)    O
cells    O
.    O

After    O
stimulation    O
with    O
IL-18    O
,    O
natural    B-Cell102991711
killer    I-Cell102991711
(    O
NK    O
)    O
cells    O
and    O
certain    O
T    B-Cell102991711
cells    I-Cell102991711
release    O
another    O
important    O
cytokine    O
called    O
interferon-γ    O
(    O
IFN-γ    O
)    O
or    O
type    O
II    O
interferon    O
that    O
plays    O
an    O
important    O
role    O
in    O
activating    O
the    O
macrophages    O
or    O
other    O
cells    O
.    O

IL-16    O
was    O
originally    O
described    O
as    O
a    O
factor    O
that    O
could    O
attract    O
activated    O
T    B-Cell102991711
cells    I-Cell102991711
in    O
humans    O
,    O
it    O
was    O
previously    O
called    O
lymphocyte    O
chemoattractant    O
factor    O
(    O
LCF    O
)    O
.    O

In    O
2006    O
Genocea    O
Biosciences    O
was    O
founded    O
based    O
on    O
work    O
of    O
Harvard    O
scientist    O
Darren    O
E.    O
Higgins    O
around    O
antigens    O
that    O
stimulate    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
the    O
use    O
of    O
these    O
antigens    O
to    O
create    O
vaccines    O
;    O
Sinclair    O
was    O
a    O
co    O
-    O
founder    O
.    O

IL-21    O
is    O
expressed    O
in    O
activated    O
human    O
CD4    O
+    O
T    B-Cell102991711
cell    I-Cell102991711
but    O
not    O
in    O
most    O
other    O
tissues    O
.    O

Interleukin-21    O
is    O
also    O
produced    O
by    O
Hodgkin    O
's    O
lymphoma    O
(    O
HL    O
)    O
cancer    O
cells    O
(    O
which    O
is    O
surprising    O
because    O
IL-21    O
was    O
thought    O
to    O
be    O
produced    O
only    O
in    O
T    B-Cell102991711
cell    I-Cell102991711
)    O
.    O

In    O
addition    O
,    O
there    O
was    O
an    O
increase    O
of    O
perforin    O
,    O
granzyme    O
B    O
,    O
IFN-γ    O
,    O
and    O
CXCR3    O
mRNA    O
in    O
peripheral    O
NK    B-Cell102991711
cell    I-Cell102991711
and    O
CD8    O
+    O
T    B-Cell102991711
cell    I-Cell102991711
.    O

Besides    O
,    O
these    O
mice    O
with    O
impaired    O
IL-21    O
signaling    O
had    O
more    O
dramatic    O
exhaustion    O
of    O
LCMV    O
-    O
specific    O
CD8+    B-Cell102991711
T    B-Cell102991711
cell    I-Cell102991711
,    O
suggesting    O
that    O
IL-21    O
produced    O
by    O
CD4+    B-Cell102991711
T    O
cells    O
is    O
required    O
for    O
sustained    O
CD8    O
+    O
T    O
cell    O
effector    O
activity    O
and    O
then    O
,    O
for    O
maintaining    O
immunity    O
to    O
resolve    O
persistent    O
viral    O
infection    O
.    O

Expression    O
of    O
this    O
protein    O
is    O
increased    O
after    O
the    O
activation    O
of    O
T-cell    B-Cell102991711
by    O
mitogens    O
or    O
the    O
activation    O
of    O
NK    B-Cell102991711
cell    I-Cell102991711
by    O
IL-2    O
.    O

5    O
)    O
It    O
enhances    O
the    O
differentiation    O
of    O
uncommitted    O
T    B-Cell102991711
cell    I-Cell102991711
lymphocytes    O
to    O
the    O
Th1    B-Cell102991711
cell    I-Cell102991711
phenotype    O
and    O
may    O
thereby    O
favor    O
the    O
development    O
of    O
inflammatory    O
rather    O
than    O
allergic    O
responses    O
to    O
immune    O
stimulation    O
in    O
rodents    O
.    O

The    O
axis    O
inhibits    O
bone    O
marrow    O
-    O
derived    O
dendritic    B-Cell102991711
cell    I-Cell102991711
(    O
i.e.    O
antigen-presenting    B-Cell102991711
cells    I-Cell102991711
that    O
process    O
antigen    O
material    O
,    O
present    O
it    O
on    O
their    O
surfaces    O
for    O
delivery    O
to    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
otherwise    O
regulate    O
innate    O
and    O
adaptive    O
immune    O
system    O
responses    O
)    O
from    O
producing    O
pro    O
-    O
inflammatory    O
cytokines    O
(    O
e.g.    O
IL-12    O
,    O
TNF    O
-    O
alpha    O
,    O
IL-1-alpha    O
,    O
and    O
IL-6    O
)    O
while    O
stimulating    O
them    O
to    O
increase    O
production    O
of    O
the    O
anti    O
-    O
inflammatory    O
cytokine    O
,    O
IL-10    O
.    O

T-cell    B-Cell102991711
receptor    I-Cell102991711
excision    I-Cell102991711
circles    I-Cell102991711
(    O
TRECs    O
)    O
are    O
small    O
circles    O
of    O
DNA    O
created    O
in    O
T-cell    B-Cell102991711
during    O
their    O
passage    O
through    O
the    O
thymus    O
as    O
they    O
rearrange    O
their    O
TCR    O
genes    O
.    O

:    O
This    O
stage    O
is    O
characterized    O
by    O
having    O
a    O
T-cell    B-Cell102991711
count    O
under    O
200    O
,    O
signaling    O
the    O
presence    O
of    O
an    O
AIDS    O
defining    O
condition    O
and/or    O
an    O
opportunistic    O
infection    O
.    O

It    O
is    O
secreted    O
by    O
basophils    O
and    O
activated    O
T    B-Cell102991711
cells    I-Cell102991711
to    O
support    O
growth    O
and    O
differentiation    O
of    O
T    O
cells    O
from    O
the    O
bone    O
marrow    O
in    O
an    O
immune    O
response    O
.    O

Activated    O
T    B-Cell102991711
cells    I-Cell102991711
can    O
either    O
induce    O
their    O
own    O
proliferation    O
and    O
differentiation    O
(    O
autocrine    O
signalling    O
)    O
,    O
or    O
that    O
of    O
other    O
T    B-Cell102991711
cells    I-Cell102991711
(    O
paracrine    B-Cell102991711
signalling    O
)    O
–    O
both    O
involve    O
IL-2    O
binding    O
to    O
the    O
IL-2    O
receptor    O
on    O
T    B-Cell102991711
cells    I-Cell102991711
(    O
upregulated    O
upon    O
cell    O
activation    O
,    O
under    O
the    O
induction    O
of    O
macrophage    O
-    O
secreted    O
IL-1    O
)    O
.    O

Further    O
subtypes    O
can    O
be    O
classified    O
;    O
for    O
example    O
,    O
among    O
lymphocytes    O
,    O
there    O
are    O
B    B-Cell102991711
cell    I-Cell102991711
,    O
T    B-Cell102991711
cell    I-Cell102991711
,    O
and    O
NK    B-Cell102991711
cells    I-Cell102991711
.    O

T    B-Cell102991711
cell    I-Cell102991711
:    O

T    B-Cell102991711
cell    I-Cell102991711
:    O

The    O
age    O
-    O
associated    O
impairment    O
of    O
dendritic    O
Antigen    B-Cell102991711
Presenting    I-Cell102991711
Cells    I-Cell102991711
(    O
APCs    O
)    O
has    O
profound    O
implications    O
as    O
this    O
translates    O
into    O
a    O
deficiency    O
in    O
cell    O
-    O
mediated    O
immunity    O
and    O
thus    O
,    O
the    O
inability    O
for    O
effector    O
T-lymphocytes    B-Cell102991711
to    O
modulate    O
an    O
adaptive    O
immune    O
response    O
(    O
see    O
below    O
)    O
.    O

The    O
functional    O
capacity    O
of    O
T-cells    B-Cell102991711
is    O
most    O
influenced    O
by    O
the    O
effects    O
of    O
aging    O
.    O

Incubation    O
of    O
T-cells    B-Cell102991711
,    O
monocytes    O
,    O
and    O
peripheral    O
blood    O
lymphocytes    O
with    O
either    O
purified    O
alpha    O
-    O
toxin    O
or    O
S.    O
aureus    O
cell    O
lysate    O
resulted    O
in    O
the    O
induction    O
of    O
apoptosis    O
via    O
the    O
intrinsic    O
death    O
pathway    O
.    O

It    O
interacts    O
with    O
interferon    O
regulatory    O
factor-4    O
and    O
plays    O
an    O
important    O
role    O
in    O
immunoregulatory    O
gene    O
expression    O
in    O
B    B-Cell102991711
and    O
T    B-Cell102991711
lymphocyte    I-Cell102991711
.    O

GECIs    O
have    O
been    O
used    O
in    O
the    O
studies    O
of    O
neuron    O
,    O
T-cell    B-Cell102991711
,    O
cardiomyocyte    O
,    O
etc    O
.    O

When    O
they    O
encounter    O
foreign    O
pathogens    O
,    O
the    O
antigen    O
presenting    O
cells    O
alert    O
the    O
T    B-Cell102991711
cells    I-Cell102991711
soldiers    O
of    O
the    O
immune    O
system”—that    O
there    O
is    O
something    O
foreign    O
in    O
the    O
body    O
with    O
specific    O
cell    O
surface    O
molecules    O
.    O

De    O
Groot    O
,    O
Martin    O
and    O
Dr.    O
Leonard    O
Moise    O
discovered    O
regulatory    O
T    B-Cell102991711
cell    I-Cell102991711
epitopes    O
,    O
called    O
“    O

It    O
inhibits    O
activation    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
B    B-Cell102991711
cells    I-Cell102991711
by    O
reducing    O
the    O
production    O
of    O
interleukin-2    O
(    O
IL-2    O
)    O
.    O

Sirolimus    O
inhibits    O
IL-2    O
and    O
other    O
cytokines    O
receptor    O
-    O
dependent    O
signal    O
transduction    O
mechanisms    O
,    O
via    O
action    O
on    O
mTOR    O
,    O
and    O
thereby    O
blocks    O
activation    O
of    O
T    B-Cell102991711
and    O
B    B-Cell102991711
cell    I-Cell102991711
.    O

Lymphocytes    O
of    O
specific    O
immunity    O
T    B-Cell102991711
cell    I-Cell102991711
—    O
including    O
the    O
subclasses    O
helper    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
and    O
killer    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
—    O
and    O
B    B-Cell102991711
cell    I-Cell102991711
.    O

The    O
laboratory    O
pathologist    O
generally    O
seeks    O
three    O
main    O
histological    O
signs    O
:    O
(    O
1    O
)    O
infiltrating    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
perhaps    O
accompanied    O
by    O
infiltrating    O
eosinophils    O
,    O
plasma    O
cells    O
,    O
and    O
neutrophils    O
,    O
particularly    O
in    O
telltale    O
ratios    O
,    O
(    O
2    O
)    O
structural    O
compromise    O
of    O
tissue    O
anatomy    O
,    O
varying    O
by    O
tissue    O
type    O
transplanted    O
,    O
and    O
(    O
3    O
)    O
injury    O
to    O
blood    O
vessels    O
.    O

Two    O
notable    O
protein    O
phosphatases    O
are    O
PP2A    O
and    O
PP2B.    O
PP2A    O
is    O
involved    O
in    O
multiple    O
regulatory    O
processes    O
,    O
such    O
as    O
DNA    O
replication    O
,    O
metabolism    O
,    O
transcription    O
,    O
and    O
development    O
.    O
PP2B    O
,    O
also    O
called    O
calcineurin    O
,    O
is    O
involved    O
in    O
the    O
proliferation    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
;    O
because    O
of    O
this    O
,    O
it    O
is    O
the    O
target    O
of    O
some    O
drugs    O
that    O
seek    O
to    O
suppress    O
the    O
immune    O
system    O
.    O

However    O
,    O
in    O
immunosuppressed    O
transplant    O
patients    O
,    O
the    O
lack    O
of    O
T-cell    B-Cell102991711
immunosurveillance    O
can    O
lead    O
to    O
the    O
proliferation    O
of    O
these    O
EBV    O
-    O
infected    O
of    O
B    O
-    O
lymphocytes    O
.    O

However    O
,    O
calcineurin    O
inhibitors    O
(    O
tacrolimus    O
and    O
ciclosporin    O
)    O
,    O
used    O
as    O
immunosuppressants    O
in    O
organ    O
transplantation    O
inhibit    O
T    B-Cell102991711
cell    I-Cell102991711
function    O
,    O
and    O
can    O
prevent    O
the    O
control    O
of    O
the    O
B    O
cell    O
proliferation    O
.    O

It    O
inhibits    O
an    O
enzyme    O
needed    O
for    O
the    O
growth    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
and    O
B    B-Cell102991711
cells    I-Cell102991711
.    O

Basiliximab    O
(    O
trade    O
name    O
Simulect    O
)    O
is    O
a    O
chimeric    O
mouse    O
-    O
human    O
monoclonal    O
antibody    O
to    O
the    O
α    O
chain    O
(    O
CD25    O
)    O
of    O
the    O
IL-2    O
receptor    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
.    O

Daclizumab    O
works    O
by    O
binding    O
to    O
CD25    O
,    O
the    O
alpha    O
subunit    O
of    O
the    O
IL-2    O
receptor    O
of    O
T-cells    B-Cell102991711
.    O

Daclizumab    O
was    O
created    O
by    O
scientists    O
at    O
PDL    O
BioPharma    O
(    O
called    O
"    O
Protein    O
Design    O
Labs    O
"    O
at    O
that    O
time    O
)    O
by    O
humanizing    O
the    O
mouse    O
mAb    O
called    O
anti    O
-    O
Tac    O
,    O
which    O
targets    O
CD25    O
,    O
the    O
IL-2    O
receptor    O
α    O
chain    O
;    O
it    O
blocks    O
the    O
interaction    O
of    O
IL-2    O
with    O
the    O
IL-2    O
receptor    O
and    O
prevents    O
activation    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
.    O

Anti    O
-    O
thymocyte    O
globulin    O
(    O
ATG    O
)    O
is    O
an    O
infusion    O
of    O
horse    O
or    O
rabbit    O
-    O
derived    O
antibodies    O
against    O
human    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
which    O
is    O
used    O
in    O
the    O
prevention    O
and    O
treatment    O
of    O
acute    O
rejection    O
in    O
organ    O
transplantation    O
and    O
therapy    O
of    O
aplastic    O
anemia    O
.    O

Anti    O
-    O
lymphocyte    O
globulin    O
(    O
ALG    O
)    O
is    O
an    O
infusion    O
of    O
animal-    O
antibodies    O
against    O
human    O
T    B-Cell102991711
cell    I-Cell102991711
which    O
is    O
used    O
in    O
the    O
treatment    O
of    O
acute    O
rejection    O
in    O
organ    O
transplantation    O
.    O

Glucocorticoids    O
cause    O
immunosuppression    O
,    O
and    O
the    O
therapeutic    O
component    O
of    O
this    O
effect    O
is    O
mainly    O
the    O
decreases    O
in    O
the    O
function    O
and    O
numbers    O
of    O
lymphocytes    O
,    O
including    O
both    O
B    B-Cell102991711
cell    I-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
.    O

Smaller    O
cytokine    O
production    O
reduces    O
the    O
T    B-Cell102991711
cell    I-Cell102991711
proliferation    O
.    O

Glucocorticoids    O
cause    O
immunosuppression    O
,    O
decreasing    O
the    O
function    O
and/or    O
numbers    O
of    O
neutrophils    O
,    O
lymphocytes    O
(    O
including    O
both    O
B    B-Cell102991711
cell    I-Cell102991711
and    O
T    B-Cell102991711
cell    I-Cell102991711
)    O
,    O
monocytes    O
,    O
macrophages    O
,    O
and    O
the    O
anatomical    O
barrier    O
function    O
of    O
the    O
skin    O
.    O

The    O
role    O
of    O
leptin    O
/    O
leptin    O
receptors    O
in    O
modulation    O
of    O
T    B-Cell102991711
cell    I-Cell102991711
activity    O
in    O
the    O
immune    O
system    O
was    O
shown    O
in    O
experimentation    O
with    O
mice    O
.    O

Gamma    B-Cell102991711
delta    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
(    O
γδ    O
T    O
cells    O
)    O
are    O
T    B-Cell102991711
cell    I-Cell102991711
that    O
have    O
a    O
distinctive    O
T    O
-    O
cell    O
receptor    O
(    O
TCR    O
)    O
on    O
their    O
surface    O
.    O

Peripheral    O
T    O
-    O
cell    O
lymphoma    O
(    O
PTCL    O
)    O
is    O
defined    O
as    O
a    O
diverse    O
group    O
of    O
aggressive    O
lymphomas    O
that    O
develop    O
from    O
mature    O
-    O
stage    O
white    O
blood    O
cells    O
called    O
T-cells    B-Cell102991711
and    O
natural    O
killer    O
cells    O
(    O
NK    B-Cell102991711
cells    I-Cell102991711
)    O
(    O
see    O
figure    O
for    O
an    O
overview    O
of    O
PTCL    O
subtypes    O
)    O
.    O

An    O
experiment    O
in    O
manipulating    O
brood    O
size    O
and    O
immune    O
system    O
with    O
barn    O
swallow    O
nestlings    O
showed    O
the    O
vividness    O
of    O
the    O
gape    O
was    O
positively    O
correlated    O
with    O
T-cell    B-Cell102991711
–    O
mediated    O
immunocompetence    O
,    O
and    O
that    O
larger    O
brood    O
size    O
and    O
injection    O
with    O
an    O
antigen    O
led    O
to    O
a    O
less    O
vivid    O
gape    O
.    O

CD23a    O
is    O
present    O
on    O
follicular    O
B    O
cells    O
,    O
whereas    O
CD23b    O
requires    O
IL-4    O
to    O
be    O
expressed    O
on    O
T-cells    B-Cell102991711
,    O
monocytes    O
,    O
Langerhans    O
cells    O
,    O
eosinophils    O
,    O
and    O
macrophages    O
.    O

Osteopontin    O
(    O
OPN    O
)    O
is    O
expressed    O
in    O
a    O
range    O
of    O
immune    O
cells    O
,    O
including    O
macrophages    O
,    O
neutrophils    O
,    O
dendritic    O
cells    O
,    O
and    O
T    B-Cell102991711
and    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
with    O
varying    O
kinetics    O
.    O

CD1    O
(    O
cluster    O
of    O
differentiation    O
1    O
)    O
is    O
a    O
family    O
of    O
glycoproteins    O
expressed    O
on    O
the    O
surface    O
of    O
various    O
human    O
antigen-presenting    B-Cell102991711
cells    I-Cell102991711
.    O
They    O
are    O
related    O
to    O
the    O
class    O
I    O
MHC    O
molecules    O
,    O
and    O
are    O
involved    O
in    O
the    O
presentation    O
of    O
lipid    O
antigens    O
to    O
T    B-Cell102991711
cells    I-Cell102991711
.    O

PASLI    O
stands    O
for    O
“    O
p110    O
delta    O
activating    O
mutation    O
causing    O
senescent    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
lymphadenopathy    O
,    O
and    O
immunodeficiency    O
.    O

These    O
patients    O
suffer    O
from    O
recurrent    O
sinopulmonary    O
infections    O
and    O
lymphoproliferation    O
,    O
exhibit    O
hyperactive    O
PI3    O
K    O
signaling    O
,    O
and    O
have    O
prominent    O
expansion    O
and    O
skewing    O
of    O
peripheral    O
blood    O
CD8    O
+    O
T    B-Cell102991711
cells    I-Cell102991711
toward    O
terminally    O
differentiated    O
,    O
senescent    O
effector    O
cells    O
with    O
short    O
telomeres    O
.    O

The    O
process    O
is    O
similar    O
to    O
T    B-Cell102991711
and    O
B    B-Cell102991711
cell    I-Cell102991711
signaling    O
through    O
their    O
specific    O
receptors    O
TCR    O
or    O
BCR    O
.    O

Double-negative    B-Cell102991711
T    I-Cell102991711
cell    I-Cell102991711
,    O
a    O
thymocyte    O
in    O
an    O
early    O
stage    O
of    O
development    O

Efforts    O
have    O
also    O
been    O
undertaken    O
to    O
develop    O
universal    O
vaccines    O
that    O
specifically    O
activate    O
a    O
T-cell    B-Cell102991711
response    O
,    O
based    O
on    O
clinical    O
data    O
showing    O
that    O
people    O
with    O
a    O
strong    O
,    O
early    O
T    O
-    O
cell    O
response    O
have    O
better    O
outcomes    O
when    O
infected    O
with    O
influenza    O
and    O
because    O
T    O
-    O
cells    O
respond    O
to    O
conserved    O
epitopes    O
.    O

ESAT-6    O
,    O
the    O
6    O
kDa    O
early    O
secretory    O
antigenic    O
target    O
produced    O
by    O
"    O
Mycobacterium    O
tuberculosis    O
"    O
,    O
is    O
a    O
secretory    O
protein    O
and    O
potent    O
T    B-Cell102991711
cell    I-Cell102991711
antigen    O
.    O

In    O
the    O
cancer    O
disease    O
state    O
the    O
interaction    O
of    O
PD    O
-    O
L1    O
on    O
the    O
tumour    O
cell    O
surface    O
with    O
PD-1    O
on    O
a    O
T-cell    B-Cell102991711
reduces    O
T    O
-    O
cell    O
function    O
signals    O
to    O
prevent    O
the    O
immune    O
system    O
from    O
attacking    O
the    O
tumour    O
cells    O
.    O

There    O
is    O
evidence    O
that    O
VISTA    O
can    O
act    O
as    O
both    O
a    O
ligand    O
and    O
a    O
receptor    O
on    O
T    B-Cell102991711
cell    I-Cell102991711
to    O
inhibit    O
T    O
cell    O
effector    O
function    O
and    O
maintain    O
peripheral    O
tolerance    O
.    O

This    O
is    O
the    O
one    O
part    O
of    O
the    O
HIV    O
virus    O
outer    O
coating    O
that    O
does    O
not    O
change    O
,    O
because    O
it    O
is    O
the    O
attachment    O
point    O
to    O
T    B-Cell102991711
lymphocytes    I-Cell102991711
,    O
the    O
key    O
cell    O
in    O
cell    O
-    O
mediated    O
immunity    O
.    O

The    O
immune    O
system    O
usually    O
does    O
not    O
react    O
to    O
self    O
-    O
antigens    O
under    O
normal    O
homeostatic    O
conditions    O
due    O
to    O
negative    O
selection    O
of    O
T    B-Cell102991711
cell    I-Cell102991711
in    O
the    O
thymus    O
and    O
is    O
supposed    O
to    O
identify    O
and    O
attack    O
"    O
non    O
-    O
self    O
"    O
invaders    O
from    O
the    O
outside    O
world    O
or    O
modified    O
/    O
harmful    O
substances    O
present    O
in    O
the    O
body    O
under    O
distressed    O
conditions    O
.    O

The    O
T    O
cell    O
/    O
T    B-Cell102991711
lymphocyte    I-Cell102991711
(    O
a    O
subtype    O
of    O
white    O
blood    O
cell    O
)    O
,    O
of    O
the    O
adaptive    O
immune    O
system    O
,    O
selectively    O
recognize    O
the    O
antigens    O
.    O

T    B-Cell102991711
cell    I-Cell102991711
can    O
not    O
bind    O
native    O
antigens    O
,    O
but    O
require    O
that    O
they    O
be    O
processed    O
by    O
APCs    O
,    O
whereas    O
B    B-Cell102991711
cell    I-Cell102991711
can    O
be    O
activated    O
by    O
native    O
ones    O
.    O

In    O
most    O
cases    O
,    O
interaction    O
of    O
the    O
B    O
cell    O
with    O
a    O
T    B-Cell102991711
helper    I-Cell102991711
cell    I-Cell102991711
is    O
necessary    O
to    O
produce    O
full    O
activation    O
of    O
the    O
B    O
cell    O
and    O
,    O
therefore    O
,    O
antibody    O
generation    O
following    O
antigen    O
binding    O
.    O

Signalling    O
from    O
these    O
receptors    O
normally    O
promotes    O
growth    O
and    O
differentiation    O
of    O
T-cells    B-Cell102991711
,    O
B    B-Cell102991711
cells    I-Cell102991711
,    O
natural    B-Cell102991711
killer    I-Cell102991711
cells    I-Cell102991711
,    O
glial    O
cells    O
,    O
and    O
cells    O
of    O
the    O
monocyte    O
lineage    O
,    O
depending    O
on    O
the    O
cell    O
type    O
and    O
receptor    O
activated    O
.    O

Thymic    O
organoids    O
seem    O
to    O
successfully    O
recapitulate    O
the    O
thymus    O
’s    O
function    O
,    O
as    O
co    O
-    O
culturing    O
human    O
hematopoietic    O
or    O
bone    O
marrow    O
stem    O
cells    O
with    O
mouse    O
thymic    O
organoids    O
resulted    O
in    O
the    O
production    O
of    O
T-cell    B-Cell102991711
.    O

14%    O
of    O
cytosines    O
are    O
methylated    O
in    O
"    O
Arabidopsis    O
thaliana    O
"    O
,    O
8%    O
in    O
Physarum    O
,    O
4%    O
in    O
"    O
Mus    O
musculus    O
"    O
,    O
2.3%    O
in    O
"    O
Escherichia    O
coli    O
"    O
,    O
0.03%    O
in    O
"    O
Drosophila    O
"    O
,    O
0.006%    O
in    O
Dictyostelium    O
and    O
virtually    O
none    O
(    O
+    O
T    B-Cell102991711
cell    I-Cell102991711
in    O
a    O
newborn    O
,    O
a    O
26    O
years    O
old    O
individual    O
and    O
a    O
103    O
years    O
old    O
individual    O
was    O
observed    O
that    O
the    O
loss    O
of    O
methylation    O
is    O
proportional    O
to    O
age    O
.    O

The    O
role    O
of    O
the    O
thymus    O
prior    O
to    O
adolescence    O
is    O
for    O
the    O
processing    O
and    O
maturation    O
of    O
thymocytes    O
,    O
which    O
become    O
T-lymphocytes    B-Cell102991711
and    O
are    O
released    O
into    O
the    O
circulation    O
.    O

MMP-2    O
and    O
MMP-9    O
are    O
both    O
produced    O
by    O
myeloid    O
cells    O
,    O
which    O
surround    O
T    B-Cell102991711
cells    I-Cell102991711
in    O
the    O
perivascular    O
space    O
.    O

Because    O
T    B-Cell102991711
cell    I-Cell102991711
recognise    O
only    O
fragmented    O
antigens    O
displayed    O
on    O
cell    O
surfaces    O
,    O
antigen    O
processing    O
must    O
occur    O
before    O
the    O
antigen    O
fragment    O
,    O
now    O
bound    O
to    O
the    O
major    O
histocompatibility    O
complex    O
(    O
MHC    O
)    O
,    O
is    O
transported    O
to    O
the    O
surface    O
of    O
the    O
cell    O
,    O
a    O
process    O
known    O
as    O
presentation    O
,    O
where    O
it    O
can    O
be    O
recognized    O
by    O
a    O
T    O
cell    O
receptor    O
.    O

CXCR3    O
is    O
expressed    O
primarily    O
on    O
activated    O
T    B-Cell102991711
lymphocytes    I-Cell102991711
and    O
NK    B-Cell102991711
cells    I-Cell102991711
,    O
and    O
some    O
epithelial    O
cells    O
.    O

BENTA    O
stands    O
for    O
"    O
B    B-Cell102991711
cell    I-Cell102991711
expansion    O
with    O
NF-κB    O
and    O
T    B-Cell102991711
cell    I-Cell102991711
anergy    O
"    O
and    O
is    O
caused    O
by    O
germline    O
heterozygous    O
gain    O
-    O
of    O
-    O
function    O
mutations    O
in    O
the    O
gene    O
CARD11    O
(    O
see    O
OMIM    O
entry    O
#    O
607210    O
)    O
.    O

The    O
main    O
exception    O
is    O
in    O
T    B-Cell102991711
cell    I-Cell102991711
.    O

The    O
second    O
,    O
in    O
2006    O
,    O
demonstrated    O
that    O
the    O
receptor    O
of    O
T    B-Cell102991711
cells    I-Cell102991711
can    O
be    O
transferred    O
to    O
immune    O
cells    O
and    O
in    O
combination    O
with    O
chemotherapy    O
and    O
high    O
doses    O
of    O
IL-2    O
can    O
be    O
used    O
to    O
treat    O
patients    O
with    O
melanoma    O
.    O

It    O
is    O
suggested    O
to    O
be    O
caused    O
by    O
T-lymphocytes    B-Cell102991711
.    O

CD137    O
can    O
be    O
expressed    O
by    O
activated    O
T    B-Cell102991711
cells    I-Cell102991711
,    O
but    O
to    O
a    O
larger    O
extent    O
on    O
CD8    O
than    O
on    O
CD4    O
T    B-Cell102991711
cells    I-Cell102991711
.    O

Scientists    O
develop    O
genetically    O
engineered    O
T-lymphocytes    B-Cell102991711
that    O
have    O
been    O
proven    O
successful    O
in    O
treating    O
cases    O
of    O
acute    O
lymphoblastic    O
leukaemia    O
.    O

T    B-Cell102991711
cells    I-Cell102991711
,    O
part    O
of    O
the    O
components    O
of    O
the    O
immune    O
system    O
along    O
with    O
B    B-Cell102991711
cells    I-Cell102991711

Mucosal    B-Cell102991711
associated    I-Cell102991711
invariant    I-Cell102991711
T    I-Cell102991711
cells    I-Cell102991711
,    O
a    O
hitherto    O
little    O
-    O
known    O
T    B-Cell102991711
cell    I-Cell102991711
type    O
.    O

The    O
thyroid    O
pouch    O
or    O
thyroid    O
diverticulum    O
is    O
the    O
embryological    O
structure    O
of    O
the    O
second    O
pharyngeal    O
arch    O
from    O
which    O
thyroid    B-Cell102991711
follicular    I-Cell102991711
cell    I-Cell102991711
derive    O
.    O

The    O
TSH    O
receptor    O
is    O
found    O
mainly    O
on    O
thyroid    O
follicular    B-Cell102991711
cells    I-Cell102991711
.    O

This    O
occurs    O
through    O
stimulation    O
of    O
six    O
steps    O
in    O
thyroid    O
hormone    O
synthesis    O
:    O
(    O
1    O
)    O
Up    O
-    O
regulating    O
the    O
activity    O
of    O
the    O
sodium    O
-    O
iodide    O
symporter    O
(    O
NIS    O
)    O
on    O
the    O
basolateral    O
membrane    O
of    O
follicular    B-Cell102991711
cells    I-Cell102991711
,    O
thereby    O
increasing    O
intracellular    O
concentrations    O
of    O
iodine    O
(    O
iodine    O
trapping    O
)    O
.    O
(    O
2    O
)    O
Stimulating    O
iodination    O
of    O
thyroglobulin    O
in    O
the    O
follicular    O
lumen    O
,    O
a    O
precursor    O
protein    O
of    O
thyroid    O
hormone    O
.    O

Many    O
of    O
the    O
features    O
found    O
in    O
ovaries    O
are    O
common    O
to    O
all    O
vertebrates    O
,    O
including    O
the    O
presence    O
of    O
follicular    B-Cell102991711
cell    I-Cell102991711
and    O
tunica    O
albuginea    O
There    O
may    O
be    O
hundreds    O
or    O
even    O
millions    O
of    O
fertile    O
eggs    O
present    O
in    O
the    O
ovary    O
of    O
a    O
fish    O
at    O
any    O
given    O
time    O
.    O

Foxp3    O
is    O
a    O
specific    O
marker    O
of    O
natural    O
T    O
regulatory    O
cells    O
(    O
nTregs    B-Cell102991711
,    O
a    O
lineage    O
of    O
T    B-Cell102991711
cell    I-Cell102991711
)    O
and    O
adaptive    O
/    O
induced    O
T    O
regulatory    O
cells    O
(    O
a    O
/    O
iTregs    O
)    O
,    O
also    O
identified    O
by    O
other    O
less    O
specific    O
markers    O
such    O
as    O
CD25    O
or    O
CD45RB    O
.    O


